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ABSTRACT 
 
Pluripotent cells are defined by their ability to both self-renew and to differentiation into 
any cell type within the human body.  As such, pluripotent cell lines are of great interest as 
starting material for drug screening and cell therapies for regenerative treatment of 
diseased tissues.  Pluripotent cell lines were originally derived from germ cell tumors 
(embryonal carcinoma cells; EC), but have since been isolated and expanded from the inner 
cell mass of an early embryo (human embryonic stem cells; hESCs).   
This project set out to investigate the relative ability of the pluripotent NTERA2 (EC) cell 
line and hESC lines: Shef3, HUES7 and RH5, to differentiate into neurons, using mechanical 
and enzymatic culture methods.  Focus was placed on monitoring differentiation efficiency 
and function between the different lines.   
The tumour origin, in addition to the poor reproducibility, low yield and reduced 
functionality of NTERA2 derived neurons, compared to primary neurons, makes their 
incorporation into regenerative therapies unlikely.  As such, an enhanced neuronal 
differentiation protocol was developed for use in hESCs.  Cell populations were monitored 
for relative changes in gene and protein expression at selected time points throughout 
differentiation using standard RT-PCR, Q-PCR and immuno fluorescence analysis.  End stage 
neurons were screened for functionality using patch clamping and calcium imaging 
techniques.  Monitoring of cellular behavior through differentiation was aided by the 
concurrent development of a portable microscope incubator stage in collaboration with 
Linkam scientific Ltd.   
These data demonstrate a variation in the ability to generate neurons from pluripotent cell 
lines, and suggests a predetermined, preferential cell fate within each line, even at the level 
of pluripotency.  This study also characterises in detail neuronal differentiation from 
pluripotent cells, adding to the understanding which is essential for translation into 
therapies for neurodegenerative diseases such as Parkinson’s, Alzheimer’s, and 
Huntingdon’s disease. 
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ABBREVIATIONS 
 
aCGH    array comparative genomic hybridisation 
AFP    alpha feto protein 
ALS    amyotrophic lateral sclerosis 
ANOVA    analysis of variance 
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ECM    extra cellular matrix 
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GFAP    glial fibrillary acidic protein 
GFP    green fluorescent protein 
GLP    good laboratory practice 
GMP    good manufacturing practice 
GOI    gene of interest 
HBS    HEPES buffered saline 
HCl    hydrochloric acid 
hEC    human embryonal carcinoma 
hES    human embryonic stem 
hESC    human embryonic stem cell 
HFEA    human fertilisation and embryology authority 
HLXB9    homeobox gene HB9 
HTA    human tissue authority 
ICM    inner cell mass 
Ig    immunoglobulin  
iMEF    inactivated mouse embryonic fibroblast 
ISL1    islet1 
KCl    potassium chloride 
KCL    Kings College London 
LCI    live cell imaging 
LDA    low density array 
LN2    liquid nitrogen 
MAP2    microtubule associated protein 
MCB    master cell bank 
MSC    Microbiological safety cabinet 
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MEF    mouse embryonic fibroblasts 
MgCl2    magnesium chloride 
MNX1    motor neuron and pancreas homeobox 1,  
MS    multiple sclerosis 
NaCl    sodium chloride 
Nanog    Nanog homeobox 
NaOH    sodium hydroxide 
NB    neurobasal 
NI    neural induction 
NIBSC    National Institute for Biological Standards and Control 
OCT4    octamer binding protein 4 
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OLIG2    oligodendrocyte lineage transcription factor 2 
PAX6    paired box 6 
PBS    phosphate buffered saline 
PCR    polymerase chain reaction 
PD    Parkinson’s disease 
PNS    peripheral nervous system 
PTEN     phosphatase and tensin homolog 
PTF1A     pancreas specific transcription factor, 1a  
QC    quality control 
Q-PCR    quantitative PCR 
RA    retinoic acid 
REST    RE1-silencing transcription factor 
RT    room temperature 
RT-PCR    reverse transcription PCR 
SCI    spinal cord injury 
SEM    scanning electron microscope 
SOP    standard operative procedure 
SOX2    SRY (sex determining region Y)-box 2 
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SSEA    stage specific embryonic antigen 
SYP    synaptophysin 
T    brachyury 
TGF-β    transforming growth factor beta 
TDGF1    teratocarcinoma derived growth factor 1 
TERT    telomerase reverse transcriptase 
TH    tyrosine hydroxylase 
Tra    trafalgar antigen 
TUBB3    β-III-tubulin 
UCL    University College London 
UKSCB    UK Stem Cell Bank 
UTF1    undifferentiated embryonic cell transcription factor 1 
UV    ultra violet 
VE    visceral endoderm 
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1 Introduction 
An estimated 35.5 million people worldwide are living with the debilitating effects of 
neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease, Multiple 
Sclerosis and Amyotrophic Lateral Sclerosis (Parkinson's Disease Society, 2009; Alzheimers 
Research Trust, 2009; ALS Society of BC, 2009; Multiple Sclerosis Society, 2009).  With 
modern advances in nutrition and health care, these figures are predicted to rise in future 
years amongst patients who may previously have died from unrelated conditions before 
reaching the age of onset.  Current therapies for such diseases rely on pharmacological 
intervention to relieve symptoms and prolong normality of life; however, over time the 
efficacy of treatment is reduced and disease symptoms inevitably return (Lindvall and 
Kokaia, 2009).  Cell therapies may provide the answer for long term alleviation of 
symptoms or curing disease, through transplantation of healthy cells which regenerate or 
replace the damaged tissue.  For neurodegenerative diseases, cell therapies carry hope for 
recovery of motor control and cognition, and a subsequently improved quality of life 
(Lindvall and Kokaia, 2009; Martinez et al., 2009).   
The concept of cell therapies for the treatment of debilitating and degenerative diseases 
has been around for many decades.  Benefits were realised as early as 1894, when the first 
islet cell transplantation was carried out from a sheep pancreas into a 15-year old boy 
suffering diabetic ketoacidosis (Williams, 1894).  Unsurprisingly, these early attempts at cell 
therapy were unsuccessful due to immune rejection; however, they paved the way for 
further research.  Today, bone marrow transplantations containing adult stem cells are a 
realisation of the benefits associated with cell therapies and have been routinely and 
successfully preformed since 1957 (Thomas et al., 1957).  However, donor stem cells for 
therapies such as bone marrow transplantation are in short supply and require 
immunosuppression to prevent rejection, which increases a patient’s susceptibility to 
secondary infections.  Alternative therapies from readily available cell stocks which do not 
require immunosuppression would therefore be desirable.   
In recent decades, stem cells have been focused upon as potential sources of cells for 
therapy.  A stem cell is defined by its ability to self renew and differentiate into any 
definitive cell type of the body (Thomson et al., 1995).  The ability of a stem cell to 
continually self-renew is key to the success of cell therapies, providing ever increasing 
numbers of cells for transplantation.   
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Different classifications of stem cells exist throughout embryonic development into 
adulthood.  An early cleavage stage embryo contains just a small number of cells, each of 
which is capable of developing into any of the cell types within the embryo, or the extra 
embryonic tissues of the placenta.  These cells are termed ‘totipotent’ and may be 
considered the ‘master’ of all stem cells.  As embryonic development progresses, the 
potency of individual cells; that is the number of possible cell types which can be 
generated, is subsequently reduced.  When the embryo reaches the blastocyst stage 
approximately 4-5 days after fertilisation, two distinct groups of cells are identifiable: the 
outer trophectodermal cells which form the placental tissue and extra-embryonic ectoderm 
(Gardner et al., 1973; Rossant and Ofer, 1977), and an inner clump of cells known as the 
inner cell mass (ICM).  Cells of the ICM go on to form the epiblast from which all of the 
different tissues of the foetus are descended in addition to a layer of visceral endoderm 
(VE; Figure 1.1) which surrounds the developing embryo; as such these cells are termed 
‘pluripotent’.     
 
1.1 Embryonic development 
The early tissue specification in the embryo is largely controlled by nodal and BMP 
signalling throughout the cells of the epiblast (Varlet et al., 1997).  Gradients in nodal 
signalling are largely responsible for establishing the anterior-posterior axis of the embryo 
which arise from two localised signalling cascades (Waldrip et al., 1998; Brennan et al., 
2001).  The extra-embryonic ectoderm cells in the proximal portion of the embryo secrete a 
range of nodal pro-protein convertases (Furin and Pace4) which cleave the nodal protein 
into its active form, enhancing the downstream effect of nodal signalling in the nearby 
posterior region of the epiblast (Varlet et al., 1997; Beck et al., 2002; Schier, 2003).  In 
concurrence with this, the anterior visceral endoderm (AVE) secretes nodal/BMP inhibitor 
molecules such as Cerberus-like and Lefty1 towards the anterior portion of the epiblast 
driving these cells into an ectodermal cells fate (Figure 1.1) (Schier, 2003).  This is the first 
of three embryological germ lineages to develop and is considered to be the default 
pathway for differentiation due to its occurrence in the absence of inhibitory signals 
(Munoz-Sanjuan and Brivanlou, 2002).  Cells from this region of the developing embryo will 
eventually go on to produce all the derivatives of the nervous system (Section 1.2) and 
epidermis (skin).   
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Figure 1.1. Tissue specification in the early embryo.   
Representative image of early tissue specification in the developing mouse embryo (5.5-6.5dpc), highlighting 
the location of the extra-embryonic ectoderm in the proximal portion of the embryo, the epiblast and its 
surrounding visceral endodermal layer (VE).  Nodal gradients are present throughout the epiblast as a result of 
convertase secretion by the extra-embryonic ectoderm, and nodal inhibitors (Lefty1 and Cerberus-like) secreted 
by the AVE.  Image taken from Schier et al., 2003. 
 
 
 
Figure 1.2. Axis formation in the neural tube. 
SHH and BMP work in combination to initiate the dorso-ventral axis of the embryo (a).  SHH from the notochord 
and floor plate ventralise the base of the neural tube.  BMP signalling from the roof plate overlying the neural 
tube dorsalises neighbouring cells.  The rostro-caudal axis of the neural tube is specified by a combination of 
SHH, FGF, Wnt and retinoid signalling (b).  Concentration gradients of these molecules segregate the nervous 
system into four distinct regions: forebrain, midbrain, hindbrain and spinal cord.  Image taken from Jessell and 
Sanes., 2000. 
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The high concentrations of nodal and BMP signalling at the posterior of the embryo is 
thought to play a key role in establishing formation of the primitive streak (Perea-Gomez et 
al., 2002; Schier, 2003) through which the mesendodermal cells of the epiblast migrate in a 
process known as gastrulation.  Gastrulation results in the transformation of 
mesendodermal cells into the innermost endodermal cell layer to form the gut and its 
appendages (liver and lungs etc) and the mesodermal cells (sandwiched between the endo- 
and ecto-dermal germ layers) which will differentiate into the muscles and connective 
tissue of the embryo.  By this developmental stage, embryonic cells are assigned along one 
of the three developmental pathways (ectodermal, mesodermal or endodermal) and are 
termed ‘multipotent’.  Throughout the remainder of development, cells progress through 
their germ lineage of choice becoming sequentially more committed into defined cell types 
(reviewed by Alberts et al., 2002b).   
 
1.2 Neural induction 
The nervous system derives from the outermost ectodermal cell layer of the embryo.  The 
process of committing these ectodermal cells into neural precursors rather than epidermal 
precursors of the skin, is known as neural induction, and is considered to be the result of 
BMP inhibition since exposure to BMP signalling in the ventral ectoderm confers and 
epidermal cell fate amongst these cells (Wilson and Edlund, 2001).  Inhibition of BMP 
signalling the in dorsal ectoderm by secreted molecules such as noggin, cerberus and 
follistatin specifies a neural cell fate amongst these cells.  Once committed into the neural 
differentiation pathway these cells can be referred to as neural precursors which go on to 
generate the various components of the nervous system (Section 1.3). 
Formation of the nervous system begins with the generation of the neural tube on the 
dorsal side of the embryo, in a process referred to as neuralation.  Neuralation is initiated 
by signalling from the mesodermal cells underlying the neural plate which localise into a 
transient rigid rod-like structure (notochord) along the dorsal midline of the embryo during 
gastrulation (Reviewed by Wolpert et al., 2002; Alberts et al., 2002b).  Signalling from the 
notochord by morphogens such as sonic hedgehog (SHH) induces thickening and inward 
rolling of the neural plate into the neural tube (Jessell and Sanes, 2000).  In opposition to 
BMP signalling gradients from the overlying dorsal roof plate, SHH signalling later promotes 
ventralisation of the neural tissue, thus creating its dorsal-ventral axis.  Subsequent 
development and regional specificity along the rostro-caudal axis of the neural tube is 
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driven by gradients in FGF, Wnt and retinoid signalling, which segregate the nervous 
system into forebrain, midbrain, hindbrain and the spinal cord regions (Figure 1.2; 
reviewed by Jessell and Sanes., 2000).  
The neural tube comprises numerous cells of epithelial phenotype which detach to from 
the ectodermal sheet and subsequently differentiate into the many neurons and glia of the 
central nervous system (CNS; brain and spinal cord; Section 1.3) in a process known as 
neurogenesis (Section 1.4) (Alberts et al., 2002b).  The cluster of cells located between the 
neural tube and developing epidermis are known as the neural crest.  Closure of the neural 
tube, initiates the migration of these neural crest cells away from the spinal cord to radial 
locations.  These cells mainly give rise to neurons (and glia) of the peripheral nervous 
system (PNS) (Baroffio et al., 1988; Artinger et al., 1999; Le Douarin and Dupin, 2003). 
 
1.3 Cell types of the nervous system 
The nervous system comprises two main groups of cells; neurons which generate electrical 
impulses to co-ordinate communication between cells throughout the body, and glial cells 
which are located throughout nervous system and collectively serve a supportive role for 
neurotransmission.  These cells have been described in more detail below. 
 
1.3.1 Glia 
Developing glial cells retain this epithelial-like phenotype from the early neural tube and 
form the supporting structures down which neurons migrate and extend axonal and 
dendritic projections for communication (Gasser and Hatten, 1990; Koul and Seth, 2008).  
There are numerous classes of glial cells throughout the nervous system; oligodendrocytes 
and astrocytes are the most well characterised glial cell populations. 
Oligodendrocytes are a form of glial cell within the CNS which wrap around neurons 
forming an insulating myelin sheath.  These cells phagocytose damaged nerve cells.  In the 
PNS, this function is carried out by Schwann cells (Keirstead et al., 2005; Nistor et al., 2005; 
Franklin and ffrench-Constant, 2008).  Spinal cord injury or trauma often causes damage to 
nerves which release excess glutamate into surrounding tissue.  Excess extracellular 
glutamate is toxic to glial cells (Park et al., 2004; Káradóttir and Attwell, 2007), resulting in a 
depletion of oligodendrocytes at the site of injury.  The loss of oligodendrocytes prevents 
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nerve re-myelination and is thought to be one of the main contributors to continued 
degeneration following spinal cord injury (SCI) (Park et al., 2004).  Regenerative cell 
therapies which transplant oligodendrocytes into the site of tissue damage have shown 
promising results for improvement of sensation and motor control following SCI (Keirstead 
et al., 2005; Nistor et al., 2005).  Indeed, in January 2009, after promising results from early 
clinical trials, the first cell therapy using human embryonic stem cell (hESC; Section 1.9) 
derived oligodendrocytes for treatment of SCI was approved (Geron Corporation, 
California).   
Astrocytes (astroglia) are so named after their ‘star’ shape.  They serve to provide both 
physical and biochemical support for the endothelial cells of the blood brain barrier, 
transferring nutrients to the nerves as required (Abbott et al., 2006).  Astrocytes promote 
survival and differentiation of neurons and influence neuronal migration (Denis-Donini and 
Estenoz, 1988; Guerri et al., 1989; Gasser and Hatten, 1990).  They are also involved in 
scarring following trauma to the brain or spinal cord (Faulkner and Keirstead, 2005).  
Similarly to neurons, astrocytes are able to respond to stimulation by releasing 
neurotransmitters such as glutamate and adenosine triphosphate (ATP) in a calcium 
responsive manner to induce neuronal signalling (Carmignoto, 2000; Newman, 2003).   
 
1.3.2 Neurons 
A neuron is a nerve cell which sends and receives electrical impulses in response to a 
stimulus, in order to initiate an effect.  Neurons are characterised by the extension of 
processes, typically a single long axon which transmits a signal towards a new cell, and a 
number of smaller dendrites which receive incoming signals from neighbouring cells.  
Neuronal projections can be identified by the expression of β-III-tubulin (TUBB3) and 
microtubule associated protein 2 (MAP2), which are commonly used as markers for 
neuronal phenotype.   
Neurons function to control movement, sensation, speech and cognition.  The plasma 
membrane of a mature neuron contains numerous ion channels, most of which fall into 
two main classes; ligand-gated (ionotropic) or voltage-gated ion channels, the presence and 
functionality of ligand-gated ion channels can be detected using calcium imaging analysis 
(Section 1.11.3.2).  Voltage gated ion channels are activated by a sudden change in local 
voltage which alters their confirmation to allow influx/efflux of positive Na+ or Ca2+ ions 
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through the membrane.  The movement of these positive ions alters the polarity of the cell, 
causing depolarisation and generation of an electrical impulse, or action potential (AP; 
Figure 1.3).  The change in polarity results in the opening of membrane voltage gated K+ 
channels, which allows K+ ions to flow out of the cell and recover the polarisation.  The 
presence of functional K+ channels is essential for the generation of recurrent APs.  The 
ability of a neuron to fire APs in response to stimulation can be tested using a technique 
known as patch clamping (Section 1.11.3.1). 
Inside the terminus of a mature axon are numerous synaptic vesicles containing 
neurotransmitters.  Release of these vesicles is regulated by cytosolic Ca2+.  A resting cell 
maintains a comparatively low free cytosolic Ca2+ concentration of 10-7 M, compared to the 
extracellular fluid of 10-3 M (Alberts et al., 2002a), creating a concentration gradient across 
the plasma membrane.  When a ligand-gated channel is stimulated by binding of a 
neurotransmitter, Ca2+ channels in the plasma membrane open and Ca2+ ions flood into the 
cytosol, increasing the polarity of the cell.  This triggers Ca2+ responsive proteins to induce 
synaptic secretion, releasing neurotransmitter into the synaptic cleft between two neurons.  
Released transmitters will then go on to stimulate a response in a neighbouring cell.  In this 
way a signal is transmitted between cells at speeds of 120 m.s-1 (Káradóttir and Attwell, 
2007).  Finally, the change in polarity of the stimulated cell, triggers Ca2+ transporters in the 
plasma membrane to pump free Ca2+ back out of the cell, (or sequester into internal 
cytoplasmic stores) returning the cell to its resting levels (Alberts et al., 2002a).   
 
1.3.2.1 Neurotransmitters 
There are two classes of neurotransmitters in the brain; excitatory and inhibitory.  
Excitatory neurotransmitters induce an inward flux of positive ions into the cells, usually 
Ca2+ ions, causing depolarisation and initiation of an excitatory electrical impulse.  
Inhibitory neurotransmitters regulate impulse transmission, usually by inducing an influx of 
Cl- ions into the cell to induce repolarisation and inhibit further electrical impulses. 
Glutamate: Glutamate is the main excitatory neurotransmitter in the nervous system; 
however, extreme doses of glutamate are toxic to neural cells, resulting in apoptosis and 
cell death.  For this reason, glutamate is sequestered by surrounding glial cells, following 
release and broken down into glutamine, preventing neurotoxicity by over stimulation 
(Rothstein et al., 1996).  Glutamate is also the precursor for the inhibitory neurotransmitter 
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GABA, which is generated from glutamate by the glutamate decarboxylase (GAD) enzyme 
(Buddhala et al., 2009). 
NMDA: N-methyl-D-aspartic acid (NMDA) is an excitatory neurotransmitter which binds to 
the NMDA group of ionotropic glutamate receptors in the plasma membrane (Hardingham 
and Bading, 2003).   This results in an influx of Ca2+ ions into the cell, generating an 
electrical impulse for cell-cell communication.  NMDA is expressed largely in the 
hippocampal region of the brain and as such is mainly thought to function in learning and 
memory (Bliss and Collingridge, 1993).  NMDA receptors have been located across 
alternative areas including: cerebral cortex,  striatum, hippocampus, amygdala, and 
cerebellum (Hanaoka et al., 2003).  The response to NMDA is considered to be potentiated 
by the presence of glycine as a co-agonist  (Johnson and Ascher, 1987; Kleckner and 
Dingledine, 1988). 
Glycine: Glycine is a non-essential amino acid with multiple functions in the body.  In the 
nervous system glycine is an inhibitory neurotransmitter for the regulation of APs following 
excitatory stimulation.  In addition, glycine serves as a co-agonist for stimulation of the 
excitatory NMDA receptor (Kleckner and Dingledine, 1988; Kemp and Leeson, 1993), 
perhaps functioning as a fine control over NMDA receptor activation. 
Acetyl Choline: Acetyl choline is an excitatory neurotransmitter in both the CNS and PNS 
involved in learning, memory, stress, and sleep cycles (Reis et al., 2009).  Acetyl choline is 
synthesised from acetyl CoA and choline by the enzyme choline acetyltransferase (Tucek, 
1985), which also acts as a molecular marker of cholinergic neurons.  Carbachol is a 
cholinergic agonist which binds to and activates the acetyl choline receptor (both 
muscarinic and nicotinic) on nerve cells.  Due to the high cost of acetyl choline, carbachol 
can be used in functional studies to detect the presence and functionality of the acetyl 
choline receptors. 
Gamma-aminobutyric acid: Gamma-aminobutyric acid (GABA) in another of the main 
inhibitory neurotransmitters of the CNS (Krnjevic and Schwartz, 1967), and is synthesised 
from glutamate by the enzyme glutamate decarboxylase (GAD) (Buddhala et al., 2009).  
GABA functions as a regulatory neurotransmitter; upon binding to its receptors GABA 
initiates an influx of Cl- ions into the cells which reinstates the negative polarity of the cell 
(Thampy and Barnes, 1984).  In this way, GABA inhibits the firing of Ca2+ induced action 
potentials caused by glutamate stimulation. 
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Serotonin: Serotonin is an alternative inhibitory neurotransmitter mainly involved in control 
of mood, pain, sleep patterns, muscle contraction and learning (Ressler and Nemerodd, 
2000; Pakalnis et al., 2009).  Serotonin also has many functional roles outside of the 
nervous system including bowel motility, bladder control and platelet aggregation (Berger 
et al., 2009).  Serotonin receptors can found throughout the brain, emphasising the 
dynamic role played by serotonin signalling (Berger et al., 2009). 
Dopamine: Dopamine is present throughout the body with a range of functions.  In the 
brain, dopamine behaves as both an excitatory and inhibitor neurotransmitter where it 
controls movement, motivation and memory.  A lack of dopamine can result in a loss of 
motor control (Parkinson’s disease) and depression (Brown and Gershon, 1993; Obeso et 
al., 2004; Björklund and Dunnett, 2007).  Elsewhere in the body it serves as a hormone 
controlling processes such as lactation and sexual arousal (Boullin et al., 1978; Hull et al., 
1999).  Dopamine synthesis occurs in several stages; L-tyrosine is first converted to 
L-3,4-dihydroxyphenylalanine (L-DOPA) by the enzyme tyrosine hydroxylase (TH) which is a 
distinguishing marker for dopaminergic neurons.  L-DOPA is then converted to dopamine in 
the brain by the dopa decarboxylase enzyme.  Loss of dopamine synthesis by dopaminergic 
neurons in the substantia nigra region of the brain causes Parkinson’s disease, typified by 
the progressive loss of motor control.  Epinephrine and norepinephrin are excitatory 
neurotransmitters derived from dopamine.  These neurotransmitters are mainly involved in 
controlling anxiety, stress and mood. 
The type of neurotransmitter released depends upon the neuronal phenotype of the cell, 
(e.g. GABAergic neurons release gamma-aminobutyric acid (GABA), glutamatergic neurons 
release glutamate and serotonergic neurons release serotonin), which is governed in part 
by the location of the neuron within the nervous system, and the environmental queues 
received during its development.  
 
1.4 Neurogenesis 
Neurogenesis is the formation of neurons from the neural precursors of the nervous 
system and occurs in two main waves during development, pre and post-natally (Hatten, 
1999).  The precise origin and sequence of signals which drive a neural precursor to 
become neuronal rather than glial remains to be fully characterised; however, it has been 
well documented that neurogenesis occurs first, and gliogenesis follows later in 
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development.  Several signalling pathways have been implicated in these processes.  Both 
in vivo and in vitro studies on neuronal differentiation from neural and embryonic stem 
cells have identified the BMP4 antagonist noggin, to play a crucial role in neurogenesis by 
inhibiting BMP signalling amongst neural fated tissues (Lamb et al., 1993; Lim et al., 2000; 
Pera et al., 2004; Itsykson et al., 2005; Stottman et al., 2006).  Basic fibroblast growth factor 
(bFGF) signalling has also been shown to play a key role in neurogenesis, acting both to 
block BMP signalling, and independently to induce neuralisation (Hongo et al., 1999; Wilson 
et al., 2000; Pera et al., 2003; Bilican et al., 2008).  However research has shown that, in 
addition to SHH, bFGF signalling is required for gliogenesis (Orentas et al., 1999; Chandran 
et al., 2003; Danesin et al., 2006; Bilican et al., 2008), suggesting that these signalling 
stimuli do not act alone in specifying a neuronal or glial cell fate, but rather that the time 
point, concentration and duration of a cells exposure must be critical to defining its 
terminal neuronal or glial cell fate.  In support of this, it has been demonstrated that a 
neuro-glial switch occurs after the initial phase of neurogenesis in response to prolonged 
SHH exposure from the notochord and floor plate.  This prolonged exposure induces the 
differentiation of neural precursors into the supporting glial cells, rather than continued 
neuronal generation (Kessaris et al., 2001; Danesin et al., 2006). 
The terminal neuronal phenotype specified during differentiation is defined by the spatial 
arrangement of the cells during development and exposure to directive stimuli.  Using 
knock-out animal models and gene expression analysis, numerous studies have been 
carried out to determine the various signalling cascades which specify the different 
neuronal phenotypes found throughout the nervous system.  These studies have shown 
that a motor neuronal cell fate in the spinal cord is induced by retinoid exposure at the 
most caudal portion of the neural tube, this can be recapitulated in vitro using retinoic acid 
to induce motor neuronal phenotypes from both neural and embryonic stem cells (Li et al., 
2005; Lee et al., 2007; Li et al., 2008).  In contrast forebrain development at the most 
rostro-dorsal portion of the nervous system is induced as a results of reduced SHH 
concentration, in the absence of retinoid signalling.  Forebrain neural precursors are 
identifiable by PAX6 expression which is inhibited in mid and caudal portions of the tube by 
increased SHH expression (Goulding et al., 1993; Ericson et al., 1997).  Midbrain neuronal 
differentiation can be induced by enhancing the ventralising effects of SHH, in combination 
with FGF8 as is present in the mid-portion of the developing neural axis (Yan et al., 2005). 
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The possibility of generating the neuronal cell types lost during neurodegenerative disease, 
is fast becoming a reality thanks to the abundance of research into the processes of neural 
induction and neurogenesis.  Following the derivation of the first hESC lines in 1998 
(Thomson et al., 1998), researchers world-wide have picked away at these intricate 
processes of differentiation, working towards the overarching aim to produce functional 
neural cells for the replacement of disease/damaged nervous tissue, and to enhance the 
throughput and efficacy of pharmacological screening.  Despite these advances, the 
reproducibility of differentiation to sufficiently generate the high cell yields required for 
therapy remains a challenge. 
 
1.5 Neuronal differentiation in vitro 
In order to generate neurons from pluripotent cells in vitro it is necessary to mimic the 
signalling events to which the cells would be exposed during embryonic development 
(Sections 1.1, 1.2, 1.4).  Firstly, these cells must be committed into the ectodermal lineage, 
followed by further specification into neural stem cells (progenitor) and finally into a 
neuronal cell type.  Commitment of pluripotent cells (Section 1.9) into the ectodermal 
lineage has been achieved using signalling molecules which mimic the signalling activities of 
the early epiblast (Section 1.1) incorporating nodal inhibitors such as SB431542, Lefty or 
follistatin (Schier, 2003; Vallier et al., 2005; Patani et al., 2009) to drive ectodermal 
commitment or BMP inhibitors such as noggin or chordin, which block the commitment of 
cells into mesodermal or endodermal lineages (Hemmati-Brivanlou et al., 1994; Piccolo et 
al., 1996; Gratsch and O'Shea, 2002; Itsykson et al., 2005; Iacovitti et al., 2007).  Equally 
positive retinoic acid, FGF and SHH signalling, as well as inhibition of Wnt signalling have 
been shown to induce neuroectodermal differentiation in hESCs (Jones-Villeneuve et al., 
1982; Roelink et al., 1995; Wilson et al., 2000; Wolpert et al., 2002; Baharvand et al., 2007; 
ten Berge et al., 2008). 
Most neural differentiation protocols transfer adherent hESCs into suspension culture, thus 
mimicking the 3D nature of the embryo to drive differentiation.  When cultured in 
suspension, pluripotent cells rapidly aggregate into clusters; signalling amongst these 
clusters has been shown to initiate differentiation in a pattern similar to that of early 
embryogenesis (Itskovitz-Eldor et al., 2000; Dang et al., 2002; Shin et al., 2005; Heeg-
Truesdell and LaBonne, 2006; Li et al., 2007).  These floating cell clusters are referred to as 
embryoid bodies (EBs).  
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1.5.1 Embryoid bodies 
Embryoid bodies are three dimensional cell aggregates which can be generated from 
pluripotent cells by culture in suspension, methylcellulose, as hanging drops, or forced 
aggregation using centrifugation (Keller, 1995; Gassmann et al., 1996; Dang et al., 2004; 
Burridge et al., 2007).  The size of an EB varies depending on the number of cells and 
process of formation, which in turn is thought to influence the terminal fate of the cells 
within.  Signalling within the EB has been shown to initiate differentiation of the 
pluripotent cells into precursors from any of the three germ lineages, and on occasion 
recapitulate the developmental process of gastrulation (ten Berge et al., 2008).  
Although EB formation and differentiation is a seemingly undirected, the size of the EB can 
be used to encourage differentiation into a specific germ lineage (Itskovitz-Eldor et al., 
2000; Li et al., 2005; Ng et al., 2005; Burridge et al., 2007; Shim et al., 2007).  The ectoderm 
germ lineage is thought to be the default pathway of differentiation in hESCs, as in the 
absence of the inhibitory signals (including BMP signalling events) cells of an ectodermal 
lineage develop (Munoz-Sanjuan and Brivanlou, 2002).  Despite this, neuronal 
differentiation from hESCs remains suboptimal, indicating a commitment of cells into 
non-ectodermal fates during early stages of differentiation.  In addition to the size of the 
EB, the media in which it is cultured can affect the direction of differentiation.  
 
1.5.2 Directing neuronal differentiation using culture media 
Pluripotent hESCs are most commonly expanded as an adherent monolayer culture in 
knock out-media (Section 1.9.3) for sustained pluripotency.  Removal from adherent 
culture and transferral into suspension has been shown to effectively induce 
differentiation; however, the media requirements of a differentiating neural precursor and 
a neuron are vastly different to those of an ESC.  The composition of the media in which 
these cells and EBs are cultured can be used to guide differentiation towards a specified 
neuronal cell fate.  Over past years dedicated media formulations have been developed 
which provide a selective environment for neuronal differentiation.  
 
1.5.2.1 DMEM:F12 
The presence of serum was removed from early differentiation media to prevent 
attachment of EBs to the culture vessel, during their suspension culture phase.  Barnes and 
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Sato combined first the high nutrient content DMEM with the relatively low nutrient 
content F12 in 1980 to create a media which was suitable for a range of cell types without 
the requirement for serum (Barnes and Sato, 1980).  Ham’s F12 does not contain serum 
and therefore is completely defined (Ham, 1965).   
 
1.5.2.2 Neurobasal media  
Neurobasal media specially was developed for selective differentiated culture of primary 
embryonic neurons (Brewer, 1995).  Its recipe is based on standard DMEM but has a lower 
NaCl and NaHCO2 concentrations, reducing the osmolarity which has been shown to be 
beneficial for neuronal cells in culture (Brewer et al., 1993; Brewer, 1995).  In addition, 
neurobasal media contains a lower cysteine and glutamine concentration than DMEM 
which reduces glial cell proliferation (Brewer et al., 1993), and is supplemented with 
alanine, asparagine, proline and vitamin B12 which are absent from the standard DMEM 
formulation (Brewer et al., 1993).  Neurobasal media does not contain ferrous sulphate 
(found in DMEM) because this has been shown to be toxic to neuronal cultures  (Brewer et 
al., 1993).  To enhance neuronal commitment and differentiation neurobasal base media 
can be further supplemented with N2 and B27 (Sections 1.5.2.3 and 1.5.2.4).   
 
1.5.2.3 N2 supplement 
N2 supplement is a chemically defined supplement based on Bottenstein's N-2 formulation 
(Bottenstein, 1985), recommended for the growth and survival of post-mitotic neurons in 
culture (Bottenstein, 1985). It contains a mixture of human transferrin, recombinant 
insulin, progesterone, putriscine, and selenium which protects the cells from peroxidises 
(McKeehan et al., 1976). 
 
1.5.2.4 B27 supplement 
B27 is a serum substitute, comprising insulin, transferrin, progesterone, putrescine, 
selenium, which is also supplemented with the thyroid hormone T3, fatty acids, vitamin E 
and other anti-oxidants (Brewer, 1995).  Substitution of serum for B27 in neuronal cultures 
results in higher neuronal survival, reduced outgrowth by glial cells and increased number 
and extension of processes from neuronal cells (Brewer et al., 1993). 
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1.5.3 Gene expression analysis of neuronal differentiation 
Differentiation is caused by a change in the molecular programming of the cell in response 
to stimuli.  Changes in the genes being expressed is reflected in the altered array of 
proteins which bring about the morphological changes visible during differentiation.  The 
gene expression profile of a neuron is different to that of a neural progenitor or other 
pluripotent cell.  Analysis of a population of cells at the level of gene expression enables 
tracking through the process of differentiation and can be carried out using molecular 
techniques such as the polymerase chain reaction (PCR).     
PCR can be used to amplify a specific DNA sequence within a sample.  PCR requires the 
presence of forward and reverse DNA primers which are designed to bind to each end of a 
target nucleotide sequence.  Activated DNA polymerase binds to the primers and moves 
along the target nucleotide sequence, generating a complimentary copy; the number of 
copies of a targeted DNA, double exponentially with each cycle of the PCR.  Amplified 
products can be detected using agarose gel electrophoresis which separates DNA 
molecules by size.  Incorporation of a DNA stain (e.g. SYBR SafeTM) into the agarose can be 
used to visualise amplified PCR products under ultra violet (UV) light.  The size of the PCR 
products can be determined using a DNA molecular marker ladder.  These techniques are 
used for in genetic diagnostics or screening for disease genes, or identifying microbial 
contamination.   
 A variation of PCR can also be used to monitor changes in gene expression using RNA as a 
starting material.  However, RNA must first be reverse transcribed into a DNA copy (cDNA) 
before PCR amplification can take place.  This step is carried out by a reverse transcriptase 
enzyme such as Moloney Murine Leukemia Virus (MMLV), sourced from retroviruses which 
use these enzymes to integrate their RNA into a hosts DNA.  For this reason, PCRs which 
monitor changes in gene expression (RNA products) are referred to as Reverse 
Transcription-PCR (RT-PCR).  Prior to cDNA synthesis, it is necessary to isolate good quality 
RNA from the cell sample using RNA extraction methods. 
 
1.5.3.1 RNA extraction 
Early methods for RNA extraction were developed in the late 1960’s using protein 
denaturants such as guanidinium thiocyanate and guanidinium chloride. In 1979, John 
Chirgwin discovered that RNA could be isolated from cells by homogenisation with 
guanidinium thiocyanate (a potent protein denaturant) followed by ethanol precipitation 
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or ultra centrifugation through a caesium chloride cushion (Chirgwin et al., 1979).  However 
ultra-centrifugation took many hours and in 1987 the method was superseded by a 
single-step RNA isolation using acid Guanidinium Thiocyanate-Phenol-Chloroform  
(Chomczynski and Sacchi, 1987).  During this procedure, total RNA remains in the upper 
aqueous phase, while most of DNA and proteins are held in the interphase or in the lower 
organic phase.  Recovery of RNA from the aqueous phase is achieved by precipitation with 
isopropanol.   
Despite its improvements on early extractions methods, the single-step RNA extraction 
method remains time consuming and in recent years high throughput spin column 
extraction kits were developed for clean RNA extraction in just 30 minutes from small 
amounts of starting material.  The spin column uses glass fibres to bind nucleic acid within 
the column.  Cells are lysed in a high concentration guanidinium salt solution (Chomczynski 
and Sacchi, 1987), followed by a dilution with ethanol (molecular grade), making the RNA 
competent for binding to the glass fibres.  Once bound with RNA, glass fibres can then be 
washed, removing contaminants before eluting the RNA (Qiagen and Ambion Inc).  It is 
essential that glass fibres are washed efficiently to avoid carry through of the protein 
denaturants used in extraction which would inhibit reverse transcriptase activity.  In recent 
years, the use of on-column RNA extraction methods has increased due to their speed of 
process and quality of extraction (Christopher-Hennings et al., 2006; Mack et al., 2007).   
Due to the similarity of DNA and RNA structure, small amounts of genomic DNA (gDNA) are 
frequently carried over in RNA preparations.  Contamination by gDNA can interfere with 
downstream RT-PCR amplifications and skew data and must therefore be removed from 
the RNA preparation.  DNA can be removed using DNase, which selectively targets and 
degrades DNA within a sample.  This has proven to be highly effective in purifying RNA 
preparations; however, it must be carried out with caution.  DNase is most commonly 
sourced from the bovine pancreas which also contains RNases (Moore and Stein, 1973).  
Whilst great care is taken during manufacture of DNase it is difficult to ensure complete 
removal of trace RNases.  During RNA purification, insufficient DNase exposure will not 
remove all gDNA whilst prolonged exposure can also result in RNA degradation.  
Purification must therefore be rigorously controlled to ensure standardisation of DNase 
exposure across all samples. 
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1.5.3.2 RNA quantification 
Following extraction the RNA concentration can be quantified using a spectrophotometer.  
Both RNA and DNA absorb UV light with an absorption peak at 260 nm wavelength.  Highly 
concentrated RNA/DNA solutions absorb more light.  A shorter path length on the 
Nanodrop ND-1000 spectrophotometer (Nanodrop®) compared with a standard 
spectrophotometer, means that the Nanodrop can quantify RNA that is 50 times more 
concentrated than a standard spectrophotometer.  Just 0.5 µl RNA is required for 
quantification, thus reducing sample wastage.  Spectrophotometer quantification does not 
take account of any other nucleic acid forms (gDNA, rRNA and tRNA etc) which will be part 
of the RNA fraction (Vandesompele et al., 2002).  It must therefore be assumed that the 
quality and composition of RNA is consistent between preparations. 
 
1.5.3.3 Primer design 
A PCR uses gene specific primers to amplify a transcript (Saiki et al., 1988).  It is essential to 
use primers which have been carefully designed to specifically target the correct gene of 
interest, and if necessary, a specific isoform of that gene.  There are a number of genes 
which encode a range of different protein isoforms; including OCT4 (Section 1.9.1).  In 
cases where different isoforms are expressed in different tissue, poor primer design can 
give misleading data on a population of cells.   
One of the main complications for gene expression analysis using RT-PCR is the 
interference of contaminating genomic DNA (gDNA), when amplifying from cDNA.  All 
hESCs from the same initial seed stock contain identical gDNA sequences; however 
expression of the mRNA will vary between cells, altering the protein content of the cell, 
depending on the developmental stage or external conditions. 
Genomic DNA comprises coding and non-coding sequences.  The coding regions are 
referred to as exons, which are separated by introns (regions of non-coding DNA).  During 
transcription, the non-coding intron regions are spliced from the molecule, generating 
mRNA comprising entirely coding sequence, as reviewed by (Watson et al., 2008).  
Therefore gDNA can be distinguished from mRNA by PCR using primers located in alternate 
exons.  In this case, the amplified gDNA product will encode both exons and introns, 
generating a larger product than the corresponding cDNA.  Alternatively, if the nucleotide 
sequence is suitable, primers can be designed to sit across exon-exon junctions and will 
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only amplify from cDNA where the complementary sequence for primer binding has been 
brought together by transcription. 
Primers should be designed with non-complementary 3’ ends to prevent formation of 
primer-dimers or self annealing.  They are usually 20 bp in length, which ensures specificity 
for the target sequence (Cha and Thilly, 1993).  However, repeating sequences for many 
genes, especially those which are constitutively expressed such as GAPDH, are present 
throughout the genome (Zhang and Gerstein, 2003).  Usually only a single copy encodes for 
mRNA, the others have usually inherited mutations which prevent their transcription, these 
are known as pseudogenes (Vanin, 1985).  On occasion, pseudogenes share a high degree 
of nucleotide similarity to their true gene nucleotide sequence and may vary by only a 
single base pair.  Pseudogenes most commonly retain the intronic sequence and so are 
easily excluded from analysis using cDNA sequence specific primers.  However, in some 
cases the mRNA nucleotide sequence has been retrotransposed back into the gDNA 
without introns, generating a non-coding pseudogene with a nucleotide sequence which 
matches that of the mRNA.  These types of  pseudogene are referred to as processed 
pseudogenes and are highly conserved through evolution (Vanin, 1985).  In genes with 
pseudogene copies, accurate BLAST and sequence alignments are especially important to 
ensure primer sequences are designed to incorporate any variations in sequence for cDNA 
specific amplification.   
For a pseudogene to become established in a population, it must be inherited into the 
germ line (Pain et al., 2005).  The likelihood of this happening is far higher in an embryonic 
cell prior to tissue specification, or in cells of the germ lineage, rather than in a somatic cell.  
Pluripotency genes are expressed by cells in the early blastocyst at very high levels and are 
therefore more likely to become established in a population following retrotransposition 
(Pain et al., 2005).  It has therefore been suggested that the retrotransposition frequency of 
genes involved in pluripotency is greater than in non-pluripotency genes (Pain et al., 2005).  
There are 11 currently identified Nanog pseudogenes, which carry up to 97% nucleotide 
sequence similarity to the functional Nanog gene and 6 pseudogenes for OCT4  (Fairbanks 
and Maughan, 2006; Liedtke et al., 2007).  In combination with their numerous isoform the 
presence of pluripotency pseudogenes creates additional confusion for gene expression 
analysis (Booth and Holland, 2004; Fairbanks and Maughan, 2006; Liedtke et al., 2007; 
Liedtke et al., 2008).   
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1.5.3.4 Quantitative-PCR 
The use of RT-PCR is ideal for investigating which genes are actively transcribed but it is not 
able to quantify changes in expression relative to a reference sample.  Throughout 
differentiation, genes are not only switched on and off but are also up and down regulated.  
Using quantitative PCR (Q-PCR) it is possible to determine how much of the gene is being 
expressed and gives an indication of the proportion of a population which are expressing 
the gene of interest (GOI). There are two methods for quantifying changes in gene 
expression: absolute or relative quantification.  Absolute quantification gives a true value of 
the active copy number of an expressed gene, relative to a standard of known 
concentration.  Relative quantification relates the signal of the target transcript in a 
treatment group to that of another sample such as an untreated control (Livak and 
Schmittgen, 2001).   
Relative abundance can be calculated using the formula (2-∆∆Ct) where the fold change in 
gene expression is calculated between a calibrator and the gene of interest (Livak and 
Schmittgen, 2001).  During differentiation studies, gene expression levels at day zero are 
usually used as the calibrator. 
A cycle threshold (Ct) value is the number of PCR cycles required for the fluorescence to 
reach an assigned threshold level for detection, this is usually when the log phase of 
amplification begins.  This value can be inversely correlated to the amount of nucleic acid 
template in the reaction  (Walker, 2002).  A delta Ct (∆Ct) value is the difference in cycle 
number between the Ct value of the calibrator and the Ct value of the sample of interest.  
In order to account for variation in sample loading, a ∆∆Ct value is calculated, which is the 
calculated difference between the ∆Ct of the GOI and the ∆Ct of the endogenous control 
gene.   
For an untreated control sample the ∆∆Ct value equals zero, and since 20 equals one, the 
fold change in gene expression relative to the untreated control is also one.  For treated 
samples, calculation of 2-ΔΔCt indicates the fold change in gene expression relative to the 
untreated control (Livak and Schmittgen, 2001). 
Recent advances in gene expression analysis have seen the release of high throughput gene 
expression screening tools in the form of low density arrays.  These arrays simultaneously 
analyse expression of a large number of genes.  In 2003 the MRC set up an International 
Stem Cell Initiative (ISCI) to explore and compare the characteristics of different hESCs at a 
cellular and molecular level (Andrews et al., 2005; Adewumi et al., 2007).  As part of this 
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study, the gene expression profile of 96 different genes across 59 hESC lines was carried 
out using a ‘Human pluripotency panel’ (Applied BiosystemsTM, California, USA).  This array 
was designed to analyse six endogenous control genes for standardisation in addition to 
90 different genes involved in pluripotency and differentiation from a single sample.  Use of 
these cards enabled standardisation between laboratories and greatly reduced the volume 
of samples and time required for analysis.  Alternative array cards have since been 
developed for gene expression analysis of definitive germ lineages by ABI and alternative 
suppliers (Anisimov et al., 2007). 
Following on from the comparison of hESC lines at the level of gene and protein expression, 
the second phase of the ISCI (ISCI2) trials are expanding into analysis of the karyotypic 
stability of different hESC lines under the range of culture conditions adopted by 
laboratories worldwide.  One of the main variables in hESC culture worldwide is the process 
by which hESCs are passaged.  There are two typical methods which can be adopted for 
passaging hESCs; mechanical passaging, whereby the hESCs are placed under a dissection 
microscope and manually cut and replated onto a fresh culture surface, or enzymatic 
passaging which is commonly used in alternative adherent cell culture lines, cleaving the 
bonds between hESCs and the culture surface. 
 
1.6 Neurodegenerative disease 
Neurodegenerative diseases are caused by the progressive loss of function of cells within 
the nervous system, affecting motor control and/or cognition.  Neurodegenerative disease 
can result from depletion of a small single neuronal population e.g. Parkinson’s disease, or 
from wide spread loss of neural populations throughout the nervous system e.g. multiple 
sclerosis.  In other cases such as Alzheimer’s disease, the cause is less distinct and 
symptoms can occur as a result of multiple cell types at a range of locations.  In each case, 
the causes and symptoms can vary, making a target therapy more challenging. 
 
1.6.1 Alzheimer’s disease  
Alzheimer’s disease is the most common form of dementia, occurring mainly in the elderly 
population affecting 1 in 14 people over the age of 65 (Alzheimer's Society, 2009).  
Incidence has increased significantly over recent years due to prolonged life expectancy 
and is predicted to continue over future years (Alzheimer's Society, 2009).  There is no 
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single cause identified for Alzheimer’s disease; however, progression is linked to the 
formation of plaques within the brain (Urbanc et al., 1999).  Unlike the other common 
forms of neurodegenerative diseases, motor function remains intact in Alzheimer’s patients 
who instead lose cognitive ability.  A patient may live for many years suffering complete 
loss of memory and recognition, placing pressure on caregivers and the healthcare system 
to provide continued support.  Subsequently Alzheimer’s disease is thought to become one 
of the largest costs to the healthcare system from a single disease. 
 
1.6.2 Huntingdon’s disease 
Huntingdon’s disease (HD) is a genetic neurodegenerative disease caused by a mutation in 
the huntingtin gene resulting in a mutated form of the Huntingtin protein.  This protein 
gradually damages areas within the brain and a HD patient loses motor control 
characterised by jerky movements and signs of dementia.  Symptoms of HD do not usually 
appear until middle age but on occasion have presented in early childhood (Vargas et al., 
2003).  There is currently no cure for HD but future therapies are aimed towards improving 
symptoms and slowing disease progression.  A HD patient will eventually die from 
suffocation, due to loss of control over the airways (Walker, 2007).  
 
1.6.3 Amyotrophic lateral sclerosis 
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease which specifically targets 
motor neurons in the CNS.  ALS is often referred to as Lou Gehrig’s disease after the first 
diagnosed patient in 1939, which results in loss of motor control and as the disease 
progresses, muscle sparing and atrophy due to loss of innervations.  The exact causes of 
ALS are unclear although in a number of patients, symptoms have been linked to a mutated 
form of the superoxide dismutase (SOD1) gene which plays a role in neuroprotection of 
motor neurons  (Patel et al., 2002).   In many patients, disease is sporadic with no current 
identifiable cause.  In most cases, sensory neurons remain intact so a patient remains able 
to see, smell, taste, hear, feel and touch.  The disease does not directly affect a patients 
mind; however, as the disease progresses patients frequently suffer depression from the 
distress of poor motor control.  Symptoms can occur rapidly or gradually and most patients 
die as a result of loss of airway control. 
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1.6.4 Parkinson’s disease  
Parkinson’s disease (PD) is primarily caused by the loss of A9 dopaminergic (DA) neurons 
from the substantia nigra region of the brain.  Deterioration of this cell pool results in 
decreased dopamine synthesis and subsequent impairment or loss of motor function.  
Parkinson’s disease affects over 4 million people worldwide (Anderson and Caldwell, 2007).  
Dopamine is unable to cross the blood-brain barrier so current PD therapies administer 
L-DOPA for conversion to dopamine in situ.  Loss of therapeutic efficacy is in part caused by 
the inability to produce sufficient dopa decarboxylase for dopamine synthesis (Lloyd and 
Hornykiewicz, 1970).  Transplantation of dopaminergic neurons back into the substantia 
nigra for synthesis of dopamine on demand is the focus of investigation for PD cell 
therapies.  The relative simplicity in replacing just a single defective cell type means that 
cell transplantation is a realistic future approach for therapy. 
 
1.7 Regenerative medicine 
In a healthy being, tissue regeneration occurs continuously to repair damaged tissue after 
injury.  ‘Guardian type’ cells are constantly surveying the body for damaged and diseased 
cells, maintaining healthy tissues.  Even in the absence of injury, these cells ensure 
replacement of old worn out tissue; however as the body ages or during disease, the ability 
for regeneration becomes increasingly limited, resulting in tissue degeneration.  The use of 
stem cell therapy for the treatment of disease is known as regenerative medicine which is 
an expanding area of scientific research.   
Over the past 15 years, a range of regenerative therapies have come to market.  
‘Regenerative medicine’ is an umbrella term for a range of treatments which induce or 
encourage regeneration of damaged or diseased tissue.  Treatments might include growth 
factors, cell-based therapies or tissue engineering of a replacement tissue/organ. 
Some of the first regenerative medicine products were growth factors: erythropoietin 
(EPO), granulocyte-colony stimulating factor (G-CSF) and keratinocyte growth factor 2 
(Repifermin) which were applied to the damaged tissue to induce the body to self-repair  
(Petit-Zeman, 2001; Sebald, 2002).  In 1995 the first cell therapy for repair of damaged 
cartilage using chondrocytes (Carticel®) was developed (Genzyme Inc, Massachusetts, USA) 
and in 1998 the first tissue engineered skin graft comprising dermal and epidermal tissue 
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(Apligraf®, Organogenesis Inc, Massachusetts, USA) was approved by the FDA for the 
treatment of patients with severe burns or persistent venous leg ulcers.   
The major limitation for tissue engineering is the supply of nutrients, and removal of waste 
products from cells embedded within a solid matrix, without exposure to larger molecules 
such as immune complexes for tissue rejection (Langer and Vacanti, 1993).  In April 2006 an 
expandable bladder-like replacement was artificially created as a major step forward in the 
field of tissue engineering of larger organs  (Atala et al., 2006).  In 2008, tissue engineering 
of a  tracheal replacement for a damaged airway in a patient suffering bronchomalacia   
(Macchiarini et al., 2008), again emphasised the increasing success of regenerative 
medicines for treatment of disease and improved quality of life. 
There is currently no routine cell therapy for the treatment of neurodegenerative diseases; 
however, early studies using transplantation of foetal derived brain tissue, containing 
neural precursors into the brain of a PD patient confirmed their proof of principal  (Lindvall 
et al., 1988; Piccini et al., 2000).  These studies demonstrated integration of graft cells into 
the host brain and partial recovery of motor control, following transplantation  (Lindvall et 
al., 1988; Lindvall et al., 1989; Piccini et al., 1999).  Despite this, supply of healthy foetal 
tissue is highly restricted and the yield of cells from a single donor is insufficient for a 
successful therapy, thereby requiring expansion of the neuronal population prior to 
transplantation.  Unfortunately, neural precursors subsequently lose their ability to 
differentiate following in vitro expansion  (Chung et al., 2006), demonstrating the need for 
an alternative source of neurons for therapy.  
The ability of pluripotent stem cells to generate any cell type of the body makes them ideal 
targets for use in regenerative cell therapies, since a single source of cells could 
theoretically be infinitely expanded and committed into a vast arrange of cell types as and 
when required.   
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1.8 Commercialisation 
In producing a cell therapy it is necessary to consider both the feasibility of production, the 
economic viability of manufacture and the overall requirement for therapy.  For 
commercial success a therapy must produce consistently large numbers of cells in a reliable 
and reproducible process, within a time frame which is suitable for therapy. 
Many of the limitations for regenerative medicine are in sourcing sufficient cells for 
treatment.  Adult and foetal stem cells have limited capacity for expansion in vitro and 
subsequently require large volumes of donor tissue for a single therapy.  When using 
progenitor cells for transplantation, it is essential to ensure that the phenotype of 
transplanted cells is consistent with no risk of uncontrollable proliferation or differentiation 
into an undesirable population (i.e. development of bone tissue in neural cell 
transplantation).   For this reason, regenerative medicine is an interdisciplinary field, 
combining biological scientists with engineers to bring about scaled-up production of cells 
in a quality controlled manner for both small scale (autologous) and large scale (allogeneic) 
therapies.   
Stem cells are not well adapted for scaled up culture.  Human ESCs (Section 1.9) are most 
commonly passaged mechanically using manual cutting tools.  However, mechanical 
passaging is a slow process which is undesirable for large scale production.  Large stirrer 
vessels can be used for scaled up production of suspension cell cultures; however, hESCs 
grow as adherent monolayers.  Addition of hESCs into stirred suspension culture vessels 
results in poor cell growth and high levels of cell agglomeration and differentiation (Section 
1.5) (Dang et al., 2002).   
The use of enzymatic passaging in hESC culture facilitates larger scale production in 
combination with a range of microcarriers are under investigation for increased culture 
surface for scaled-up monolayer culture.  Equally, facilities for automated culture of hESCs 
have been developed for automated scaled-up production of hESCs (CompacT SelecT; the 
automation partnership) (Thomas et al., 2008).  However, these facilities are yet to prove 
successful for therapeutic applications due to heterogeneous growth of hESCs on 
microcarriers and the inability to maintain prolonged passaging under controlled 
conditions.  Despite this, the use of automated cell culture will undoubtedly be the future 
for standardised routine expansion or differentiation of hESCs for use in cell therapy once 
conditions have been optimised. 
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1.9 Embryonic stem cells 
Embryonic stem cells (ESC) are pluripotent cells, which can generate all of the cell types 
within a developing embryo.  These cells were first characterised following isolation of the 
ICM from a blastocyst stage mouse embryo in 1981, and were later shown to be capable to 
differentiating into a range of mature tissue types in vitro (Evans and Kaufman, 1981; 
Martin, 1981).  The definitive criteria for a ESC line include: derivation from the 
pre-implantation embryo, prolonged undifferentiated proliferation, and stable 
developmental potential to form derivatives of all three embryonic germ layers even after 
prolonged culture (Thomson et al., 1995).  Some 18 years later, the first human ESCs (hESC) 
were derived, which demonstrated comparable capabilities for in vitro differentiation 
(Thomson et al, 1998).  In the years following derivation, a range of signature 
characteristics of hESCs were compiled, including expression of typical markers found to be 
associated with pluripotency (Table 1.1). 
 
1.9.1 Markers of pluripotency 
Cellular markers can be either internal or surface proteins and are used to identify a 
population of cells.  Transcription factors such as: NANOG, Octamer binding protein-4 
(OCT4), and SRY-box 2 (SOX2) have been shown by various research groups to be essential 
for promoting self-renewal and pluripotency of ESCs (Nichols et al., 1998; Chambers et al., 
2003; Mitsui et al., 2003; Avilion et al., 2003).  Over or under expression of any one of these 
transcription factors results in differentiation (Niwa et al., 2000; Hyslop et al., 2005).  These 
transcription factors interact directly with DNA targets for each other and for additional 
genes which are also highly expressed in pluripotent cell populations including: TDGF1, 
UTF1, FGF4, REST, DPPA4 and EBAF/LEFTY2 (Okuda et al., 1998; Ambrosetti et al., 2000; 
Boyer et al., 2005; Levine and Brivanlou, 2006; Babaie et al., 2007; Johnson et al., 2008).  
Co-occupancy of OCT4, SOX2 and Nanog at their target genes determines the activity of 
auto-regulatory feedback loops involved in retaining pluripotency (Boyer et al., 2005).  As 
such these three genes are thought to be the master regulators of pluripotency.   
The use of these transcription factors in characterising a pluripotent population must be 
undertaken following an understanding of their gene expression profile.  In 2006, 
alternative splice variants of the OCT4 protein were identified in culture (OCT4A, OCT4B 
and OCT4B1), each with different expression patterns across different cell populations 
(Cauffman et al., 2006).  Expression of the OCT4A isoform is detectable in hESC and EC 
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populations; however, OCT4B is located in the cytoplasm of non-pluripotent cells and is 
therefore likely to have an alternative role in cellular function (Atlasi et al., 2008).  On 
further investigation, the OCT4B1 isoform was identified as nucleus specific, expressed only 
in pluripotent cells and has been shown to be down regulated following differentiation 
(Atlasi et al., 2008).  Prior to identification of the various OCT4 isoforms, early pluripotency 
studies used antibodies raised towards all OCT4 splice variants, raising concerns over the 
validity of these results generated during historical differentiation studies.  This example 
clearly highlights the need for further research in the field of pluripotency regulation, and a 
detailed understanding of different protein isoforms when used for population 
identification. 
It is the complex interactions between OCT4, SOX2 and Nanog which retain a cells 
pluripotent state; however, SOX2 has also been shown to play a role in neurogenesis by 
regulating self renewal and differentiation of neural precursors (Graham et al., 2003; 
Episkopou, 2005)  
Additional markers have been identified in pluripotent populations which are down 
regulated during differentiation (Table 1.1), these include a range of cell surface antigens: 
stage specific embryonic antigen-3 (SSEA3) and SSEA4, trafalgar-antigen-1-60 (Tra-1-60) 
and Tra-1-81, and enzymes: alkaline phosphatase and telomerase reverse transcriptase 
(TERT) (Thomson et al., 1998; Cowan et al., 2004; Adewumi et al., 2007). 
Marker Location Description
SSEA3 Cell surface Globoseries membrane bound glycolipid
SSEA4 Cell surface Globoseries membrane bound glycolipid
Tra-1-60 Cell surface Keratin sulphate associated antigen
Tra-1-81 Cell surface Keratin sulphate associated antigen
OCT4 Nucleus Transcription factor
SOX2 Nucleus Transcription factor
Nanog Nucleus Transcription factor
 
Table 1.1. Human embryonic stem cell markers. 
Expression of these markers were identified in the first hESC line derived and are used as signature markers for 
all pluripotent hESC lines.  
 
The loss of pluripotency and the gain of neuron specific markers can be used to track a cells 
progress through differentiation.  In this way, changes in marker expression can be used to 
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monitor the efficiency of differentiation and compare cell populations.  Changes in the 
expression of these markers can be detected using immunocytochemistry, with 
fluorescently conjugated antibodies towards a specific epitope to identify the presence of 
the marker protein.  Fluorescently labelled cells can be quantified using flow cytometry 
analysis or imaged using epi-fluorescence or confocal imaging, these tools help to build up 
the phenotypic profile of a population of cells.  In addition to fluorescently conjugated 
antibodies, a number of hESC lines have been transfected with green fluorescent protein 
(GFP) conjugated to a promoter which is placed under the control of specific pluripotency 
genes (Singh Roy et al., 2005; Gerrard et al., 2005b; Wernig et al., 2007).  By combining 
with bright field and epi-fluorescence imaging, the GFP expressing cell lines are proving to 
be excellent tools for observing changes in cellular behaviour in situ.  Using this principal, 
changes in gene expression can be observed using long term live cell imaging, generating a 
wider picture of cellular behaviour and response to cell culture conditions.  The additional 
benefits of live cell imaging have been described in detail in Chapter 6. 
Whilst a number of key markers for pluripotency have been characterised, the factors 
which control their expression are less well understood.  Under suboptimal culture 
conditions, hESCs lose expression of these markers and begin to differentiate.  This would 
seem to be a logical process, since cells of ESC morphology are only transient in the 
developing embryo and quickly commit into a developmental pathway for embryogenesis.  
To retain the pluripotent state of these cells in vitro, it is necessary to block this natural 
progression to differentiate.  Retention of pluripotency in hESCs is achieved using 
co-culture with a mouse fibroblast feeder cell layer.   
 
1.9.2 Feeder layers 
The co-culture of ESCs with feeder layers to retain pluripotency has been used since the 
derivation of the first mouse ESCs (Evans and Kaufman, 1981).  The feeder layers for hESC 
culture, most commonly comprise mouse embryonic fibroblasts (MEFs), which secrete 
growth factors into the media and extracellular matrices onto the culture surface which 
work to sustain pluripotency amongst hESCs.  Although not yet fully defined, many of these 
secreted factors have been identified, examples include: basic fibroblast growth factor 
(bFGF/FGF2), transforming growth factor-β2 (TGF-β2), extracellular matrix (ECM) proteins 
(type IV collagen, laminin and fibronectin), Wnts, BMP/TGF-β1, activin/Inhibin, and insulin-
like growth factor-1 (IGF-1) (Alitalo et al., 1982; Moscatelli et al., 1986; Amit et al., 2004; 
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Wang et al., 2005a; Chen et al., 2006; Prowse et al., 2007; Villa-Diaz et al., 2009).  To 
prevent the overgrowth of hESCs by the feeder layer, iMEFs are mitotically arrested by 
γ-irradiation or Mitomycin C which prevents MEF proliferation whilst retaining their 
metabolic activity (Roy et al., 2001; Conner, 2001).   
Despite a loss of proliferative capacity and a subsequently reduced lifespan of the iMEFs, 
the use of cross species co-culture systems, raises concern over cross-species 
contamination of hESCs.  These concerns were supported when murine sialic acids which 
had integrated into the membrane of hESCs were identified (Martin et al., 2005).  With this 
in mind, the likelihood of using hESC lines co-cultured with MEFs in therapeutic treatment 
is poor.  However, their incorporation into hESC studies has generated considerable data 
covering behaviour and differentiation of hESCs and the affordability of using this 
co-culture system maintains their existence in hESC research.   
With a view for therapeutic application, focus shifted towards the growth of hESCs in the 
absence of MEF layers.  Initial studies using human dermal fibroblast feeders reported 
success in retaining pluripotency (Richards et al., 2002; Amit et al., 2003; Choo et al., 2004); 
however, even same species feeder layers do not negate all risk of human viral 
transmission creating additional problems for risk management and licensing in therapeutic 
applications. 
Feeder-free hESC culture was subsequently achieved using MEF conditioned media 
supplemented with bFGF on a MatrigelTM coated surface (Ludwig et al., 2006a).  Basic FGF 
is regularly supplemented into hESC culture media both in the presence and absence of 
iMEFs, to improve clonal efficiency and prolonged pluripotent cell culture by inhibiting BMP 
induced differentiation (Amit et al., 2000; Xu et al., 2005; Levenstein et al., 2006).  
However, MatrigelTM is a gelatinous protein matrix secreted by mouse tumour cells 
(Kleinman et al., 1982; Kleinman and Martin, 2005), and its use in combination with MEF 
conditioned media retains the exposure to animal derived products in hESC culture, 
thereby maintaining a risk of cross-species contamination.   
The first hESC line which was entirely free from animal products was derived in 2006 
(Ludwig et al., 2006a).  These cells were cultured on a matrix of human derived collagen IV, 
fibronectin, vitronectin and laminin, in a synthetic media (TeSR1) containing a cocktail of 
recombinant growth factors known for their involvement in pluripotency; (Section 1.9.3.8) 
(Ludwig et al., 2006a).   
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1.9.3 Cell culture media 
Different cell lines have different growth requirements which must be accounted for in the 
choice of media used for culture.  In a differentiation study, whereby the cell population is 
changing, it is important to understand the different growth requirements for each 
transient cell type and identify the media components which can best provide support.  In 
the case of directed differentiation, a change of media composition can be used to select 
for the survival of target cell populations.   
During early cell culture the conditions required for cell expansion were poorly understood.  
The first in vitro cell cultures, used extracts of natural body fluids for survival and expansion 
(reviewed by Freshney, 2005).  Extensive biochemical analysis of these fluids provided the 
formulations for artificial cell culture media (Freshney, 2005).  In 1955, the formulation for 
the first defined cell culture media was produced – Eagle’s Basal Medium, and subsequent 
decades saw the development and refinement of this media into a range of media for cell 
types of varied origin (Eagle, 1955; Freshney, 2005).  
 
1.9.3.1 DMEM 
Dulbecco’s modification of Eagle’s Medium (DMEM) was adapted from earlier media 
compositions for specific use in mouse fibroblast cultures but has since become a widely 
used medium for many different cell types (Freshney, 2005).  DMEM is a highly nutritious 
media with twice the amino acid and four times the vitamin concentrations of basic MEM 
(Freshney, 2005).  Most significantly, DMEM contains glucose, a carbon source for 
glycolysis.  A CO2 atmosphere is required to maintain a balanced pH in most for cell culture 
media.  The presence of pyruvate in the media serves several purposes.  Pyruvate is an 
energy source for rapidly dividing cells, and also enables increased oxidative 
decarboxylation of H2O2 resulting in the production of CO2 and water; this reduces cellular 
exposure to reactive oxygen species whilst at the same time reducing the requirement for 
exogenous CO2 (Freshney, 2005; Babich et al., 2009).   
 
1.9.3.2 Serum 
The continued reliance on natural serum for cell culture results from its as yet undefined 
composition.  As time progresses the factors within serum which are essential for cellular 
survival and expansion are slowly being identified.  In addition to uncharacterised growth 
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factors, serum contains a range of hormones including insulin which promotes the uptake 
of glucose and amino acids, which aids fatty acid and glycogen synthesis within the cells.  
Insulin has been shown to improve the plating efficiency of cells in the absence of serum, 
but must be supplemented at high concentrations due to its instability at 37 °C (Barnes and 
Sato, 1980; Freshney, 2005).  The presence of fibronectin and fetuin improve cellular 
attachment and spreading of cells in media containing serum (Freshney, 2005). 
Serum also contains iron binding proteins such as transferrin and albumin which carry 
lipids, minerals and globulins (Barnes and Sato, 1980; Freshney, 2005).  These binding 
proteins stabilise and mop up toxic by-products of cell metabolism: oxygen radicals and 
peroxidase (Barnes and Sato, 1980).  A range of protease inhibitors have also been 
identified in serum, which aid cell survival following passaging by scavenging proteases or 
hydrolases released by dead and dying cells (Barnes and Sato, 1980).  It is therefore 
important to change serum-free media regularly and soon after passaging to remove cell 
debris and inhibitory enzymes from culture.  
 
1.9.3.3 Glutamine/GlutaMAXTM 
Glutamine is utilised by most cells in culture as a carbon source for metabolism (Freshney, 
2005).  However glutamine stability at 37 °C is poor, and deamination produces ammonia 
which is toxic to the cells, limiting growth, requiring regular media changes.  The use of 
synthetic glutamine substitutes such as GlutaMAXTM, an alanyl-glutamine di-peptide, which 
have different break-down pathways has been shown to minimise ammonia accumulation 
and improve cell survival.   
 
1.9.3.4 Knockout DMEM 
The optimal osmolarity required by ESCs for successful culture is lower than that of the 
common fibroblast cell lines, as was determined from early studies on mESCs (Gonzalez et 
al., 2007).  Knockout-DMEM (KO-DMEM) was developed with a lower osmolarity and 
bicarbonate content than standard DMEM to suit this ESC requirement.   KO-DMEM is 
usually supplemented with 20 % KnockoutTM serum replacement (KOSR) for optimal hESC 
growth and expansion.  
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1.9.3.5 KnockOutTM serum replacement 
The use of KO-SR became standard in hESC culture following demonstration that the clonal 
efficiency of hESCs was improved when using KO-SR in place of serum (Amit et al., 2000). 
KO-SR is a defined product, with a proprietary mixture of reagents which support cell 
survival (Price Tilkins Goldsborough 1998 Embryonic stem cell serum replacement 
International patent application WO98/30679).  The use of KO-SR reduces variation in hESC 
culture from the natural variation in foetal bovine serum; however, KO-SR retains 
transferrin, insulin, BSA and a mixture of other protein and non-protein components of 
animal origin which mean batch-batch variation is still a likely possibility.  Batches of KO-SR 
must therefore be tested for optimum undifferentiated growth of hESCs before routine 
culture is carried out. The addition of BSA in this media means it is not animal 
component-free and therefore not likely to be approved for use in the culture of hESCs for 
therapy.   
In addition to KO-SR supplementation of KO-DMEM, hESC media is supplemented with 
2 mM GlutaMAXTM in place of L-glutamine for improved stability, 1 X NEAA, 10 µM 
β-mercaptoethanol and 4 ng.ml-1 bFGF.   
 
1.9.3.6 Non-essential amino acids 
In 1955 an experiment was carried out to determine the amino acid requirement for in 
vitro culture of mammalian cells (Eagle, 1955).  Mouse fibroblasts were used as the model 
line which identified 12 essential amino acids (arginine, cystein, histidine, isoleucine, 
leucine, lysine, methionine, phenylalanine, threonine, tryptophan, tyrosine and valine) and 
7 non-essential amino acids (alanine, aspartic acid, glutamic acid, glycine, hydroxyproline, 
proline and serine (Eagle, 1955)).  DMEM media contains all the essential amino acids in 
addition to serine and glycine (Freshney, 2005).  Supplementation of KO-DMEM with 
non-essential amino acids improves protein synthesis and cellular growth and function. 
 
1.9.3.7 Beta-mercaptoethanol 
Beta-mercaptoethanol (β-ME) has been incorporated into embryonic stem cell culture 
since the first mESC lines were derived (Evans and Kaufman, 1981).  It scavenges reactive 
oxygen species, protecting cells from oxidative stresses. 
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1.9.3.8 Feeder free media - TeSR1 
A number of factors in addition to bFGF are involved in the support of pluripotency, 
including but not limited to: noggin, TGFβ1, lithium chloride (LiCl), γ-aminobutyric acid 
(GABA), neurotrophins (Wang et al., 2005a; Amit, 2006; Moore, 2006; Pyle et al., 2006; 
Ludwig et al., 2006a).  In 2006 a defined serum- and animal-free medium was developed, 
comprising recombinant bFGF, TGF-β, LiCl, gamma-aminobutyric acid, pipecolic acid and 
human albumin in place of BSA.  This media is referred to as TeSR1 (Ludwig et al., 2006a) 
and is used for hESC derivation and expansion in combination with cell culture surfaces 
pre-coated with fibronectin, human collagen and laminin for clinical grade lines (Ludwig et 
al., 2006a).  A modified version of TeSR1 was later developed (mTeSR) using animal derived 
BSA and MatrigelTM to reduce the cost of the defined media, increasing its accessibility in 
smaller laboratories worldwide (Ludwig et al., 2006b).  Although use of mTeSR enables 
hESC culture in the absence of MEFs, reducing variation and preparation times, the effect 
of long term culture on mTeSR media remains controversial with question over the 
karyotypic stability of hESCs after long term mTeSR culture.     
 
1.9.4 Karyology  
The existence of pluripotent cells in the developing embryo is only transient, before their 
programmed commitment into one of the three germ layers.  The in vitro expansion of 
pluripotent populations therefore actively inhibits a cells natural progression into 
differentiation.  Long term inhibition of the natural behaviour of a cell will inevitably impact 
upon internal programming, adapting for survival in what should be considered ‘abnormal’ 
conditions.  Indeed, many laboratories have reported adaptations which enhance the 
survival and proliferation of hESCs in the form of karyotypic abnormalities, frequently 
resulting in additional copies of chromosomes 12, 14, 17, 20 and X (Cowan et al., 2004; 
Rosler et al., 2004; Draper et al., 2004a; Mitalipova et al., 2005; Catalina et al., 2008).  
Additional copies of these chromosomes, or the genes within them, have been associated 
with uncontrollable proliferation in tumours, especially trisomies for 17q (Petty et al., 1996; 
Plantaz et al., 1997; Glukhova et al., 1998; Katoh et al., 2005; Kasamatsu et al., 2005; Choi 
et al., 2006).  The frequent occurrence of these reported instabilities is of high concern for 
the incorporation of hESCs into regenerative therapies, for fear of tumour formation 
following transplantation (Buzzard et al., 2004a).  As such, karyotypic analysis of hESCs is 
rapidly becoming a routine part of hESC culture, and is frequently questioned in the event 
of unexpected behaviour.   
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The cause of karyotypic alterations is the subject of debate but are thought to be 
influenced by a range of factors including: the age of the hESCs, the choice of cell line or 
the adaptation to feeder-free culture (Buzzard et al., 2004a; Draper et al., 2004a; Catalina 
et al., 2008).  In addition, the methods applied during routine passaging and expansion of 
hESC have also been targeted as a possible instigator of karyotypic instability (Buzzard et 
al., 2004a; Mitalipova et al., 2005).  Following initial derivation of hESCs, mechanical 
passaging whereby cells are transferred to fresh culture in clusters, has proven to be 
efficient at retaining karyotypic stability (Buzzard et al., 2004a; Mitalipova et al., 2005); 
however, it is highly labour intensive and as such is not amenable to large scale hESC 
culture.   
Enzymatic passaging was incorporated into hESC culture to facilitate hESC expansion; 
however, these reagents function by cleaving cell-cell bonds, frequently dissociating cell 
layers into single cell suspensions.  The result of which is thought to reduce cross-talk 
amongst hESC populations, and induce the accumulation of mutations which facilitate 
survival under these conditions.  Not all publications indicate gross karyotypic 
abnormalities following enzymatic passaging (Catalina et al., 2008; Thomson et al., 2008); 
however, it is possible that the reasons for this may be due poor detection of small 
abnormalities rather than an absence of their occurrence.  More recently, small alterations 
in chromosome content amongst hESC lines previously reported as ‘normal’ have been 
identified using array Comparative Genomic Hybridisation (aCGH) (Thomson et al., 2008).  
Array CGH detects changes in copy numbers of small DNA nucleotide sequences.  The use 
of this technique in hESC culture enables the detection of small gains or deletions in DNA to 
an accuracy of 100 kb, thus providing a more accurate report of a cell line’s karyotype 
(Shinawi and Cheung, 2008).  It should be noted that, aCGH does not detect chromosomal 
translocations, therefore serves as a supplement to G-banding analysis rather than a 
replacement.  The effect of karyotypic instability on the behaviour of hESCs following 
differentiation is a largely unexplored area, and is investigated in more detail in later 
sections.   
 
1.9.5 UK Stem Cell Bank (UKSCB) 
In 2003 the Medical Research Council (MRC) and Biotechnology and Biological Sciences 
Research Council (BBSRC) funded the establishment of the UK Stem Cell Bank (UKSCB) at 
the National Institute for Biological Standards and Control (NIBSC; Potters Bar, UK); the 
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UKSCB holds master stocks of all stem cell lines (adult, foetal and embryonic) for use in 
stem cell research and therapeutic applications.  Under HFEA and HTA regulations, every 
newly derived hESC line must be deposited with the UKSCB, for banking and 
characterisation under strict quality control (QC) procedures.  In this way, a consistent 
source of stem cells is available for comparative research between laboratories (Healy et 
al., 2005). 
Regulations by the human fertilisation and embryology authority (HFEA) and human tissue 
authority (HTA) stipulate that hESC lines may only be derived from embryos which are 
surplus to requirements following IVF treatment, which have been donated with parental 
consent and would otherwise be destroyed.  However, the fact remains that the generation 
of hESC lines ultimately results in the destruction the embryo which has ethical 
implications.  Advances in the hESC line derivation from single cells and the genetic 
reprogramming of somatic cells, to an induced pluripotent state (iPS cell) for subsequent 
directed differentiation, may reduce future reliance upon the embryo (Takahashi and 
Yamanaka, 2006; Takahashi et al., 2007).  However, reprogramming currently relies upon 
retroviral transduction which has been shown to induce tumour formation in a murine 
model following incorporation into a developing blastocyst (Klimanskaya et al., 2006; Okita 
et al., 2007).  Whilst this may be a promising avenue for generating large numbers of 
patient specific cells for therapy with limited ethical restriction, it is likely to be many years 
before reprogramming meets the safety regulations required for routine therapy. 
 
1.10 Adult stem cells 
An adult stem cell is an undifferentiated cell found in a differentiated tissue, capable of 
self-renewal and differentiation into specialised cell types.  Adult stem cells have been 
discovered in a range of tissues in the body including bone marrow, cord blood, brain, 
intestinal tract, eye, liver, skin (Knudtzon, 1974; Potten and Loeffler, 1990; Weiss et al., 
1996; Alonso and Fuchs, 2003; Limb et al., 2006) and there are likely to be many more yet 
to be discovered.  Mesenchymal stem cells are probably the most well characterised adult 
stem cells, and can be used for the derivation of hematopoietic and non-hematopoietic 
cells, such as bone, cartilage, muscle and neural cells (Pittenger et al., 1999).  Umbilical 
cord stem cells derived shortly after birth, can be used for bone marrow therapy in place of 
adult bone marrow.  Adult stem cells have a defined expansion capacity and more limited 
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scope for differentiation when compared to pluripotent hESCs, limiting the number of 
applications for which a single sample can be applied.   
 
1.11 Embryonal Carcinoma cells 
Most of the current understanding of hESC culture derives from more than three decades 
of research on an alternative source of pluripotent cells, isolated from germ cell (GC) 
tumours which contain a haphazard array of differentiated cell types.  These tumours are 
known as teratocarcinomas and occur most commonly in the testis and ovaries, although 
have been identified in alternative anatomical sites including the base of the spine 
(Andrews et al., 2001).  In some cases these tumours are benign and can be removed 
without complication; however, if these tumours retain an uncommitted proliferating 
population of cells they often become malignant.  The stem cells within these tumours 
were originally identified in 1964  and termed ‘embryonal carcinoma’ (EC) cells due to their 
apparent recapitulation of embryonic-like development within the tumour, generating an 
array of distinct cell types (Kleinsmith and Pierce, 1964).   
Perhaps a symptom of the tumour origin of these cells, EC cells often gain and lose 
chromosomes over time in culture and are subsequently aneuploidy in nature.  This may 
pose a problem when considering the use of hEC cells for therapy, for fear of tumour 
formation.  Early trials from transplantation of hEC derived post mitotic neurons into the 
infracted site of the brain in stroke patients, showed cellular integration with no signs of 
tumour formation, in the 2 years following transplantation (Kleinsmith and Pierce, 1964; 
Nelson et al., 2002).  Despite this result subsequent little investigation has been carried out 
into the incorporation of hEC derived cells into transplantation therapies, likely to be a 
result of fear from the unknown, and prevention of any possible deleterious side effects. 
Many hEC cell lines maintain similar morphology to hESC lines, and are often easier and less 
expensive to culture, without ethical restrictions on their use.  In alignment with their 
similarity to embryonic development, hEC cells are an excellent facility as a model for 
neurogenesis in vitro. 
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1.11.1 2102Ep 
The 2102Ep cell line was derived from a testicular teratocarcinoma in 1980 (Andrews et al., 
1980; Andrews et al., 1982).  This cell line stably expresses the typical markers of 
pluripotency (Section 1.9.1) but responds poorly to differentiation stimuli (Matthaei et al., 
1983).  If consistently grown at low cell density, initial signs of differentiation can be 
observed (Andrews et al., 1982), although cultures can be readily recovered into a 
pluripotent state over time.  The inability to successfully differentiate this line makes its 
incorporation into any cell therapy risky for fear of tumour formation.  However, the 
likeness of hEC cells to hESCs in appearance and expression of pluripotency markers makes 
it a useful research tool as control line for studies into pluripotent hESC behaviour.  Indeed 
the 2102EP hEC cell line was used as a control in a large scale comparative study of hESCs 
by the International stem cell initiative (Section 1.5.3.4; (Adewumi et al., 2007)). 
 
1.11.2 NTERA2 
NTERA2 is an alternative hEC cell line to 2102EP.  The origin of NTERA2 dates back to 1975 
when the predecessor cell line TERA2 was derived from a testicular germ cell tumour (Fogh 
and Trempe, 1975).  In 1984 the TERA2 line was passaged through an athymic (nude) 
mouse, generating a tumour containing cell types from all three germ layers (Andrews et 
al., 1984).  Subclones of the proliferating population of this tumour were later created in 
culture and to date the most common clone used in research is NTERA2.Cl.D1.  Similarly to 
the 2102Ep cell line, undifferentiated NTERA2 can be continually expanded in culture and 
express common markers of pluripotency (Section 1.9.1), which are down regulated during 
differentiation (Andrews et al., 1996; Andrews et al., 2001).   
The NTERA2 cell line presents a highly variable karyotype, which might be expected when 
reminded of its tumour origin.  Early publications from the sourcing laboratory (Professor. 
P. Andrews, University of Sheffield) published a modal hyper-tetraploidy 63 XY karyotype 
including a translocation of the terminal arm of chromosome 1 (q23-qter) onto 
chromosome 9, in addition to the presence of a marker chromosome t(12;13)(q13;qter) in 
all cells (Andrews et al., 1984; Duran et al., 2001).  In addition to the tumour origin, the 
many years of adaptation into in vitro culture across worldwide laboratories, is likely to 
have further contributed to additional karyotypic abnormalities.  
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Directed differentiation of the NTERA2.Cl.D1 subclone has shown that these cells readily 
differentiate into an array of different cell types, in response to hexamethylene 
bisacetamide (HMBA), bromodeoxyuridine (BUdR) and members of the BMP family of 
signalling molecules (Andrews et al., 1990; Andrews et al., 1994).  However, since the 
discovery that all-trans-retinoic (ATRA) induces neuronal differentiation in EC cell lines  
(Jones-Villeneuve et al., 1982), NTERA2 has been used extensively in research towards 
understanding neurodegeneration and neurogenesis.   
The NTERA2.Cl.D1 sub clone has been shown to lack many of the genes involved in the 
nodal signalling pathways (Schwartz et al., 2005) which are essential for the differentiation 
of mesodermal and endodermal derived cell types  (Pfendler et al., 2005).  This would 
suggest that the neuroectodermal lineage is the favourable option for NTERA2 
differentiation and might explain why neurons are the predominant identifiable cell types 
within differentiated NTERA2 cells.  For this reason the NTERA2 hEC cell line is an excellent 
starter line for understanding neuronal differentiation from pluripotent cell lines. 
 
1.11.3 Screening for neuronal functionality 
Neuronal functionality is not guaranteed by the ability to produce neurotransmitters, or by 
the presence of receptors for transmitters in the plasma membrane but rather by the 
behaviour of the neuron upon neurotransmitter binding.  The functionality of neurons can 
be tested using techniques such as patch clamping and calcium imaging. 
 
1.11.3.1 Patch clamping 
The patch clamp technique was developed in 1976 by Bert Sakmann and Erwin Neher 
(Neher et al., 1978), revolutionising studies of cellular physiology by enabling the study of 
membrane bound ion channels.  The method uses a fine glass capillary which is placed 
close to the membrane of the cell.  Suction is usually applied to the capillary drawing the 
membrane and capillary into a seal, usually in the gigaohm (GΩ) range, referred to as a GΩ 
seal.  For whole cell patching, where the behaviour of the entire cell rather than an 
individual ion channel is recorded, further suction may be applied to break the cell 
membrane.  To prevent dialysis of the cell, the capillary tube is filled with a fluid roughly 
matching the composition of intracellular fluid.  A fine electrode is located within the glass 
capillary and is able to transmit a current into the cell to alter its polarity.  By controlling 
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the polarity of the cell, it is possible to monitor for the presence and activity of ion channels 
in the membrane.  Patch clamping can be performed using either current clamp or voltage 
clamp modes. 
Current clamping measures the voltage within a single cell, relative to the voltage outside.  
It is a method for recording the voltage of an excitable cell while keeping the electrical 
current constant.  A low impedance microelectrode is attached to the cell through the 
patching capillary, and a background electrode in the fluid around the cell is connected to a 
differential voltage amplifier.  The output from the amplifier is displayed on an oscilloscope 
for analysis.   
In contrast, voltage clamping measures the flow of ions in and out of the cell whilst keeping 
the membrane voltage constant.  Due to the sensitive nature of the currents under 
investigation, patching is usually carried within a Faraday cage to eliminate interference 
from external influences.  (See Figure 1.3 for a typical recording from a neuronal action 
potential). 
 
1.11.3.2 Calcium imaging 
The fluorescence imaging plate reader-96 (FLIPR; Molecular Devices, California) is a high 
throughput screening device for real-time capture of receptor and ion channel activity 
across a population of cells.  The FLIPR is primarily used in the pharmaceutical industry for 
drug screening to monitor dose dependent cellular responses to a neurotransmitter or 
novel drug.  The UCL FLIPR is currently the only machine of its kind for use in an academic 
setting.   
The system runs on a 96-well plate format enabling screening of up to 96 individual, or 32 
triplicate samples in parallel.  The FLIPR has precise control over temperature and humidity, 
minimising external influences on cell behaviour and is able to simultaneously deliver a 
drug to all 96 wells.  As such, the FLIPR can be used to rapidly characterise the functional 
behaviour of large populations of neurons.   
Calcium flux across a cell can be monitored by the coupling or decoupling of free Ca2+ to a 
pre-loaded calcium indicator dye: Fluo-4-AM.  When bound by Ca2+, the dye forms a 
complex which is excited by an argon laser at 488 nm.  Emitted light (~550 nm) is captured 
by a charge coupled device (CCD) camera.  Changes in fluorescence can be correlation to 
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levels of cytoplasmic Ca2+.  The ability of the camera to focus on a monolayer of cells, 
avoids detection of background fluorescence.   
By measuring the fluorescence before, during and after stimulation, Ca2+ flux across the cell 
membrane can be observed.  Fluorescence values are usually recorded every second for 
five minutes generating a detailed picture of the response to stimulation.  The typical 
response of a cell can be divided into several phases (Figure 1.4; A-F).  Recordings are 
usually captured for 30 seconds prior to addition of the stimulus to establish the 
background fluorescence from cytosolic Ca2+(A).  Addition of the neurotransmitter (B) 
dilutes the overall sample volume, therefore reducing background fluorescence (C).  If a cell 
expresses functional receptors to the stimulant, membrane Ca2+ channels open and 
cytosolic Ca2+ levels increase, resulting in an overall increase in fluorescence (D-E).  
Increased cytosolic calcium levels alter a cells polarity, initiating the opening of ion pumps 
to pump free Ca2+ out of the cell (F), thus returning to basal levels.   
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Figure 1.3. Description of a neuronal action potential.   
During patch clamping a cell is commonly hyperpolarised to reduce the membrane voltage to -70 mV.  Release 
of the hyperpolarising current causes voltage gated ion channels in the membrane to open and initiates an 
influx of Na
+
 or Ca
2+
 ions into the cell.  This causes rapid depolarisation, generating an electrical impulse (AP).  
The change in polarity causes membrane voltage gated K
+
 channels to open and K
+
 ions to flow out of the cell 
returning the polarity to its resting state. 
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Figure 1.4. Typical cellular calcium response to stimulation on the FLIPR.  
The 6 phases of a typical calcium response of a cell to neurotransmitters in the FLIPR.  The response from each 
cell was standardised to ensure background fluorescence was equal to one.  A - fluorescence from resting levels 
of cytosolic Ca
2+
.  B - addition of the neurotransmitter.  C - baseline fluorescence, Ca
2+ 
channels open.  D - influx 
of calcium and binding to Fluor-4-AM resulting in increased fluorescence.  E - maximum fluorescence.  
F - calcium pumped out of cell or sequestered to cytoplasmic stores.    The overall calcium response can be 
determined by the difference between C and E. (i.e. the difference between the maximum and minimum 
fluorescence values after addition of the drug.) 
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1.12 The need for a reproducible source of neurons 
The availability of human primary neurons is extremely limited.  With the exception of 
olfactory neurons which are constantly renewing, mature mammalian neurons are not very 
mitotically active  (Moulton, 1970).  It is possible to commercially source neural stem cell 
lines such as Millipore’s ReNcell® VM neural stem cell line (MilliporeTM, Massachusetts, 
USA) for expansion and differentiation; however, cells often lose their ability to 
differentiate into a range of terminal neurons following expansion which in itself is limited 
by the proliferative capacity of a neural progenitor cell   (Elkabetz et al., 2008; Bajpai et al., 
2009).  It is possible to derive neurons from cell lines isolated from neuroblastomas such as 
the SH-SY-5Y  (Encinas et al., 2000); however, expansion and maturation of these neurons 
in vitro and their response to stimulation is variable and in most instances is limited to a 
slow response.   
Primary neurons for pharmacological screening are routinely sourced from animal models 
and are most commonly of mouse or rat origin.  In such cases, animal derived neurons are 
usually sufficiently sensitive to stimulation for comparison to in vivo scenarios; however, 
sourcing these neurons requires regular animal sacrifice.  There is therefore a requirement 
for a continual source of functional neurons to relieve the reliance on animal sacrifice and 
facilitate early drug screening.  Ideally these would come from a continuous cell line which 
would enable expansion of neuronal populations as required. 
Additionally, incorporation of primary animal source neurons into routine cell therapies is 
unlikely due to risks of transmission of cross-species infections.  Production of a reliable 
supply of functional neurons in vitro, under GMP grade conditions, from a continual supply 
would enable routine applications for cell based regenerative therapies.   
In order to generate a cell therapy which produces sufficiently large numbers of neurons it 
is essential to have a source of cells which are expandable, and a process of differentiation 
which generates reproducible yields of cells for transplantation.  Incorporation of 
pluripotent cells into this process offers the opportunity for cellular expansion prior to 
neural commitment, enhancing the final neuronal yield for therapy.  Many worldwide 
laboratories have researched neuronal differentiation from pluripotent cells with varied 
levels of success  (Carpenter et al., 2001; Zhang et al., 2001; Baharvand et al., 2007; 
Iacovitti et al., 2007).  In most cases, cells of neuronal morphology have been derived; 
however, comment is rarely made regarding the reproducibility of differentiation.  Personal 
communications frequently report varying degrees of success.   
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In most pluripotent differentiation systems, comment over the purity of the definitive 
neuronal phenotype is largely avoided due to the mixed array of neurons (both inhibitory 
and excitatory) at the end stage of differentiation which would undoubtedly result in a 
varied response following stimulation.  Equally, for a therapy to replace a definitive cell 
type (as would be the case for PD), the neuronal subclass would not only need to be of a 
dopaminergic phenotype but would also need to generate the specific A9 dopaminergic 
neurons lost during PD whilst expressing functional machinery for reliable dopamine 
synthesis on demand.   
With this in mind, mechanisms of neuronal differentiation must be extensively 
characterised to yield sufficient numbers of neurons which may form just a small 
proportion of the final neuronal yield.  In order to achieve this goal, it is first necessary to 
further our basic understanding of the starting cell pools for differentiation; that is the 
pluripotent cell populations.  
The transient nature of hESCs in embryonic development would suggest that these cells are 
highly susceptible to differentiation stimuli.  Indeed these cells will have already been 
exposed to differentiation cues prior to derivation to initiate their position within the ICM.  
Removal or addition of cells from the ICM results in a normal progression of embryonic 
development without the loss or gain of developmental features  (Teramura et al., 2007), 
confirming that the cells of the ICM are uncommitted to differentiation into a specified 
tissue.  However, when considering the speed to embryonic development, it might be 
suggested that the position of a cell within the ICM induces a preference rather than a 
commitment into a differential fate, which is overridden in the event of interruption. 
The various methods of hESC derivation and expansion are likely to have varied affect on 
the communication and survival of hESCs during early stages of cell line establishment, 
inducing a selective advantage of hESC subpopulations for expansion.  This might explain 
the variable behaviour observed between different hESC lines despite similar pluripotent 
morphology.  Using this theory, it is possible that some pluripotent lines may be more 
suited to neuronal differentiation than others.   
The characterisation of pluripotent cell lines in response to in vitro expansion has been 
subject to investigation throughout this project, focusing on the behaviour of different 
pluripotent cell lines in response to directed neuronal differentiation and their subsequent 
neuronal yield, phenotype and function.  The results of this study are presented herein. 
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1.13 Aims and Objectives 
This project aims to investigate the effect of in vitro culture on the comparative stability, 
expansion and neuronal differentiation of different pluripotent cell lines, with a view to 
testing the following hypotheses:  
 
Hypotheses:  
1. The method of culture (enzymatic or mechanical) does not affect the karyotypic 
stability of a pluripotent cell line in culture.   
2. Pluripotent cells are equally directable into neuronal differentiation when cultured 
under standardised and controlled conditions. 
3. The method of culture does not affect the ability of a pluripotent cell line to be 
differentiated into a functional neuron.   
 
 
To our knowledge a comparative study into the effect of mechanical and enzymatic 
passaging on neuronal differentiation across a range of pluripotent cell lines has not been 
previously carried out.   
 65 
2 Materials and Methods 
2.1 Standard cell culture media 
2.1.1 Glutamine culture media 
Dulbecco’s modified Eagle’s medium (DMEM; Gibco, Rockville, MD, 21969-035), 
supplemented with 10 % (v/v) foetal bovine serum (FBS; Gibco, 10108-157) and 2 mM 
L-glutamine (Gibco, 25030-032). 
 
2.1.2 GlutaMAXTM culture media 
Dulbecco’s modified Eagle’s medium (Sigma, St Louis, D6546) supplemented with 
10 % (v/v) FBS (Biosera, East Sussex, UK, S170G) and 2 mM GlutaMAXTM (Gibco, 
31980-022). 
 
2.1.3 Freeze media 
Mix 10 % (v/v) dimethyl sulfoxide (DMSO; VWR international, 103232J) with 90 % (v/v) FBS. 
 
2.2 Cryopreservation 
Cells were detached from adherent culture using TrypLETM Express (Gibco, 12604-013) and 
counted using a bright line haemocytometer (Section 2.3).  Cells were washed in standard 
culture media, followed by centrifugation at 170 g for 3 minutes.  Cells were resuspended 
at the desired density in standard freeze media (Section 2.1.3), and aliquoted into 1 ml 
cryovials (Corning, 430525).  Vials of cells were placed in a Mr Frosty (Nalgene, 5100-0001) 
and transferred to -80 °C freezer for 24-48 hours to freeze at a slowed rate of -1 °C/minute.  
Finally cells were moved into Liquid Nitrogen (LN2) for long term storage. 
 
2.3 Cell counting 
Cell viability and number counts throughout this project were calculated using a bright-line 
haemocytometer (Sigma, Z359629).  Cells were resuspended in culture/wash solution and 
100 µl sample removed for dilution 1:1 (v/v) with Trypan blue solution (Sigma, T8154).  The 
haemocytometer and coverslip (Sigma, Z375357) were cleaned with 70 % ethanol and 10 µl 
of the cell suspension added to each side of the haemocytometer.  Eight separate 4X4 grids 
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of the haemocytometer were counted per sample to obtain an idea of both cell number 
and viability.  Viable cells are phase bright and dark cells which have taken up Trypan blue 
as a result of a permeable cell membrane were deemed to be non-viable.  Live:dead cell 
counts were recorded and final numbers from all eight grids were averaged.  Final cell 
counts were multiplied by the dilution factor then 104 giving total and viable cell count.ml-1.  
 
Figure 2.1. Bright-line Haemocytometer. 
Cells were counted in eight 4x4 grids as highlighted by the red-dashed line.  Cells on the top and right hand 
border of the 4x4 grid were counted.  Outlying cells on the bottom and left hand border of the 4x4 grid were 
excluded from all counts.  In the above NTERA2 cell sample 28 viable cells (green arrows), 1 non-viable cell was 
counted (blue arrow). 
 
2.4 NTERA2 
NTERA2.cl.D1 were sourced from Professor Peter Andrews (University of Sheffield) at 
passage 27 (p27) for use in this study.  A master cell bank was prepared following standard 
protocols (Andrews., 1984).  Cells were cultured in NTERA2 culture media (Section 2.4.1) in 
a humidified incubator at 37 ºC, 7 % (v/v) CO2
 using ventilated T75 tissue culture flasks 
(Nunc, TKT-130-210T).  Cultures were grown to approximately 90 % confluence and 
passaged every 3-4 days (Section 2.4.2).  Cultures were re-fed with complete media change, 
every other day. 
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2.4.1 NTERA2 culture media 
High glucose DMEM with no sodium pyruvate (Gibco, 11960) supplemented with 2 mM 
GlutaMAXTM and 10 % (v/v) FBS (Gibco). 
 
2.4.2 NTERA2 passaging  
Spent medium was removed, leaving approximately 5 ml in the flask.  Sterile glass beads 
(Section 2.4.2.1) were added and rolled gently over the growth surface, removing the cells 
from the flask in clumps.  Cells were aspirated up and down three times to break up large 
clumps of cells into small clusters.  Cells were counted using a bright-line haemocytomer 
(Section 2.3) and resuspended in and 5 x 106 cells, seeded into a fresh T75 flasks 20 ml fresh 
culture media (this was approximately a 1:3 split ratio).   
 
2.4.2.1 Glass bead preparation 
Soda lime glass beads (3 mm; VWR, 1.04015.0500) were routinely used for passaging 
NTERA2 stocks.  The beads were cleaned in 2 M hydrochloric acid (HCl) overnight, 
neutralised in an equal volume of 2 M sodium hydroxide (NaOH) and rinsed thoroughly in 
water.  Beads were aliquoted: 20-30 beads/eppendorf tube (VWR, 211-0015) and 
autoclaved prior to use. 
 
2.4.3 NTERA2 differentiation 
Neuronal differentiation from NTERA2 was carried out as previously described by Pleasure 
et al., 1992.  Cells were washed in PBS (without Ca2+ and Mg2+: Gibco, 14190-094) and 
detached from adherent culture using 5 minute exposure to Trypsin/EDTA (Sigma, T4049) 
at 37 °C.  Following detachment, cells were quenched in NTERA2 culture media, pipetted 
up and down to create a single cell suspension and centrifuged to pellet.  Cells were seeded 
into a fresh culture vessel at 2.6 x 104/cm2 flask 0.2 ml NTERA2 differentiation media/cm2 
(Section 2.4.4).  Cells were left to grow for 4 weeks with twice weekly differentiation media 
feeds. 
Four weeks after ATRA treatment, cells were detached from adherent culture and split 1:6 
into fresh culture flasks.  On the following two days, cells were exposed to a rapid 
30 second Trypsin treatment and mechanically dislodged with a sharp knock of the flask 
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with the palm of the hand.  Floating cells were washed with 5 ml NTERA2 culture medium 
and replated into a fresh culture vessel in NTERA2 culture medium supplemented with 
mitotic inhibitors: 1 µM cytosine arabinoside (Section 2.4.4.2), 10 µM fluorodeoxyuridine 
(Section 2.4.4.3) and 10 µM uridine (Section 2.4.4.4).  Cytosine arabinoside has been found 
to kill post-mitotic neurons (Wallace and Johnson, 1989), in addition to fast replicating cells 
and was therefore supplemented into culture for just 1 week.  Fluorodeoxyuridine and 
uridine were incubated for four weeks to prevent non-neuronal cell overgrowth with a 
media change every 3-4 days. 
 
2.4.4 NTERA2 differentiation media 
All-trans-retinoic acid (Section 2.4.4.1) was dissolved in NTERA2 culture media to 10-5 M 
final concentration.   
 
2.4.4.1 All-trans-retinoic acid for NTERA2 differentiation 
One hundred milligrams of all-trans-retinoic acid (ATRA) powder (Sigma, R2625) was 
dissolved in 33.3 ml DMSO producing a 10-2 M stock solution.  The stock solution was 
aliquoted into 1 ml volumes and stored in the dark at -20 °C. 
 
2.4.4.2 Cytosine arabinoside stock solution 
One hundred milligrams cytosine-β-D-arabinofuranoside powder (Sigma, 30399) was 
dissolved in 411 ml water and passed through a 0.2 micron filter, producing a 10-3 M stock 
solution.  This was stored in the dark at -20 °C for up to 12 months as per manufacturer’s 
instructions. 
 
2.4.4.3 Fluorodeoxyuridine stock solution 
One hundred milligrams 5-fluoro-2-deoxyuridine powder (Sigma, F0503-100MG) was 
dissolved in 40.6 ml sterile water and passed through a 0.2 micron filter, producing a 10-2 M 
stock solution. This was stored in the dark at 4 °C as per manufacturer’s recommendations. 
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2.4.4.4 Uridine stock solution 
One hundred milligrams uridine powder (Sigma, U3003) was dissolved in 40.9 ml sterile 
water and passed through a 0.2 micron filter, producing 10-2 M stock solution for storage at 
4 °C.   
 
2.4.5 NTERA2 Cryopreservation 
A master cell bank for NTERA2 was prepared at approximately 5 x 106 cells/vial in 1 ml as 
detailed in Section 2.2.   
 
2.5 2102Ep – Human embryonal carcinoma 
2.5.1 2102Ep cell culture 
The 2102Ep embryonal carcinoma (EC) cell line was cultured in standard GlutaMAXTM 
culture media as previously described (Section 2.1.2).  Cells were grown to approximately 
90 % confluence, washed in PBS and exposed to TrypLETM express at 37 °C for 3-4 minutes.  
The flask was knocked several times sharply against the palm of the hand to dislodge the 
cells from the growth surface.  The TrypLETM reaction was quenched in 5x volume growth 
media and the cells centrifuged to pellet at 170 g for three minutes before replating onto a 
fresh growth surface (~5 x 106 cells per T75 flask). 
 
2.5.2 2102Ep cryopreservation 
Cryopreservation of 2102Ep cells at approximately 5 x 106 cells/vial, was carried out as 
described in Section 2.2. 
 
2.6 SH-SY-5Y - Human neuroblastoma  
2.6.1 SH-SY-5Y cell culture 
The SH-SY-5Y cell line was sourced at passage 7 from the Cell Supply group at NIBSC and 
cultured in MEM:F12 (Gibco, 21765-029: 21090-022) 1:1 (v/v), supplemented with 15 % 
(v/v) FBS, 2 mM L-glutamine and 1 % (v/v) Non-essential amino acids (NEAA; Gibco, 11140) 
in a standard humidified incubator at 37 °C, 7 % CO2.  Upon reaching confluence, cells were 
split 1:5 using 0.25 % (v/v) Trypsin/EDTA solution.  Cultures were fed every 3-4 days. 
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2.6.2 SH-SY-5Y differentiation 
Cells were grown to confluence as described in Section 2.6.1, before dissociation with 
0.25 % (v/v) Trypsin/EDTA solution for 2 minutes at 37 °C.  Samples were quenched with 
SH-SH-5Y culture media and centrifuged at 110 g for 5 minutes.  Cells were resuspended in 
culture media supplemented with 10-5 M ATRA and incubated for eight days in a 37 °C, 7 % 
CO2, humidified atmosphere.   
 
2.6.3 SH-SY-5Y cryopreservation 
Cryopreservation of SH-SY-5Y cells at approximately 5 x 106 cells/vial, was carried out as 
described in Section 2.2. 
 
2.7 Primary neurons from an embryonic day 14 rat 
Tissue sections were sourced from Sprague-Dawleys rats (UCL biological services), following 
procedures according to the National Institutes of Heath guidelines.  Tissue sections were 
prepared by Ms. Sophie Finch (Centre for the Cellular Basis of Behaviour & MRC Centre for 
Neurodegeneration, Kings College London, UK).   
 
2.7.1 Dissection of cortex and ganglionic eminence 
The rat embryo (14 day) was removed from the mother and placed into a petri-dish 
containing HBS.  A line was cut between each embryo using a sterile tool to allow the 
release of the embryonic sac.  The sac was pierced at the abdomen end to remove the 
embryo.  The head was separated from the rest of the body and placed in a fresh dish 
containing DMEM with streptomycin/penicillin (50 µg.ml-1).  Under a light microscope the 
skin and the skull was peeled back exposing the two hemispheres of the brain.  The two 
hemispheres were removed and the rest of the brain discarded.  The hemispheres were 
positioned with the cortex on the base of the petri-dish and the olfactory bulbs at the top.  
Using the olfactory bulb as a guide, an incision was made to open up the hemisphere.  The 
ganglionic eminence (GE) and cortex were removed from each hemisphere.  Sections were 
transferred into separate tubes containing either 10 ml DMEM wash media or warm Sato’s 
media for transport (Section 2.7.1.1). 
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For patching and staining, tissue sections were prepared as follows.  Media was removed 
and the tissue exposed to 1 ml Trypsin/EDTA (0.25 mg.ml-1) containing 0.01 % (v/v) DNase 
for 10 minutes at 37 oC.  After which, 1 ml Trypsin inhibitor containing 0.01 % (v/v) DNase, 
was added to the sample.  Initial dissociation was carried out using a 21 g needle and 
pipetted up and down three times.  This was repeated a further 3 times with a 23 g needle.  
Following dissociation, 10 ml Sato’s media was added to the sample and cells left to settle 
for 20 minutes before transferring the liquid to a fresh tube, discarding large amounts of 
debris.  Cells in suspension were counted and centrifuged at 180 g for 5 minutes.  The 
supernatant was removed and cells resuspended in Sato’s medium at the desired 
concentrations for plating.  Cells were resuspended in Sato’s medium such that a 50 µl drop 
was equivalent to 2 x 105 cells per 24-well for cortical cells and 3 x 105 cells per well for the 
GE.  Cells were initially plated in droplets of small volumes into the centre of the well/cover 
slip and incubated for 1 hour so that cells adhered to the centre of the plate/slide (50 µl 
into the centre of each 24-well, 100 µl for 12-well or 300 µl for 6-well), after which media 
was increased to 0.5 ml per 24-well, 1 ml per 12-well and 2 ml per 6-well.   
 
2.7.1.1 Sato’s media 
Dulbecco’s modified Eagle’s medium: F12 (Invitrogen, 31330-095) supplemented with 
5.6 mg.ml-1 glucose (Sigma, G-6152), 100 µg.ml-1 BSA (Sigma, A-8806), 16 µg.ml-1 putrescine 
(Sigma, P-5780), 60 ng.ml-1, progesterone (Sigma, P-8783), 400 ng.ml-1 L-thyroxine (Sigma, 
T-0397), 300 ng.ml-1 3,3’,5-triiodothyronine (Sigma, T-5516), 2 mM L-glutamine (Sigma, 
G-7513), 5 µg.ml-1 insulin (Sigma, I-1882), 5 µg.ml-1 transferrin, (SCIPAC, UK, T100-5) and 
5 ng.ml-1 selenium (Sigma, S-5261). 
 
2.8 Mouse embryonic fibroblast feeder cells (MEFs) 
Mouse embryonic fibroblasts were derived from the MF1 mouse strain sourced from 
Harlan UK Ltd and supplied by the UKSCB at p0. 
 
2.8.1 Mouse embryonic fibroblast culture 
Mouse embryonic feeder cells (MEFs) were routinely cultured in standard GlutaMAXTM 
culture media (Section 2.1.2).  Cells were received from the UKSCB and typically cultured to 
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p3 before mitotically inactivating the cells with Mitocycin C (Section 2.8.1.1), for use as a 
supportive feeder layer in hESC culture. 
 
2.8.1.1 Mitomycin C inactivation of MEFs 
Feeder banks were grown up as described in Section 2.8.1 and typically mitotically inhibited 
when approximately 70 % confluent.  Cells were mitotically inactivated using Mitomycin C 
inactivation media (Section 2.8.1.2) for 2 hours.  Following inactivation, the monolayer of 
cells was washed twice in PBS before TrypLETM treating the cells to dislodge from adherent 
culture.  Cells were centrifuged and washed once in standard GlutaMAXTM culture media 
(Section 2.1.2) before finally centrifuging to pellet.  Cells were resuspended in standard 
freeze media (Section 2.1.3) at 1-2 x 106 cells/cryovial.  Vials were placed in a Mr Frosty for 
slow rate freezing overnight at -80 °C before transferral into racks for long term storage at 
-80 °C for use as required.   
 
2.8.1.2 Inactivation media 
Two milligrams Mitomycin C powder (Acros Organics, Belgium, 226940020) was dissolved 
in 200 ml DMEM (Sigma) creating a 10 µg.ml-1 solution which was filter sterilised and then 
supplemented with 10 % (v/v) FBS. 
 
2.9 Human embryonic stem cells 
2.9.1 Human embryonic stem cell culture 
Human embryonic stem cells were routinely cultured in the presence of an inactivated MEF 
(iMEF) layer (Section 2.8).  Cells lines were obtained from the UKSCB, with the appropriate 
permission from the Steering Committee.  Cells were routinely cultured in 6-well plates 
pre-coated with 0.1 % gelatin to aid attachment.  Cells were passaged using both 
mechanical and enzymatic techniques (Sections 2.9.1.1 and 2.9.1.2).  Fresh stocks of cells 
were thawed approximately every six months in culture to retain young comparable hESCs 
for experimentation. 
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2.9.1.1 Mechanical passaging 
Good quality hESC colonies were identified and located with an inverted dissection 
microscope under protection of a class II microbiological safety cabinet (MSC), using the 
criteria outlined in Section 4.2.1.  Areas of pluripotent stem cells were mechanically 
dissected into grids (Figure 2.2) from the colony using a micro-tool 90° hook and handle 
(Agar, T5338 and T5344) and lifted away from the culture surface.   
Fragments of cells ~400 µM across were transferred onto fresh feeders using a P20 Gilson 
pipette and distributed evenly across a fresh iMEFs layer for attachment (~10 colonies/IVF 
cell culture dish).  Care was taken during passaging to avoid folding over of cut fragments 
which frequently resulted in stacking of cell layers and subsequent colony differentiation.  
In addition, areas of differentiation were also removed from culture using this method.  
Each time mechanical passaging was undertaken the passage number of the cells was 
increased by +1.  Human ESCs colonies were mechanically passaged every 5-7 days. 
 
2.9.1.2 Enzymatic passaging 
Spent hESC media was removed from culture (Figure 2.3A).  Cells were washed in sterile 
tissue culture grade PBS (without Ca2+ and Mg2+) before exposure to TrypLETM Express at 
37 °C for 2 minutes.  Care was taken to avoid over exposure of the cells to TrypLETM, 
preventing a single cell suspension following passaging.  When cells began to detach (Figure 
2.3), the TrypLETM was gently aspirated away leaving the monolayer of detaching cells 
which were gently washed with fresh hESC media to remove residual TrypLETM.  Fresh hESC 
media (Section 2.9.2) was triturated over the cells to break the culture into small 
fragments, roughly 10 cells per clump.  The cell suspension was transferred onto a fresh 
iMEF layer with 3 ml fresh hESC media/well of a 6-well plate in a 1:6 split ratio (Figure 
2.3C).  Note: hESCs were not counted prior to passaging retaining cells in small clumps. 
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Figure 2.2. Mechanical passaging 
Stem cell colonies were cut into fragments approximately 400 µM square (A; x10 magnification, B; x4 
magnification).  Fragments entirely comprised cells of hESC morphology (Section 4.2.1).  Following dissection, 
fragments were lifted away from the culture surface from the corners and edges and transferred to fresh iMEFs. 
 
A B C
 
Figure 2.3. Enzymatic passaging with TrypLE
TM
 Express.   
Cell culture before (A), during (B), and after (C) TrypLE
TM
 passaging (x10 magnification), cells were detached 
from monolayer into a suspension containing small clumps of cells for re-growth on a fresh iMEF layer. 
 
 
2.9.2 Human embryonic stem cell culture (hESC) media 
KnockoutTM D-MEM (KO-DMEM; Gibco, 10829) was supplemented with 20 % (v/v) 
KnockoutTM Serum Replacement (KO-SR; Gibco, 10828), 2 mM GlutaMAXTM (Gibco, 35050), 
1x NEAA, 0.1 mM β-mercaptoethanol (Gibco, 31350-010) and 4 ng.ml-1 basic fibroblast 
growth factor (bFGF; Invitrogen, 13256-029). 
 
2.9.2.1 Basic fibroblast growth factor 
Basic fibroblast growth factor (bFGF) (Invitrogen, 13256-029) was prepared to 2 µg.ml-1 in 
PBS, supplemented with 0.1 % (v/v) BSA (Sigma, A1595) and 2 µg.ml-1 heparin. 
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2.9.2.2 Heparin stock solution 
Twenty milligrams heparin (Sigma, H3149-2KKU) was dissolved in 10 ml DMEM (Sigma, 
D6546) to prepare a 2 mg.ml-1 stock.  The solution was filter sterilised through a 0.2 micron 
filter and stored at -80 °C 
 
2.9.3 Vitrification 
Vitrification solutions VS1 (Section 2.9.3.1) and VS2 (Section 2.9.3.3) were thawed and one 
200 µl aliquot of VS1 solution and three 100 µl drops of VS2 solution were placed onto a 
sterile dish.  Using a thumb prick, holes were pierced at the top and bottom ends of 
cryovials (Corning, 430663).  Colonies were cut slightly larger than for routine passaging.  A 
miniature vessel containing LN2 was placed into the Class II Microbiological Safety Cabinet 
(MSC) and cryovials pre-cooled in the vessel.  Using a Gilson P20 pipette 10-15 colonies 
were transferred in 20 µl hESC media (Section 2.9.2) into the first VS1 droplet for precisely 
1 minute.  The fragments were then transferred to the first VS2 droplet for 25 seconds 
followed by transferral into the second VS2 droplet for a non-critical time.  Using a Gilson 
P20 pipette set at 4 µl, the stem cell fragments were collected and the small droplet 
dispensed onto the dish.  A sterile vitrification straw (Minitüb Abfüll- und Labortechnik 
GmbH & Co, Germany, 19050/0150) was placed into the droplet and hESC fragments 
entered the straw.  Finally VS2 solution was sucked from the final droplet to move the 
fragments away from the bottom of the straw.  The straw end was placed into the cooled 
cryovial (2/3 straws into each vial).  Cryovials were then transferred for long-term LN2 
storage. 
 
2.9.3.1 Vitrification solution 1  
A 10 % (v/v) vitrification solution  (VS) 1 solution was prepared by supplementing HEPES 
media (Section 2.9.3.2) with 10 % (v/v) DMSO and 10 % (v/v) ethylene glycol (Sigma, E9129) 
 
2.9.3.2 HEPES media 
KnockoutTM D-MEM was supplemented with 20 % (v/v) FBS and 1 M HEPES (Invitrogen, 
15630-049). 
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2.9.3.3 Vitrification solution 2 
A 20 % (v/v) VS2 solution was prepared by supplementing ES HEPES solution with 20 % 
(v/v) DMSO, 20 % (v/v) ethylene glycol and 30 % (v/v) 1 M sucrose solution (Section 
2.9.3.4). 
 
2.9.3.4 1 M sucrose solution 
Sucrose powder (Sigma, S7903), 3.42 g, was dissolved in 8 ml DMEM supplemented with 
2 ml FBS. 
 
2.10 Human embryonic stem cell differentiation 
2.10.1 Embryoid body directed neuronal differentiation 
This method  was adapted from an early dopaminergic neuronal differentiation protocol (Li 
et al., 2007) (Zhang et al., 2001; Yan et al., 2005).  Prior to differentiation, stem cell colonies 
were grown to the density used for passaging.  Spent culture media was removed, and pre-
warmed dispase (Sigma, D4818; 1 mg.ml-1 in DMEM/F12) was added to cells for incubation 
at 37 °C for 2-5 minutes until colonies began to curl up.  Cells were dispersed in fresh hESC 
culture media (Section 2.9.2) and triturated 3-5 times to break up the colonies until they 
were twice the size of fragments for normal passaging.  Fragments were washed in fresh 
hESC media to remove any remaining dispase before centrifuging at 200 g for 2 minutes.  
Fragments were resuspended in hESC media for suspension culture in non-attachment 
6-well plates (Nunc, TKT220-006R).  Suspension EBs were fed every day for four days 
before transferring into neural induction (NI) media (Section 2.10.1.1) supplemented with 
20 ng.ml-1 bFGF (Section 2.9.2.1) for a further two days before plating onto a laminin (20 
µg.ml-1, Section 2.10.1.4) or poly-L-ornithine (0.1 mg.ml-1, Section 2.10.1.3) coated cover 
slips in NI media.   
Fragments were expected to attach and spread after 1-2 days.  On day ten, spent media 
was removed and fresh NI media supplemented with FGF8 (Section 2.10.1.5) 20 ng.ml-1 and 
SHH (Section 2.10.1.6) 100 ng.ml-1 added to each sample.  Cultures were fed every other 
day with a half volume media change of fresh NI media containing FGF8 and SHH.  
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2.10.1.1 Neural induction media  
DMEM/F12 (Gibco, 31330-038) was supplemented with 1x N2 (Gibco, 17502-048), 1x NEAA 
and 2 µg.ml-1 heparin. 
 
2.10.1.2 Neuronal differentiation media 
Neurobasal media (Gibco, 21103-049) was supplemented with 1x N2 supplement and 
0.1 mM MEM-NEAA. 
 
2.10.1.3 Poly-L-ornithine 
Poly-L-ornithine hydrobromide (Sigma, P3655-50 mg), 0.1 mg, was diluted in 1 ml sterile 
water for storage at 4 °C. 
 
2.10.1.4 Human placental laminin  
Human placental laminin (Sigma, L6274) was thawed in a Class II MSC hood on ice to avoid 
solidification and diluted in sterile water for a 250 µg.ml-1 stock solution to be stored at 
-80 °C.   
 
2.10.1.5 Fibroblast growth factor 8 
One milligram of fibroblast growth factor 8 (FGF8; PeproTech, New Jersey, 100-25) was 
dissolved in 10 ml PBS with 0.1 % (v/v) BSA and 2 µg.ml-1 heparin.  Stock solution was 
prepared at 100 µg.ml-1 and stored at -80 °C. 
 
2.10.1.6 Sonic hedgehog 
One milligram of Sonic Hedgehog (SHH; R+D systems, 1845-SH) was dissolved in 10 ml PBS 
with 0.1 % (v/v) BSA.  Stock solution was prepared at 100 µg.ml-1 and stored at -80 °C. 
 
2.10.2 Adherent monolayer neuronal differentiation 
This method was adapted from (Baharvand et al., 2007).  Cells were cultured as described 
in Section 2.9.1.  Colonies were left to proliferate for 4-5 days before exposure to 4 x 10-6  M 
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ATRA (Section 2.10.2.1) in hESC media without bFGF for six days at which point columnar 
cells organizing into rosettes were observed.  Retinoic acid was removed from culture for a 
further six days to promote additional rosette formation.  Cells were exposed to 25 ng.ml-1 
bFGF for a further six days, resulting in formation of neural tube-like structures which were 
mechanically dissected and plated on poly-ornithine (15 µg.ml-1; Section 2.10.1.3) and 
laminin (5 µg.ml-1; Section 2.10.1.4) coated tissue culture dishes in neurobasal medium 
(Gibco, 21103-049), supplemented with 1 % (v/v) N2 supplement (Gibco, 17502-048) and 
2 % (v/v) B27 supplement (Gibco, 17504-044) for up to 30 days. 
2.10.2.1 All-trans-retinoic acid for stem cell differentiation 
Fifty milligrams ATRA (Sigma, R2625) was dissolved in 41.6 ml DMSO, producing a 4 x 10-3 M 
stock solution.  The solution was stored at -20 °C in darkened conditions. 
 
2.10.3 Semi-directed differentiation 
Stem cell colonies were passaged, plated and fed as usual.  Colonies beginning to 
differentiate neuronally in a spontaneous manner either due to long term culture or due to 
too high feeder density were identified by the presence of rosette-like structures in the 
colony.  Rosettes were mechanically cut away and transferred into neurobasal 
differentiation (NBD) media (Section 2.10.3.1) onto poly-ornithine coated surface with half 
volume NBD media feed every other day.   
 
2.10.3.1 Neurobasal media (NBD) 
Neurobasal media supplemented with 2 mM glutaMAXTM, 1 x N2 supplement (Gibco, 
17502-048) and 1 x B27 supplement (Gibco, 17504-044).  
 
2.10.4 Enhanced EB differentiation 
Fragments were cut to roughly twice the size for normal passaging and cultured in 
suspension in 25-well bacteriological grade compartmentalised perti-dishes (Sterilin, 
PD/16630) in NI media (Section 2.10.1.1) supplemented with 20 ng.ml-1 bFGF.  Cell clusters 
were cultured in NI media for five days before transferring into NBD media (Section 
2.10.3.1), removing bFGF from the culture for a further four days in suspension culture.  On 
day nine fragments were transferred onto 0.1 mg.ml-1 poly-ornithine and 1 µg.ml-1 laminin 
 79 
coated culture surface.  Surfaces were coated and incubated overnight at 37 °C before 
plating.  Floating cell clusters attached and collapsed over the following 1-3 days and were 
maintained in culture for up to ninety days and fed every other day with NBD media 
(Section 2.10.3.1).   
 
2.11 Comparison of surface coatings for neuronal attachment and spreading 
Eight-well chamber slides were coated with 75 µl/well of each of the following surface 
coatings,: poly-D-lysine (0.1 mg.ml-1), gelatin (0.1 %, w/v), poly-L-ornithine hydrobromide 
(0.1 mg.ml-1), human collagen IV (1 µg.ml-1 BD Biosciences, 354245), laminin (20 µg/ml-1) or 
fibronectin (200 µg.ml-1, Sigma, F2006) and left to incubate for 3 hours at 4 °C, 1 hour at RT, 
37 °C overnight, 1 hour at RT, 37 °C overnight and 30 minutes at RT, respectively.  
Rosette-like structures were mechanically dissected from Shef3 and RH5 cut hESC colonies 
grown at high feeder densities.  A single fragment was transferred into each pre-coated 
well in NBD media (Section 2.10.3.1) and the attachment and spreading from each 
fragment monitored over a period of eight days. 
 
2.12 Gene expression 
2.12.1 RNA extraction 
All RNA extractions were carried out using cooled reagents at 4 °C to minimise RNase 
activity.   
 
2.12.1.1 Qiagen RNeasy 
Cells were lysed and RNA harvested using Qiagen RNeasy (Qiagen, 74104) spin columns 
according to manufacturer’s instructions.  Briefly, cells were trypsinised from the culture 
surface and washed twice in PBS to remove all culture media from the sample.  Cells were 
lysed in RLT buffer (for ≤ 5 x 106 cells 350 µl buffer RLT was used, for 5 x 106 – 1 x 107 cells 
700 µl RLT buffer was used).  Samples were pipetted or vortexing to ensure complete cell 
lysis.  The lysate was transferred into a QIA shredder column within a 2 ml collection tube 
and centrifuged at full speed for 2 minutes.  One volume of 70 % (v/v) ethanol was added 
to the lysate and mixed well.  The sample was transferred into an RNeasy spin column 
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within a fresh 2 ml collection tube, centrifuged for 15 seconds at ≥ 8,000 g and the flow 
through discarded.   
RW1 buffer (350 µl), was added to the spin column and centrifuged for 15 seconds at 
≥ 8,000 g to wash the membrane.  Samples were DNase treated on the column using the 
Qiagen RNase-free DNase kit (Qiagen, 79254).  Flow through was discarded from the RW1 
buffer wash and a mixture of 10 µl DNase stock I solution and 70 µl RDD buffer was added 
to the spin column, before incubating at RT for 15 minutes.  A further 350 µl RW1 buffer 
was added to the spin column and centrifuged at ≥ 8,000 g, and the flow through 
discarded.  700 µl buffer RW1 was then added to the column and centrifuged for 
15 seconds at ≥ 8,000 g to wash and the flow through discarded.  500 µl RPE buffer was 
added to the spin column and centrifuged at ≥ 8,000 g for 15 seconds followed by a second 
500 µl RPE wash step with a 2 minute centrifugation before removal of the flow through 
and returning the membrane for a final 2 minute centrifugation to dry.  The membrane was 
then transferred into a fresh 1.5 ml collection tube and 30-50 µl RNase-free water added to 
the membrane.  This was centrifuged for 1 minute at ≥ 8,000 g to elute the RNA.  This 
elution step can be repeated if a high yield of RNA is expected.  RNA samples were 
quantified using a Nanodrop spectrophotometer (Nanodrop Technologies Inc) before 
transferral to -80 °C for long term storage to inhibit endogenous RNase activity and prevent 
RNA degradation. 
 
2.12.1.2 Ambion RNAqueous 
RNA was extracted using Ambion’s RNAqueous extraction kit (Ambion, AM1912) following 
manufacturer’s instructions.  Briefly, cells were Trypsinised from the culture surface, 
washed twice in PBS and centrifuged to pellet.  Lysis/binding solution was added to the cell 
pellet in 200-700 µl volume depending on the cell number.  Cell lysates were 
pipetted/vortexed to ensure complete lysis and a homogeneous solution.   Equal volumes 
of 64 % ethanol were added to the lysate and mixed before applying the solution to a filter 
cartridge in a collection tube.  The sample was then centrifuged at 10,000 g for 3 minutes 
and the flow through discarded.  Wash solution #1, 700 µl, was added to the filter cartridge 
and centrifuged as before.  Wash solution #2/3, 500 µl, was added to the cartridge and 
centrifuged, discarding the flow through.  This step was repeated with an additional 500 µl 
wash solution #2/3.  The supernatant was discarded and the filter cartridge centrifuged for 
30 seconds to dry the membrane.  The cartridge was placed into a fresh collection tube and 
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the membrane covered with 40 µl elution solution (pre-heated to 70 °C).  The cartridge was 
centrifuged for 2 minutes to elute the RNA.  Elution was repeated with an additional 10 µl 
elution solution.  Note: the elution volume was increased for larger cell pellets.  RNA 
samples were quantified using a Nanodrop spectrophotometer before transferral to -80 °C 
for long term storage. 
 
2.12.2 DNase treatment 
The Ambion RNAqueous extraction method required an additional DNase treatment step.  
This was carried out using TURBO DNA-freeTM (Ambion, AM1907) in 28 µl volumes within 
RNase and DNase-free PCR tubes (Costar, 6547), according to manufacturer’s instructions.  
Briefly, 2.5 µl 10x TURBO DNase Buffer and 1 µl TURBO DNase was added to the RNA, 
mixed gently and incubated at 37 °C for precisely 20 minutes.  Samples were removed from 
37 °C incubation and 2.5 µl DNase inactivation reagent was added to each tube for 
2 minutes incubation at RT with occasional mixing to inhibit the DNase activity.  In addition, 
the DNase inactivation reagent also removes divalent cations, such as magnesium and 
calcium, which can catalyze RNA degradation when RNA is heated in the RT-PCR reaction.  
Finally, samples were centrifuged at 10,000 g for 1.5 minutes and RNA supernatant 
transferred to a fresh tube for storage at -80 °C.   
Note: TURBO DNase is less effective at RNA concentrations exceeding 200 µg.ml-1.  For 
highly concentrated samples (determined by Nanodrop quantification), RNA was diluted in 
nuclease free water to a concentration ~ 200 µg.ml-1 before DNase treating. 
 
2.12.3 Reverse transcription 
Reverse transcription reactions converting RNA into cDNA were carried out using an 
Ambion RETROScript kit (Ambion, AM1710) following manufacturer’s instructions in a 
pre-PCR laboratory.  RNA was quantified using a NanoDrop Spectrophotometer 
(Nanodrop®).  Total RNA, 1-2 µg, was combined with 2 µl Oligo (dT).  The total volume was 
increased to 12 µl with nuclease free water and heated to 70 °C for 3 minutes using an 
Applied Biosystems 2720 Thermal cycler before placing on ice.  2 µl 10 X RT buffer, 4 µl 
dNTP mix, 1 µl RNase inhibitors and 1 µl MMLV-RT were added to each tube and mixed.  
The reverse transcription reaction was carried out at 44 °C for one hour before heating 
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samples to 92 °C for 10 minutes to inactivate the reverse transcriptase and transferring to 
-20 °C storage until use.   
 
2.12.4 Custom primer design 
To ensure that primers were specific for cDNA of mRNA transcripts only avoiding 
pseudogene amplification, primers were individually designed according to guidelines in 
Section 1.5.3.3.  All sequences for primer design were taken from the reference assembly 
sequence in NCBI GENE.  The genomic DNA sequence of each gene was identified using the 
NCBI genomic nucleotide reference assembly, in addition to the mRNA nucleotide 
sequence.  Pseudogenes for genes of interest and their nucleotide sequences were also 
identified.  All gDNA, RNA and pseudogene sequences were aligned using EMBL-EBI 
ClustalW2 alignment software (http://www.ebi.ac.uk/Tools/clustalw2/index.html).  This 
software highlighted variations in sequences which were incorporated into RNA sequence 
specific primers (sequence alignments available upon request).  Finally primer sequences 
were checked using the NCBI BLAST programme to ensure sequence specificity to the gene 
of interest (GOI).  Due to the incorporation of an iMEF layer during hESC culture, where 
possible primers were also checked against the mouse genome sequence to ensure 
amplification was specific to the human GOI.   
 
2.12.5 Polymerase Chain Reaction (PCR) 
All RT-PCR reactions were loaded in a pre-PCR laboratory and transferred to a post-PCR 
laboratory to run.  Each reaction used 250 ng cDNA (quantified at the RNA level using a 
Nanodrop spectrophotometer).  All reagents were thawed and stored on ice during 
preparation.  Reagents for reactions (Section 2.12.6) were mixed together with cDNA, 
gently vortexed and then loaded into an Applied Biosystems 2720 Thermal cycler machine.  
All samples were inactivated at 94 °C for four minutes, followed by 35 cycles of 
denaturation at 94 °C for 45 seconds, annealing at 55 °C for 45 seconds and elongation at 
72 °C for 45 seconds.  Final extension was 72 °C for 10 minutes before cooling to a 4 °C 
hold. 
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2.12.6 PCR reagents 
2.12.6.1 Roche Faststart DNAtaq polymerase dNTPack 
Roche Faststart DNAtaq polymerase dNTPack (Roche, 04738314001) reagents were mixed 
as follows: 5 µl PCR buffer (with MgCl2), 1 µl nucleotide mix, 2 µl primer pair, 0.4 µl 
FastStart Taq polymerase and increased to 50 µl with nuclease-free water within a PCR 
tube.   
 
2.12.6.2 Promega PCR master mix  
The Promega PCR master mix (Promega, M7502) is a 2x pre-mixed PCR master mix 
including nuclease-free water, Taq DNA polymerase, dNTPs and MgCl2 in optimal 
concentrations for PCR reactions.  For 25 µl PCR reactions, 12.5 µl 2 X Promega PCR mix 
was added to a PCR tube and mixed with 1 µl forward primer (0.4 µM), 1 µl reverse primer 
(0.4 µM), 250 ng cDNA, and increased to 25 µl total volume with nuclease-free water. 
 
2.12.7 Agarose gel electrophoresis 
Agarose gels were prepared to the desired concentrations by dissolving agarose powder 
(Invitrogen, 10975-035) in 1X Tris-Borate EDTA (TBE) buffer (Sigma, T4415) 10X stock 
diluted to 1x in water.  The gel was heated in a microwave to dissolve before adding 1X 
SYBR SafeTM (Invitrogen, S33102) and pouring into a cast to set for 30 minutes at RT, before 
loading into a gel electrophoresis tank and submerging in 1X TBE buffer.  Each PCR sample 
was pre-loaded with three times loading buffer (Promega, G190A), mixed and dispensed 
into the wells of the agarose gel.  A PCR ladder was added to each gel for identification of 
PCR products by size.  DNA ladders were selected depending on the size of the PCR 
product.   
 
2.12.8 Quantitative-PCR  
2.12.8.1 Low density array cards 
TaqMan Low density array Human stem cell pluripotency panel cards (Applied Biosystems 
(ABI), 4385225, Lot A3566) were used for screening 96 different genes throughout 
differentiation.  Cells were cultured and differentiated as previously described.  Cell 
samples were isolated at distinct time points through differentiation (day 0, 4, 10, 18 and 
28), RNA was extracted and cDNA synthesised (Sections 2.12.1 and 2.12.3).  For each 
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sample 75 ng cDNA was resuspended in nuclease free water to a 50 µl volume (Ambion, 
AM9937) and combined with 50 µl TaqMan Gene expression master mix (ABI, 4369016) 
before loading into each lane on the LDA card.  For all 96 genes screened, 2 x 100 µl 
samples were loaded.  Once loaded the card was centrifuged to disperse the cDNA solution 
throughout the card which could then be sealed using the card sealer (ABI), and run on the 
ABI 7900HT Fast Real time PCR system.  Data were collected and analysed using ABI 
Sequence detection systems (SDS) software version 2.3.   
Triplicate samples were run for each differentiation time point using three different 
passages of each hESC line, allowing for internal variation within a cell line.  Different 
passages of the same hESC line presented variation in gene expression.  For this reason, 
changes in gene expression were standardised to the appropriate day 0 sample.  Each LDA 
card analysed four samples simultaneously, therefore it was not possible to run all 5 
differentiation time points on the same LDA card.  It was therefore decided to run each of 
the three triplicate samples (same differentiation time point and cell line but different 
passage numbers) in addition to a day zero calibrator per card.    All LDA cards were from 
the same manufactured batch and run on the same machine for analysis to minimise 
sample variation.   
Relative changes in gene expression were determined using 2-∆∆Ct to represent the fold 
change in expression for each gene.  ∆Ct values were calculated using the difference 
between Ct day X and Ct at day 0.  ∆∆Ct values were calculated by subtracting ∆Ct for the 
endogenous control at day X, from ∆Ct GOI at day X.   
 
2.12.9 Fluorescence Imaging Plate Reader 
Culture media was removed by gentle inversion of the plate, so as not to dislodge the cell 
layer.  Each well was rinsed gently with 200 μl HEPES buffered saline (HBS; Section 
2.12.9.2), prior to incubation with 70 μl of 2 μM Fluo-4 AM as a calcium indicator dye 
(Section 2.12.9.3) at room temperature (RT) for 45 minutes.  Cells were washed twice in 
200 µl HBS per well, and incubated in 150 µl HBS before loading into the FLIPR. 
The drug plate, a transparent flat bottomed 96 well plate (Greiner Bio-One, 655180) was 
prepared in advance with 80 μl of the relevant drug under test *N-methyl-D-aspartic acid 
(NMDA; Sigma, 65831), glycine (Sigma, G8790), potassium chloride (KCl; Sigma, P-3911)], 
and loaded into the FLIPR.  Each experiment was run for 5 minutes with fluorescence 
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sampling every second.  The first 30 readings provided the baseline fluorescence data 
before addition of the drug to the cells.  Following addition of the drug, fluorescence 
intensities of the cells was recorded for a further 270 sec.  Finally data were exported for 
analysis. 
 
2.12.9.1 Poly-D-lysine 
Five milligrams poly-D-lysine powder (Sigma, P7405) was dissolved in 50 ml sterile tissue 
culture grade water producing a 0.1 mg.ml-1 stock solution. 
 
2.12.9.2 HEPES buffered saline 
HEPES buffered saline solution, pH 7.2, was prepared fresh for each experiment.  The 
following reagents were added to distilled water: 120 mM NaCl (Sigma, S5886), 4.5 mM 
glucose (Sigma, G7021), 5.5 mM KCl, 1.8 mM CaCl2
 (Sigma, C8106), 1 mM MgCl2 (Sigma, 
M4880), 20 mM HEPES (Fluka, 54455). 
 
2.12.9.3 Fluo-4 AM calcium indicator dye for FLIPR 
The calcium indicator dye Fluo-4 AM (Invitrogen, F14201) was used in the FLIPR assay to 
monitor calcium flux across the cells.  Fluo-4 AM was supplied as a 50 µg powder and mixed 
with 23 μl of 2.5 % (w/v) pluronic F-127 (Invitrogen, P6867) in DMSO (w/v).  For use in the 
FLIPR, 1 μl of this stock solution was added/ml buffer. 
 
2.12.10 Calcium imaging 
Cells cultured on glass coverslips (40 mm X 22 mm) were transferred into a calcium imaging 
clamp and incubated in the dark under a CO2 atmosphere with 1 ml culture media 
supplemented with 1 µl Fura-2 AM stock solution (Section 2.12.10.1) for 30 minutes.  Cells 
were washed in HBS buffer for 1 minute before the addition of neurotransmitter drugs 
(High potassium (Section 2.12.10.2), glutamate (Sigma, G2834), NMDA and glycine) which 
were added to the sample at a constant flow rate of 0.6 ml.minute-1. Cell images were 
captured every second using a Zeiss Axiovert 100 TV, fluorescence microscope fitted with 
an Oriel Arc lamp.  Kinetic imaging, AQM Advance 6 software was used for image analysis.  
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Cells were washed in HBS following drug exposure to enable recovery of basal intracellular 
calcium levels. 
 
2.12.10.1 Fura-2 AM - calcium indicator dye 
Fura-2 AM (Invitrogen, F1221) stock solution was prepared to 2 mM in DMSO with 2.5 % 
(v/v) pluronic F-127. 
 
2.12.10.2 High potassium solution 
The following was prepared in water: 125.5 mM KCl, 1.8 mM CaCl2, 1 mM MgCl2  and 
20 mM HEPES and the pH adjusted to 7.2 with NaOH. 
 
2.12.11 Patch clamping 
Patch clamping was performed using an Axopatch 200B (Axon instruments) patching rig 
and a Zeiss Axiovert 135 microscope under 40 X magnification.  Data was collected using 
pCLAMP software (Molecular Devices, USA).   Cells were plated onto 13 mm round glass 
cover glasses pre-coated with poly-D-lysine (10 µg.ml-1) 24-72 hours prior to patching. 
Fine glass pipettes were drawn out from capillary glass tubing, attached to the patching 
attachment arm of the micromanipulator (Burleigh PCS-500).   The electrode was inserted 
down the pipette which was then filled with patch clamping fluid.  A cell was selected with 
morphologically neuronal features (phase bright, rounded cell body and axon-like process).  
The pipette was gradually lowered onto the cell until a change in resistance was recorded 
at which point the cell membrane was sucked up to form a seal with the end of the pipette 
until a seal resistance exceeding 1 GΩ was recorded.  The membrane of the cell was 
ruptured and the cell contents left to equilibrate with the fluid within the pipette.  Each cell 
was current clamped (I-clamp) by hyperpolarisation to -70 mV, before releasing the 
current; after which electrophysiologically active cells fired action potentials.  Following this 
a current-voltage curve (IV) for each cell was generated by firing a family of voltages 
though the cell.  The changes in output current were recorded and plotted for each cell. 
Cells were exposed to 1 µM Tetrodotoxin (TTX; Sigma, T8024) at a flow rate 0.6 ml.minute-1 
for 2 minutes before re-testing for the ability to fire an action potential. 
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2.13 Immuno-staining 
2.13.1 Fixation 
A 4 % (v/v) formaldehyde fixative solution was prepared from 16 % (v/v) formaldehyde 
stock (Polysciences Inc, 18814) diluted in PBS containing 0.1 % (v/v) BSA stored at 4 °C and 
pre-warmed to 37 °C before use.  Following fixation, cells were gently washed in PBS and 
left in blocking solution (Section 2.13.1.1) ready for staining. 
 
2.13.1.1 Blocking solution 
Standard blocking solution was prepared with 0.1 % (v/v) BSA in PBS and stored at 4 °C. 
 
2.13.2 Permeablisation 
For staining internal cell markers, cells were fixed (Section 2.13.1) and permeablised using 
0.1 % (v/v) Triton-X-100 (BDH, 30632 4N) in blocking solution (Section 2.13.1.1) for 
20 minutes at 37 °C.  After permeablising, cells were washed and left in blocking solution.   
 
2.13.3 Staining 
Cells were fixed as described in Section 2.13.1.  All samples were blocked for a minimum 
30 minutes in blocking solution (Section 2.13.1.1).  Samples stored in blocking solution at 
4 °C did not need to be blocked prior to staining unless intracellular proteins were targeted.  
For intracellular proteins the cell samples were permeablised prior to blocking (Section 
2.13.2).  Following blocking, cells were incubated with primary antibodies (Table 2.1) at 
37 °C for 1 hour (antibodies towards intracellular targets were diluted in blocking solution 
containing 0.01 % (v/v) Triton-X-100).  Samples were washed three times in PBS in quick 
succession (removing just 50 % volume for each successive wash so as not to detach cells 
from the culture surface) before washing twice for 15 minutes at RT on a bench-top shaker 
set to 30 rpm.  Secondary antibodies (Table 2.2) were prepared in blocking solution 
(+/- 0.01 % (v/v) Triton-X-100) and incubated with cells at RT for 1 hour in the dark.  Cells 
were washed as above, taking care to ensure minimal light exposure to the sample.  If 
required, cells were incubated with Hoechst stain (Molecular probes, H-3570) for 
30 seconds before washing the secondary antibody.   
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Stained samples were mounted using mounting media (DAKO, S3023) and sealed with clear 
nail varnish for imaging.  Bright field and fluorescence images were captured using Olympus 
IX70 inverted epi-fluorescence microscope.  Images were analysed using Olympus 
CellF/CellR software.  Confocal images were captured using a Lecia DMRE microscope and a 
Leica TCS SP2 confocal scanner head.   
 
2.13.4 Flow cytometry 
Flow cytometry analysis was carried out using a Guava EasyCyte (Guava technologies).  
Cells (1 x 105) were cultured and differentiated as required before TrypLETM treatment to 
create a single cell suspension.  Cells were fixed in 4 % (v/v) formaldehyde (Section 2.13.1) 
and washed in PBS.  For internal cell markers, cells were permeablised (Section 2.13.2) and 
incubated with blocking solution (Section 2.13.1.1).  Primary antibodies (Table 2.1) were 
diluted and incubated with cells at 37 °C for at least 20 minutes.  Samples were washed 
three times in PBS blocking solution and centrifuged at 240 g for five minutes.  Secondary 
antibodies (Table 2.2) were diluted and incubated with the cells in the dark for at least 
20 minutes.  Cells were washed three times in PBS blocking solution and centrifuged at 
170 g for five minutes before finally resuspending in 200 µl blocking solution and 
transferring into 96-well flat bottomed plate.  Samples were run on the guava flow 
cytometer and data analysis was carried out using Guava Cytosoft software version 3.6.1. 
 
2.13.4.1 Comparison of cell dissociation reagents 
Embryoid bodies and neuronal clusters were washed twice in PBS without Ca+2 and Mg2+ 
before dissociation reagents: TrypLETM Express (1 X), 0.25 % Trypsin-EDTA (Gibco, 
25200-056), 1 mg.ml-1 Collagenase IV (Gibco, 17104-019), AccutaseTM (1 X, Chemicon, 
SR005) and 1 mg.ml-1 Dispase (Stem Cell Technologies, 07923), were applied and incubated 
at 37 °C for 10 minutes.  Samples were centrifuged to remove the dissociation reagents and 
resuspended in NBD media (Section 2.10.3.1).  Each cell sample was triturated ten times to 
break up clusters before counting using a bright line haemocytometer to determine cell 
number and viability.   
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Isotype Host Target Supplier Product code Concentration working dilution
IgY Chicken MAP2 Abcam ab5392 19mg/ml 1:1000-5000
IgY Chicken TH Millipore AB9702 0.2mg/mL 1:200-1000
IgY Chicken Isotype control Chemicon PP25 1mg/ml variable
IgG Mouse Isotype control Chemicon SCR060 Part PP54 1mg/ml variable
IgG1 Mouse Beta III tubulin Chemicon MAB1637 ascite 1:1000 
IgG1 Mouse 70kD neurofilament Abcam ab7255 ascite 1:250-400
IgG1 Mouse Nestin Chemicon SCR060 Part 2005895 1mg/ml 1:500
IgG1 Mouse GFAP Chemicon MAB360 ascite 1:400-1:800
IgG2b Mouse OCT3/4 Santa Cruz Sc5279 0.2mg/ml 1:75
IgG3 Mouse SSEA4 Abcam ab16287 1mg/ml 1:50
IgM Mouse Tra-1-60 abcam ab16288 2mg/mL 1:70
IgM Mouse Tra-1-81 Chemicon 90233 1mg/ml 1:100
IgM Mouse Isotype control Chemicon PP50 0.74mg/ml variable
IgM Mouse Isotype control Chemicon SCR060 Part 2003599 2mg/ml variable
antiserum Rabbit GABA Sigma A2052 ascite 1:500
antiserum Rabbit Serotonin Sigma S5545 ascite 1:500
IgG Rabbit Synaptophysin Abcam ab52636 ascite 1:100
IgG Rabbit GFAP Chemicon SCR060 Part AB5804 ascite 1:200-250
IgG Rabbit Isotype control Chemicon PP64 1mg/ml variable
IgG Rabbit Sox2 Abcam ab59776 1.28mg/ml 1:400
IgG Rabbit Sox2 Chemicon SCR060 Part 2003600 1mg/ml 1:1000
Primary antibodies
 
Table 2.1. Primary antibodies. 
Antibodies listed were used throughout this project at the specified working dilution.  Isotype controls were run 
for each sample at the same antibody concentration as the specific primary antibody.  Ascite antibody 
concentrations were not specified by the supplier.  
 
Host Target Fluorochrome Supplier Product code Concentration Working dilution
Chicken IgY Donkey FITC Chemicon AP194F 1mg/ mL 1:100
Mouse IgG Goat Alexa Fluor 488 Invitrogen A31633 2mg/ml 1:100-500
Mouse IgG Donkey Cy3 Chemicon AP192C 1mg/ml 1:500
Mouse IgG3 Goat FITC Caltag M32601 - 1:500
Mouse IgM Goat FITC Chemicon AP500F 1mg/ml 1:100-200
Mouse IgM Goat FITC Sigma 085K6118 - 1:500
Rabbit IgG Donkey Cy3 Chemicon AP182C 1mg/ml 1:500
Rabbit IgG H+L Goat FITC Abcam ab6717 2mg/ml 1:500
Secondaries labelled
 
Table 2.2. Secondary antibodies.   
Secondary antibodies used throughout this project at the specified working dilution. 
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2.14 Karyology 
Fresh methanol:acetic acid (3:1; BDH, 291926G; BDH, 10001CU) fixative was prepared and 
stored at -20 °C prior to use.  Cells were harvested at 50 % confluence.  Spent media was 
aspirate from cultures and transferred to a 15 ml centrifuge tube (Falcon).  KaryoMAX® 
Colcemid® (Gibco, 15212-046) was added to each culture to a final concentration 
0.04 µg.ml-1 before incubation at 37 C for 2-4 hours, to arrest cells in the metaphase stage 
of the cell cycle.  Colcemid® media was carefully removed from cultures and cells washed in 
PBS.  All spent and wash media was transferred to the 15 ml tube for centrifugation.  Cells 
were dislodged using TrypLETM Express before finally resuspending in original culture media 
from the morning.  Cell samples were centrifuged at 240 g, for up to 5 minutes.  
Supernatant was removed leaving cells in 1.5 ml spent media to which 6 ml distilled water 
was added, creating a hypotonic solution.  Cells were incubated to swell for 15 minutes at 
37 °C before centrifugation at 240 g, 5 minutes.  Supernatant was removed from the cell 
pellet and 2 ml pre-cooled fixative was added slowly to the cells. Cells were left to incubate 
at RT for ≥ 15 minutes.  Cells were re-centrifuged and fixative supernatant replaced with 
2 ml fresh fixative. Cell solutions were dropped onto ethanol cleaned glass slides at 60° 
angle and left to dry before staining with fresh Giemsa stain:water (1:3; Sigma, GS1L)  for 
20 minutes at RT.  Slides were washed in distilled water and left to air dry for visualisation.  
This protocol was sourced from the UKSCB.  
 
2.14.1 Modified karyotypic analysis 
Cells were cultured as described in Section 2.9.1 and harvested at approximately 50 % 
confluence for enzymatically passaged lines or 5-6 days post-passaging for mechanically 
passaged lines.  Healthy cells were treated with TrypLETM Express, creating a single cell 
suspension, washed in PBS and resuspended in 1.5 ml media with 6 ml sterile tissue culture 
grade waster producing a hypotonic solution.  Samples were incubated for 15 minutes at 
37 °C.  Following swelling, 1 ml methanol:acetic acid fixative, pre-cooled to -20 °C was 
added to the cells in hypotonic solution and centrifuged at 170 g for three minutes.  The 
supernatant was poured off and 3 ml fix added per sample to resuspend the cells.  Finally, 
three 20 µl volumes of cell suspension in fix were dropped onto a clean glass slide and left 
to dry.  Slides were incubated with 2 ml Giemsa stain for 15 minutes at RT before rinsing 
thoroughly before imaging.  Cell suspensions containing large numbers of metaphase 
spreads were sent to TDL Genetics (The Doctors laboratory; London, UK) for analysis. 
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3 Neuronal differentiation of the Embryonal Carcinoma cell line – NTERA2 
3.1 Introduction to NTERA2 
In order to generate a successful therapy for neurodegenerative diseases, it is necessary to 
understand neurogenesis in healthy tissue, and then determine at what point the system 
malfunctioned so that a suitable preventative or curative therapy can be identified.  Studies 
on early embryonic development are excellent tools for understanding neurogenesis.  
Much of the work in this field has been carried out in animal models, mainly in the 
developing chick, mouse and rat.  However, due to species variation, developmental cues 
are not always directly translatable to humans.  Ethical constraints in researching human 
embryonic development mean that surrogate models must be applied to further our 
understanding in this area.   
The derivation of the first hESC lines in 1998 created an alternative source of investigation, 
due to their ability to recapitulate embryonic development in vitro (Thomson et al., 1998).  
However, it was some time before these cells were widely accessible for research and 
difficulties with cell supply and sustained pluripotent culture limited their use in early 
years.  Instead, research using alternative pluripotent cell lines such as hEC cells 
(Section 1.11) generated much of the underpinning for our knowledge of hESC culture and 
differentiation. 
The hEC cell line: NTERA2 is a pluripotent cell line with a long published history of neuronal 
differentiation and serves as a model for characterising in vitro neuronal differentiation.  
NTERA2 derived neurons are sustainable in long term culture for up to 10 months with no 
sign of reversion to pluripotency (Pleasure et al., 1992).  As such NTERA2 provides an 
alternative source of neurons for pharmacological screening including assay to test for the 
toxicity of Tetanus and Botulinum toxoids prior to batch release (Department of 
Bacteriology, NIBSC), reducing reliance on animals for primary neural tissue.  However, 
neuronal yield and reproducibility of differentiation from NTERA2 was perceived to be 
poor.  More significantly, the sensitivity of NTERA2 derived neurons to stimulation was 
considerably lower than that of primary tissue making them an unsuitable alternative cell 
source for routine screening (personal communication, Dr. C. Escargueil and Dr. T. Sesardic, 
Bacteriology, NIBSC).  This highlights just one of the limitations in using neurons derived 
from pluripotent cell sources, for routine pharmacological screening.  These assays in 
addition to many others, returned to using primary rat neurons with the required 
sensitivity, demonstrating the requirement for improvements in directed differentiation of 
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neuronal cell types, and identification of an optimal starting pool of cells for high neuronal 
yields.  For any cell line to be a suitable source of neurons for use in cell based assays, like 
those described above, or to be incorporated into a cell based therapies, differentiation 
must be reliable, robust and reproducible, yielding a consistent supply of neurons with 
comparable functionality and sensitivity to that of a primary neuron.   
All cells of the body are derived from the early pluripotent cells of the embryo, therefore 
under the correct stimuli; a pluripotent cell line should be capable of directed 
differentiation into highly functional neurons.  With this in mind, this project placed early 
focus on characterisation the neuronal differentiation in NTERA2.  
Whilst many groups have investigated neuronal differentiation in this hEC cell line, the 
overall objective for the work in this chapter was focused towards understanding the 
process of neuronal differentiation from pluripotent cell lines with a view to identifying the 
key parameters which affect the efficiency of differentiation.  With the need for high 
reproducibility and enhanced functional response of cell line derived neurons in mind, the 
electrophysiological response of NTERA2 derived neurons was screened in comparison to 
primary neurons.   
 
3.2 Results 
3.2.1 Pluripotency in NTERA2 
NTERA2 stocks were cultured and differentiated as detailed in Section 2.4.  Pluripotent 
NTERA2 cells were identified by their compact cell body with large nucleus to cytoplasm 
ratio; prominent nucleoli and uniform morphology across the culture surface (Figure 3.1).  
NTERA2 cells grew most effectively when passaged every 3-4 days, seeding cells at 
relatively high density (6 x 104 cells/cm2).  Cultures often underwent spontaneous 
differentiation into an epithelial-like cell fate when seeded at lower low densities (Figure 
3.2), losing the distinctive morphology which was not recoverable to a pluripotent state. 
The reason behind the spontaneous differentiation at low cell density is yet to be 
confirmed; however, cell to cell contact is thought to play a key role in sustained 
pluripotency  (Andrews et al., 2001).  The NTERA2 cell line was therefore most successfully 
maintained using mechanical methods of passaging (i.e. sterile glass beads or cell scrapers) 
which retained cells in small clumps.   
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3.2.2 Neuronal differentiation in NTERA2 
3.2.2.1 Neurons in culture 
Neurons were identified by their large rounded, phase bright cell body forming long 
extensions (axons or dendrites) projected towards neighbouring cells (Figure 3.3).  
Neuronal projections differed in number and length between cells but were easily visible 
under bright field microscopy. 
 
3.2.2.2 Directed differentiation in NTERA2 
NTERA2 cells were differentiated towards a neuronal cell fate following an ATRA induced 
differentiation protocol detailed in Section 2.4.3 which was adapted from Pleasure et al., 
1992.  Images of cells differentiating along the six week process were captured using phase 
contrast imaging (Figure 3.5).  In the early stages of ATRA-induced differentiation, a 
reduced rate of proliferation was evident during which, the NTERA2 cells flattened out and 
lost their defined cell edges.  After 2 weeks in culture the cells formed a monolayer which 
remained tightly attached to the culture surface, amongst which small islands of tight cell 
clusters became visible.  Between weeks 2-4 these clusters became larger and neuronal-like 
cells could be identified with rounded phase bright cell bodies, buried amongst them.  At 
week 4 the entire cell layer was detached from the culture surface using Trypsin/EDTA cell 
dissociation reagent.  Cells were dissociated into very small clusters/single cells and 
replated into fresh culture surfaces in a 1:6 ratio.  Dissociation of the cell layer in this way 
enabled dispersal of the developing neurons from amongst the tight cell clusters.   
The rounded neuronal cell body resulted in a minimal area for attachment to the fresh 
culture surface.  Subsequently neurons were very weakly attached to the tissue culture 
surface.  Neurons were most commonly seen to settle and attach on top of the 
non-neuronal cells in culture rather than directly onto the tissue culture surface (Figure 
3.6).  Weak attachment of neurons to the culture surface meant that these cells could be 
readily selected for purification.   Neurons were usually the first cells to detach when 
mechanical or enzymatic detachment procedures were applied due to their rounded 
morphology meaning minimal contact with the culture surface.   
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Figure 3.1. Identification of NTERA2.   
Pluripotency in NTERA2 was identified by the high nucleus to cytoplasm ratio (red dotted lines) and prominent nucleoli (green arrows).  A: x20, B:  x10, C: x4 magnification. 
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Figure 3.2. Spontaneous differentiation in NTERA2.   
At low cell density (< 6 x 10
4
 cells/cm
2
) NTERA2 spontaneously differentiated, losing distinct features of pluripotency, forming a flattened epithelial-like morphology (green dash).  Varying 
degrees of spontaneous differentiation occurred from small areas of patchy differentiation (A, B) to complete loss of pluripotent NTERA2 identity (C).  A heterogeneous population was often 
evident across the culture surface with areas of pluripotent NTERA2 cells visible (A; red dash). Without intervention the culture completely differentiated (C) and it was necessary to recover 
fresh NTERA2 stocks LN2 storage.   
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Figure 3.3. Typical neuronal morphology.  
Typical neurons in culture with rounded, phase bright cell bodies (red arrows) and projecting axons and 
dendrites (green arrows).  Image captured under phase contrast imaging at x10 magnification.  
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Following replating at week 4, cultures were incubated with mitotic inhibitors (cytosine 
arabinofuranoside, fluorodeoxyuridine and uridine) which block cell cycle progression.  The 
activity of these inhibitors targeted proliferating epithelial-like cells, during the DNA 
synthesis phase of the cell cycle, initiating apoptosis (Figure 3.6).  The loss of the epithelial 
cells also resulted in a depletion of neurons through their inability to attach directly to the 
culture surface. 
To confirm that the neuronal differentiation of the NTERA2 pluripotent population was 
induced by ATRA rather than by seeding at low density, an untreated control sample of 
NTERA2 cells was prepared.  In the presence of ATRA, NTERA2 cells proliferated at a slower 
rate than was seen in untreated samples (Figure 3.7; Day 3; (Encinas et al., 2000)).  Upon 
reaching confluency, untreated cells began to detach from the culture surface and could 
not be rescued into pluripotent growth or differentiation (data not shown).  After ten days 
in culture without ATRA the cell layer was completely detached (Figure 3.7). 
Stock ATRA solution was prepared in DMSO (Section 2.4.4.1).  DMSO is used in 
cryopreservation media and has been shown to induce differentiation in multipotent 
populations (lu et al., 2004).  However, it have been previously shown that DMSO does not 
affect neuronal differentiation in NTERA2 either positively or negatively  (Andrews et al., 
1986; Bani-Yaghoub et al., 1999; Veal et al., 2000), therefore a DMSO control was not 
included in these experiments. 
The differentiated NTERA2 population was largely heterogeneous containing cells of 
neuronal and non-neuronal morphology (Figure 3.5).  The presence of contaminating 
non-neuronal cells in NTERA2 ATRA-induced differentiation has been previously described 
(Andrews, 1984; Pleasure et al., 1992; Encinas et al., 2000).  The presence of non-neuronal 
cells will result in mixed signalling across the culture, which is likely to reduce the neuronal 
yield and possibly affect neuronal maturation.  It was therefore clear that improvement in 
neuronal purity was necessary.   
During experimental screening of NTERA2 derived neurons, cells were cultured in a range 
of different culture vessels.  For routine differentiation, cells were differentiated in T75 
tissue culture flasks.  However, when larger numbers of neurons were required for study, 
differentiation was initiated in larger tissue culture vessels (T175).  In running these 
protocols, variations in the yield of neurons achieved were observed.  This led to a study to 
compare the effect of the size of culture vessel of the success of neuronal differentiation.  
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3.2.2.3 The effect of culture vessel size. 
Differences in neuronal yield were observational using bright field microscopy.  Cells were 
seeded into 24-well or 6-well plates, and tissue culture flasks T25, T75 and T150 at 
2.6 x 104 cells/cm2.  The ratio of surface area to media volume was kept constant between 
samples.  Initial studies suggested that smaller culture vessels generated larger proportion 
of neuronal cells.  This was thought to have been a result less dispersion of the signalling 
molecules required for neuronal differentiation and retention close to the cell layer 
(subjective data not included).  This would need to be repeated for confirmation and the 
numbers of neurons quantified following each culture vessel, ideally using flow cytometry 
to demonstrate whether this is a significant effect.  The time required for handling and 
processing cells in smaller vessels is similar to that for handling larger vessels, although in 
smaller vessels the number of cells generated is markedly reduced.  Therefore by means of 
a compromise between time for processing and optimal neuronal yield, NTERA2 were 
routinely cultured in T25 tissue culture flasks for neuronal differentiation rather than the 
T75 as is more standard for NTERA2 differentiation protocols (Pleasure et al., 1992).   
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Figure 3.4. Differentiation of NTERA2 into neurons (part 1).  
A: x4 magnification, B: x10 magnification.  On day 0 a confluent layer of pluripotent NTERA2 cells were dissociated into small clusters/single cells and seeded into a fresh culture vessel at 
1.3 x 10
4
 cells/cm
2
 in culture media containing 10
-5
 mM ATRA.  After 24 hours in culture the cells were attached and proceeded to proliferate but lost their compacted cell structure.  After 
1 week in culture, the cells were mainly of a flattened morphology.  On reaching confluency proliferation continued at a slower rate, until small compacted areas of cells were visible (week 2A 
– red dashed area) and cells with rounded phase bright cell bodies were visible (Week 2B – green arrow).  See part 2 for continued story. 
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Figure 3.5. Differentiation of NTERA2 into neurons (part 2).  
A: x4 magnification, B: x10 magnification.  Between weeks 3 and 4 the number of compacted cell structures increased, in addition to the number of visible neuronal cells around the outside of 
these structures.  After 4 weeks in ATRA, the cell layer was dissociated with Trypsin/EDTA and replated onto a fresh culture surface in a 1:6 split ratio.  Cultures were incubated with mitotic 
inhibitors to remove non-neuronal cells from culture.  At 5 weeks neurons (Week 5B - blue arrow) were clearly visible in culture, growing on the surface of flattened epithelial-like cells (Week 
5B – orange arrow).  By 6 weeks the overall number of neurons increased as clusters of neurons increased in size and fascicle of axons become obvious (Week 6B - purple arrow).  However, 
the number of single neurons in culture was reduced.  The differentiated population remained heterogeneous in cell type with non-neuronal cells forming a mostly confluent layer of cells on 
which the neurons attach. 
 BA
 
Figure 3.6. Purification of neurons using mitotic inhibitors. 
Mitotic inhibitors selectively targeted the proliferating cells which were mostly of non-neuronal morphology and formed the largest fraction of the differentiated population (A; red arrows - 
apoptotic cells).  Neurons attached to these cells in preference to the culture surface (B).  Loss /death of these non-neuronal cells resulted in eventual depletion of neuronal population due to 
inability to adhere to the culture surface.  
 Day 10 ControlDay 7 ControlDay 3 Control
Day 7 ATRA Day 10 ATRADay 3 ATRA
 
Figure 3.7. NTERA2 +/- ATRA.   
NTERA2 cells were seeded at 1.3 x 10
4
 cells/cm
2
 in ATRA differentiation media and standard culture media (control).  Cultured cells were fed twice weekly and left to grow.  Images of cells 
were captured 3, 7 and 10 days after neuronal induction with ATRA.  No obvious difference in cellular morphology was detected by day 3 although the overall number of cells was visibly 
higher in the untreated control than in the ATRA treated cells.  By day 7 reduced rate of proliferation was very apparent in ATRA treated cultures.  After 10 days ATRA induction cells in the 
untreated control samples had overgrown and were seen detaching from the culture surface, from which it was concluded that it was not the low seeding density which induced neuronal 
differentiation but a result of cellular exposure to ATRA in culture. 
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3.2.2.4 Improving neuronal purity 
In an attempt to reduce the heterogeneity of the six week differentiated NTERA2 
population, an experiment was carried out to identify the optimal conditions and exposure 
time for Trypsin detachment of the neurons from the non-neuronal cell layer.  
Heterogeneous neuronal populations were washed in fresh media or PBS, and exposed to 
Trypsin/EDTA for either: 30 seconds, 1 minute and 2 minutes followed by incubation at 
37 °C.  All experiments were carried out by a single operator to reduce additional variable 
factors.  Samples without a PBS wash did not detach effectively due to the presence of 
serum which blocked the activity of the Trypsin.  Exposure to Trypsin/EDTA for 1-2 minutes 
at 37 °C resulted in complete detachment of the cell layer, and therefore resulted in poor 
control over neuronal selection.  Optimal separation of neurons from underlying 
epithelial-like cells was achieved following a rapid PBS wash and 30 seconds Trypsin/EDTA 
incubation at 37 °C.  Cells were subsequently centrifuged to remove the Trypsin/EDTA and 
washed in differentiation media before replated into a fresh culture vessel.   
 
3.2.3 Characterisation of differentiation using immunostaining 
Throughout this study pluripotent NTERA2 and differentiated neurons were identified by 
morphology (Sections 3.2 and 3.2.2.1).  To ensure that pluripotent cells expressed typical 
markers of pluripotency and that the morphology of the cells which appeared to be 
neuronal were truly neuronal, immunostaining analysis of populations was carried out.   
NTERA2 cells at p37 were stained for a selection of markers to characterise the populations 
throughout differentiation according to the methods outlined in Section 2.13.  Pluripotency 
markers: SSEA4, Tra-1-60, OCT4 and SOX2 (Section 1.9.1) and pan neuronal markers: 
TUBB3, MAP2 and synaptophysin (SYP; a glycoprotein found in the membrane of synaptic 
vesicles (De Camilli and Navone, 1987)) were used for identification of the differentiating 
populations.  At the end of the 6 week differentiation procedure, cells were stained for the 
presence of neurotransmitters: Serotonin, TH and GABA in an attempt to identify the 
neuronal phenotype generated.  Optimal antibody dilutions and immunostaining 
procedures were identified and Isotope controls run for each antibody at equivalent 
concentrations, confirming specificity of positive staining.  Cellular morphology was found 
to be best preserved during fixation using pre-warmed reagents to 37 °C.  A DNA stain was 
included in all preparations to confirm the localisation of positive staining.   
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Undifferentiated NTERA2 cells were positive for both SSEA4 (Figure 3.8) and Tra-1-60 
(Figure 3.9), revealing variable levels of expression (high and low) across the population.  
Expression of SSEA4 was more consistent than Tra-1-60. 
Expression of the pluripotency transcription factors OCT4 (Figure 3.11) and SOX2 (Figure 
3.12) were positive in undifferentiated NTERA2.  Some OCT4 and SOX2 negative cells were 
identified, suggesting a loss of pluripotency in parts of the population.  OCT4/SOX2 
negative cells were found as single cells or in small clumps on the outer edge of larger cell 
groups suggesting cell-to-cell contact aided retention of pluripotency. 
Prior to induction of differentiation, NTERA2 cells did not express neuronal markers TUBB3 
or MAP2 (Images available on request), confirming the absence of neurons in the starting 
cell pools; however, undifferentiated populations were positive for the neural stem cell 
marker Nestin (Figure 3.10).  Expression of pluripotency and neuronal markers in 
differentiated NTERA2 cells were analysed after 6 weeks.  Staining was carried out on the 
same day as for undifferentiated samples to eliminate variation in sample preparation 
during staining.  Undifferentiated cells were fixed on day 0 and stored at 4 °C until 6 week 
differentiated samples were ready. 
NTERA2-derived neurons stained positive for TUBB3 (Figure 3.13) and MAP2 (Figure 3.14), 
confirming the generation of neurons as a result of differentiation.  Combined Hoechst and 
FITC images for these markers highlight the number of non-neuronal cells in culture after 
6 weeks.  Neuronal projections from large numbers of neurons align into fascicles and 
extended long distances to communicate with cells across the culture surface.   
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Figure 3.8. Immunostaining for SSEA4 in undifferentiated NTERA2 
Expression of the surface pluripotency marker SSEA4 (A) was positve across the undifferentiated NTERA2 population (A: x10 magnification).  Isotype controls were negtive (B: x10 
magnification). 
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Figure 3.9.  Immunostaining for Tra-1-60 in undifferentiated NTERA2.  
Expression of the surface pluripotency marker Tra-1-60 was positve across the undifferentiated NTERA2 population (A: x10 magnification).  Isotype controls were negtive (B: x10 
magnification). 
 Bright Field FITC Hoechst Combined
A
B
C
 
Figure 3.10. Immunostaining of Nestin in undifferentiated NTERA2.  
Expression of the Type VI intermediate filament Nestin was positve across the undifferentiated NTERA2 population seen (A: x10 magnification, B: x4 magnificaiton).    Isotype controls were 
negtive (C: x10 magnification). 
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Figure 3.11. Immunostaining for OCT4 in undifferentiated NTERA2. 
Expression of the OCT4 pluripotency transcription factor was positive across the undifferentiated cell population; however, OCT4 negative cells were present amongst the pluripotent 
population suggesting loss of pluripotency in some cells (A: x10 magnification).  Variations in OCT4 protein levels were also evident across the population (B: x4 magnification). Isotype 
controls were negtive (C: x10 magnification). 
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Figure 3.12. Immunostaining for SOX2 in undifferentiated NTERA2 
Expression of the SOX2 pluripotency transcription factor was positive across the undifferentiated cell population.  Expression of the protein was higher in the middle of the cell cluster than in 
individual cells outside the cluster suggesting that cell-cell contact aids the retention of pluripotency (A: x10 magnification). Isotype controls were negative (B: x10 magnification). 
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Positive Nestin staining was identified in the differentiated cells but staining was localised 
to mainly non-neuronal cells (Figure 3.17).  Expression of the two surface markers of 
pluripotency (SSEA4 and Tra-1-60) and the OCT4 transcription factor was negative in 
6 week ATRA treated cell populations (Figure 3.15).  At first glance, SOX2 expression was 
also negative in the differentiated population (Figure 3.16). However, at high magnification 
it was possible to identify a few cells which retained some positive SOX2 expression (data 
not shown due to inability to capture image).  Positive expression of SOX2 after 6 weeks 
might be an artefact of the staining process; however, it may also suggest retention of a 
small proportion of neural progenitor cells in the population after just 6 weeks induction, 
which might also explain retention of Nestin positive cells in this population. 
The maturity of the NTERA2-derived neurons was investigated using an antibody towards 
synaptophysin.  Synaptophysin is expressed in the membrane of synaptic vesicles in nerve 
terminals but have also been detected in dendrites (De Camilli and Navone, 1987).  No 
positive staining for synaptophysin was observed (Figure 3.18).  After 6 weeks in culture, 
NTERA2 derived neurons were stained for a range of markers to identify the class of 
neurons generated from this method.  Due to limited resources, neurons were stained for 
only 3 subclasses of neuron: dopaminergic (tyrosine hydroxylase (TH) positive), 
serotonergic (serotonin (SERT) positive) and GABAergic (GABA positive) neurons.  No 
positive stained was identified for SERT or TH (Figure 3.18).  Staining for GABA resulted in a 
large amount of non-specific binding but staining of neuronal projections was considerably 
stronger than the background (Figure 3.19), suggesting that a proportion of neurons 
derived from ATRA induction of NTERA2 were of interneuron GABAergic morphology. 
 Differentiated cells were also stained for the glial cell marker GFAP but no positive staining 
was observed, suggesting that the epithelial-like cells supporting the neuronal attachment 
were not of a glial cell fate (Image available upon request).  However, the reliability of this 
result is questionable as GFAP antibody sourced from different suppliers resulted in high 
and low levels of background with sporadic positive staining. 
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Figure 3.13. Immunostaining for neuronal marker TUBB3 in differentiated NTERA2. 
NTERA2 derived neurons stained positive for TUBB3 along neuronal projections.  Alignment of projections from numerous neurons were visible spreading from the cell cluster towards 
neighbouring cells (A: x10 magnification, B: x4 magnification). Isotype controls were negtive (C: x10 magnification).  
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Figure 3.14. Immunostaining for neuronal marker MAP2 in differentiated NTERA2. 
NTERA2 derived neurons stained positive for MAP2.  FITC and Hoechst combined images highlighted the heterogeneity of the differentiated population (A: x10 magnification, B x4 
magnification). Isotype controls were negtive (C: x10 magnification). 
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Figure 3.15. Immunostaining SSEA4, Tra-160 and OCT4 in differentiated NTERA2. 
All cells were negative for SSEA4 (A), Tra-1-60 (B) and OCT4 (C) after 6 weeks ATRA induced differentiation x10 magnification). Isotype controls were negtive  
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A
B
 
Figure 3.16. Immunostaining for pluripotency marker SOX2 in differentiated NTERA2. 
SOX2 was mostly negative in the 6 week ATRA treated population (A: x10 magnification).  At high magnification some remaining SOX2 expression was detected in sporadic cells but at a much 
reduced level to that of the undifferentiated cells (data not shown). Isotype controls were negtive (B: x10 magnification). 
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Figure 3.17. Immunostaining for Nestin in differentiated NTERA2. 
Positive staining for Nestin was detected after 6 weeks differentiation.  Expression was mainly located in non-neuronal cells (A: x10 magnification). Isotype controls were negtive (B: x10 
magnification). 
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Figure 3.18. Immunostaining for SYP, SERT, TH in NTERA2 derived neurons. 
No positive for SYP(A), SERT(B) or TH (C) was seen in NTERA2 derived neurons after 6 weeks (x10 magnification). Isotype controls were negtive. 
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Figure 3.19. Immunostaining for GABA in differentiated NTERA2. 
Neuronal axons stained positive for GABA.  Background staining was high for the GABA antibody with staining visible in most cells; however, staining more intense in neuronal axons 
suggesting the presences of GABAergic neurons within the NTERA2 derived neurons after 6 weeks (A: x10 magnification). Isotype controls were negtive (B:  x10 magnification). 
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To quantify the number and purity of neurons within the differentiated population 
following modifications to differentiation, cells were analysed using flow cytometry at 
day 0 and 6 weeks after ATRA induction for TUBB3 expression.  The population was also 
analysed after 8 weeks to see whether the number of neurons continued to change.  
Samples were stained for TUBB3 following methods outlined in Section 2.13.4, before 
analysis on the Guava Easycyte flow cytometer (Guava Technologies, Millipore, 
Massachusetts).  Isotype controls were run at the same antibody concentration as TUBB3 
to determine the threshold above which staining could be assumed positive (Figure 3.20).   
The purity of TUBB3 positive cells within the population increased from 1.3 % of cells in the 
undifferentiated population, to 61.4 % of cells after 6 weeks.  After a further 2 weeks of 
purification, the proportion of TUBB3 positive cells further increased to 90.2 % due to the 
death of non-neuronal cells following exposure to mitotic inhibitors in culture.  However, 
after 8 weeks the overall number of cells was considerably reduced due to the selection of 
neurons and death of non-neuronal cells in culture. 
Flow cytometry analysis was also carried out for pluripotency markers at day 0 to correlate 
the level of expression throughout the population with the in situ immuno staining (Table 
3.1).  Positive Tra-1-81, SSEA4 and Nestin expression in the undifferentiated population 
were recorded at 84.6, 92.6 and 94.0 % respectively.  Expression of OCT4 decreased from 
79.4 % positive expression at day 0 to just 3.5 % after 6 weeks, confirming reduction in the 
pluripotent population. 
As highlighted in previous sections, the morphology of a cell and its expression of neuronal 
genes is indicative of neuronal phenotype; however, a cell based therapy or assay relies on 
the functionality of the neuron.  Previous sections also highlighted the requirement for 
functionality comparable to that of a primary neuron in order to be incorporated into a 
successful assay.  NTERA2 derived neurons following the optimised differentiation protocol 
were screened for functionality in response to stimuli, including depolarisation and 
neurotransmitter activity.  This was carried out using two basic approaches; patch clamping 
(the gold-standard for electrophysiology) which monitored a cell’s ability to fire an action 
potential in response to depolarisation, and calcium imaging to monitor the activity of 
specific ion channels and cell surface receptors for specific neurotransmitters within the 
cell population. 
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B Day Antibody Cell count % positive cells
0 TUBB3 2161 1.3
36 TUBB3 127 61.4
48 TUBB3 2692 90.2
 
Figure 3.20. Flow cytometry analysis of TUBB3 in differentiating NTERA2.   
Dot plots (A) show the spread of differentiated cells and the gating applied to score positive staining according 
to the Mouse IgG Isotype control.  The proportion of TUBB3 positive cells increased from 1.3 % to 90.2 % of 
differentiated cells after 8 weeks (B).  The overall number of analysed cells in the 6 week sample was lower than 
at day 0 and 8 weeks due to a loss of cells in the staining process. 
 
Day Antibody Cell count % positive cells
0 Tra-1-81 4402 84.6
0 SSEA4 3469 92.6
0 Nestin 1981 94.0
0 OCT4 1193 79.4
36 OCT4 255 3.5
 
Table 3.1. Flow cytometry analysis of pluripotency markers in NTERA2. 
84.6 and 92.6 % of undifferentiated NTERA2 cells stained positive for Tra-1-81 and SSEA4 respectively.  94 % of 
cells stained positive for Nestin and 79.4 % positive for OCT4.   
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3.2.4 Patch clamping NTERA2 derived neurons. 
NTERA2 cells were cultured and differentiated as described in Section 2.4.  After 4 weeks of 
ATRA induced differentiation, NTERA2 derived neurons were treated with Trypsin/EDTA 
and replated onto glass slides for patching.  Cells were tested for their ability to fire both 
action potentials (AP) in response to a hyperpolarising current under current clamp mode.   
To be confident of a functional response following stimulation, a neuronal control cell 
sample was required. Due to ethical limitations in sourcing primary human neural tissue, 
primary neurons were sourced from the ganglionic eminence (GE) region of an embryonic 
day 14 (e14) rat.  The GE regions form part of the developing forebrain and are present 
transiently during embryonic development (Wai et al., 2008).  Cells from the GE go on to 
develop into the basal ganglia comprising large numbers of GABAergic neurons.  By e14 
much of the neurogenesis in the rat has been completed and it is possible to isolate neural 
cells from the tissue.  Immunostaining of differentiating NTERA2 neurons suggest a 
proportion of these cells were of GABAergic phenotype (Figure 3.19).  Therefore primary 
cells from the GE were a logical positive control for electrophysiology studies.  Primary 
neurons from the GE were isolated and kindly provided by Ms. S. Finch and Professor. B. 
Williams (Centre for the Cellular Basis of Behaviour & MRC Centre for Neurodegeneration, 
Kings College London).     
NTERA2 cells were tested at weekly intervals of neuronal commitment, for their 
electrophysiological behaviour.  The resting membrane voltage of each cell was recorded 
by setting the current to zero (Figure 3.21) before hyperpolarising at -70 mV.  The flattened 
morphology of pluripotent and 1 week differentiated NTERA2 cells meant that it was not 
possible to reach a seal.  No recordings were generated from pluripotent populations and 
only one of the seven cells attempted reached a seal after 1 week ATRA.  For this reason, it 
was not possible to patch these cells or determine their resting membrane voltage.  A 
typical mature neuron should present with a resting membrane voltage of -70 mV.  Primary 
e14 rat GE neurons presented the lowest average membrane resting voltage of -56 mV 
(± 6.1) when compared to the NTERA2 derived neurons.  However, ANOVA between all 
groups showed that there was no significant difference between the resting membrane 
voltage of differentiating NTERA2 derived neurons at week: 2, 3, 4, 5 and 6, or the primary 
e14 rat GE neurons (p = 0.09).  The single resting voltage recording from 1 week ATRA 
treated cells meant that it was not possible to incorporate this sample into statistical 
analysis.   
 120 
Prolonged exposure to ATRA did not appear to improve the neuronal resting membrane 
voltage but rather increased the overall number of excitable neurons.  This was further 
supported by the increased success of patching following prolonged differentiation (Figure 
3.22).  A failure to patch was defined by the inability to generate a GΩ seal between the cell 
membrane and capillary to run a current and voltage clamp procedure. 
After recording the resting membrane voltage of each cell, a hyperpolarising current was 
passed down the electrode to hold the membrane between -70 and -100 mV.  Following 
release of the hyperpolarising current, electrically excitable cells fired electrical impulses.  
Examples of the APs generated from cells at each stage of differentiation are presented in 
(Figure 3.23).  No recordings were taken from pluripotent or 1 week ATRA treated samples 
for reason described above.  Action potentials were generated by NTERA2 derived neurons 
as early as 2 weeks following induction.  However, the number of neurons which 
repeatedly fired APs in response to hyperpolarisation increased as the duration of 
differentiation increased.  Despite a distinct AP fired from 1 of the 7 cells tested at 2 weeks 
(Figure 3.23C), none of the other 2 week cells responded to stimulation in this way.  
Equally, it was difficult to find a response from cells 3 weeks after induction and the 
response shown in Figure 3.23D did not cross the 0 mV threshold.  The slower speed of 
these APs suggests that these were calcium responses rather than the normal fast sodium 
induce AP but its reverberating nature suggests this was a true response from an immature 
cell.   
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Figure 3.21. Average resting membrane voltage of patchable cells. 
No correlation was determined between the resting membrane voltage of NTERA2 derived neurons between 
1-6 weeks of ATRA treatment.  Primary e14 rat GE neurons presented the lowest resting membrane voltage 
suggesting that these are more mature neurons than those derived from NTERA2; however, this was not 
significantly different from the resting membrane voltage of the NTERA2 cells throughout differentiation 
(p = 0.09).  NTERA2 (blue) 1 week ATRA (n=1), 2 weeks ATRA (n=5), 3 weeks ATRA (n=2), 4 weeks ATRA (n=3), 5 
weeks ATRA (n=4), 6 weeks ATRA (n=2), primary e14 rat GE neurons (red) 14 days post isolation (n=3).  Error 
Bars represent ± 2SE.   
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Figure 3.22. Failure rate of patching process. 
Failure to patch these cells was defined by the inability to generate a GΩ seal with the patching capillary.  The 
success rate of patching was vastly improved 2 weeks following induction of neuronal differentiation.  The 
flattened morphology of undifferentiated and 1 week ATRA treated NTERA2 cells resulted in a high failure rate 
of seal generation and therefore an inability to patch.  NTERA2 (blue) undifferentiated (n=3), 1 week ATRA 
(n=7), 2 weeks ATRA (n=8), 3 weeks ATRA (n=7), 4 weeks ATRA (n=9), 5 weeks ATRA (n=13), 6 weeks ATRA 
(n=4), primary e14 rat GE neurons (red) 14 days post isolation (n=4). 
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The overall number of cells which fired an AP in response to hyperpolarisation increased as 
the differentiation period increased (Figure 3.24).  In the control primary rat e14 GE neuron 
sample, 100 % cells successfully fired APs confirming successful patching technique.  In 
comparison, primary neurons also spontaneously fired APs without a hyperpolarising 
current, confirming the maturity of these cells (Figure 3.23A).  When the primary neuron 
membrane was placed under a hyperpolarising current, the AP response increased, 
resulting in a reverberating burst of electrical impulses as would be seen in vivo (Figure 
3.23B).  The reduced ability to fire reverberating APs in NTERA2 derived neurons was 
therefore a true result rather than an inability to detect this response. 
Neurons were voltage clamped and IV curves generated for each cell (data available upon 
request).  Cells were depolarised through a range of voltages (-50, -30, -10, 10, 30, 50, 70, 
90, 110, 130, 150, 170 mV) to test for the presence of voltage gated ion channels which 
would open in response to depolarisation resulting in an inward flux of Na+ or Ca2+ ions.  An 
example of the IV curve generated by an inward current in response to this stimulation is 
presented in Figure 3.25.   
Calcium and sodium are the only ions with a large inward concentrations gradient in a 
neuronal cell.  Inward currents observed were a result of the opening of these channels in a 
voltage dependent manner.  The absence of inward current in response to voltage 
clamping from undifferentiated NTERA2 cells has previously been published (Rendt et al., 
1989).  In agreement with Rendt et al., these data have shown that NTERA2 derived 
neurons express functional Na+ and/or Ca2+ gated channels which were detectable 2 weeks 
after induction of differentiation.  The functionality of these membrane channels was 
variable between neurons within differentiation samples, and across the different time 
points of differentiation.  No correlation between the length of differentiation and the 
ability to generate an inward current was identified (Figure 3.26); however, the size of the 
inward current increased with prolonged duration of differentiation.   
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Figure 3.23. Action potential generation in NTERA2 derived neurons. 
The resting membrane voltage of e14 rat GE neurons after 14 days of in vitro maturation was -58 mV.  These 
cells sporadically fired Action Potentials (A).  Following hyperpolarisation to -70 mV e14 primary rat neurons 
generated a series of reverberating action potentials typical of excitatory GABAergic neurons (B).  A single cell 
from the 2 weeks ATRA induced population (n=7) fired an action potential in response to hyperpolrisation (C). 
The only 1 cell fired an AP after 3 weeks ATRA exposure (n=4), this AP did not cross the 0 mV line, suggesting 
that these neurons were still immature (D).  Three cells fired APs after 4 weeks of differentiation (n=8; E). Three 
cells fired AP’s after 5 weeks differentiation (n=7; F), the membrane of the representing cell at 5 weeks was 
very unstable under hyperpolarisation resulting in the notable fluctuations in membrane voltage throughout 
the trace.  Two cells tested after 6 weeks of differentiation fired APs (n=3; G), these neurons were reliably firing 
reverberating APs as seen in primary neurons. 
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Figure 3.24. Action Potential generation in differentiated NTERA2 cells. 
The proportion of neurons which fired APs increased with increasing duration of differentiation.  NTERA2 (blue) 
undifferentiated (n=0), 1 week ATRA (n=1), 2 weeks ATRA (n=7), 3 weeks ATRA (n=4), 4 weeks ATRA (n=8), 5 
weeks ATRA (n=7), 6 weeks ATRA (n=3), primary e14 rat GE neurons (red) 14 days post isolation (n=3). 
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Figure 3.25. IV curve. 
Inward current caused by the movement of Ca
2+
 and Na
+
 ions into the cell through ion gated channels, was 
visible by the current trace dropping below zero.  Outward currents are caused by the flow of K
+
 ions out of the 
cell via K
+
 ion channels of the Na
+
/K
+
 membrane pump, resulting in an increase in current recorded.  The 
number of Ca
2+
, Na
+
 and K
+
 membrane channels increased with neuronal maturity resulting in the detection of 
distinct inward currents followed by larger outward currents. 
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Figure 3.26. Inward currents in differentiating NTERA2 cells. 
The efficiency of inward current generation was variable between neurons at different points of differentiation.  
By 6 weeks of differentiation 100 % of patched neurons generated an inward current in response to voltage 
clamping.  NTERA2 (blue) undifferentiated (n=0), 1 week ATRA (n=1), 2 weeks ATRA (n=7), 3 weeks ATRA (n=4), 
4 weeks ATRA (n=8), 5 weeks ATRA (n=7), 6 weeks ATRA (n=3).  Primary e14 rat GE neurons (red) 14 days post 
isolation consistently generated a strong inward current (n=3). 
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Although the patch-clamping data demonstrates a correlation between neuronal 
morphology and electrophysiological activity, the neuronal population was heterogeneous 
in response to stimulation.  However, the skill required and the labour intensity of the 
patch-clamping technique prevented the screening of the large numbers of cells required 
for a true representation of the population.  To complement the data from patch clamping, 
a high throughout calcium imaging facility (FLIPR) was also incorporated into this study 
which was able to simultaneously screen large numbers of cells, capturing the behaviour 
the entire neuronal and non-neuronal population. 
 
3.2.5 Fluorescence imaging plate reader  
The FLIPR was incorporated into this study in an attempt to characterise the behaviour of 
NTERA2 derived neurons in response to stimulation.  Cells were prepared as detailed in 
Section 2.12.9.  Following a one hour incubation with the Fluor-4 AM calcium indicator 
samples were loaded into the FLIPR and background fluorescence levels recorded.  Cells 
were stimulated with a range of neurotransmitters and images of changes in fluorescence 
captured every second for five minutes (Figure 3.27).   
For the purpose of analysis, background fluorescence readings were standardised to one, 
and changes in fluorescence expressed relative to basal levels, enabling comparison 
between wells and samples.  The overall calcium response was calculated from changes in 
fluorescence from the minimum to maximum recorded levels.  An even monolayer of cells 
was required to ensure even excitation of the plate by the laser avoiding skewed results 
from auto fluorescence.  Cellular responses were averaged across each well, providing the 
behaviour of the population rather than of individual cells.   
Early trials highlighted the need for a pre-coating of the FLIPR plate with poly-D-lysine to 
aid cellular attachment and reduce loss during washing stages.  Due to interference in 
fluorescence from cell culture media, it was not possible to run the FLIPR in standard 
culture media.  Viability was maintained using pre-warmed HBS buffer, containing a glucose 
source for metabolism (Section 2.12.9.2) during all wash steps and incubations, in place of 
PBS.   
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Figure 3.27. Schematic diagram of FLIPR stimulation 
A confluent cell layer in a black bottomed 96-well plate was incubated for 1 hour with Fluo 4 AM (calcium 
indicator).  Cells were washed to remove excess dye and loaded into the FLIPR.  Addition of a drug stimulated 
calcium influx across the plasma membrane in responsive cells.  Free cytosolic calcium binds to the Fluo-4 AM, 
which when excited by a 488 nm argon laser, emitted light in the 550 nm spectrum.  Image capture of 
fluorescence emissions was correlated to the level of calcium influx.   
 
0.6
0.7
0.8
0.9
1
1.1
1.2
1.3
1.4
0 30 60 90 120 150 180 210 240 270
F
lu
o
re
s
c
e
n
c
e
 U
n
it
s
Time (s)
A
C
D
E
F
B
 
Figure 3.28. Typical cellular calcium response to stimulation.  
The 6 phases of a classical response to neurotransmitters.  The response from each cell is standardised to 
ensure background fluorescence is equal to 1.  A; background fluorescence.  B; drug stimulation.  C; baseline 
fluorescence of cell, calcium channels open.   D; influx of calcium and binding to Fluo-4-AM resulting in 
increased fluorescence.  E; maximum fluorescence.  F; calcium pumped out of cell or sequestered to 
cytoplasmic stores.    The overall response is determined by the difference between C and E. (i.e. the difference 
between the maximum and minimum fluorescence values after addition of the drug.) 
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3.2.5.1 Calcium response to potassium chloride depolarisation. 
To establish the FLIPR study, undifferentiated NTERA2 cells at p56 and p58 were seeded at 
5 x 104 cells/well, in 200 µl standard GlutaMAXTM media (Section 2.1.2) 24 hours before 
stimulation.  Each sample was run in triplicate wells.  The calcium response to KCl 
depolarisation was tested from high to low concentration (100 mM, 75 mM, 50 mM, 
25 mM, 10 mM, 5 mM and 0 mM in PBS).  The maximum cellular response was calculated 
relative to background fluorescence (Figure 3.29). 
The large overlapping error bars and minimal response to KCl depolarisation suggested that 
there was no difference in Ca2+ response between the different KCl concentrations, this was 
confirmed by ANOVA (p = 0.054).  The apparent response at 0 mM KCl suggests that these 
cells were responding to the addition of a volume of solution rather than to the KCl. 
 
3.2.5.2 Comparative response of NTERA2 neurons to KCl depolarisation 
The responses of undifferentiated NTERA2 cells and NTERA2 derived neurons to KCl were 
compared.  Samples were run over a number of days and results combined for comparison.  
Results from undifferentiated NTERA2 at p58 (Figure 3.29) were used as the baseline 
response.  Differentiating NTERA2 cells at 10 days, 3 weeks and 6 weeks post ATRA 
induction were not as actively proliferating as the undifferentiated cells (Figure 3.7) and so 
were seeded at a higher density 2 x 105 cells/well, ensuring even coverage across the base 
of the well.  Cells were stimulated with 100 mM, 75 mM, 50 mM, 25 mM, 10 mM, 5 mM 
and 0 mM KCl in PBS.  In order to determine whether the minimal response from 
undifferentiated cells in Figure 3.29 was a true response or an artefact due to addition of 
volume, an unexcitable human dermal fibroblast control cell line was included in analysis 
(p18, Karocell Tissue Engineering AB, Sweden).   
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Figure 3.29. Calcium response by undifferentiated NTERA2 to KCl depolarisation 
Pluripotent NTERA2 cells were seeded into a FLIPR plate and stimulated with KCl at concentrations ranging from 
100 mM to 0 mM (X-axis).  No true calcium response was detected from undifferentiated NTERA2 cells at p56 
(red) or p58 (green) in response to KCl, suggesting the absence of voltage gated calcium channels in 
undifferentiated cells.  Error bars represent ± 2SE.   
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Figure 3.30. Comparison of Calcium response to KCl of differentiating NTERA.   
Undifferentiated NTERA2 (blue), 10 days ATRA treated NTERA2 (red), 3 week ATRA treated NTERA2 (green), 6 
week ATRA treated NTERA2 (orange), dermal fibroblasts (purple).  Overlapping of error bars indicates that no 
difference in calcium response was detected following KCl stimulation between undifferentiated, 10 day ATRA 
treated and human dermal fibroblasts.  A larger response to KCl was seen by cells which are 3 and 6 weeks 
differentiated compared to cells earlier in differentiation, although the concentration of KCl did not seem to 
affect the size of the calcium response, suggesting that the response was due to the addition of a drug volume 
rather than neuronal depolarisation.  Error bars represent ± 2SE.   
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No difference was detected between the Ca2+ responses of undifferentiated NTERA2, 
10 days differentiated NTERA2 and dermal fibroblasts, at KCl stimulation between 100 mM 
and 0 mM (Figure 3.30).  The similarity of undifferentiated cells and the dermal fibroblasts 
confirmed the absence of a true response to KCl stimulation.  This was not surprising when 
correlated to the morphology of the cells at each condition (Figure 3.5).  Very few cells 
presented a neuronal morphology after 10 days of differentiation, and so would not be 
expected to express function voltage gated ion channels.   
The response from NTERA2, 3 weeks and 6 weeks after ATRA induction was higher than 
that of the undifferentiated and 10 day ATRA treated cells (Figure 3.30) at ≥ 50 mM KCl, 
confirming the presence of voltage gated Ca2+ channels in the plasma membrane after this 
point.  This correlates with data from the patch clamping experiments on these cells (Figure 
3.23 and Figure 3.26).  The relative indifference in response of cell between 3 and 6 weeks 
differentiation suggests that the number of voltage gated Ca2+ channels in the membrane 
does not increase with prolonged differentiation.  However, the response of these cells to 
0 mM KCl is suggestive of cellular reponse to the addition of a drug volume rather than 
specifically to KCl depolarisation. 
 
3.2.5.3 Neurotransmitter stimulation 
In an attempt to identify the neuronal phenotype within the differentiated population, cells 
were stimulated with a range of common neurotransmitters and monitored for a response.  
NTERA2 cells were screened throughout differentiation at 0, 10, 21 and 36 days post 
induction.  Dermal fibroblasts were included as a baseline control for unresponsive cells.   
Cells were stimulated with NMDA at a range of concentrations from 20 µM to 0 µM, 
3-5 repeats were run for each cell type and stimulant.  Due to the limited availability of 
fibroblasts when preparing this experiment, these cells were tested for a response to 
NMDA at just 20 µM, 10 µM and 0 µM. 
No significant difference was detected in the response of undifferentiated NTERA2 cells or 
dermal fibroblasts to NMDA (p = 0.61, Figure 3.31) as would be expected for unexcitable 
cells.  The response of the undifferentiated NTERA2 and the dermal fibroblasts to NMDA 
was of a similar level to that of KCl stimulation (Figure 3.30), suggesting that this was a 
normal baseline response by unstimulated cells in the FLIPR.  The response of 3 and 6 week 
differentiated cells to NMDA was significantly higher than that of undifferentiated NTERA2 
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as determined by ANOVA (p = 0.00002 and 0.01 respectively), which would suggest that the 
expression of functional NMDA channels in neurons after 3 weeks ATRA induced 
differentiation.  However, the response generated by cells at 0 µM NMDA, in combination 
with large error bars (2SE) suggests that the increased calcium flux detected may have been 
a consequence of cell number and coverage rather than overall cellular response, and that 
none of these populations were genuinely responding to NDMA stimulation.   
To rule out the possibility the non-response was due to the absence of the NMDA 
co-agonist glycine, undifferentiated and 10 day differentiated cells were stimulated with 
NMDA (10 µM and 20 µM) in the presence of glycine at 10 µM and 20 µM concentrations.  
A glycine control for 10 day treated sample was also included to identify response to 
glycine alone.  Results from the comparative response of undifferentiated NTERA2 cells 
with 10 day ATRA treated NTERA2 the NMDA ± glycine would suggest that no expression of 
NMDA receptors on cells up to 10 days of differentiation (Figure 3.31 and Figure 3.32).  
Cells did not respond to glycine stimulation.  Variable cell coverage due to loss of sample 
during washing might explain the larger error bars within these samples.   
 
3.2.5.4 The requirement for a neuronal control   
The high variability in cellular response from undifferentiated and differentiating cells 
highlighted the need for a positive control.  Limited availability to primary neurons, meant 
that it was not possible to source sufficient numbers of cells as a positive control for the 
FLIPR.  Incorporation of the neuroblastoma-derived cell line SH-SY-5Y, was trialled as a 
positive control.  There is extensive literature to demonstrate that these cells can be 
differentiated into post-mitotic neurons under the influence of ATRA and BDNF in just 
8 days (Påhlman et al.;Encinas et al.).  However, attempts to culture and differentiate these 
cells (Section 2.6) resulted in a population of cells which, despite being of neuronal 
morphology did not respond to KCl stimulation, instead these cells generated a response 
similar to undifferentiated NTERA2 (p = 0.199, Figure 3.33).  From these data it was 
concluded that the SH-SY-5Y was an unsuitable cell line for use as a functional neuronal 
control, even with ATRA and BDNF differentiation. 
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3.2.5.5 6-week NTERA2 derived neurons  
Following attempts to purify neurons using rapid trypsin exposure (Section 1.1.1.1), a 
comparative experiment was carried out to investigate the difference in response of the 
top layer of purified neurons and the remaining cells from 6 week ATRA treated NTERA2.  
Cells were seeded at 2 x 105/well, 72 hours before stimulation enabling the neurons to 
recover from damage caused by replating.  Poor neuronal yield resulted in sufficient cells 
for only single well per stimulation.  This meant that results were only representative and 
not conclusive for a comparison between these populations.  Results demonstrated a 
consistently increased Ca2+ response of NTERA2-derived neurons to KCl stimulation in 
6 week differentiated samples than in undifferentiated NTERA2 (Figure 3.34).  Results also 
suggest a better response from the top layer of 6 week ATRA treated cells when compared 
to the underlying cells from which they were separated.  This can be explained by a higher 
purity of neurons in the top layer of cells when compared to the remaining layer, 
generating a larger calcium flux across the well. 
 
3.2.6 Calcium imaging 
Due to the interference of non-neuronal cells in the output of the FLIPR, a higher 
magnification calcium imaging system was used to focus analysis on a selected population 
of neurons, distinguishable by morphology from that of the non-neuronal cells.  Cells were 
cultured, differentiated and prepared for imaging as described in Section 2.12.10.  Calcium 
indicator dye (Fura-2 AM) was incubated with the cells for 30 minutes before loading the 
cells into the system for stimulation.  A continual feed and purge system was set up to 
deliver a constant flow of HBS (Section 2.12.9.2) or stimulus to the cells.  At defined time 
points, a neurotransmitter of interest was added to the flow feed.  The flow rate was set to 
0.6 ml.min-1 to prevent disruption and detachment of the cell layer.  Fluorescence images 
were captured in real time for the duration of the run and subtracted from background 
readings.  Changes in fluorescence intensity were correlated to cytoplasmic Ca2+. 
The calcium imaging system was set to focus on a small group of neurons 6 weeks (Figure 
3.35A) and 8 weeks (Figure 3.35B) post induction.  Cells were stimulated with KCl (60 mM), 
NDMA (100 µM), glycine (20 µM), glutamate (100 µM) and carbachol (100 µM) and 
monitored for changes in Ca2+ response.   
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Figure 3.31.  Calcium response of differentiating NTERA2 cells to NMDA stimulation.   
Undifferentiated NTERA2 p58 (blue), 10 day ATRA treated NTERA2 p57 (red), 3 week ATRA treated NTERA2 
(green), 6 week ATRA treated NTERA2 (orange), dermal fibroblasts p18 (purple) were stimulated with NMDA 
and subsequent calcium influx detected.  No significant difference in the calcium influx of pluripotent NTERA2 
and dermal fibroblasts was detected across all NMDA concentrations (p = 0.61).  As with KCl stimulation, the 
response from 3 and 6 week differentiated NTERA2 was higher than that of undifferentiated and 10 day treated 
samples; however, this increased response was also observed at 0 µM NMDA and is therefore likely to be a 
result of difference in overall cell number rather than functionality. Error bars represent ± 2SE.  
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Figure 3.32. The affect of NMDA with Glycine on differentiating NTERA2 cells.   
Undifferentiated (blue) and 10 day ATRA treated NTERA2 (red) were stimulated with NMDA (10 µM and 20 µM) 
in the presence of the co-agonist glycine at 10 µM and 20 µM.  No difference was detected in the calcium 
response of undifferentiated NTERA2 at either concentration of NMDA with or without glycine, confirming that 
NDMA receptors are not expressed by these cells.  The general response of 10 day ATRA treated cells to NMDA 
in the presence of glycine was higher than that of the undifferentiated cells but the concentration of NMDA and 
glycine did not affect the response, suggesting that the overall higher response may also be a factor of cell 
number not behaviour.  Error bars represent ± 2SE.   
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Figure 3.33. The use of SHSY5Y as a positive control.  
SH-SY-5Y (green) cells were differentiated for 8 days with ATRA into a neuronal morphology, stimulated with 
KCl and the calcium response compared to that of undifferentiated NTERA2 (blue) and dermal fibroblasts (red).  
No significant difference between the calcium response of SY-SY-5Y derived neurons and undifferentiated 
NTERA2 cells was observed (p = 0.199). Error bars represent ± 2SE.  
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Figure 3.34. Calcium response of purified 6-week ATRA NTERA2 neurons. 
Comparison of 6-week old NTERA2 derived neurons purified using rapid trypsin exposure.  Both the top layer of 
purified neurons from a 6 weeks ATRA treated NTERA2 population (red) and the remaining cells from the ATRA 
treatment (green), generated a higher calcium influx than undifferentiated NTERA2 cells (blue).  Error bars 
represent ± 2SE. 
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In combination with glycine, glutamate induced a delayed Ca2+ influx in 6 week ATRA 
neurons, demonstrating the presence of glutamate receptors in these cells.  The response 
from cell 1 (200 nM cytosolic calcium) was greater than that of cell 2 (120 nM cytosolic 
calcium) which may be a result of more membrane glutamate channels, or a larger cell 
body.  Both cells responded well to KCl confirming as with the patch clamping data, that 
these cells express function voltage gated ion channels.  The response to KCl was 
comparable between cells (310 and 325 nM; Figure 3.36) and was higher than the response 
to glutamate but not significantly different (p = 0.06).  The KCl response was also more 
instantaneous than the glutamate response due to the rapid opening of the voltage gated 
calcium channels in response to KCl depolarisation.  It was not ideal to monitor the KCl 
response of the cells after stimulation with glutamate as the cells may have been 
exhausted by glutamate stimulation.  However due to limited cell numbers, these neurons 
were left to recover to basal calcium levels in HBS buffer before re-stimulation with KCl. 
In both examples the influx of Ca2+ came in two waves.  A similar occurrence was seen in 
the patching data where recurrent bouts of depolarisation occurred following stimulation.  
This was a good sign for mature neuronal status. 
After 8 weeks NTERA2 neurons were stimulated with NMDA with glycine (as run in the 
FLIPR), glutamate with glycine, KCl, and carbachol (Figure 3.37).  None of the neurons 
elicited a Ca2+ response to NMDA stimulation, suggesting that the non-result on the FLIPR 
may have been a true result.  Only one of the five cells monitored generated a Ca2+ influx in 
response to glutamate which was surprising when compared to the earlier results from 
6 week ATRA neurons.  Screening of such small neuronal samples was due to limited 
recovery following replating, but would not have generated a fair representation of the 
entire neuronal population at this age.  No response was detected following carbachol 
stimulation suggesting an absence of acetyl choline receptors on these neurons.  In 
contrast to early results from the FLIPR, all cells responded to KCl stimulation at 60 mM.  It 
is likely that this response was not detected by the FLIPR due to the low purity of neurons 
in each well compared to the non-responsive non-neuronal cells. 
The small sample size of neurons required for Ca2+ imaging meant it was possible to run a 
positive control with primary rat neurons, as for the patching, these neurons were isolated 
from the GE region of an e14 rat.  Cells were prepared as for NTERA2 neurons and 
stimulated for a calcium response to NMDA (100 µM) with glycine (20 µM), KCl (60 mM), 
and carbachol (100 µM).  The number of primary neurons on the slide was considerably 
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more than that of the NTERA2 derived neurons, suggesting a difference in the recovery of 
primary neurons to plating, or a survival benefit posed by the presence of larger numbers 
of neuronal cells.  A background fluorescence image of these cells was captured (Figure 
3.38) and each cell body highlighted (blue) for recording the fluorescence output.  The 
response from a total of 38 cells was recorded (video of the calcium response of these cells 
is available on request). 
The number primary neurons which responded to NMDA with glycine were considerably 
lower than the number of cell responding to glutamate stimulation (representative results 
from the first 20 cells presented in Figure 3.39).  The cell which responded to NMDA, also 
responded to glutamate with a larger response than any other cell in culture.  As was seen 
in the patching of these primary neurons, reverberating currents of Ca2+ flux were visible in 
these cells.  It is likely that on each depolarisation, the neurons released a range of 
neurotransmitters which in turn stimulated a response in neighbouring cells, thereby 
creating waves of signalling across the plate.  When the basal Ca2+ levels were restored 
after washing in HBS buffer, cells were stimulated with KCl (60 mM).  Unsurprisingly the 
response by each cell was less than that seen in response to glutamate; this was likely to 
have been because these cells were exhausted from earlier stimulations. 
The response of cells to carbachol was lower than that of NMDA, glutamate or KCl (Figure 
3.40) but was a true response which generating a slowly oscillating Ca2+ influx in the cell.  
The response of the cell appeared to induce opening of ion channels in nearby cells 
generating Ca2+ waves across the dish.  Carbachol stimulation was not toxic to the cells as a 
similar KCl response to the first run was seen in these cells after recovery of basal Ca2+ 
levels. 
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Figure 3.35. NTERA2 derived neurons for calcium imaging 
NTERA2 derived neurons at 6 weeks (A) and 8 weeks (B) post induction. Areas monitored for changes in 
fluorescence highlighted in red (left) and blue (right). 
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Figure 3.36. Calcium imaging of 6 week ATRA neurons.  
Two neurons (cell 1 – red and cell 2 – blue) were imaged for calcium response to stimulation by glutamate with 
glycine (100 µM/20 µM; green arrow) and KCl (60 mM; red arrow).  Changes in fluorescence were calculated 
relative to T0.  Background fluorescence readings were subtracted from all recordings.  Cells were washed in 
HBS before and after stimulation until recovery of basal calcium levels returned.  Start of the HBS washes as 
indicated by the black arrows.  Both cells responded to glutamate/glycine and KCl stimulation.  The response of 
cell 1 to glutamate and glycine was greater than that of cell 2.  After recovery KCl stimulation resulted in a 
comparable response from both cells. 
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Figure 3.37. Calcium imaging from NT2-neurons,  
None of the cells responded to NMDA and glycine stimulation (yellow arrow).  Only one cell responded to 
glutamate and glycine stimulation (green arrow).  A variable response was seen to high KCl stimulation (red 
arrow), suggesting the number of voltage gated channels on these cells may be inconsistent.  No response to 
carbachol at 100 µM concentration (purple arrow).  Between each stimulus cells were washed in HBS (black 
arrow). 
 
 
Figure 3.38. Rat e14 GE neurons for calcium imaging. 
Cells were highlighted for recording fluorescence output in response to stimulation and labelled 2-20 (blue).  
Channel one recorded the background florescence which was subtracted from all readings.  
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Figure 3.39. Calcium imaging from e14 rat neurons after 2 weeks maturation.  
Two primary rat neurons generated a calcium flux in response to NMDA and glycine stimulation (yellow arrow).  
Between each stimulant the system was flushed with HBS (black arrow).  Reverberating calcium waves were 
stimulated across the plate in response to glutamate and glycine stimulation (green arrow).  KCl induced a 
simultaneous single calcium flux in primary neurons (red arrow). 
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Figure 3.40. Calcium imaging from e14 rat neurons after 2 weeks maturation. 
Few primary GE rat neurons responded to carbachol stimulation (purple arrow).  A calcium flux was detected in 
response to KCl (red arrow).  Between each stimulus, cells were flushed with HBS (black arrow). 
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3.3 Discussion 
Culture of the pluripotent NTERA2 was highly variable during pluripotent expansion, with 
the population in apparent waves of sustained pluripotency versus spontaneous 
differentiation.  Reagents for culture and trend systems of environmental conditions were 
consistently recorded for full traceability, yet no underlying cause for apparent loss of 
pluripotent self-renewal could be attributed to the culture conditions.  Pluripotent 
expansion required culture at high cell density and close monitoring of confluency levels 
and routine passaging at ~90 % confluence (approximately every three days).  When 
passaged too early, cells underwent spontaneous differentiation, suggesting close cell-cell 
contact was essential for pluripotent expansion.  When left to culture beyond 100 % 
confluence, cells detached and were unrecoverable into adherent pluripotent culture.   
Undifferentiated NTERA2 positively expressed the pluripotency markers OCT4 and SOX2.  In 
addition, these cells also expressed the neural stem cell marker Nestin.  Nestin is commonly 
used as an indicator of neural commitment following differentiation of pluripotent 
populations but has been shown to drop off in post-mitoitc neurons (Lendahl et al., 1990).  
In the absence of genes required for endodermal and mesodermal differentiation, the 
propensity for ectodermal differentiation in NTERA2 would be high, and might explain 
expression of early ectodermal markers such as Nestin in undifferentiated populations.  
Nestin was not detected in the 6-week neurons; however, it was observed in non-neuronal 
cells after 6-weeks ATRA induction.  Nestin expression has been confirmed in the 
development of non-neural cell types including a range of epithelial cells (Frojdman et al., 
1997; Lardon et al., 2002; Mokry et al., 2004; Bertelli et al., 2007; Cicero et al., 2009) which 
might explain its expression in the epithelial-like produce of ATRA induced differentiation.  
NTERA2 cells were highly susceptible to spontaneous differentiation, demonstrating a 
preference for an epithelial-like cell fate  (Damjanov and Andrews, 1983; Pleasure et al., 
1992).  During embryogenesis, neural cells in addition to a range of epithelial cells are 
derived from the ectodermal germ lineage.  The discovery that NTERA2 cells lack many of 
the genes involved in mesodermal and endodermal differentiation  (Schwartz et al., 2005), 
might explain the propensity for ectodermal derived epithelial cells during spontaneous 
differentiation and their frequent derivation during neuronal differentiation.  In order to 
inhibit the formation of these cells it would be necessary to block epithelial differentiation 
following ectodermal commitment.  Non-neural, ectodermal derived cell types, including 
epithelia have been induced from NTERA2 following exposure to BMP2  (Chadalavada et 
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al., 2005).  Therefore inhibition of BMP2 signalling, using Noggin might shift ectodermal 
differentiation towards a neural fate in preference to epithelia.  Incorporation of noggin 
would also aid ectodermal commitment by blocking BMP4 signalling required for 
mesodermal lineage commitment (Winnier et al., 1995; Marom et al., 1999). 
The yield of neurons throughout the study remained variable.  Successful differentiation 
was dependent upon a homogeneous pluripotent starting population, with fluctuations in 
pluripotency mirrored in the success of differentiation.  On occasion, no neurons were 
visible in culture after 4 weeks of differentiation (data available upon request).  Culture of 
cells in smaller vessels appeared to reduce spontaneous differentiation and increased 
neuronal yield (Section 3.2.2.3).  Smaller vessels contained fewer cells, making it easier to 
select pure populations in which to initiate differentiation.  This also enabled selective 
expansion of pluripotent populations.   
Upon successful differentiation, neurons were derived as part of a heterogeneous 
population, containing different varieties of cells of non-neuronal phenotype.  Mitotic 
inhibitors were incorporated into the latter stages of differentiation to prevent the over 
growth of post-mitotic neurons by non-neuronal cells.  Mitotic inhibitors target fast 
replicating cells by integrating into the DNA to halt mitosis.  However, in this study neurons 
demonstrated a preference for attachment to the non-neuronal cells layer (Figure 3.6) 
which supported their survival in culture.  Loss of the epithelial-like cells consequently 
resulted in a depletion of the neuronal population.  In addition, cytosine arabinofuranoside 
has been reported to have a cytotoxic affect on post mitotic neurons (Wallace and Johnson, 
1989) which may also have contributed to the detachment and loss of neurons overtime.  
Some variations of ATRA induced neuronal differentiation only supplement cultures with 
mitotic inhibitors overnight  (Park et al., 2007); however, this is unlikely to be sufficient long 
exposure to target all proliferating cells.   
Alternative procedures remove serum from culture media which reduces the proliferation 
of glial cells in neuronal cultures (Brewer et al., 1993).  Serum of bovine origin was 
incorporated into the media throughout this study which would explain the prevalence of 
non-neuronal cells.  Instead, serum could be supplemented with alternative sources of 
neurotrophic factors such as N2 and B27 supplements (Sections 1.5.2.3 and 1.5.2.4) which 
selectively promote neuronal survival. 
NTERA2 derived neurons displayed rounded phase bright cell bodies and extended 
projections which stained positively for TUBB3 and MAP2.  Immunostaining of 6-week 
 142 
neurons for the synaptic vesicle glycoprotein synaptophysin was unsuccessful; however, 
the absence of a positive neuronal control meant that it was not possible to confirm the 
absence of synaptophysin.  In some cases during calcium imaging, an influx of Ca2+ within a 
population of neurons was visible in response to glutamate, followed by a secondary 
delayed Ca2+ wave in neighbouring cells.  It is possible that dispersal of glutamate was not 
uniform; however, a more likely explanation for the secondary Ca2+ wave would be the 
release of neurotransmitters by the first cells in response to glutamate stimulation, which 
later stimulated Ca2+ influx in alternative cells, as would be seen during in vivo 
communication.  This would suggest the presence of synaptic vesicles within a proportion 
of NTERA2 derived neurons, which would contain the synaptophysin.  Communication of 
this nature has also been identified following formation of functional synapses by NTERA2 
derived neurons (Hartley et al., 1999). 
The lack of positive GFAP staining would suggest that there were no glial cells amongst the 
differentiated neurons populations.  Although this may also have been a factor of poor 
antibody specificity, the absence of glia following NTERA2 differentiation is has also been 
observed by other laboratories  (Marchal-Victorion et al., 2003; Podrygajlo et al., 2009).  
However, there are a number of groups who report the derivation of glia from NTERA2, 
suggesting that the method of culture is critical for glial cell derivation (Ozdener, 2007; 
Sanchez et al., 2009).  When cultured in the presence of glial cells, the formation and 
functional activity of synapses is increased in both NTERA2 derived and primary neurons  
(Pfrieger and Barres, 1997; Hartley et al., 1999).  The absence of glia derivation during 
differentiation may therefore reduce maturity of the neuronal population and 
subsequently reduce functional activity.  This would suggest a requirement for co-culture of 
neurons and glia, during differentiation in accordance with in vivo neurogenesis, to 
improve neuronal functionality. 
Immunostaining of 6-week neuronal populations confirmed an absence of both 
dopaminergic and serotonergic neurons.  The presence of GABAergic neurons was 
confirmed by positive GABA staining.  Indeed the presence of GABAergic neurons following 
differentiation has been confirmed by alternative research publications (Guillemain et al., 
2000; Podrygajlo et al., 2009).  In addition, alternative laboratories have also reported 
derivation of glutamatergic neurons from NTERA2 (Hartley et al., 1999; Podrygajlo et al., 
2009).  Due to limited resources, glutamatergic neuronal markers were not screened for in 
this study.  However, glutamatergic and GABAergic neurons are two of the main classes of 
forebrain neuron.  Development of the embryonic forebrain is regulated by retinoic acid 
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(Schneider et al., 2001; Ribes et al., 2006), as was used to induce neuronal differentiation in 
this study.  It would therefore not be surprising to find glutamatergic neurons within the 
neuronal population. 
The absence of a positive control for all the neuronal in situ immunostaining meant that 
these results are open to interpretation.  During differentiation studies it is important to 
assign a suitable positive control to validate both positive and negative data.  Limited 
access to primary human neurons restricted their incorporation into parts of this study.  
Attempts to use a neural cell line: SH-SY-5Y, derived from a bone marrow biopsy of a 
metastatic neuroblastoma site, and a record of neuronal functionality, failed due to the 
need for further differentiation of the control line (Biedler et al., 1973; Encinas et al., 2000).  
Many of the antibodies used in this study were specific to human isoforms, therefore 
non-human primary neurons would not have been suitable controls.  Despite this positive 
controls should have been incorporated into this study and would be commercially sourced 
and included in any future immunostaining applications.   
A control cell sample must be selected based upon the desired experimental outcome.  For 
functionality studies where the control served to demonstrate function of the equipment 
rather than the cell, animal source primary neurons were sufficient.  In addition, activity of 
the primary neurons during functional studies, enabled a comparison of activity and 
sensitivity between cell line derived and the currently used animal derived primary neurons 
for cell based functional assays.  In order to reduce reliance on primary neurons in a 
cell-based assay, cell line derived neurons must at least as sensitive as the primary neurons 
currently used.   
NTERA2 derived neurons were shown to generate electrical impulses as determined by 
patch-clamp analysis from just 2 weeks after ATRA induction.  Patch-clamping is a highly 
skilled technique.  The delicacy of the process meant that a negative result could have been 
a result of an unexcitable cell or poor technique.  On the most efficient day, the behaviour 
of just 19 cells were screened.  In addition, the high failure rate induced a subconscious 
selection of neurons for screening, which were accessible and displayed appropriate 
neuronal morphology.  These cells were usually located towards the edge of neuronal 
clusters and so may have been exposed to different developmental stimuli, resulting in a 
different response to stimulation, compared to neurons in the centre of clusters.  To this 
extent, patch-clamping generated a poor representation of the electrophysiological activity 
of the neuronal population.   
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Incorporation of the FLIPR for functional analysis meant that screening was reproducible 
across samples and analysis of the behaviour of an entire population could be carried out in 
minutes.  However, neurons were highly susceptible to detachment during processing, 
leaving just a few neurons per well for screening.  Resulting data was therefore derived 
mainly from the unexcitable non-neuronal population of cells.   
In agreement with findings by (Rendt et al., 1989), undifferentiated cells were 
non-responsive to KCl depolarisation, confirming that EC cells do not express voltage gated 
Ca2+ channels in their pluripotent state.  The Ca2+ response to KCl depolarisation was shown 
to increase with duration of differentiation, suggesting an increase in the number of 
voltage gated channels (Figure 3.30).  However, it was not possible to determine whether 
the increased response was a results of an improve response by a few cells, or an increase 
in the overall number of cells responding.  Data from the FLIPR was considered to be 
subjective due to low neuronal purity.  In addition, the intervals between fluorescence 
detection (once/second) were considerably longer than the frequency of 
neurotransmission which has on occasion been shown to reach 100 Hz or faster  (Dunant 
and Bloc, 2003).  Data from immediate response of neurons to stimulation may therefore 
have been lost between sample intervals.  Neuronal responses to stimulation by alternative 
neurotransmitters could not be confirmed by the FLIPR due to the low magnification of 
detection and overriding interference from unresponsive non-neuronal cells.  A higher 
magnification calcium imaging facility was therefore incorporated into the study to more 
clearly identify the response attributable to NTERA2 derived neurons.   
The presence and functionality of voltage gated channels in NTERA2 derived neurons was 
confirmed using higher magnification calcium imaging, in addition to the presence of 
functional glutamate receptors.  These responses have been previously identified in 
NTERA2  (Squires et al., 1996). 
Interestingly, NTERA2 derived neurons have been shown to respond to acetyl choline and 
NMDA stimulation (Squires et al., 1996), which was not detected in this study.  Even in the 
presence of the co-agonist glycine, no Ca2+ response was initiated by NMDA stimulation.  
NMDA receptors are expressed by a subclass of neurons located amongst the cerebellum 
and cortex  (Bliss and Collingridge, 1993) and which would not be expected to be present in 
such small numbers of ATRA induced neurons.  As an inhibitory neurotransmitter which 
induces influx of Cl- ions for repolarisation rather than Ca2+, no visible response to glycine 
stimulation was expected or exhibited by NTERA2 derived neurons. 
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3.3.1 Summary 
Data from this study revealed that neurons derived from the NTERA2 population following 
ATRA induction were of a morphological neuronal phenotype and expressed a range of 
functional membrane ion channels which initiated electrical impulses following stimulation.  
However, when compared to functional response of e14 GE primary neurons, NTERA2 
derived neurons were consistently less sensitive and responsive to stimulation with no sign 
of the spontaneous activity which was consistently present throughout primary cultures.  
This suggests that immaturity in a large proportion of the derived neurons, which might be 
explained by the lack of supporting glial cells throughout the differentiating populations.  
Despite improvements to the efficiency of differentiation, these data confirm that hEC cell 
line derived neurons were not sufficiently responsive for reliable incorporation in cell based 
toxicity assays.   
Successful directed differentiation requires an uncommitted starting cell pool.  The 
originating cells of this line were germ cells which underwent a process of internal 
reprogramming to generate the pluripotent population.  Despite expressing pluripotency 
markers, these cells may have retained memory from stimuli encountered during germ cell 
specification which would need to be over-ridden to allow efficient direction to a neuronal 
fate. Thus, a hEC line may not be the most effective starting cell source for efficiency in 
generating neurons, rather the use of a naïve pluripotent cell type such as a hESC line, with 
no somatic cell memory may be more amenable to a specified cell fate.   
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4 Stability and expansion of pluripotent hESCs in culture 
4.1 Introduction - hESCs as a model for neuronal differentiation. 
The need for an alternative source of neurons for cell therapies and pharmacological 
screening has been described in detail in the previous sections.  Investigation into the use 
of a teratocarcinoma derived cell line NTERA2, demonstrated an inherent variability in the 
efficiency of neuronal differentiation and the reduced functional response when compared 
to primary neurons.  Despite expression of pluripotent markers and a demonstrable ability 
to differentiate into cells from all three germ lineages (Andrews et al., 1984), both 
spontaneous and ATRA directed differentiation yielded large numbers of epithelial-like 
cells, suggesting a predetermined preference for differentiation, which limited neuronal 
yield. 
It was hypothesised that the tumour origin of the NTERA2 cell line in addition to its 
aneuploidy karyotype (Andrews et al., 1984), was responsible for the poor efficiency in 
pluripotent expansion and directed neuronal differentiation.  To investigate this hypothesis 
further, three pluripotent hESC lines (Shef3, HUES7 and RH5) with varying degrees of 
aneuploidy were compared for their stability in pluripotent expansion and their subsequent 
ability to generate functional neurons following directed differentiation.   
 
4.1.1 Description of hESC lines 
4.1.1.1 Shef3 
The Shef3 hESC line was derived by Professor. H. Moore’s group, (Centre for Reproductive 
Medicine and Fertility, Sheffield) in 2004 along with a range of other Shef hESC lines 
(Draper et al., 2004b).  This line was sourced from the UKSCB at p33 for use in this study.  
The Shef3 line has a diploid XY karyotype, derived in standard knock-out hESC media 
(Section 2.9.2).  Shef3 was routinely passaged mechanically onto iMEFs (UKSCB, cell line 
master file).  At the start of this project there was no published literature using Shef3 and 
its ability to differentiate into a neuronal cell fate (or any other cell fate or germ lineage). 
 
4.1.1.2 RH5 
The RH5 (Roslin Human 5) stem cell line was derived in 2006 by The Roslin Institute, 
(Scotland, UK) and was aneuploidy with a 101 XX complement at the time of deposition to 
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the UKSCB (Fletcher et al., 2006).  This line was sourced from the UKSCB at p36 for use in 
this study.  This cell line was derived in MEF conditioned media supplemented with bovine 
serum replacement media, on mitoticaly inactivated neonatal human dermal fibroblasts.  
Following establishment, the RH5 cell line was routinely passaged enzymatically using 
collagenase (Fletcher et al., 2006).  Very little research has been carried out using this line 
with regards to behaviour in culture and response to differentiation.   
 
4.1.1.3 HUES7 
The HUES7 cell line was derived in 2004 by the Harvard Stem Cell Institute, (Harvard 
University, USA), along with 16 other HUES lines freely available to the research community 
(Cowan et al., 2004).   These hESC lines were derived and cultured on iMEFs.  Cells were 
adapted to enzymatic passaging (using Trypsin) within five passages of derivation (Cowan 
et al., 2004).  This line was sourced from the UKSCB at p20 for use in this project.  Early 
karyotypic analysis of this line reported a normal 46 XY complement (Cowan et al., 2004).  
The HUES7 cell line has a small publication history for neuronal differentiation (Iacovitti et 
al., 2007; Kumar et al., 2008) and as such was known to differentiate neuronally.  This line 
therefore served as a positive control of neuronal differentiation in hESCs and as a 
comparison for additional hESC lines. 
 
 148 
4.2 Results 
4.2.1 Defining hESCs in culture 
During establishment of hESCs in culture, optimal conditions for maintenance of 
pluripotency were identified.  Pluripotent hESCs were identifiable by their high ratio of 
nucleus to cytoplasm, prominent nucleoli (Figure 4.1A), and compact colony structure 
(Figure 4.1B); (Thomson et al., 1998; Cowan et al., 2004); to the untrained eye hESC 
colonies have an appearance similar to frog spawn.  Healthy stem cell colonies presented 
clearly defined borders (Figure 4.1C-F) and appeared almost translucent under a dissection 
microscope (Figure 4.1D).  These criteria were used for identification and scoring the 
quality of all hESCs throughout this project. 
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Figure 4.1. Human embryonic stem cell colonies. 
Human embryonic stem cells were identified by their high nucleus to cytoplasm ratio, prominent nucleoli 
(A - red arrows, x20 magnification, B - x10 magnification), compact rounded colony structure with defined 
borders (blue arrow) against the iMEF feeder-layer (green arrows). C-F: x4 magnification. 
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4.2.2 Adaptation of hESCs to alternative culture 
Human ESCs are largely reliant on their culture environment for retention of pluripotent 
characteristics (Section 4.2).  The effect of different passaging techniques on the survival, 
expansion and subsequent neuronal differentiation of different hESC lines has been 
speculated but not fully investigated.  Passaging of hESC can be broadly divided into two 
categories: mechanical and enzymatic (Sections 2.9.1.1 and 2.9.1.2).  This project set out to 
investigate the differences which these techniques induce upon the pluripotent culture and 
expansion of different hESC lines (herein), and their subsequent effect on directed neuronal 
differentiation (Chapter 5). 
To determine whether differences in behaviour were a consequence of cell line choice, or 
passaging technique, the RH5 cell line was adapted from enzymatic to mechanical 
passaging methods creating two different cell lines (RH5 cut and RH5 TrypLE).  Attempts to 
adapt the Shef3 cell line into enzymatic passaging from mechanical passaging were 
unsuccessful.  TrypLE treated Shef3 cells failed to proliferate following passage and rapidly 
differentiated losing all characteristics of pluripotent hESCs (images available upon 
request).  This phenomenon has also been observed by alternative researchers during 
adaptation Shef3 into enzymatic culture (Personal communications with Ms. A. Hemsley, 
Regenerative Medicine and Bioprocessing, UCL). 
Mechanically passaged hESC colonies retained a uniform rounded shape in culture, pushing 
iMEFs aside as colonies expanded, creating defined colony borders.  Enzymatically 
passaged cells grew more efficiently as a monolayer, initiating outgrowth from smaller 
clusters of cells following passaging.  Inactivated MEFs were identified with minimised 
spreading integrated amongst the hESC monolayer.  
 
4.2.3 Confirmation of pluripotency using immunostaining 
Immunostaining was carried out on each of the hESC lines to confirm pluripotency during 
culture.  All hESC lines positively expressed the OCT4B1 isoform and SOX2, localised to the 
nucleus, conferring pluripotency (Figure 4.2); the Santa Cruz antibody for OCT4 was 
selected based upon its specificity to the pluripotent OCT4B1 isoform (Atlasi et al., 2008).  
During optimisation, staining for SSEA3 was weak compared with SSEA4 and difficult to 
detect under epi-fluorescence imaging.  As such, SSEA4 was used in preference to SSEA3 as 
a marker of pluripotency (Figure 4.3).  This phenomenon has been previously observed by 
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(Thomson et al., 1998).  Additional images of all immunostaining in all hESC lines available 
on request.  All four hESC lines also stained positively for SSEA4 and Tra-1-60.  The iMEF 
feeder layer was clearly visible around the edge of mechanically passaged colonies and 
interspersed between TrypLETM passaged cells.  iMEFs did not stain for OCT4, Tra-1-60 or 
SSEA4.  Marginal staining in the iMEFs was visible for SOX2; however, this was detected 
throughout the nucleus and cytoplasm and was likely to be a result of non-specific staining 
(Figure 4.2). 
 
4.2.4 Spontaneous differentiation in hESCs 
Under suboptimal culture conditions, hESC underwent spontaneous differentiation.  
Examples of spontaneously differentiating colonies were captured and described, building a 
reference for healthy and unhealthy hESC colonies (Figure 4.4).  During differentiation, the 
translucence of hESC colonies was lost, becoming opaque and yellow in appearance.   
In the absence of sufficient support from iMEF layers, the hESCs failed to retain a 
compacted colony structure associated with pluripotency and individual cells aligned, 
collapsed and differentiated into a flattened cell layer (Figure 4.4A).   
Spontaneous differentiation of hESCs did not always occur throughout the entire colony, 
more commonly partial differentiation was observed which occurred at the edge (B), in the 
middle (C), or at various sites within the colony (D).  If hESC fragments were too large 
following mechanical passaging (> 600 µM diameter), colonies curled up before attaching 
to the culture surface, resulting in a multi layered fragment which underwent spontaneous 
differentiation (Figure 4.4D).   
Following the removal of hESC fragments, remaining hESC’s re-grew into the area from 
which fragments were removed.  Resulting re-growth retained characteristics of hESCs 
(Section 4.2), but adopted a more flattened morphology, surrounded by differentiating 
cells at the edge of the pre-cut surface (Figure 4.4E).   
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Figure 4.2. OCT4 and SOX2 immunostaining in undifferentiated hESCs. 
Representative images for OCT4B1 isoform staining of enzymatically passaged cell line RH5 TrypLE (A; x4 magnification) and mechanically passaged line RH5 cut (B; x4 magnification).  SOX2 
staining for mechanically passaged cell line Shef3 (D; x10 magnification), and RH5 cut (E; x10 magnification).  Staining was localised to the nucleus in all sample indicating specific staining for 
pluripotency genes.  Mouse IgG (C) and Rabbit IgG (F) isotype controls were negative.  Inactivated MEFs were negative for OCT4 but non-specific cytoplasmic staining was observed in iMEFs 
during SOX2 antibody. 
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Figure 4.3. Tra-1-60 and SSEA4 immunostaining in undifferentiated hESCs.  
Representative images of Tra-1-60 (green) staining in RH5 TrypLE (A; x10 magnification) and Shef3 (B; x4 magnification).  All hESC cell lines RH5 cut (D; x4 magnification) and HUES7 (E; x10 
magnification) stained positively for SSEA4 (red).  Mouse IgM (C) and Mouse IgG (F) isotype controls were both negative confirming the absence of non-specific staining.  Inactivated MEFs 
were negative for both Tra-1-60 and SSEA4. 
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Figure 4.4. Spontaneous differentiation in human embryonic stem cell colonies.  
Too low feeder cell density resulted in a flattened, collapsed hESCs morphology which were seen to align across 
the colony before eventually peeling from the plate (A).  Spontaneous differentiation occurred at the edge (B; 
red arrows), in the middle (C) and at sporadic locations within the hESC colonies (D).  Re-growth of hESCs into 
areas which have been mechanically removed showed a flattened collapsed morphology (E; orange arrow, 
green arrows – scratching on tissue culture vessel from mechanical passaging).  Human ESCs colonies left in 
culture long term without passaging became spontaneously differentiated into a range of cell types (F) these 
colonies were opaque in nature and retained minimal pluripotent cells.   
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4.2.5 Mouse Embryonic Fibroblast feeder-layer 
Human ESCs were routinely maintained in culture for 2-3 weeks; however prolonged 
culture eventually resulted in undirected differentiation.  This was thought to be a result of 
failure by the iMEF layer to support pluripotent growth.  To ensure a fair comparison 
between the behaviour of different hESC lines, it was necessary to identify the iMEF 
conditions which provided optimum support to their pluripotent expansion.     
 
4.2.5.1 Feeder density 
The primary origin of MEFs meant that different batches were inherently variable in 
behaviour and as such provided varying levels of support for hESC culture and expansion.  
The density of the feeder layer was found to be critical for sustained pluripotency in hESCs.  
For this reason, a feeder cell density experiment was carried out at the start of each new 
batch of feeders to determine the optimum seeding density for hESC support.   
Human ESCs were most commonly cultured in 6-well plates, pre-coated with gelatin to aid 
cellular attachment.  Inactivated MEFs were thawed from -80 °C and washed in standard 
GlutaMAX culture media (Section 2.1.2).  Cells were counted using a bright-line 
haemocytometer (Section 2.3) and seeded onto well plates at the following cell densities 
1.6 x 104, 2.1 x 104, 2.6 x 104, 3.1 x 104, 3.6 x 104, 4.2 x 104, 4.7 x 104, 5.2 x 104 cells/cm2.  
Fibroblasts were plated in standard GlutaMAX culture media and left to attach overnight at 
37 °C before changing the media for standard hESC culture media (Section 2.9.2).  Cultures 
were left for a further 24 hours to condition the media, prior to hESC passaging.  Optimum 
feeder density was determined by bright field observation of hESC colony morphology, 
scoring colonies according to the criteria outlined in Section 4.2.  Images of typical colonies 
were captured from each of the iMEF seeding densities eight days after plating (Figure 4.5).   
At low iMEF densities (1.6 - 2.1 x 104 cell/cm2), hESC fragments attached but rapidly lost 
their compact colony structure.  Cells within the colony flattened out with an epithelial-like 
morphology (Figure 4.5A-B).  At 2.6 x 104 cells/cm2 colonies retained a high nucleus to 
cytoplasm ratio but the colony lost its compact structure with poorly defined borders 
(Figure 4.5C).  Prolonged culture at low iMEF density resulted in elongation and alignment 
of individual hESC cells which eventually peeled away from the culture surface (Figure 
4.5D).  When the feeder density was ≥ 4.7 x 104 cells/cm2, hESC colonies attached to the 
culture surface, but spreading was less noticeable; cells were seen piling up and colonies 
formed irregular shapes.  Cells in the central region and very outer edge of these colonies 
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differentiated within a few days of plating (Figure 4.5G-H).  Feeder cell densities at 
3.6 x 104 - 4.2 x 104 cells/cm2 maintained undifferentiated growth of hESC in uniform 
colonies with the classic hESC features outlined in Section 4.2.1. (Figure 4.5E-F) (Note: 
seeding density correct for iMEF bank 3).   
 
4.2.5.2 The effect of MEF passage level 
Upon reaching senescence, iMEFs lose their ability to support undifferentiated growth of 
hESCs (Stubban and Wesselschmidt, 2007).  It was therefore critical to expanded and freeze 
each iMEF bank within an appropriate period to ensure support of pluripotency.  Personal 
communication with Ms. L. Young, (UKSCB, NIBSC) suggested the optimum age for a iMEF 
bank was at p3.  An iMEF bank at p3 generated approximately 4 x 107 (± 9 x 106) cells 
(calculated as an average of the nine iMEF banks created in this project); however, with an 
additional expansion, a bank at p4 generated up to a four times higher yield (1.6 x 108 
cells/bank), with the advantage of a longer working life for each bank, reducing the number 
of iMEF banks required.  A comparison of hESC condition on iMEFs at p3 and p4 following 
Mitomycin C inactivation was subsequently carried out to determine the optimal expansion 
of iMEFs for sufficient hESC support.  MEFs were sourced at p3 and p4 from the same 
feeder stock and inactivated as described in Section 2.8.1.1.  Inactivated MEFs were seeded 
at a range of cell densities and hESC fragments (9-10 fragments/well) monitored after 
72 hours, for attachment and morphology. 
The age of the iMEF layer was crucial for fragment attachment (Table 4.1).  At seeding 
densities 3.6 x 104 - 5.2 x 104 cells/cm2, 100 % of hESC fragments attached on p3 iMEFs, 
compared with 60 % and 80 % fragment attachment at p4 respectively.  At lower cell 
densities, 1.6 x 104 - 2.6 x 104 cells/cm2, attachment of fragments at p3 dropped to 77.8 % 
in both cases, compared with 20 % and 45 % attachment at p4 respectively.  Suggesting the 
p3 iMEF bank was most suitable for hESC fragment attachment.   
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Figure 4.5. Human embryonic stem cell colonies in feeder density experiment. 
Human ESCs were plated onto a range of iMEF cell densities and colony morphology observed for optimal 
retention of pluripotent characteristics.  Images were captured eight days following passaging (x4 
magnification).  Low feeder cell density (1.6 x10
4 
cells/cm
2
) resulted entire differentiation of the hESC colonies 
into a flattened collapsed epithelial-like cell fate (A-B).  With increased iMEF cell density increasing numbers of 
cells retained pluripotent characteristics (C-D - 2.6 x 10
4
, E - 3.6 x 10
4
).  An optimal feeder cell density was 
determined for each bank where hESC colonies were maintained entirely undifferentiated (F - 4.2 x 10
4
).  
Increased iMEF cell density beyond this point resulted in higher levels of spontaneous differentiation (G - 
4.7 x 10
4
, H - 5.2 x 10
4
 cells/cm
2
). 
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In addition to attachment, the support provided by the p3 and p4 iMEF layers was variable.  
Using p3 feeders, 88.9 % and 85.7 % undifferentiated colonies were supported at cell 
densities of 3.6 x 104 and 2.6 x 104 cells/cm2 respectively (Table 4.1).  Spontaneous 
differentiation was seen in all colonies on p3 feeder layers at a cell density 1.8 x 104 
cells/cm2 (100 %).  Spontaneous differentiation was also seen in parts of 44.4 % of colonies 
on p3 fibroblasts at the higher density 5.2 x 104 cells/cm2.  Differentiation was mainly 
visible in the very centre or around the very edge of these colonies in agreement with data 
from Figure 4.5.   
In contrast, all attached fragments on p4 feeder layers underwent spontaneous 
differentiation to some degree, varying from partial to complete differentiation.  Wholly 
undifferentiated colonies were on p4 iMEFs at 2.6 x 104 cells/cm2 but this was only seen in 
33.3 % attached fragments (Table 4.1).  Cells within undifferentiated colonies were not 
compact and over longer periods in culture flattened out into an epithelial-like appearance 
(data not shown).  Therefore, in addition to the poor fragment attachment on p4 iMEFs, 
support of undifferentiated growth was also reduced.  iMEFs were subsequently frozen at 
p3 for all hESC culture. 
The optimal feeder density for support was determined for all new iMEF banks.  It should 
be noted, that the iMEF passage level experiment was carried out on a different iMEF bank 
(iMEF bank 4) to the feeder density experiment (Section 4.2.5.1), highlighting the variability 
between iMEF banks and the need to routinely screen each fresh iMEF bank for the 
optimum feeder layer cell density to support undifferentiated growth of hESCs. 
As an alternative approach MEFs could have been continually cultured and Mitomycin C 
inactivated prior to use rather than using frozen iMEF banks.  (Personal communications 
with Mrs. L. Ruban; Regenerative Medicine Group, Advanced Centre for Biochemical 
Engineering, UCL).  However, retaining MEFs in routine culture and inactivating for 
passaging hESCs as required (often twice weekly) is a more time consuming process than 
free-thaw retrieval of iMEF stocks.  More significantly, the condition of fresh MEF banks 
would be difficult to standardise, creating variability in support of hESCs.  For this reason, 
frozen iMEF banks were use throughout this study.  Non-supportive (as determined by 
hESC morphology) iMEF banks were discarded. 
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4.2.6 Long term storage of iMEFs 
Mouse embryonic fibroblast banks were bulked up in culture and mitotically inhibited using 
Mitomycin C as described in Section 2.8.1.1, and stored at -80 °C ready for use. 
Unlike other cell types iMEFs were frozen and maintained at -80 °C for ready access.  This is 
not ideal for long term storage of mammalian cells; however, fresh banks were prepared as 
required.  Viability of feeder banks was monitored for the duration of the iMEF bank as an 
indicator to their healthy and support of pluripotent hESCs.  A significant drop in viability 
may be indicative of a poor freeze/thaw process during which cells are exposed to DMSO.  
The function of DMSO within the freeze solution is to protect the cells from damage by ice 
crystal formation during freezing, by partially solubilising the cell membrane (Lovelock and 
Bishop, 1959).  This solubilisation results in small holes in the membrane which prevent 
rupturing of the cells (Lovelock and Bishop, 1959).  However, this solubilisation is toxic to 
the cells and upon thawing and must be rapidly washed away to minimise exposure.  A 
delay in washing out, or an error in the rate of freezing will result in extended exposure of 
the cells to DMSO which may have been detrimental to survival and function.   
A threshold in viability for usable iMEFs was set at 85 %.  Following thawing and prior to 
seeding, viability counts were recorded using a bright-line haemocytometer (Figure 4.6).  
Inactivated MEFs cells retained high viability for their entire period of use.  Inactivated MEF 
banks were used within a three month period from inactivation during which all MEFS 
retained viability above 88.9 %.  Loss of cell viability was noted after storage at -80 °C for 
longer periods (79.2 % after 167 days).  
In addition to seeding density and the age of the fibroblast cells before plating, other 
factors involved in the supportive ability of feeder layers include the length of time 
following plating before use as a feeder-layer (Villa-Diaz et al., 2009).  Fibroblasts were 
seeded 24 hours prior to passaging hESCs, which provided the best support for pluripotent 
culture.   
 iMEFs 
Number of 
wells Density/cm2 
Fragments 
plated 
Attached after 
72 hours 
Fragments 
attached (%)   
Undifferentiated 
colonies (%) 
Part differentiated 
colonies (%) 
All differentiated 
colonies (%) 
p3 1 5.2 x 104  9 9 100 55.6 44.4 0 
p3 2 3.6 x 104  18 18 100 88.9 - 11.1 
p3 1 2.6 x 104  9 7 77.8 85.7 - 14.3 
p3 1 1.8 x 104  9 7 77.8 - - 100 
p4 2 5.2 x 104  20 16 80 0 12.5 87.5 
p4 2 3.6 x 104  20 12 60 0 16.7 83.3 
p4 2 2.6 x 104  20 9 45 33.3 - 66.7 
p4 1 1.8 x 104  10 2 20 0 - 100 
Table 4.1. Attachment and culture of hESCs on iMEFs. 
At p3, iMEFs best supported undifferentiated hESC growth at 3.6 x10
4
 cells/cm
2
 with 88.9 % colonies wholly undifferentiated.  Inactivated MEFs at p4 were unable to support high levels of 
undifferentiated hESC growth.  At best, just 33.3 % colonies remained undifferentiated after 72 hours at 2.6 x 10
4
 cells/cm
2
, where 85.7 % colonies remained undifferentiated at the p3 feeder 
layer of the same cell density.  Extreme levels of spontaneous differentiation were seen at all tested p4 feeder cell densities 5.2 - 1.8 x 10
4
 cells/cm
2
. 
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Figure 4.6. Viability of iMEF banks following storage at -80 °C.   
Inactivated MEF bank A (red), B (blue), D (green), F (orange), H (purple).  Some iMEF banks (C, E and G) were 
used within just a few weeks of production and are not presented here.  Inactivated MEF banks were stored at 
-80 °C following Mitomycin C inactivation and thawed for use as required for up to 3 months, after which fresh 
iMEF banks were produced.  Viability of all iMEFs remained high >88.9 % as determined by Trypan blue cell 
counting after three months storage.  After 167 days at -80 °C viability of the iMEF bank F remained high at 
79.2 %; however viability dropped below the 85 % threshold for use and were subsequently not used for hESC 
culture beyond this point. 
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Figure 4.7. Human embryonic stem cell colony in conditioned media. 
Shef3 colony on gelatin coated surface in the absence of iMEFS but in iMEF conditioned media 24 hours after 
plating (A) demonstrated outgrowth of cells with pluripotent characteristics.  After five days hESCs cultured in 
iMEF conditioned media were entirely differentiated (B) demonstrating a need for the presence of iMEFs to 
support pluripotent growth. 
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4.2.6.1 Conditioned media 
The requirement for iMEFs in co-culture with hESCs was investigated using iMEF 
conditioned media (CM).  iMEFs were plated as for passaging, followed by 36 hours 
incubation with hESC media, creating iMEF CM.  Culture surfaces were coated with gelatin 
before passaging hESC fragments in CM.  All fragments attached within 24 hours of plating.  
Human ESCs were visible spreading around the edges of all colonies (Figure 4.7A); however, 
fragments failed to collapse in the centre, and showed initial signs of differentiation.  On 
subsequent days, colonies lost all hESC morphology (according to guidelines set out in 
Section 4.2) and underwent complete differentiation within five days of plating (Figure 
4.7B).  It was therefore concluded that CM alone was insufficient to support pluripotent 
hESCs on a gelatin surface coating.  An iMEF feeder layer was subsequently used for all 
hESC culture in this project. 
 
4.2.7 Quality control 
Quality control (QC) is an essential part of any bioprocess.  It is especially critical in 
processes with pharmacological or therapeutic applications, ensuring full traceability from 
reagents to equipment and environmental parameters.  In the event of a problem, 
traceability enables the user to identify potential areas of concern, whilst providing a 
record of progress for replication of any positive outcome.  Work within this project was 
carried out according to good manufacturing practice (GMP) and good laboratory practice 
(GLP) guidelines. The main QC measures applied to this project included: laboratory records 
documenting suppliers and catalogue numbers for all reagents, servicing and calibration 
certificates for facilities and equipment, microbiological screening for contaminations, DNA 
fingerprinting to confirm identity of the cells in use, and karyotypic analysis to monitor 
stability of hESCs in culture. 
 
4.2.7.1 Microbiological screening 
Mycoplasma testing: Spent culture media was routinely collected from each cell line and 
screened for mycoplasma contamination using PCR amplification.  All samples remained 
free from infection as compared to an in-house positive control (data available upon 
request). 
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Cell culture supernatant: In addition to routine mycoplasma screening, spent cell culture 
media was tested for microbial contamination using three common culture solutions: malt 
extract broth to test for mould and yeast, tryptone soya broth which indicates the presence 
of any microbial contamination, and thioglycollate medium to test for the presence of 
anaerobic, aerobic and microaerophilic contamination.  All sterility broths were prepared 
in-house (NIBSC, Scientific Support Services) and incubated at 37 °C in a separate 
laboratory to cell culture for up to two weeks before discarding.  Culture supernatants 
remained free from detectible microbial contamination for the duration of this project. 
 
Viral testing: Human ESCs were screened for viral contamination as part of the UKSCB cell 
line release criteria.  Cell lines were screened by The Doctors Laboratory (TDL; London) for 
viral contamination by Cytomegalovirus, Human T-lymphotropic virus Type I, Human 
immunodeficiency virus 1, Hepatitis C, Hepatitis B, Epstein Barr virus and Mycoplama 
genus/Ureaplasma.  All hESC lines were negative for viral screens.  Inactivated MEFs used 
for hESC feeder layers were sourced from virus-free certified mouse stocks (personal 
communication, Ms. L. Young, UKSCB,). 
 
4.2.7.2 DNA fingerprinting 
DNA fingerprinting was carried out on each cell line to ensure no cross contamination of 
lines occurred as a result of culturing multiple cell lines in parallel.  Cell pellets were 
washed in PBS and shipped to TDL Genetics on dry ice for DNA profile analysis.  Fingerprint 
traces were obtained and cross checked with records from the UKSCB.  No cross 
contamination of cell lines occurred throughout this project.  DNA profiles for each of the 
hESC lines and the two hEC lines used in this project are presented in Table 4.2. 
 2102Ep Genotype
Marker Allele 1 Allele 2 Allele 3
D8S1179 14 15
D21S11 28 29
D7S820 7 13
CSF1PO 11 12
D3S1358 16 16
TH01 9 9.3
D13S317 8 8
D16S539 11 12
D2S1338 17 20
D19S433 13 14
VWA 16 17 18
TPOX 8 11
D18S51 15 15
D5S818 11 11
FGA 22 22
NTERA2 Genotype
Marker Allele 1 Allele 2 Allele 3
D8S1179 13 15
D21S11 30 31
D7S820 10 12
CSF1PO 10 12
D3S1358 16 16
TH01 9.3 9.3
D13S317 13 13
D16S539 11 12 13
D2S1338 22 25
D19S433 14 15.2
VWA - -
TPOX 8 8
D18S51 14 14
D5S818 9 12
FGA 23 23
HUES7 Genotype
Marker Allele 1 Allele 2
D8S1179 10 11
D21S11 27 32.2
D7S820 8 11
CSF1PO 12 12
D3S1358 15 18
TH01 6 9.3
D13S317 11 12
D16S539 11 12
D2S1338 16 17
D19S433 13 14
VWA 16 18
TPOX 8 8
D18S51 14 15
D5S818 11 13
FGA 25 25
RH5 Genotype
Marker Allele 1 Allele 2
D8S1179 11 15
D21S11 28 29
D7S820 10 11
CSF1PO 10 12
D3S1358 14 16
TH01 6 9
D13S317 11 12
D16S539 9 12
D2S1338 19 21
D19S433 14 14.2
VWA 16 18
TPOX 8 11
D18S51 15 18
D5S818 10 12
FGA 20 24
Shef3 Genotype
Marker Allele 1 Allele 2
D8S1179 13 14
D21S11 28 30.2
D7S820 8 12
CSF1PO 12 13
D3S1358 16 18
TH01 7 9.3
D13S317 8 8
D16S539 12 12
D2S1338 24 24
D19S433 11 15
VWA 17 18
TPOX 8 8
D18S51 15.3 17
D5S818 11 13
FGA 21.2 23
 
Table 4.2. DNA profiles for pluripotent cell lines. 
DNA profiles for all pluripotent cell lines were carried out by TDL genetics: Shef3(orange), HUES7 (red) and RH5 (green) NTERA2 (purple), 2102Ep (blue),  In agreement with the DNA profile for 
NTERA2 supplied by ATCC, a third allele was repeatedly detected at the D16S539 locus.  An additional allele for locus VWA was consistently detected in the 2102Ep.  Profiling for HUES7 was 
carried out at p22, p52 and p62. The RH5 cut line was originally DNA profiled at p33.  Subsequent profiling was consistent at p50 and p96 (TrypLE passaged samples), and p80 (mechanically 
passaged samples).  Shef3 was profiled at p48 and p61.  No alterations in profile were identified throughout this project confirming no cross-contamination of cell lines had taken place in 
culture. 
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4.2.7.3 Karyology 
The direct causes of karyotypic instability of hESCs are yet to be clarified; however, the 
passaging techniques used for hESCs expansion have been suggested to induce karyotypic 
alterations which enhance their proliferation and survival in culture.  To detect for 
alterations in the karyotype caused by mechanical or enzymatic passaging, G-banding 
analysis was carried out on the hESC lines at the start and end of this project.  Results were 
compared to the original starting populations from UKSCB cell line master files (authorised 
by Mrs. A. Iriajen, QC coordinator, UKSCB).   
Metaphase spreads were prepared according to the UKSCB ‘Karyological analysis of cell 
lines’ SOP (Section 2.14).  However, due to limited success in obtaining sufficient numbers 
of scorable metaphase spreads, a modified version of the protocol was developed (Section 
2.14.1).  The number of metaphase spreads were increased by incubating cells with 
KaryoMAX® Colcemid® (Gibco, 15212-046) 0.4 µg.ml-1 in hESC media for just 30 minutes 
prior to harvesting.  Colcemid® is an anti-mitotic reagent which depolymerises 
microtubules, limiting their formation, thus arresting cells in metaphase (Invitrogen, UK).  
Longer Colcemid® incubations were found to condense the chromosomes such that 
G-banding could not be analysed.    
Using the modified protocol, sufficient metaphase spreads were usually visible for scoring 
by TDL (Figure 4.10); however, heterogeneity was visible across the spreads.  This may have 
been partially due to processing artefacts in preparation, but it is also a likely indicator of 
heterogeneity of the karyology of the hESC population.  Chromosome alignments and the 
number of metaphases scored for each cell line are presented in Figure 4.12 - Figure 4.11.   
Despite publications of a normal 46 XY karyotype (Cowan et al., 2004), analysis by the 
UKSCB at the Master cell bank level reported this line to be triploidy for chromosomes 12 
and 17 (48, XY,+12,+17; Figure 4.12, (UKSCB, cell line master file).  After a further 46 
passages throughout this project the HUES7 line had gained two additional chromosomes, 
resulting in the modal karyotype in the population 50 XXY, +12, +14, +17 (Figure 4.13).   
Shef3 retained its normal 46 XY karyotype (Figure 4.15) throughout this project when 
compared to the original MCB (Figure 4.14).  The RH5 cell line was originally published as 
an aneuploidy line with 101 chromosomes (Fletcher et al., 2006).  At passage 99, 63 
passages after sourcing from the UKSCB, the modal karyotype of RH5 cells was 73 XXX, +1, 
-4, +12, +13, -17, +(17q) +18, with an additional marker chromosome unidentifiable by TDL 
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(Figure 4.11).  A metaphase spread was not available from the UKSCB Master Cell Bank 
(MCB) records.   
Despite further optimisation of karyological preparations, the numbers of scorable 
metaphase spreads within the cell populations remained low.  Personal communications 
with Ms. S. Osborn (Regional Cytogenetics Unit, St Marys Hospital Manchester) suggested 
the need to synchronise the cell population prior to karyotypic analysis in order to increase 
the number of cells in metaphase.  This could have been achieved by incubation of cell 
cultures with thymidine for the duration of one cell cycle which may vary between 24-
72 hours, depending on the cell lines (Cowan et al., 2004).  Following thymidine incubation, 
cell cultures should then be left to progress through the remainder of the cell cycle into 
metaphase, for harvesting as previously described (Section 2.14.1).  Optimisation of 
karyotypic analysis in this way would require an in depth understanding of the duration of 
each cell cycle phase in the different hESC lines; however, this would save significant time 
and reagents from unscorable metaphase cell preparations, and would therefore be a 
worthwhile investigation to undertake.  However, with the common occurrence of 
karyotypic abnormalities which demonstrably alter cell cycle times, it may be necessary to 
fully understand the cell cycle duration for each cell line and treat accordingly to produce 
metaphase spreads for analysis, preventing a ‘one for all’ protocol for karyotypic analysis of 
hESCs. 
Poor efficiency in metaphase spread preparation, meant that is was not possible to 
generate a record of the RH5 cut cell line for comparison of karyotypic stability with the 
RH5 TrypLE sample.  In an attempt to determine differences between these samples, array 
Comparative Genomic Hybridisation (aCGH) analysis was carried out on the RH5 cut and 
RH5 TrypLE cell line, each compared to the UKSCB distribution cell bank (DCB).   
 
4.2.7.4 Array Comparative Genomic Hybridisation  
Array CGH was carried out to compare the karyotype of RH5 TrypLE and RH5 cut cell with 
the RH5 DCB from the UKSCB, monitoring for chromosomal aberrations which may have 
occurred between the two populations as a consequence of enzymatic versus mechanical 
passaging.  Array CGH (Perkin Elmer, ProScanArray microarray scanner) was used to 
analyse alternations in copy number of 5000 human clones.  
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Results from aCGH analysis were preliminary and would need further in-depth analysis 
including sequencing of the chromosomal regions to confirm any findings.  Each sample has 
been represented by red and blue spectral lines.  In copy number match samples, the red 
lines were visible on the left of the central black line and the blue on the right.  The two 
vertical blue lines on each side of the central black line define the ‘limits’ as set by the user, 
in this case limits were set as is used for standard genetic diagnostic analysis.   
No complete chromosomal duplications or losses were identified amongst the RH5 cut and 
RH5 TrypLE populations which would have been identified by the spectral lines moved 
away from the centre for the entire length of the chromosome; however, losses of genomic 
content were identified by the movement of spectral lines at individual loci crossing over 
the central line to the opposite side (ie red to the right and blue to the left).  Similarly 
duplications of genomic content were identified by mirrored extensions of the spectral 
lines beyond the detection limits.   
When compared to the RH5 cut cell line, RH5 TrypLE demonstrated a gain of chromosome 
region 16p13.3 (Figure 4.8).  Investigation into the behaviour of genes in this chromosomal 
region revealed that gains in this region, are used in diagnostics for a range of carcinomas 
including lung, liver and salivary gland (Katoh et al., 2005; Kasamatsu et al., 2005; Choi et 
al., 2006). 
When compared to RH5 TrypLE, RH5 cut highlighted a gain of chromosomal region 17q25.2 
(Figure 4.9A).  Gains of chromosome 17 have been described in detail by many laboratories 
following in vitro culture of different hESC lines and have been associated with tumour 
formation in vivo (Skotheim et al., 2002; Westermann and Schwab, 2002; Draper et al., 
2004a; Mitalipova et al., 2005; Catalina et al., 2008).  However, alterations specifically in 
the 17q25.2 region have been attributed to breast cancers (Petty et al., 1996).  Close 
inspection of this cell line suggest a possible gain of chromosomal region 2p25.2 (Figure 
4.9B) which has been associated with autism, however this mutation is close to the limits 
set for analysis which are subjective, so would need to be repeated for confirmation.   
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Figure 4.8. RH5 TrypLE aCGH idiogram. 
The gain of chromosomal region 16p13.3 was identified by the movement of both the blue and the red lines 
away from the mid line, beyond the limits of detection on the aCGH idiogram output.  Cross over of the spectral 
lines was also observed at various points on each chromosomal iodigram output but these cross-overs were not 
mirrored on each side and were therefore deemed to be due to sampling error or error in analysis. 
 
        
Figure 4.9. RH5 cut aCGH analysis idiogram. 
The gain of chromosomal regions 17q25.2 (A) and 2p25.2 (B) was identified by the mirrored movement of both the blue and the red lines away from the mid line, beyond the limits of 
detection at these loci on the aCGH idiogram output.  The loss of chromosomal region 5q35.1 (C) was identified by the mirrored cross-over of both the blue and the red lines onto the 
opposite side of the midline, beyond the limits of detection.   
   
A B C 
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Perhaps most interestingly, a loss of the chromosomal region 5q35.1 was detected in the 
RH5 cut (Figure 4.9C).  Using aCGH is was not possible to identify whether either of the RH5 
cell lines expressed the normal two copies of this gene or whether both cell lines were 
abnormal.  Instead it could only be concluded that the UKSCB RH5 DCB contained an 
additional copy of this gene, when compared with RH5 cut.  This chromosomal region 
encodes the FBXW11 gene (NCBI, Entrez Gene) which is expressed at high levels during 
forebrain development in the foetus (Koolen et al., 2006).  In addition, gains of this region 
have been associated with Holoprosencephaly (HPE), a developmental defect affecting the 
forebrain development in humans, also suggesting that this chromosomal region may be 
directly involved in brain development (Koolen et al., 2006).  A mutation in this region 
might suggest a difference in directability of neuronal differentiation between the RH5 cut 
and RH5 TrypLE cell line but would also need to be repeated for confirmation.  
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Figure 4.10. In Situ metaphase spreads from hESCs.  
Considerably more chromosomes are visible in from the RH5 TrypLE sample, p99 (A) when compared to HUES7, 
p65 (B).   
 
 
 
Figure 4.11. RH5 TrypLE p99.   
Hypertriploid karyotype complement ranging from 72-78 chromosomes.  Extra copies (4 or more) of 
chromosomes 1, 12 and 13 were seen in all cells examined as was a structurally abnormal isochromosome 17q 
and a structurally abnormal unidentified chromosome (above spread: 73XXX, +1, -4, +12, +13, -17, +(17q), +18, 
+mar). Images supplied by TDL Genetics. 
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Figure 4.12. HUES7 UKSCB Master Cell Bank. 
HUES7 p19 Abnormal male karyotype with 48 chromosomes with trisomy 12 and 17 present (above spread: 
48XY +12, +17).  Images supplied by TDL Genetics. 
 
 
Figure 4.13, HUES7 p65.  
Abnormal male karyotype, with a complement of 50 chromosomes including two copies of the X chromosome 
and three copies of chromosomes 12, 14 and 17 seen in all analysable cells (above spread: 50, XXY +12, +14, 
+17).  Images supplied by TDL Genetics. 
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Figure 4.14. Shef3 UKSCB Master Cell Bank.   
The UKSCB master cell bank for Shef3 presented a diploid male chromosome complement (46 XY). Images 
supplied by TDL Genetics. 
 
 
Figure 4.15. Shef3 p60 metaphase spread 
Shef3 retained a normal diploid male chromosome complement (46 XY) throughout this project.  Spread taken 
at p60, following 27 passages in culture. Images supplied by TDL Genetics. 
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4.3 Discussion 
During establishment and expansion of the four hESC lines in culture (Shef3, HUES7, RH5 
TrypLE and RH5 cut), it became apparent that there was no difference in appearance of 
hESCs in these lines.  Mechanically passaged lines retained uniform colony shape, where 
enzymatically passaged cells grew as a monolayer but individual cells from all four lines 
retained the morphological features of pluripotent hESCs (Section 4.2) and expanded well 
under standard culture conditions.  All hESC lines expressed typical markers of pluripotency 
(OCT4, SOX2, Tra-1-60 and Tra-1-81).   
All hESCs were co-cultured with iMEFs which provided support for their pluripotent 
expansion.  MEFs are primary cells, sourced from 13.5 day old embryos and as such have a 
finite expansion time in culture (Stubban and Wesselschmidt, 2007).  Although there are 
commercial alternatives to the use of such feeder-layers (Xu et al., 2001; Rosler et al., 2004; 
Amit, 2006; Ludwig et al., 2006b), these systems are yet to be fully characterised for their 
ability to retain stable hESC culture over prolonged periods, whilst retaining the ability of 
hESCs to be directed into differentiation.  Additionally, MatrigelTM and mTeSR1 media 
systems are costly alternatives to iMEFs (Ludwig et al., 2006a).  For this reason, hESCs were 
cultured on an iMEFs throughout this project.  Inactivated MEF banks were prepared as 
required and stored at -80 °C prior to use.  Stocks of iMEFs were stored for up to three 
months during which they retained high viability (> 85 %) and supportive capacity for hESC 
culture.   
The density of the iMEF layer was crucial for sustained hESC pluripotency, and due to their 
primary origin was found to be variable between iMEF banks.  Spontaneous differentiation 
was consistently observed in hESCs on iMEFs at the extremes of high (> 5.2 x 104/cm2) and 
low (< 1.8 x 104/cm2) seeding cell density (Section 4.2.4).  The reasons for this have not 
been fully characterised; however, iMEFs are known to secrete soluble factors into the 
culture media including bFGF, TGF-β2, Wnts, BMP/TGF-β1, activin/Inhibin, and IGF-1 which 
work in combination to support pluripotency in hESCs (Alitalo et al., 1982; Moscatelli et al., 
1986; Amit et al., 2004; Vallier et al., 2005; Wang et al., 2005a; Chen et al., 2006; Prowse et 
al., 2007; Saha et al., 2008; Villa-Diaz et al., 2009).  However, throughout embryonic 
development chemical gradients of these growth factors are responsible for tissue 
specification.  The concentration of secreted growth factors is therefore essential for 
determining either pluripotency of differentiation.   
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Insufficient support due to low feeder cell density or poor activity of individual fibroblasts 
(as seen in p4 versus p3 iMEFs) resulted in the differentiation of hESCs into a flattened 
epithelial-like morphology, which was likely to be a consequence of an imbalance in the 
secretion of soluble growth factors.  This morphology has been previously identified in 
hESCs and has in part been attributed to insufficient bFGF signalling (Amit et al., 2000; 
Diecke et al., 2008) which was also supplemented into hESC media to improve pluripotent 
survival (Duran et al., 2001).  When iMEFs were too dense, differentiation was also induced 
amongst hESCs.  A high iMEF density would have increased the growth factor 
concentrations, again creating an imbalance in the signalling required for pluripotency.  
Alone, many of these growth factors are actively involved in tissue specification (Johansson 
and Wiles, 1995), thus, alterations to the concentrations of these factors are likely to have 
initiated spontaneous differentiation.  In addition, high feeder cell density restricted the 
outgrowth of hESCs, resulted in piling up of cell layers which subsequently spontaneous 
differentiated.  For this reason, the optimal iMEF density for pluripotent hESC support was 
determined for each fresh iMEF bank. 
Inactivated iMEF conditioned media alone was insufficient for supporting pluripotent hESC 
expansion on gelatin coated surfaces as indicated by the rapid differentiation of hESC 
colonies (Section 4.2.6.1), despite supplementation with bFGF.  This suggested that either 
the secreted factors were subject to rapid degradation, or that they were not the only form 
of support provided by iMEFs in the co-culture system.  In feeder-free systems an 
extracellular matrix surface coating is used onto which hESCs can attach and proliferate.  
Interaction with ECM has been shown to be important in hESCs culture (Kleinman and 
Martin, 2005). Indeed, iMEFs secrete ECM (Villa-Diaz et al., 2009), which would explain why 
their presence was necessary for hESC pluripotency.  Production of growth factors and ECM 
by iMEFs decreases with time, reducing their supportive capacity (Villa-Diaz et al., 2009).  
This would explain the propensity for spontaneous differentiation after prolonged culture. 
Although no difference in hESC morphology was identified between the hESC lines, 
differences in their behaviour between the enzymatically and mechanically passaged lines 
were more apparent.  Mechanically passaged hESCs were slower growing than 
enzymatically passaged lines which in combination with the more time consuming process 
of manual passaging, made production of large cell volumes more difficult, and a 
unfavourable approach for bioprocessing.  However, both enzymatically passaged cell lines 
were identified to be karyotypically abnormal (Section 4.2.7.3).  The RH5 TrypLE cell line 
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was abnormal from derivation, and the HUES7 cell line was aneuploidy for chromosomes 
12 and 17 at the UKSCB MCB level.  Extended enzymatic culture of HUES7 resulted in a 
further gain of chromosome X and 14, reaching a model karypotype of 50 XXY, +12, +14, 
+17.  In accordance with observations from this study, karyotypic abnormalities have been 
correlated to a shortening in hESC doubling time (Cowan et al., 2004; Baharvand et al., 
2006), suggesting a survival advantage following a gain of these chromosomes.  This would 
also explain how the HUES7 line became abnormal in the short preparation time for a MCB.  
In contrast to these findings, publications by the depositors following derivation and 
alternative laboratories report a normal HUES7 karyotype (Cowan et al., 2004; Thomas et 
al., 2008); however, personal communication between the UKSCB and Professor D. 
Melton’s laboratory (Harvard, USA) confirmed that similar abnormalities had been 
detected in the HUES3 and HUES4 cell lines (Cowan et al., 2004).   
The common occurrence of genetic drift within hESCs under long term culture was first 
reported in 2004 (Draper et al., 2004a).  The frequency at which hESC lines gain 
abnormalities in culture is of concern for their use in therapeutic application, seeding 
worries of tumour formation in vivo.  In light of the fact that embryological development 
does not usually result in such abnormalities, their prevalence is likely to be a result of 
prolong exposure to suboptimal culture conditions.  Most commonly accumulated 
abnormalities include a gain of chromosomes 12 and 17, but additional copies of 
chromosomes 14 and X have also been noted (Draper et al., 2004a; Mitalipova et al., 2005; 
Catalina et al., 2008), as was also seen in the HUES7 line throughout this project.  It is likely, 
that additional abnormalities within the populations were also present but that alterations 
which did not confer a survival advantage died out before detection.   
Karyotypic analysis of RH5 TrypLE revealed the presence of a marker chromosome which 
was unidentifiable by the cytogenetisist at TDL.  The gain of this marker chromosome 
would be of serious concern for therapy but is a great indicator of the possible mutations 
which can arise from long term hESC culture.  Whatever the cause, safety is of great 
concern for therapeutic application, and the possibility of tumourogensis following hESC 
cell therapy must be ruled out.  For this reason, it is vitally important to understand the 
possible causes of genetic instabilities and to monitor cells both with and without theses 
instabilities for their behaviour in subsequent culture and differentiation.   
Laboratories worldwide culture different hESC lines with various culture techniques, and 
report conflicting evidence for instabilities within different lines.  Possible causes of 
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karyotypic instabilities include cell culture density, feeder-free culture or enzymatic 
passaging (Draper et al., 2004a; Buzzard et al., 2004b; Mitalipova et al., 2005; Catalina et 
al., 2008).  It could also be argued that in addition to culture conditions, some hESC lines 
may simply be more susceptible to abnormalities than others.  This would seem a 
reasonable, considering hESC lines are derived from embryos (surplus to requirement) 
following In vitro fertilisation (IVF) procedures.  Couples undertake IVF for a variety of 
reasons, but in many cases this is due to genetic disease susceptibility.  It is therefore not 
surprising that only 42 % of surplus IVF embryos were chromosomally normal at the 
blastocyst stage (Hardarson et al., 2003), and possible that hESC lines derived from ‘normal’ 
embryos would be less prone to instability than those from a family history pre-disposed to 
genetic disease. 
Human ESC lines under enzymatic culture were more susceptible to karyotypic aberrations 
than mechanically passaged lines.  The inability to adapt karyotypically normal hESC lines to 
enzymatic passaging, has also been observed in alternative laboratories, with persistence in 
enzymatic culture demonstrably resulting in the development of karyotypic abnormalities 
(Personal communications with Ms. A. Hemsley; Regenerative Medicine and Bioprocessing, 
UCL, and Dr. C. Machado; Cell Biology and Imaging, NIBSC).  Thus supporting a link between 
enzymatic passaging and karyotypic instability.  
Sadly the inability to adapt Shef3 to enzymatic culture did not enable comparison of 
pluripotent expansion and differentiation in this karyotypically normal hESC line under both 
mechanical and enzymatic conditions.  However, the same originating starting pool of the 
RH5 cut and RH5 TrypLE cell lines did enabled a comparison of the effect of passaging on 
karyotypic stability and subsequent expansion and differentiation behaviour, since all other 
parameters of culture remained constant.   
It was not possible to generate metaphase spreads from the RH5 cut line (thought to have 
been a result of lower cell numbers due to the nature of mechanical passage).  Instead, 
comparison of these two lines was carried out in more detail using aCGH technology.  Array 
CGH identifies discrepancies in the gDNA content between two samples to an accuracy of 
100 kb, confirming the presence of duplications or deletions in whole genes or regions of a 
chromosome.  Using aCGH analysis, laboratories claiming to have normal hESC karyotype 
under enzymatic passaging have later demonstrated small alterations in genomic content 
(Thomson et al., 2008), confirming the occurrence of chromosomal aberrations which are 
not detectable under standard G-banding analysis of metaphase spreads.   
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At the end of this project, both the RH5 cut and TrypLE cell lines were compared to the 
original gDNA content of the UKSCB RH5 DCB.  Array CGH highlighted a number of 
differences between the two RH5 cell lines, included a gain of the chromosomal region 
16p13.3 in RH5 TrypLE and 17q25.2 in RH5 cut, when compared to the UKSCB DCB.  Both of 
these alterations have been associated with in vivo development of carcinomas, suggesting 
a link between the in vitro culture of these cell lines and a risk of tumour formation (Petty 
et al., 1996; Katoh et al., 2005; Kasamatsu et al., 2005; Choi et al., 2006).  G-banding 
analysis of the RH5 TrypLE metaphase spread reported triplicate copies of both 
chromosomes 16 and 17; however, this does not indicate the duplications or deletions of 
individual genes which can go unnoticed under this form analysis.  The inability to quantify 
copy number using aCGH technology meant that it was not possible to identify whether the 
UKSCB RH5 DCB contained normal copy number of these genes and in vitro culture induced 
duplication, or whether there were already numerous copies of these genes in the 
originating population, which already were subject to duplication.     
Interestingly, the RH5 cut cell line also suffered a loss at chromosomal region 5q35.1, which 
encodes a number of genes including FBXW11 (NCBI, Entrez Gene).  FBXW11 is expressed 
at high levels during foetal forebrain development and gains of this region have been 
associated with holoprosencephaly (HPE) (Koolen et al., 2006), a condition caused by a 
defect in foetal forebrain development.  Clinical symptoms of HPE include a depletion of 
mature cortical interneurons neurons in the forebrain region of patients (Schell-Apacik et 
al., 2003; Fertuzinhos et al., 2009).  Although these are only preliminary findings, mutations 
in this region might suggest a difference in directability of neuronal differentiation between 
the RH5 cut and RH5 TrypLE cell line, or a difference in their terminal neural cell fate. 
The retention of a normal karyotype of Shef3 under mechanical passaging, and the 
additional alterations in enzymatically passaged cell lines from this study, indicate an affect 
of culture techniques on the karyotypic stability of hESCs which are not obvious upon 
morphological examination.  However, when considering the incorporation of hESCs in 
pharmacological or therapeutic applications, the effects of karyotypic abnormalities are 
more important than their cause.  A mutation inferring uncontrollable proliferation, would 
be unsuitable for incorporation into transplantation due to the high risk of tumour 
formation.  Equally, a mutation which affects signalling involved in neuronal maturation are 
unlikely to be of use in cell lines required for the production of large numbers of 
post-mitotic functional neurons.  To improve understand the effect of differences in 
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behaviour of enzymatic and mechanically passaged hESC lines, further investigation was 
carried out onto their subsequent directability into neuronal differentiation (Chapter 5). 
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5 Neuronal differentiation in pluripotent hESC lines 
5.1 Introduction 
Data from the previous chapter has compared the effect of in vitro culture and on the 
pluripotency and karyotypic stability of different hESC cell lines.  Results from karyotypic 
analysis suggested a susceptibility of hESC lines under enzymatic passaging to chromosomal 
abnormalities.  On occasion, abnormalities included just small alterations in genomic 
content; however, upon closer investigation copy numbers of genes associated with 
tumour formation (uncontrolled proliferation) and neuronal maturation were affected by 
the different culture techniques.   
Despite this, any differences induced by passaging technique did not appear to affect the 
pluripotency of the cell lines as determined by expression of pluripotency markers OCT4, 
SOX2, Tra-1-60 and SSEA4.  To determine whether the mode of passaging had implications 
on the directability of neuronal differentiation following pluripotent expansion, a study into 
the comparative efficiency of neuronal differentiation across the four hESC lines (Shef3, 
HUES7, RH5 cut and RH5 TrypLE) was carried out.   
 
5.2 Results: Neuronal differentiation in  hESCs 
Neurons were first generated from hESCs in 2001 (Carpenter et al., 2001; Schuldiner et al., 
2001; Zhang et al., 2001); however, on commencing this project there were only a limited 
number of protocols available for their neuronal differentiation and high neuronal yield 
and reproducibility remained a challenge.  Initial phases of this study, required the 
development of a reliable and reproducible method of neuronal differentiation, to facilitate 
a comparison of different hESC lines.   
 
5.2.1 Embryoid body directed mid/hind neuronal differentiation 
Initial experiments into neuronal differentiation followed an established method using 
FGF8 and SHH to direct hESCs into a midbrain dopaminergic neuronal cell fate, based on 
the first neuronal differentiation protocols in hESCs  (Zhang et al., 2001; Li et al., 2007).  
Due to limited availability of hESCs in the UK on commencing this project, early studies on 
neuronal differentiation were carried out on Shef3, a cell line with no prior history of 
neuronal differentiation.  Human ESCs were differentiated according to the methods 
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outlined in Section 2.10.1; however attachment and spreading of the EBs following 
differentiation to the culture surface following plating was limited, making it difficult to 
identify individual differentiating cells and determine whether neuronal differentiation was 
successful, suggesting that identification of a suitable surface coating for optimised EB 
attachment was necessary. 
   
5.2.1.1 Comparison of surface coating for neuronal attachment 
To determine the optimal surface coating for EB attachment a comparison of six different 
coatings (laminin, poly-d-lysine, gelatin, poly-L-ornithine, fibronectin and collagen IV) was 
carried out.  In an attempt to identify a surface coating which positively selected for EBs 
containing neuronal progenitors, this experiment was carried out using differentiating 
fragments containing known to contain neural progenitors in rosette-like structures.   The 
methods for this experiment are detailed in Section 2.11.  Results from eight wells per 
chamber slide for two cell lines (Shef3 and RH5 cut) were averaged for overall comparison.  
Images were captured of attached fragments on each of the surface coatings (Figure 5.1).   
The highest level of fragment attachment after eight days in culture was seen on the 
poly-L-ornithine coated surface (93.8 % ± 4.4; Figure 5.2).  High levels of attachment were 
also noted for fibronectin and collagen (87.5 % and 81.3 % respectively); however, the cells 
spreading from attached fragments were of predominantly non-neuronal morphology 
(Figure 5.1), suggesting that these coatings were not selective for neuronal selection and 
proliferation.   Attachment on laminin coated surfaces was lower than other surface 
coatings with only 68.75 % fragments attached after eight days in culture; however, 
neuronal outgrowth from these attached fragments was higher than was seen for any 
other surface coating (37.5 % ± 22.1) as seen by the increased numbers of phase bright 
rounded neuronal cell bodies with outgrowing neurites, indicating a positive selection for 
attachment of fragments containing neurons.   
The survival of Shef3 fragments for attachment after eight days was significantly lower than 
the RH5 cut fragments as determined by ANOVA (p = 0.01).  When combining data from 
RH5 and Shef3, ANOVA revealed that there was no significant difference in the rate of 
fragment attachment (p = 0.73) or the level of neuronal outgrowth (p = 0.94) between all 
culture surfaces.  However, based upon the average levels of attachment and neuronal 
outgrowth these data support findings that poly-L-ornithine and laminin are optimum 
surface coatings for improving attachment, differentiation and outgrowth of neuronal cell 
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types (Reynolds and Weiss, 1992; Lathia et al., 2007; Hall et al., 2008).  A combination of 
poly-L-ornithine to aid attachment and laminin to promote survival of neural cells was 
subsequently used for all further studies. 
Using this method of differentiation (Section 2.10.1), EBs were irregular in size and shape 
with very few containing visible rosette-like structures (Figure 5.3).  Despite optimised 
conditions for attachment and spreading of EBs following FGF8 and SHH induced 
differentiation, the number of neurons which were visible spreading from these attached 
EBs was minimal and the majority of spreading cells were of a non-neuronal morphology.  
In a number of cases, EBs failed to collapse following attachment and retained a compacted 
cell cluster (Figure 5.4). 
Under bright field microscopy it was not possible to detect cells of neuronal morphology 
due to the presence of large numbers of non-neuronal cells. To determine whether 
neurons were present amongst the differentiating EBs, samples were fixed with 4 % PFA 
(Section 2.13.1) and stained for a range of antibodies which confer neural identity.  After 
ten days SOX2 was positively expressed in cells of rosette morphology (Figure 5.5) but 
predominantly negative in the surrounding non-neuronal cells.  Expression of N-cadherin 
(an alternative marker for neuroepithelial cells) was detected throughout the attached EB 
(Figure 5.5), confirming the presence of cells with a neuroepithelial phenotype; however, 
further immunostaining for TUBB3 demonstrated that very few of these cells were of 
neuronal morphology (Figure 5.5). Continued culture and differentiation of these cells 
increased the numbers of TUBB3 positive cells.   
By the presence of very few TUBB3 positive neurons within the EBs it was concluded that 
Shef3 hESCs were not responsive to EB directed neuronal differentiation using just FGF8 
and SHH.  Instead an alternative approach to differentiation was carried out using ATRA (as 
used for NTERA2 differentiation) whilst retaining the cells in an adherent monolayer, 
according to methods outlined in Section 2.10.2 (Baharvand et al., 2007).   
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Figure 5.1. Comparison of six surface coatings for EB attachment.   
Fragments containing neural rosettes were plated into 8-well chamber slides pre-coated with a range of factors 
which aided cellular attachment.  Images of fragments following attachment were captured four days after 
seeding.  Neural rosettes were clearly visible in fragments spreading on gelatin coated surface, but limited 
neuronal outgrowth was observed (A).  Outgrowth from fragments on collagen IV (B) and fibronectin (C) 
comprised predominantly non-neuronal cells.  Mixed behaviour was seen on poly-D-lysine from no cellular 
spreading (D) to outgrowth of neuronal and non-neuronal cell types.  Neural progenitors were visible in large 
number spreading from fragments on poly-L-ornithine (E) and laminin (F) coated surface.   
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Figure 5.2. Surface coatings for optimal neuronal differentiation.   
Six surface coatings were compared for attachment of cell fragments containing neural rosettes.  Results from 
Shef3 and RH5 were combined.  Optimal levels of fragment attachment (blue) were achieved using 
poly-L-ornithine when compared to alternative surface coatings.  Optimal neuronal outgrowth from attached 
fragments (red) as determined by the numbers of rounded phase bright neuronal cell bodies with extended 
neurites, was achieved with a human laminin coated surface (37.5 % ± 22.1), with neuronal differentiation also 
seen in poly-L-ornithine (31.3 % ± 8.8).  Error bars (2SE). 
 
 184 
BA
C D
 
Figure 5.3. EBs displaying rosette-like structures following differentiation.   
EBs displaying rosette-like structures (A-B) were present in very small numbers, and were irregular in size and 
shape (C-D) following differentiation according to methods outlined in Section 2.10.1.   
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Figure 5.4. Non-neuronal outgrowth from FGF8 and SHH differentiated EBs.  
Neuronal outgrowth was seen from a minority of differentiated EBs following differentiation (A).  Outgrowth 
from the majority of attached EBs was of non-neuronal morphology (B-C).  In a minority of cases, attached EBs 
failed to collapse and spread, retaining their compacted structure throughout differentiation D). 
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Figure 5.5. Immunostaining of neurons following EB directed differentiation.   
Positive SOX2 staining was visible in neural rosettes within the attached EBs (A-B).  Positive N-cadherin 
expression was detected throughout the attached EB (C-D).  Very few cells within the attached cell mass were 
positive for TUBB3 (E-F), highlighting a poor efficiency of neuronal differentiation according to this method.  
TUBB3 positive neurons were deeply embedded within the cell mass, preventing isolation for functional 
analysis.   
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5.2.2 Adherent monolayer neuronal differentiation 
Cells were differentiated according to the method outlined in Section 2.10.2.  Following 
exposure to ATRA, large parts of the hESCs colonies collapsed and flattened out into 
epithelial like cells, which were apoptotic in appearance (Figure 5.6B).  In areas of high 
density growth, some neural rosettes were visible (Figure 5.6C) which were mechanically 
dissected and transferred onto poly-ornithine/laminin coated IVF dishes in NBD media (4-6 
fragments/dish).  Following plating, 65.0 % ± 20.9 fragments attached, the remaining 
fragments either stayed in suspension or disintegrated.  Small areas of neuronal outgrowth 
were visible from some attached fragments (Figure 5.6D; red arrows).  However most 
fragments attached with no sign of neurons amongst outgrowing cells (Figure 5.6E).  
Non-ATRA treated controls retained features of hESCs (Section 4.2.1).  After repeated 
attempts, Shef3 hESCs were also deemed unresponsive to ATRA induced differentiation 
when cultured on iMEFs.   
 
5.2.3 Semi-directed differentiation 
After many failed attempts to differentiate Shef3 neuronally, using two established 
protocol, (suspension EBs and monolayer), it was questioned whether the Shef3 line was 
capable of differentiating to cells of a mature neuronal phenotype.  To investigate this 
further rosette-like structures from spontaneously differentiating Shef3 on high cell density 
iMEF layer, were mechanically dissected and transferred into NBD media (Figure 5.7A-B), 
for neuronal specification.  For the purpose of this study, this process was referred to as 
semi-directed differentiation.  As a comparison, cells from the RH5 TrypLE cell line were 
also treated in this way to control for cell line variation. 
Twenty-four hours after attachment neuronal-like cells were visible spreading from 
rosettes in both cell lines, which continued to increase in number over time.  
Immunostaining of these cells confirmed the neuronal phenotype by positive TUBB3 
expression (Figure 5.7C-D).  Patch clamp analysis demonstrated the ability to fire electrical 
impulses in response to stimulation, thereby confirming true neuronal identity from cells of 
both RH5 TrypLE and Shef3 origin (data available upon request). 
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Figure 5.6. Adherent monolayer neuronal differentiation.   
Pluripotent hESC colonies (A) were treated with ATRA.  After five days in culture many of the colonies appeared collapsed and of an epithelial-like cell morphology (B).  Some colonies 
developed high density rosette-like structures (C) which were mechanically dissected and transferred into NBD media for further differentiation.  Neuronal outgrowth was visible from a 
minority of attached fragments (D).  Outgrowth of non-neuronal cells (E) was most commonly observed indicating poor efficiency of neuronal differentiation.  In non-ATRA treated controls, 
hESCs retained the morphology of pluripotent cells (F).   
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Figure 5.7. Neural rosettes following semi-directed neuronal differentiation.   
When cultured on a high feeder density, hESC colonies underwent spontaneous differentiation.  On occasion, 
this generated structures similar in appearance to neural rosettes A).  Following mechanical dissection (B) these 
rosettes were transferred onto a poly-ornithine/laminin coated surface in NBD media (Section 2.10.3.1).  After 
24 hours neurons were seen spreading from the rosettes (C).  After several days, the number of neuronal cells 
continued to increase and stained positively for TUBB3 (D-red, overlaid image)  
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The semi-directed method of differentiation demonstrated the ability of both the RH5 
TrypLE and Shef3 to differentiate into functional neurons; however, the reproducibility of 
this process was limited by the rate of spontaneous differentiation, which was an adverse 
side-effect of poor hESC culture.  A reproducible method for inducing the formation of 
neural rosettes in culture was therefore required to enable a reliable comparison of the 
neural differentiation capacity of different hESC lines.  Using experience of differentiation 
from the above studies and additional literature an alternative ‘enhanced’ method of 
differentiation was established combining aspects of these different protocols. 
 
5.2.4 Enhanced EB differentiation  
The HUES7 cell line was incorporated into this part of the study as a comparative hESC line 
and a positive control for neuronal differentiation due to its history of neuronal 
differentiation.  Human ESCs were cultured as described in Section 2.9.1, until TrypLE lines 
reached confluency (Figure 5.8A) and mechanically passaged colonies were sufficiently 
large for dissection.  Prior to differentiation, all hESCs presented pluripotent characteristics 
(Section 4.2.1).  Fragments approximately twice the size as for passaging (Figure 5.8B-C) 
were dissected and cultured in suspension as EBs.  The cell signalling within an EB has been 
shown to recapitulate early embryonic development, inducing tissue specification into each 
of the three germ layers (Itskovitz-Eldor et al., 2000).  In an attempt to reduce loss of cells 
into alternative germ lineages and increase the speed of specification into a neuronal cell 
fate, EBs were cultured directly into a neural Induction medium (NI; Section 2.10.1.1), 
rather than incubating the first four days in standard hESC as detailed in alternative 
protocols (Li et al., 2007).   
The efficacy of this adaptation was demonstrated using flow cytometry to compare 
expression of OCT4 and Nestin (a neural stem cell marker) within these populations.  
Embryoid bodies were dissociated into single cells after four days in their respective 
medium.  After four days in NI media the expression of OCT4 had dropped to 20.97 % when 
compared to 82.34 % positive expression on the day 0.  The levels of OCT4 positive cells in 
the hESC treated EBs was also reduced after four days, but a higher proportion of cells 
retained OCT4 30.95 %, confirming that NI media induced more rapid down regulation of 
pluripotency than hESC media.   
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To determine whether the NI media was specifically directing differentiation neuronally, 
expression levels of Nestin were compared in NI and hESC media treated EBs after four 
days.  EBs were imaged using confocal microscopy, confirming a consistent reduction in the 
number of OCT4 positive cells within the NI treated EBs when compared to EBs cultured 
directly in hESC media (Figure 5.9).  Remaining OCT4 positive cells within the EB were 
located in clusters, rather than spread throughout the EB. 
Neural induction media increased the yield of Nestin positive cells from 22.3 % on day zero 
to 63.68 % on day four, compared to just 40.14 % in hESC media.  Direct culture in NI media 
also increased the final neuronal yield, as determined by increased outgrowth of cells with 
neuronal morphology after 28 days.   
In light of published data and evidence from neuronal differentiation in NTERA2, 
demonstrating the effect of serum on the outgrowth of non-neuronal cells (Brewer et al., 
1993; Brewer, 1995), serum-free media was used throughout differentiation.  After four 
days differentiating in culture, neural progenitors were transferred into a NBD media 
(Section 2.10.3.1) for further differentiation which contained a range of neurotrophic 
factors to promote neuronal differentiation and survival (Section 1.5.2). 
The cost and volume of differentiation media was also reduced by differentiating EBs in 
25-well bacteriological grade perti-dishes, using 2 ml NI media per well, compared to the 
minimum 10 ml media required for 60 mm round petri-dishes as were used in earlier 
publications.  Additional advantages of the square compartmentalised cultured dishes 
include stability in transit, reducing spillages and therefore reduced risk of contamination.  
Two wells of the compartmentalised dish were used to culture EBs from one confluent well 
of a 6-well plate.    
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Figure 5.8. Generating embryoid bodies for neural induction.  
Confluent hESCs (A) were washed in NI media and dissected from the culture surface under a dissection 
microscope using a sterile 1 ml pipette tip (B) using a scraping motion at perpendicular angles across the dish 
(C).  Resulting EBs were relatively uniform in size and shape after 24hours in culture (D). 
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Figure 5.9. OCT4 after four days in neural induction media.   
After four days in NI media, OCT4 expression was almost completely lost from the EBs (A).  OCT4 positive cells 
were located in clusters rather than evenly dispersed through the EB (B).  Images were captured using Leica 
DMRE confocal microscope on the RH5 cell line. 
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5.2.4.1 The effect of bFGF on neuronal differentiation 
The effect of basic fibroblast growth factor (bFGF) on hESC culture and differentiation has 
been the subject for numerous studies.  bFGF is a mitogen known to be required for  
maintaining pluripotent expansion of hESCs (Friesel and Maciag, 1995; Amit et al., 2000).  It 
has also been shown to stimulate proliferation (Tienari et al., 1995).  A proliferating cell will 
usually exit the cell cycle prior to differentiation (Walsh and Perlman, 1997; Maione and 
Amati, 1997; Brown et al., 2003).  For this reason, removal of bFGF from differentiation 
media has been previously described, with reported increases in neural progenitors and 
outgrowth of mature neurons (Lee et al., 2000; Shin et al., 2005; Schwindt et al., 2009).  As 
such, bFGF was removed from media following the first four days of neural induction in an 
attempt to improve commitment into neuronal differentiation.  To identify the effect of 
bFGF removal on neuronal differentiation, a comparative study was carried out in the 
presence and absence of bFGF in NBD media.   
Cellular outgrowth from EBs following attachment was greatly increased in NBD media 
containing bFGF (Figure 5.10); however cells were mainly of a non-neuronal morphology.   
Neurons were identifiable in samples cultured in both the presence and absence of bFGF, 
but neuronal purity was considerably higher in NBD media without bFGF.  Non-neuronal 
cells continued to proliferate in bFGF containing media and eventually overgrew neurons in 
culture.  The higher neuronal purity from samples grown in the absence of bFGF was 
confirmed using immunostaining where TUBB3 positive neurons were identified in both 
samples with a higher proportion of non-neuronal cells in NBD media containing bFGF 
(Figure 5.11).  It was therefore decided to remove bFGF from NBD differentiation media. 
To determine whether the removal of bFGF affected the function of hESC derived neurons, 
cells were screened using the patch-clamp.  Neurons produced in both the presence and 
absence of bFGF generated APs in response to stimulation (Figure 5.12), which were 
reversibly inhibited by Tetrodotoxin (TTX; a sodium channel blocker), confirming genuine 
sodium APs.  On several occasions neurons from samples differentiated in the absence of 
bFGF fired a series of APs which were not detected in neurons derived in bFGF containing 
media (Figure 5.12), indicating the presence of functional voltage gated K+ channels.  This 
suggests that the absence of bFGF improved neuronal maturation.  Following confirmation 
of functional neuronal differentiation using the ‘enhance’ method of differentiation, hESC 
from all four hESC lines were directed into differentiation for comparison of efficiency and 
functionality between cell lines.  
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Figure 5.10. Cell proliferation with and without bFGF.   
Following EB attachment, outgrowth from fragments was greater in bFGF containing NBD media (A-B, x4, x10 
magnification) compared to media without bFGF (C-D, x4, x10 magnification).  In the presence of bFGF neuronal 
outgrowth was accompanied by non-neuronal cells thus reducing the neuronal purity.  
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Figure 5.11. TUBB3 staining in neurons derived with and without bFGF.   
TUBB3 (red) positive neurons were generated following differentiation protocols with bFGF (A-B) and without 
bFGF (C-D), x4 magnification.   
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Figure 5.12. Action potentials from neurons derived +/- bFGF.   
Positive action potentials were generated by neurons derived both in the presence of bFGF (blue) and in the absence of bFGF (red).  Only single APs were fired by neurons derived in the 
presence of bFGF (A –blue) where in the absence of bFGF neurons were able to fire a series of AP’s (A – red).  Action potentials were inhibited by TTX (B) and recoverable following washing 
(C), confirming genuine sodium action potentials.  Upon recovery only single APs were fired by neurons which previously fired multiple APs suggesting incomplete clearance of the membrane 
bound sodium channels following washing (C – red). 
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5.2.5 Determining neuronal yield 
Flow cytometry analysis was carried out on undifferentiated and differentiating hESCs to 
quantify the efficiency of neuronal differentiation based on the expression of neuronal 
proteins.  Before this was possible, it was first necessary to break up neuronal populations 
into single cells for analysis.  Neurons were difficult to disrupt into small cell clusters, 
without damaging the delicate neurite projections.  This frequently resulted in high levels 
of cell death and debris, making it difficult to quantify the true efficiency of differentiation.  
A comparison of cell dissociation reagents was carried out to determine the optimal 
method for dissociating EBs and neuronal cultures to retain cellular integrity and viability. 
 
5.2.5.1  EB dissociation  
There are a wide range of reagents available for cell dissociation based on different 
dissociation chemistries.  Five different cell dissociation reagents were compared for their 
ability to dissociate clusters into single cells, whilst retaining high viability; TrypLETM 
Express, Trypsin-EDTA, Collagenase IV, AccutaseTM and Dispase.  Each of these reagents 
have different modes of activity.  Type IV collagenase is isolated from Clostridium 
histolyticum and is commonly used for enzymatic passaging of hESCs because it has low 
tryptic activity, retaining cellar integrity (Gonzalez et al., 2007).  AccutaseTM is an 
animal/bacterial free product comprising a  mixture of proteolytic and collagenolytic 
enzymes in EDTA (Gonzalez et al., 2007).  Trypsin is a porcine derived proteolytic enzyme 
which is produced by the pancreas to digest large proteins.  Trypsin is one of the principle 
enzymes in the body for protein digestion and has a long history of use in tissue culture for 
cell dissociation.  TrypLETM Express is an animal product free, alternative to Trypsin.  It is 
derived from microbial fermentation (Invitrogen) which is gentler on cellular dissociation. 
Eight day differentiated EBs were treated as detailed in Section 2.13.4.1.  Following 
incubation, EBs were triturated ten times to enhance dissociation, before determining cell 
number and viability (Figure 5.13).  Due to variation in the size and shape of EBs, 20 EBs 
were used for each sample reducing error in dissociation which may arise from EBs of 
different sizes.  Observations of cellular appearance and behaviour were noted for each of 
the reagents (Table 5.1). 
Dissociation of EBs using was most efficient using AccutaseTM, TrypLE Express and 
Trypsin-EDTA, resulting in cells with 95.4, 95.8 and 98.5 % viability respectively (Figure 
5.13).  The overall number of single cells achieved was considerably higher using 
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AccutaseTM (9.3 x 105 cells/ml) when compared to the other dissociation reagents.  
Collagenase and Dispase both retained cells in small clusters following incubation which 
were unable to be counted using the haemocytometer and would not be sufficiently 
dissociated for quantification using the flow cytometer; however, this was as expected 
since these enzymes are commonly used for hESC passaging due to their ability to retain 
cells in small clumps (Freshney, 2005) rather than single cells. 
Reagent
Single cell 
suspension
Observation
Trypsin EDTA No
Large amount of cell lysis.  Stringy, sticky cell suspension.
Clumps of cells visible after 10 triturations.
TrypLETM Express Yes Dissociated into single cells in 10 triturations
AccutaseTM Yes
Cells dissociated into single cells/ very small clusters.
Minimal cell debris following trituration.
Dispase No
Large cell clumps remain.
Lots of debris following trituration.
Collagenase No
Large cell clumps remain.
Lots of debris following trituration.
 
Table 5.1. Enzymatic cell dissociation observations. 
Each of the enzymes used for cell dissociation had different modes of action and consequently different end 
results for dissociation. 
 
This experiment was repeated on monolayer samples of 18 day differentiating neurons 
which were visibly extending large numbers of intermingling axons and dendrites.  Single 
wells of a 6-well plate of differentiating cells from the same starting pool were prepared as 
for suspension EBs (Section 2.13.4.1).  In monolayer culture, AccutaseTM also recovered the 
largest number of viable single cells 93.1 %, 1.8 x106 cells/well).   
Based on the number and viability of single cells generated, this data suggests that 
AccutaseTM or TrypLETM were the best reagents for single cell dissociation of EBs.  This study 
would need to be repeated with up to three different cell samples for full validation; 
however, this trend supported finding by alternative research groups which use AccutaseTM 
for dissociating neural cell cultures (Personal communication: Dr. M. Caldwell).  AccutaseTM 
or TrypLE Express were subsequently used for dissociating all samples for flow cytometry 
analysis.  
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Figure 5.13. Comparison of cell dissociation regents. 
Differentiating hESCs retained a high viability (red) following dissociation with all reagent; however, the total 
cell count x 10
4
 (blue) following EB dissociation was variable between reagents.  This was largely due to an 
inability of Collagenase and Dispase to separate EBs into single cell, retaining clumps of cells which were 
uncountable using the haemocytometer.  Most efficient dissociation was achieved using Accutase
TM
 and TrypLE 
express retaining 95.4 % and 95.8 % viability respectively and yielding 9.3 x 10
5
 and 7.7 x 10
5
 single cells/ml.   
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Figure 5.14. The efficiency of dissociation on 18 day neurons.   
Cell viability (red) and count/well (x 10
4
; blue) following dissociation of day 18 RH5 TrypLE derived neurons.  The 
viability of cell following dissociation was relatively comparable between different dissociation reagents.  
However, the overall number of single cells was considerably higher following Accutase dissociation than from 
any of the alternative dissociation reagents (TrypLE, Trypsin, Collagenase and Dispase), due to higher efficiency 
of dissociating EBs into single cells.  In alternative reagents, cells remained in clusters of varying sizes, resulting 
in a lower overall single cell count. 
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5.2.5.2 Flow cytometry analysis 
Flow cytometry analysis was carried out on the RH5 TrypLE differentiating cells to identify 
neuronal yield following the newly developed method.  The differentiating population were 
dissociated into single cells using AccutaseTM and analysed at day 0, 4, 18 and 28 for 
changes in expression levels of OCT4, Nestin and TUBB3.  Expression levels of OCT4 were 
significantly reduced from 82.3 % ± 7.4 at day 0 to 2.9 % ± 3.9 positive cells at day 28 
(p = 0.0001) as determined by ANOVA.  Nestin expression increased from 22.3 % ± 27.6 at 
day 0 to 62.7 % ± 23.5 at day 4, after which expression levels did not significantly change 
(p = 0.14).  Neuronal yield reached 42.2 % ± 16.0, according to positive TUBB3 expression.    
However, this was contradictory to data from bright field and In situ immunostaining 
images which indicated a considerably higher neuronal purity.  Attempts as analysing the 
expression of GABA within the neuronal population using flow cytometry were 
unsuccessful due to poor antibody detection.   
Whist flow cytometry analysis was helpful for screening neuronal cell populations, damage 
to matured neurons during dissociation, might explain the lower neuronal yields than 
expected.  This was also confirmed by the presence of debris amongst the flow cytometry 
analysed samples.  With this in mind, despite optimising the dissociation reagents, the flow 
cytometer was not considered to be a suitable method for reliably comparing the efficiency 
of neuronal differentiation between the different hESC lines.  In situ immuno fluorescence 
images were considered to be a better mode of comparison for differences in neuronal 
yield across hESC lines.   
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Figure 5.15. Flow cytometry analysis of in-house neuronal differentiation.   
RH5 TrypLE cells were differentiated according to methods outlined in Section 2.10.4.  Samples were taken at 
day 0, 4, 18 and 28.  Only single samples were recorded at day 18.  Cells were analysed for OCT4 (blue), Nestin 
(red) and TUBB3 (green).  After 28 days, 42.2 % ± 16.0 cells were neuronal, as determined by positive TUBB3 
expression.  OCT4 expression decreased from 82.3 % ± 7.4 positive expression at day 0 to just 2.9 % ± 3.9 
positive cells at day 28.  Nestin expression reached 62.7 % ± 23.5 at day 4 from 22.3 % ± 27.6 at day 0, after 
which expression levels did not significantly increase (p = 0.14) as determined by ANOVA.  Error bars represent 
2SE.   
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5.2.6 Comparison of hESC lines for neuronal differentiation 
After developing a successful method of neuronal differentiation, all four hESCs lines were 
differentiated as outlined in Section 2.10.4.  The efficiency of differentiation, neuronal yield 
and subsequent neuronal functionality between each of the lines were compared to 
determine whether there was an inherent difference in their response to differentiation, 
despite all presenting morphological features of pluripotent cell lines. 
Differentiation relies on a sequential chain of events to regulate the expression of genes in 
response to environmental stimuli.  Up or down regulation of gene expression is used to 
regulate the level of RNA which is transcribed and thus control the protein content within a 
cell.  Alterations to the gene and protein expression induce the necessary changes in 
behaviour and function required for differentiation.  Analysis of the changes in gene and 
protein expression between the four hESC lines was used to compare their responses to 
neuronal differentiation.  Changes in the expression of markers for pluripotency, neural 
progenitors and mature neuronal markers were monitored, in addition to the comparative 
functional responses of neurons from each cell line using patch-clamp analysis.  
 
5.2.6.1 In situ immunocytochemistry of neuronal status 
Cells undergoing differentiation according to the enhanced EB method were divided into 
five groups: day 0 – pluripotency, day 4 – after incubation in NI media, day 10 - following 
attachment in NBD media, day 18 and day 28 – neuronal populations.  Undifferentiated 
day 0 samples positively expressed OCT4, SOX2, TRA-1-60 and SSEA4 (Section 4.2.3) 
confirming pluripotency.  All immunostaining isotype controls were negative. 
Similarly to NTERA2, all undifferentiated (day 0) samples stained positively for the neural 
stem cell marker Nestin (Figure 5.16) but were consistently negative for neuronal markers 
MAP2, TUBB3 and 70 kDa neurofilament (Figure 5.16), confirming that any increase in 
these markers was a result of differentiation.  Inactivated MEF feeder layers were negative 
for antibodies used within these samples (images available upon request).   
Embryoid bodies were plated onto a poly-L-ornithine and laminin coated surface, nine days 
after induction.  By day ten, early signs of neuronal outgrowth were visible.  Outgrowing 
populations stained positively for Nestin, TUBB3 and MAP2 (Figure 5.17).   
After 18 days differentiation, all cell lines presented neurons which stained positively for 
Nestin, TUBB3, MAP2 and Neurofilament (Figure 5.18, Figure 5.19 and Figure 5.20). A 
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higher proportion of neuronal projections stained positively for TUBB3 and the 70 kDa 
neurofilament than was seen for MAP2.  To confirm that the TUBB3 antibody was neuron 
specific, samples were co-stained for TUBB3 and the neuron specific 70 kDa Neurofilament, 
which demonstrated co-expression in all neural projections (Figure 5.19). Neurons were 
visible in the highest purity from the RH5 TrypLE cell line when compared to the additional 
three hESC lines.  Synaptophysin was sporadically detected amongst day 18 neurons but in 
the absence of a positive control, it was not possible to determine whether fluctuations in 
synaptophysin were a true result or whether they were due to poor antibody specificity. 
Day 28 differentiated neurons also retained positive expression for TUBB3, MAP2, and 
Neuroflament (Figure 5.21 and Figure 5.22).  Synaptophysin expression remained sporadic 
amongst the neuronal populations (Figure 5.22).  Positive Nestin expression was also 
detected amongst the day 28 neuronal samples (Figure 5.22), which was unexpected due to 
the apparent loss of Nestin in post-mitotic neurons (Lendahl et al., 1990) 
The neuronal identity of differentiated populations at day 28 was screened according to 
Tyrosine hydroxylase (TH; for dopaminergic neurons), Serotonin (SERT; serotonergic 
neurons) and GABA (GABAergic neurons).  A proportion of day 28 neurons stained 
positively for GABA in all cell lines except Shef3, where no staining for mature neuronal 
phenotypes was identified.  Neurons from all hESCs were negative for TH and SERT (Figure 
5.23).  GABA was detected in day 18 samples but not in day 10 (Figure 5.17), suggesting 
that neurons were immature at this stage of differentiation.  Day 28 neurons in all hESCs 
lines were negative for OCT4 (images available upon request). 
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Figure 5.16. Immunostaining for Nestin in pluripotent hESCs 
Representative images of hESC staining for Nestin (green) which was positive in all hESC lines; Shef3 (A; x10 magnification) and RH5 cut (B; x10 magnification).  Staining for TUBB3 (D; HUES7, 
x10 magnification), MAP2 (E; RH5 cut, x10 magnification) and 70 kDa Neurofilament (F; Shef3, x10 magnification) were negative in all undifferentiated cells. Mouse IgG (C) isotype controls 
were negative.  Mouse embryonic feeder layer were also negative for the above antibodies. 
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Figure 5.17. Attached embryoid bodies with neuronal outgrowth at day 10.   
Cells from attached and spreading EBs staining positively for neuronal markers; TUBB3 and MAP2 (A - Shef3, and B – HUES7), and neural stem cell marker; Nestin (C – RH5 cut).  No positive 
staining for GABA (D) was detected in cells after 10 days neural induction.  Images were captured under x10 magnification.  Isotype controls were negative. 
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Figure 5.18. Immunostaining of hESCs on day 18; MAP2 and TUBB3.   
Representative images for all for cell lines (A-B = Shef3).  Images captured under x10 magnification.  A larger proportion of the cells expressed neuronal marker TUBB3 than MAP2.  Dual 
staining was visible in some cells as highlighted yellow in combined images.  Isotype controls were negative.   
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Figure 5.19. TUBB3 and Neurofilament in day 18 hESC derived neurons.  
RH5 TrypLE (A-B).  Combined images include Hoechst staining, demonstrating the high neuronal yield and purity in the RH5 TrypLE cell line, following 18 days neuronal differentiation and 
co-expression of TUBB3 and Neurofilament in neural projections.  Isotype controls were negative. Images captured under x10 magnification.   
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Figure 5.20. Synaptophysin, MAP2, Nestin and Neurofilament in day 18 neurons.   
Representative images for all four hESC lines.  Neural projections stained positively for Neurofilament (red) and MAP2 (green; A - RH5 cut).   Higher Neurofilament expression was detected 
than MAP2.  Neurons remained positive for Nestin (B - HUES7).  Synaptophysin was sporadically detected in samples at day 18 (C - RH5 cut), although this followed trouble with the primary 
synaptophsyin antibody dilutions, which would need to be repeated for confirmation of expression levels.  Isotype controls were negative.  Images captured under x10 magnification.   
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Figure 5.21. Immunostaining of hESCs on day 28; TUBB3 and MAP2. 
A – HUES7, B – Shef3, C – RH5 cut.  Neruons were identified which stainiend positive for TUBB3 and/or MAP2 after 28 days neuronal differentiation.  Higher expression of TUBB3 was detected 
than MAP2 throughout all populations.  Representative images for 4 cell lines, Isotype controls were negative.  Images captured under x10 magnification.   
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Figure 5.22. Synaptophysin, MAP2, Nestin and TUBB3 in day 28 neurons. 
A – Shef3, B – RH5 TrypLE, C – RH5 TrypLE, D – HUES7.  Images captured under x10 magnification.  Positive staining for Nestin, MAP2 and TUBB3 was detected throughout neuronal 
populations.  Synaptophysin expression was weakly detected in day 28 samples, although positive staining was not detected in all day 28 repeated samples.  Representative images for all 4 
cell lines.  Isotype controls were negative. 
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Figure 5.23. Neurofilament, GABA, TUBB3, Serotonin and TH in day 28 neurons.  
A – RH5 cut, B – RH5 TrypLE, C – HUES7, D – RH5 TrypLE, E – RH5 TrypLE.  Positive staining for Neurofilament was detected in all neuronal projections.  GABA was detected in a proportion of 
neurons but all neurons were negative for TH and SERT at day 28.  Representative images for all 4 cell lines.  Isotype controls were negative.  Images captured under x10 magnification. 
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5.2.7 Functionality of hESC derived neurons 
It was clear from the immunostaining that all four hESC lines were capable of generating 
neurons as characterised by morphology according to Figure 3.3.  To determine whether 
there was any difference in the functional behaviour of the four cell lines, cells were 
analysed using a patch-clamp.   
Neurons derived from all four cell lines reproducibly fired APs following stimulation which 
were and reversibly inhibited by TTX.  Due to time constraints on the equipment, it was not 
possible to test for recovery of HUES7 derived neurons to TTX inhibition.  In the absence of 
these data, inhibition of APs due to cell death by TTX toxicity, rather than blockage of Na+ 
channels cannot ruled out.  However, neurons from all other lines recovered functional 
activity which would suggest TTX was not toxic to these neurons in culture, and that the 
HUES7 neurons would also have recovered with sufficient time.  Preliminary calcium 
imaging data on Shef3 derived neurons confirmed the presence of voltage-gated ion 
channels.   
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Pre-TTX Post-TTX Recovery
 
Figure 5.24. Patch clamping hESCs.   
Neurons derived from all four hESC lines Shef3 (orange), HUES7 (red), RH5 cut (blue) and RH5 TrypLE (green), 
successfully fired sodium action potentials following manual depolarisation which were inhibited by TTX.  
Recovery of APs was observed following a five minute wash step with HBS buffer. Example graphs presented for 
each cell line, recovery data for HUES7 was not available.   
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5.2.8 Gene expression 
No real difference was observed between the morphology of the neurons derived from 
each of the four hESC lines.  However, there were clear differences in the response of each 
of these lines to neuronal differentiation which impacted up on the final neuronal yield.  In 
an attempt to understand the different responses by these four hESC lines, a comparative 
study of the changes in gene expression in response to differentiation was carried out.  
Gene expression analysis monitors fluctuations in the levels of mRNA within a sample; 
therefore analysis was carried out using RT-PCR (Section 1.5.3). 
 
5.2.8.1 RNA extraction 
Total RNA was extracted as described in Section 2.12.1, using a column based method.  The 
quality of RNA extracted was of key importance to ensuring a true representation of gene 
expression within a population of cells, therefore all RNA extractions and RT-PCRs were 
carried out in a clean pre-PCR laboratory using United Kingdom Accreditation Service 
(UKAS) calibrated equipment assigned for RNA work only.  This reduced the risk of 
PCR-product contamination within the RNA preparations.   
Two different spin column RNA extraction kits Qiagen RNeasy and Ambion RNAqueous 
were compared to identify the most suitable kit for obtaining RNA preparations with 
highest possible yield and purity.  In each case, RNA was extracted following 
manufacturer’s instructions (Sections 2.12.1.1 and 2.12.1.2).  Extractions procedures were 
comparable in time with the exception of the DNase step, where the Qiagen kit included an 
on-column treatment prior to RNA elution and the Ambion kit required a separate DNase 
treatment following elution, extending the procedure by an additional 30 minutes.   
On-column extraction kits were designed to remove gross gDNA contamination from the 
RNA elute; however, it is notoriously difficult to remove all traces of gDNA carryover.  Less 
than 1 % contamination of gDNA in an RNA sample is considered to be sufficient for false 
positive data on gene expression (Dilworth and McCarrey, 1992).  Therefore efficiency of 
gDNA removal in each of the extraction kits was tested using a PCR on from RNA prior to 
reverse transcription.  DNA polymerase is only able to amplify from DNA, therefore any 
amplified product from the RNA elute would have originated from contaminating gDNA.  To 
further test the efficiency of gDNA removal using DNase, half of each RNA sample was 
treated with DNase and a PCR run using two different primer pairs, encoding GAPDH and 
Nestin. 
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The presence of amplified product in both the Qiagen and Ambion RNA extractions in the 
absence of a DNase treatment (Figure 5.25) demonstrated the carryover of gDNA following 
RNA extraction.  In DNase treated samples, these bands were absent highlighting the 
efficacy and requirement of a DNase incubation step prior to reverse transcription.  
Amplification of more than the single PCR product by both the Nestin and the GAPDH 
primers, demonstrated that the primers were not specific to the true RNA sequences.  
Non-specific amplification resulted in a range of products from gDNA amplification, as 
indicated by the Nestin primers.  However, amplification of a product of the expected RNA 
size was indicative of retrotransposed pseudogene amplification (Section 1.5.3.3), which 
would confuse quantification of gene expression if gDNA amplification was not avoided. 
The relative indifference in RNA extraction between the Qiagen and Ambion kits was 
further investigated using a minus reverse transcriptase (-RT) control during cDNA 
synthesis.  Two parallel PCR reactions were run with and without reverse transcriptase 
using Nestin and GAPDH primers.  The presence of amplified products in –RT samples was 
the result of DNA contamination. 
All control cDNA samples without DNase treatment or reverse transcriptase, amplified 
multiple products confirming DNA contamination (Figure 5.26; A: lanes 7 and 11, B: lanes 8 
and 12).  The presence of reverse transcriptase in each reaction amplified product of the 
size expected for RNA, demonstrating the efficacy of both the primers and the MMLV-RT.  
In agreement with result from Figure 5.25, DNase was essential for removing 
contaminating DNA.  No difference between amplification of the Nestin product using the 
two kits was identified.  However, during GAPDH amplification (Figure 5.26; B) the Ambion 
kit with a separate DNase step removed more of the contaminating DNA than the Qiagen 
kit, indicated by the absence of a band at ~170 bp in lanes 11 and 13 when compared with 
lanes 7 and 9 (red arrow).  The Ambion RNAqueous kit was therefore considered to be 
most appropriate and was used for all further RNA isolations.  TURBO DNase was used 
throughout DNase preparations due to its higher affinity for DNA, thus reducing exposure 
to RNA (RNAqueous user manual, Ambion).  DNase treatment was rigorously controlled to 
ensure consistent exposure across samples for comparison. 
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Figure 5.25. PCR amplification from RNA. 
Genomic DNA products were amplified by both the Ambion and Qiagen RNA extraction kits, for Nestin (A; 
RNA - 160 bp, gDNA - 408 bp) and GAPDH (B; RNA – 224 bp, gDNA - 328 bp).  Genomic DNA contamination was 
removed following exposure of RNA to DNase, confirming the requirement for DNase treatment of the RNA 
sample.  Amplification of more than the single product in both Nestin and GAPDH suggests a cross reactivity of 
primers to alternative gDNA sequences in addition to the true Nestin and GAPDH genes. 
 
 
Figure 5.26. The effect of reverse transcriptase.  
Nestin (A; RNA - 160 bp, gDNA - 408 bp) and GAPDH (B; RNA – 224 bp, gDNA - 328 bp).  In the absence of DNase 
or reverse transcriptase (RT) gDNA contamination was amplified in all samples (A: lanes 7 and 11, B: lanes 8 and 
12).  In the presence of RT, expected RNA products were amplified.  No difference between Nestin amplification 
(A) was identified from the Ambion and Qiagen extraction kits.  During GAPDH amplification (B), the Ambion kit 
with separate DNase removed more gDNA than the Qiagen, indicated by the absence of a band at ~170 bp in 
lanes 11 and 13 when compared with lanes 7 and 9 (red arrow).   
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5.2.9 Reverse transcription-PCR 
Reverse transcription PCRs were carried out on pluripotent and differentiating samples 
from all hESC lines to compare changes in gene expression throughout differentiation 
across the four hESC lines.   
Primers were designed according to Section 2.12.4 to amplify the pluripotency genes; 
OCT4, Nanog, SOX2, and neural genes; Nestin, TUBB3, MAP2, PAX6, SOX1, and 
synaptophysin (Table 5.2).  Where possible, primers were designed to span exon-exon 
junctions, avoiding amplification from contaminating DNA.  However. the SOX family of 
genes are encoded by a single exon, therefore it was not possible to design primers which 
were specific to the cDNA of the mRNA transcript.  In addition, there is a large repeated 
sequence which is present in a large proportion of the SOX genes, meaning that accurate 
sequence alignments and BLAST searches was essential for these genes to ensure 
amplification of the correct GOI.   
Primer RNA product (bp) gDNA product (bp)
GAPDH 240 not amplified
OCT4 43 not amplified
Nanog 147 not amplified
Sox2 71 71
Sox1 71 71
Nestin 203 not amplified
Pax6 88 not amplified
MAP2 137 not amplified
TUBB3 132 not amplified
Synaptophysin 145 not amplified
 
Table 5.2. Expected product size for designed primers.   
Where possible primers were designed to be RNA specific, crossing exon-exon junctions to prevent gDNA 
amplification.  This was not possible for SOX genes which contain just a single exon. 
 
5.2.9.1 Optimising PCR conditions 
Each new primer pair was checked for amplified product size and the optimum annealing 
temperature using a gradient PCR ranging from 50 °C to 65 °C, according to methods 
outlined in Section 2.12.5.  PCR products were subjected to agarose gel electrophoresis 
(Section 2.12.7) and the bands analysed with the aid of a DNA size marker.  MAP2 and 
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TUBB3 primer pairs amplified the cDNA product of the expected product size: 137 bp and 
132 bp respectively (Figure 5.27).  The annealing temperature did not appear to affect 
amplification for MAP2.  However, primer dimers were formed at all temperatures, visible 
by the consistent small band at the base of the agarose gel (Figure 5.27A).  Primer dimers 
form when the forward and reverse primers, each 20 bp in length bind together.  
Formation of these dimers can interfere with amplification of the GOI, making these 
primers unsuitable for other applications such as Q-PCR reactions due to fluorescence 
interference, these MAP2 primers were subsequently re-designed.   
The TUBB3 primer pair amplified products of the expected size across the temperature 
gradient (Figure 5.27B).  Amplification was optimal at annealing temperatures below 
62.7 °C, where brighter bands were visible (indicating more product amplification).  
Minimal primer dimer formations were detected using annealing temperatures above 
62.7 °C.  These primers were used for further PCR analysis. 
During amplification of the SOX1 and SOX2 genes control samples without reverse 
transcriptase were included in the temperature gradient study to ensure amplification was 
cDNA specific (Figure 5.28).  Both SOX1 and SOX2 primers amplified products of the 
expected 71 bp size.  Amplification of the SOX1 product (Figure 5.28A) was most affected 
by annealing temperature, amplifying well at low temperature (50 - 52.5 °C) but failed to 
amplify at temperatures any higher.  An additional band was amplified across all samples 
(including control samples without RNA or cDNA, suggesting contamination of the PCR 
reagents.  Fresh reagents were ordered for future reactions.  SOX2 primers amplified the 
correct product size but primer dimers formed throughout the temperature gradients 
(Figure 5.28B), suggesting that primer sequence optimisation was required.  The absence of 
amplified product at 71 bp in the first three lanes for each reaction confirmed removal of 
DNA contamination from the samples. 
In addition to designing primers, the primer sequence for GAPDH was taken from an earlier 
publication (Anisimov et al., 2007).  These primers amplified the expected 240 bp product 
(Figure 5.29A); however, an additional an unexpected product was also amplified around 
75 bp in size.  This product was later identified to correlate with one of the many GAPDH 
pseudogenes, highlighting the importance of checking a primer sequence before use, and 
the requirement for specificity in design. 
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Figure 5.27. Optimising PCR conditions for MAP2 and TUBB3 primers  
Both MAP2 (left) and TUBB3 (right) primers amplified product of the expected size for RNA. Primer dimer 
formation across the temperature gradient for MAP2 rendered these primers unsuitable for further PCR 
analysis.  Clean amplification of TUBB3 with no additional products below 62.7 °C confirmed suitability of these 
primers for both RT-PCR and Q-PCR analysis. 
 
Figure 5.28. Optimising PCR for SOX1 and SOX2 primers.   
SOX1 (left) and SOX2 (right) primers amplified the expected 71 bp RNA products.  Amplification of SOX1 was 
achieved at lower annealing temperature (50 - 52.5 °C).  An additional band was amplified across all samples 
(including control), indicating contamination of the PCR reagents.  SOX2 primers also amplified the expected 
71 bp product size but primer dimers formed throughout.  Water and -RT controls confirmed the absence of 
contaminating DNA. 
 
Figure 5.29. Optimising PCR conditions for GAPDH and OCT4 primers.   
Both GAPDH (left) and OCT4 (right) amplified product of the expected size for RNA.  In GAPDH amplification was 
not specific for the RNA product resulting in amplification of an additional product around 75 bp in size.  Primer 
dimers were also visible at all annealing temperatures rendering these primers unsuitable for further PCR 
analysis.  Amplification of the expected 43 bp OCT4 RNA product was considerably less than expected 
suggesting inefficient annealing of the primers across the investigated annealing temperature range. 
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The OCT4 primers were used in a PCR amplification cDNA from pluripotent hESCs 
(according to guidelines set out in Section 4.2.1).  Amplification resulted in a product at 
43 bp corresponding to the expected mRNA nucleotide sequence (Figure 5.29B); however, 
this band was considerably less intense than all other samples.  The OCT4 primers was 
designed to span exon junctions and specifically bind only the true pluripotency mRNA 
nucleotide sequence, excluding amplification from alternative OCT4 splice variants and 
pseudogenes.  It may have been that OCT4 expression was lower than expected; however, 
a more likely explanation it that the primers did not work and that the detected product 
was a result of primer dimer formation.  Unsuccessful amplification of the OCT4 product, 
rendered them unsuitable for analysis of pluripotency and alternative OCT4 primers were 
subsequently designed. 
 
5.2.10 Gene expression analysis by semi-quantitative  
Following optimisation of each of the primer pairs (including re-design where necessary) 
RT-PCR reactions were carried out on cDNA from differentiated samples to identify when 
pluripotency genes (OCT4 and Nanog) were down regulated and neural stem cell genes 
(SOX1 and Nestin) and neuron specific genes (TUBB3, SYP and MAP2) were up regulated 
through differentiation.  Total RNA was extracted at day 0, 4, 10 and 18 (Section 2.12.1.2), 
reverse transcribed (Section 2.12.3) and RT-PCR carried out (Section 2.12.5).  Control 
samples without cDNA and in the absence of reverse transcriptase were run for each 
reaction.  The RT-PCR amplified products were size separated by agarose gel 
electrophoresis (Figure 5.30; OCT4, Nanog, SOX1, TUBB3 and SYP).   
Despite a clear loss of pluripotent morphology and a gain in neuronal identity, the band 
intensity of pluripotency genes Nanog and OCT4 was only slightly reduced in day 18 
samples compared to day 0, 4 and 10 (Figure 5.30A-B).  Expression of OCT4 and Nanog was 
expected to decrease following induction of differentiation, to undetectable levels by 
day 18 in correlation with immunostaining data (Section 5.2.6.1).  It was also unexpected to 
detect high expression levels of the neuron specific genes TUBB3 and SYP in day 0 and 4 
samples (Figure 5.30D-E), due to their absence in pluripotent populations.   
SOX1 is involved in early neuroectodermal commitment (Pevny et al., 1998), yet its 
expression was consistently detected throughout differentiation using RT-PCR (Figure 
5.30C).  This could be explained if the pluripotent population were in very early stages of 
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lineage commitment or if the primers were poorly designed with cross reactivity between 
the range of SOX genes, due their similarity of mRNA nucleotide sequence.  Synaptophysin 
was expressed in all samples but was up regulated in the day 18 samples, correlating with 
neuronal maturation; this was the only gene which presented a clear change in expression 
throughout differentiation using RT-PCR amplification (Figure 5.30E).   
Consistent detection of these genes across all differentiation samples was considered to be 
a result of the RT-PCR process.  With each successive PCR cycle, the amount of amplified 
product increased exponentially.  After a certain number of cycles, amplification was 
limited by PCR reagents/polymerase enzyme and plateaux out to a constant level.  
Therefore, with excess PCR cycles a single cDNA would be detected as the same intensity as 
a highly expressed transcript.  For SYP which is present only in the membrane of mature 
synaptic vesicles, gene expression would have been extremely low (undetectable) in 
pluripotent populations and would have increased throughout differentiation according to 
neuronal maturation.  Using RT-PCR, it was not possible to quantify these expression 
changes and to address this, efforts were transferred to quantitative-PCR (Q-PCR) analysis.   
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Figure 5.30. RT-PCR for OCT4, Nanog, SOX1, TUBB3 and SYP in differentiating hESCs. 
RT-PCR for OCT4, Nanog, SOX1, TUBB3 and SYP each generated product of the expect band size (130, 147, 71 
and 132 bp respectively).  All controls samples were negative proving amplification from cDNA only. However, 
despite a slight drop in intensity of OCT4 and Nanog amplification by the day 18 sample, no real change in the 
levels of expression of these genes was detected throughout differentiation using RT-PCR.  Expression of the 
neural gene SOX1 and the neuronal gene TUBB3 was detected in all differentiating samples, including day 0 
samples were no cells of neural morphology were visible.  Amplification of differentiating hESCs using primers 
for SYP showed an increase in SYP expression of the expected 145 bp product, during the latter stages of 
differentiation, corresponding to neuronal maturation.  All control samples were negative. 
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5.2.11 Q-PCR - low density array cards 
Q-PCR analysis was carried out using a low density array cards.  The human pluripotency 
gene low density array cards were designed by Applied Biosystems (ABI; California, USA) 
and incorporated into the first ISCI study in 2007 for comparison of gene expression 
profiles across 59 hESC lines (Adewumi et al., 2007).  Throughout this study, these LDA 
cards were used to quantify changes in expression of genes involved in pluripotency, and 
neural commitment throughout the five major differentiation time points (day 0, 4, 10, 18 
and 28).  Analysis was carried out using just 50 ng cDNA per sample, thus greatly reducing 
the sample size required for screening when compared to standard Q-PCR analysis.   
 
5.2.11.1 Confirming reproducibility across LDA cards 
To ensure differences in the samples were a result of differentiation rather than variability 
between cards, a single pluripotent hESC cDNA preparation was repeated across three 
lanes of an LDA card, and compared to cDNA from 2102Ep as a positive control.  Across all 
the genes screened for pluripotency and differentiation, the average variability in Ct values 
was 0.53 ± 0.12, less than one amplification cycle, confirming reproducibility across the 
cards.  Due to the high cost of the LDA cards, analysis of triplicate samples across cards was 
not carried out but reassurance of reproducibility between LDA cards was taken from the 
QC procedures during manufacture which demonstrated high reproducibility (personal 
communication and data supplied by Ms. K. Warrington, ABI). 
  
5.2.11.2 Identifying a suitable endogenous control gene 
Changes in gene expression were calculated using the 2-∆ΔCt method (Section 1.5.3.4).  The 
fold change in expression of the GOI was normalised to an endogenous control gene, 
relative to expression at day 0.  LDA cards were processed for all samples before assigning 
an endogenous control.  The endogenous control gene was calculated as the gene with 
minimum variation in Ct value throughout differentiation in all of the cell lines.  The median 
Ct values were calculated for each gene and cell line, throughout differentiation and 
biological replicates, and aligned from lowest to highest.  
A Ct value of 40 was assumed to be unexpressed (MYF5 and GCM1).  Expression of 18S, 
GADPH and ACTB were the three highest expressed genes across the four hESC lines.  
Genes with low expression (Ct ≥ 30) were excluded from the endogenous control selection, 
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due to high error margins in the expression of these genes.  This identified 30 genes which 
were expressed at suitable levels for further analysis of variability in Ct (Max Ct – Min Ct; 
Table 5.3).  These values were determined separately for each hESC line.  Genes with 
minimum variation in Ct value throughout differentiation and biological replicates (< 3 Ct) 
in all hESC lines were identified as GAPDH, ACTB and RAF1 (Table 5.3; red).  The remaining 
genes were considerably more variable and were subsequently excluded from further 
analysis.  Although ACTB and RAF1 occasionally showed lower variation in Ct values for 
individual cell line repeats, GAPDH was minimally variable for all cell lines, with the lowest 
maximum variation of 2.37 Ct values.  GAPDH was therefore assigned as the most suitable 
gene for use as the endogenous control, remembering that ∆Ct values ≤ 2.37 for Shef3, 
≤ 2.12 for RH5 TrypLE, ≤ 1.98 for HUES7 TrypLE and ≤ 1.77 for RH5 cut, could not be 
assumed true changes in gene expression due to internal variation in the endogenous 
control. 
Data for changes in gene expression of three commonly used Q-PCR endogenous control 
genes; 18S, ACTB, GAPDH in addition to RAF1 (identified in these samples as stably 
expressed) were combined for the four cell lines to demonstrate stability in expression 
throughout differentiation.  Expression levels were not significantly variable throughout 
differentiation as determined by AVOVA (p = 0.512, 0.762, 0.314 and 0.960, for 18S, ACTB, 
GAPDH and RAF1 respectively; Figure 5.31). 
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Line gene
Max Ct – Min Ct 
across differentiation
and repeats
HUES7 tryple 18S 2.371019
RH5 cut 18S 3.818019
RH5 tryple 18S 6.237662
Shef3 cut 18S 5.037742
HUES7 tryple ACTB 2.382473
RH5 cut ACTB 2.870308
RH5 tryple ACTB 2.31509
Shef3 cut ACTB 1.575149
HUES7 tryple AFP 7.360128
RH5 cut AFP 6.47186
RH5 tryple AFP 13.298605
Shef3 cut AFP 11.288266
HUES7 tryple BRIX 2.532546
RH5 cut BRIX 3.740488
RH5 tryple BRIX 1.718741
Shef3 cut BRIX 1.800275
HUES7 tryple CD9 5.178489
RH5 cut CD9 3.504261
RH5 tryple CD9 5.263254
Shef3 cut CD9 3.010959
HUES7 tryple COL1A1 4.173062
RH5 cut COL1A1 3.533123
RH5 tryple COL1A1 10.548433
Shef3 cut COL1A1 5.857698
HUES7 tryple COLA2A1 5.280939
RH5 cut COLA2A1 4.586706
RH5 tryple COLA2A1 10.101187
Shef3 cut COLA2A1 6.635119
HUES7 tryple CRABP2 3.100614
RH5 cut CRABP2 2.010749
RH5 tryple CRABP2 3.217194
Shef3 cut CRABP2 1.888994
HUES7 tryple CTNNB1 3.091623
RH5 cut CTNNB1 1.848331
RH5 tryple CTNNB1 2.920311
Shef3 cut CTNNB1 1.946844
HUES7 tryple DNMT3B 5.561177
RH5 cut DNMT3B 6.232057
RH5 tryple DNMT3B 6.746884
Shef3 cut DNMT3B 6.896215
Line gene
Max Ct – Min Ct 
across differentiation
and repeats
HUES7 tryple LIN28 6.417068
RH5 cut LIN28 4.595346
RH5 tryple LIN28 4.19513
Shef3 cut LIN28 6.866551
HUES7 tryple NES 1.779337
RH5 cut NES 3.123269
RH5 tryple NES 3.139637
Shef3 cut NES 2.450606
HUES7 tryple NOG 2.636833
RH5 cut NOG 3.601334
RH5 tryple NOG 6.463183
Shef3 cut NOG 4.322112
HUES7 tryple PAX6 9.144992
RH5 cut PAX6 4.63686
RH5 tryple PAX6 10.461065
Shef3 cut PAX6 7.584847
HUES7 tryple PODXL 6.032442
RH5 cut PODXL 6.475205
RH5 tryple PODXL 7.893104
Shef3 cut PODXL 5.021003
HUES7 tryple PTEN 2.723984
RH5 cut PTEN 3.880289
RH5 tryple PTEN 3.109432
Shef3 cut PTEN 2.029785
HUES7 tryple RAF1 2.314371
RH5 cut RAF1 2.707816
RH5 tryple RAF1 2.179492
Shef3 cut RAF1 1.958437
HUES7 tryple SEMA3A 3.711927
RH5 cut SEMA3A 2.843435
RH5 tryple SEMA3A 4.484783
Shef3 cut SEMA3A 2.613439
HUES7 tryple SFRP2 3.472256
RH5 cut SFRP2 1.746332
RH5 tryple SFRP2 2.487529
Shef3 cut SFRP2 2.630481
HUES7 tryple SOX2 3.888494
RH5 cut SOX2 3.89032
RH5 tryple SOX2 3.112678
Shef3 cut SOX2 3.337796
Line gene
Max Ct – Min Ct 
across differentiation
and repeats
HUES7 tryple FN1 4.429905
RH5 cut FN1 2.758682
RH5 tryple FN1 5.737585
Shef3 cut FN1 3.265968
HUES7 tryple FOXD3 4.874696
RH5 cut FOXD3 5.525645
RH5 tryple FOXD3 3.098529
Shef3 cut FOXD3 4.588144
HUES7 tryple GABRB3 4.223007
RH5 cut GABRB3 3.709299
RH5 tryple GABRB3 3.886524
Shef3 cut GABRB3 4.687573
HUES7 tryple GAL 11.364713
RH5 cut GAL 8.621433
RH5 tryple GAL 10.680534
Shef3 cut GAL 8.002324
HUES7 tryple GAPDH 1.984163
RH5 cut GAPDH 1.774199
RH5 tryple GAPDH 2.124784
Shef3 cut GAPDH 2.37153
HUES7 tryple IFITM1 6.606448
RH5 cut IFITM1 3.384272
RH5 tryple IFITM1 5.614742
Shef3 cut IFITM1 4.034235
HUES7 tryple IFITM2 3.394109
RH5 cut IFITM2 3.299866
RH5 tryple IFITM2 2.501106
Shef3 cut IFITM2 1.313399
HUES7 tryple IMP2 3.532192
RH5 cut IMP2 5.980346
RH5 tryple IMP2 1.898939
Shef3 cut IMP2 2.120135
HUES7 tryple LAMB1 4.611481
RH5 cut LAMB1 4.033489
RH5 tryple LAMB1 2.43306
Shef3 cut LAMB1 2.218597
HUES7 tryple LAMC1 3.236291
RH5 cut LAMC1 3.527588
RH5 tryple LAMC1 5.21939
Shef3 cut LAMC1 3.153822
 
Table 5.3. Determining the endogenous control gene. 
Variation in Ct value for each gene and cell lines were calculated.  RAF1, GAPDH and ACTB were the least 
variable in expression throughout differentiation and biological replicates across the four hESC lines screened. 
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Figure 5.31. Gene expression for 18S, ACTB, GAPDH and RAF1. 
Expression of the four house-keeping genes 18S (brown), ACTB (grey), GAPDH (turquoise), and RAF1 (purple) 
was consistent throughout differentiation when all four hESC lines were combined. Error bars representing 2SE, 
show the largest variation in 18S expression and minimal variation in GAPDH. 
 
Gene Lineage Location
NOG marker of stemness 17q21-q22
OCT4 pluripotency 6p21.31
OLIG2 ectoderm 21q22.11
PAX6 ectoderm 11p13
PTEN marker of stemness 10q23.3
PTF1A endoderm 10p12.2
RAF1 house keeping 3p25
REST marker of stemness 4q12
SOX2 pluripotency 3q26.3-q27
SYP ectodermal Xp11.23-p11.22
TDGF1 marker of stemness 3p21.31
TERT marker of stemness 5p15.33
TH ectoderm 11p15.5
T mesoendoderm 6q27
UTF1 marker of stemness 10q26
Gene Lineage Location
18S house keeping 22p12
ACTB house keeping 7p15-p12
AFP endoderm 4q11-q13
CRABP2 ectoderm 1q21.3
DNMT3B marker of stemness 20q11.2
EBAF marker of stemness 1q42.1
FGF4 marker of stemness 11q13.3
GAPDH house keeping 12p13
GDF3 marker of stemness 12p31.1
GFAP ectoderm 17q21
HLXB9 ectoderm/mesoderm 7q36
ISL1 ectoderm 5q11.2
NANOG pluripotency 12p13.31
NES ectoderm 1q23.1
NODAL mesoendoderm 10q22.1
 
Table 5.4. Genes analysed for changes in expression using LDA cards. 
Thirty genes from the 96 included on the LDA card were analysed for changes in genes expression according to 
their roles in pluripotency and neural differentiation, or commitment to alternative germ lineages. 
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Technical replicates were not carried out due to high reproducibility of the LDA cards, and 
the prohibitive cost of running each sample three times.  Standard errors (SE) for three 
replicates of each differentiation time point were calculated and plotted for the average 
∆∆Ct.  One SE represented the spread of the average ∆∆Ct values, two SE’s would have 
presented the 95% confidence intervals of the mean; however, average values were 
calculated from only three biological replicates and as such 2SE was considered to be an 
inaccurate representation for the spread of the data (Personal communication with Dr. A. 
Heath, Biostatistics, NIBSC).   
Thirty genes from the 96 included on the LDA cards were selected for further investigation 
in this study, based on their role in pluripotency or ectodermal differentiation, or their key 
representation of alternative germ lineage (Table 5.4). 
 
5.2.11.3 Expression of pluripotency genes 
The average expression of both Nanog and OCT4 decreased throughout differentiation in 
all four of the cell lines (Figure 5.32).  The largest variation in gene expression, as 
determined by the length of the error bars, was seen at day 4 for all samples.  
Immunostaining of EBs at day four also reported variable expression of OCT4.  This may 
have been because larger EBs required longer for inner cells to commit to differentiation.  
After day 10 the error in OCT4 and Nanog expression was reduced suggesting by day 10 
most cells had committed to differentiate. 
The average expression of Nanog increased in day 28 samples, when compared to day 18, 
in both of the enzymatically treated cell lines (HUES7 and RH5 TrypLE), suggesting 
proliferation of a background pluripotent population in the late stages of differentiation 
(Figure 5.32A), ANOVA showed that these increases were not significant (p = 0.460 and 
0.379, in RH5 TrypLE and HUES7 respectively).  In addition, to Nanog, the RH5 TrypLE line 
also showed an increase in average OCT4 expression in the day 28 sample of differentiation 
(Figure 5.32B), ANOVA revealed that this difference was not statistically significant 
(p = 0.213) from day 18. Expression of SOX2 did not change significantly throughout 
differentiation in the RH5 cut, RH5 TrypLE or HUES7 cell lines (p = 0.479, 0.118 and 0.950 
respectively).  However, in the Shef3 cell line average expression of SOX2 consistently 
decreased, with a significant 0.33-fold change in expression on day 28 from levels at day 0 
(p = 0.007).  
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5.2.11.4 Markers of stemness 
In addition to OCT4, Nanog and SOX2 there are numerous other genes which are expressed 
in pluripotent or progenitor populations which play a key role in the commitment of cells 
into specified germ lineages; a range of these genes were analysed for their involvement in 
differentiation.  These genes were referred to as markers of stemness because they are 
most commonly expressed in pluripotent or progenitor cell populations but do not appear 
to actively regulate pluripotency. 
DNA (cytosine-5-)-methyltransferase 3 beta (DNMT3B) is involved in DNA methylation and 
has been associated with early stages of embryonic development and pluripotent 
embryonic stem cells (Watanabe et al., 2002; Adewumi et al., 2007).  The DNMT3B mRNA 
was expressed in day 0 samples and decreased throughout differentiation.  Fibroblast 
growth factor 4 (FGF4) expression is regulated by SOX2 and OCT4 and as such is expressed 
amongst pluripotent populations (Yuan et al., 1995; Ambrosetti et al., 2000; Avilion et al., 
2003; Mayshar et al., 2008).  The FGF4 mRNA was detected in day 0 pluripotent 
populations and decreased as differentiation progressed (data available upon request).   
Endometrial bleeding associated factor (EBAF; also known as LEFTY2) and growth 
differentiation factor 3 (GDF3) are both members of the TGF-β family of signalling 
molecules involved in maintaining pluripotency (Levine and Brivanlou, 2006).  Expression of 
these genes decreased throughout differentiation in all four cell lines, in accordance with a 
loss of pluripotency (data available upon request).  Expression of telomerase reverse 
transcriptase (TERT), an enzyme required for active maintenance of telomere length in 
pluripotent cells (Yang et al., 2008), was also detected in all pluripotent populations and 
decreased throughout differentiation.  No increase in TERT expression was detected in the 
latter stages of differentiation (data available upon request).   
In the mechanically passaged hESCs lines, average expression of Noggin (BMP inhibitor) 
increased to a peak on day 10 (11.7-fold and 4.6-fold in Shef3 and RH5 cut respectively), 
followed by a decrease in expression until day 28 (Figure 5.33B).  In the HUES7 cell line, 
Noggin expression increased by 4.4-fold between day 0 and day 4.  Levels of Noggin 
expression in HUES7 plateaux out after day 4 at approximately 2.5-fold increase from 
expression at day 0.  The RH5 TrypLE cell line presented considerably higher Noggin 
expression than the other three lines, between 24.5-fold and 35.5–fold increased 
expression from day 10 onwards, when compared to day 0.   
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Figure 5.32. Gene expression analysis for Nanog and OCT4. 
Average gene expression for Nanog (A) and OCT4 (B) decreased throughout differentiation, with the largest 
drop in expression in the first 4 days of induction.  The average expression of Nanog and OCT4 almost doubled 
between day 18 and day 28 in the RH5 TrypLE sample.  However, reproducibility of this data suggests this was 
not a significant increase (p = 0.379 and 0.213, Nanog and OCT4 respectively).  A similar increase in average 
Nanog expression was detected in the HUES7 cell line but this was not significantly different to expression levels 
at day 18 (p = 0.460).  Error bars represent 1SE. Shef3 - orange, HUES7 – red, RH5 cut - blue and RH5 
TrypLE - green.   
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Figure 5.33. Gene expression analysis for SOX2 and Noggin.  
SOX2 (A) expression remained consistent throughout differentiation in the HUES7, RH5 cut and RH5 TrypLE cell 
lines.  However, expression of SOX2 was seen to consistently decreased throughout differentiation in the Shef3 
cell line.  Expression of Noggin (B) increased in the mechanically passaged cell lines to a peak at day10 (11.7 and 
4.6-fold higher than day 0 in Shef3 and RH5 respectively).  Noggin expression in HUES7 increased and to a 
plateau at approximately 2.5-fold higher expression than day 0.  Considerably higher Noggin expression was 
detected in the RH5 TrypLE cell line when compared to the additional lines up regulated to between 24.5 and 
35.5-fold higher expression than day 0, between day 4 and day 10.  Error bars represent 1SE.  Shef3 - orange, 
HUES7 – red, RH5 cut - blue and RH5 TrypLE - green.   
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Figure 5.34. Analysis of PTEN and REST expression. 
The average expression of PTEN (A) in RH5 TrypLE were consistently lower than in Shef3, HUES7 and RH5 cut.  
In Shef3, HUES7 and RH5 cut PTEN expression peaked as day 10 followed by down regulation.  In Shef3 and 
HUES7 REST (B) peaked at day 10 followed by down regulation.  At day 10 average REST was higher in RH5 cut 
than RH5 TrypLE, there was no real change in REST across the remaining sample period.  Error bars represent 
1SE.  Shef3 - orange, HUES7 – red, RH5 cut - blue and RH5 TrypLE - green.   
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 Average expression of the neural stem cell self-renewal regulator, phosphatase and tensin 
homolog (PTEN) was consistently lower in RH5 TrypLE than in RH5 cut, HUES7 and Shef3 
(Figure 5.34A).  RE1-silencing transcription factor (REST) expression peaked at day 10 in the 
Shef3 cell line (3.25-fold increase from day 0) followed by down regulation.  Expression of 
REST, an additional regulator of neural stem cell self-renewal, did not vary significantly in 
HUES7 or RH5 cut throughout differentiation (p = 0.465 and 0.866 respectively).  Average 
REST expression decreased by half in the RH5 TrypLE on day 10 (Figure 5.34B).   
High levels of both Teratocarcinoma derived growth factor 1 (TDGF1) and undifferentiated 
embryonic cell transcription factor 1 (UTF1), markers of pluripotent hESCs (Okuda et al., 
1998; Babaie et al., 2007), were detected in pluripotent populations of all four hESC lines, 
as determine by comparatively low Ct values from the raw Q-PCR data.  Results from this 
study revealed a rapid decrease in TDGF1 expression (0.1-fold change) in the Shef3 cell line 
by day 4, to almost undetectable levels throughout the remainder of differentiation.  
Expression of TDGF1 in the remaining three hESC lines, also decreased to basal levels 
following differentiation, but large error bars in the day 4 samples highlight a greater 
variability in the rate of down regulation (Figure 5.35A).  Expression of the UTF1 gene 
decreased from day 0 throughout differentiation in all four hESC lines.  However, in RH5 
TrypLE the average expression levels increased in the latter stages of differentiation from 
the minimal expression levels at day 10 (0.02-fold change from day 0) to a 0.12-fold change 
in expression at day 28, relative to day 0 (Figure 5.35B).   
 
5.2.11.5 Expression of ectodermal genes 
Nestin expression increased in Shef3 and HUES7 from day 0 to a peak at day 10, followed 
by a slow decline (Figure 5.36A).  This would correspond to an increase in the number of 
neural progenitors, followed their commitment into a mature neuronal cell fate.  For the 
HUES7 cell line, decreased Nestin expression correlates with an increased expression of the 
matured neuronal markers synaptophysin (SYP) and tyrosine hydroxylase (TH).  Expression 
of these genes was highest in the HUES7 cell line, reaching 126-fold increased expression 
from day 0 (Figure 5.37).  This suggests that the largest proportion of mature dopaminergic 
neurons was derived from the HUES7 cell line.  Tyrosine hydroxylase was not detected at 
day 0, therefore analysis of gene expression for this marker was standardised to day 4.   
Interestingly, Nestin expression peaked in both the RH5 cut and RH5 TrypLE cell lines at 
day 28, suggesting a continued expansion of neural progenitors within the cell pool.  This 
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was confirmed by the increased numbers of neurons visible under bright field microscopy 
in the two RH5 cell lines, when compared to Shef3 and HUES7.  Both SYP and TH also 
increased throughout differentiation (Figure 5.37) in the RH5 cell lines confirming that 
there were mature neurons amongst the neural precursors on day 28. 
The cellular retinoic acid binding protein 2 (CRABP2) was expressed in high amounts 
throughout differentiation but increased to a peak at day 10 in the Shef3, HUES7 and RH5 
cut cell lines, followed by a gradual decrease in expression by day 28.  In the RH5 TrypLE 
cell line CRAPB2 continued to increase in expression throughout differentiation, with down 
regulation only seen in one of the three replicates of this cell line on day 28 (Figure 5.36B).   
The oligodendrocyte lineage transcription factor 2 (OLIG2) is a marker of oligodendrocyte 
precursors (Lu et al., 2000); however, it is also expressed in motor neuron precursors 
(Novitch et al., 2001).  In Shef3 and HUES7 the average levels of OLIG2 expression increased 
to a peak at day 10.  In the RH5 cut and RH5 TrypLE cell lines, OLIG2 continued to increase 
throughout differentiation.  There was no change in GFAP expression throughout 
differentiation, confirming the negative staining for GFAP antibody (data not included). 
PAX6 gene expression was not detected at day 0 in the RH5 TrypLE sample, therefore 
changes in expression of PAX6 were standardised to levels at day 4.  In RH5 TrypLE, PAX6 
expression increased by 134-fold on day 28 from levels at day 4.  In contrast, RH5 cut PAX6 
expression was considerably lower with just a 5.34-fold increased from day 4 to day 28.  
PAX6 expression in the Shef3 cell line was up regulated by 155-fold from day 0 to its peak 
on day 10, followed by subsequent down regulation (Figure 5.38A).  PAX6 expression also 
increased in HUES7 to a 142-fold increase from day 0 at the peak on day 28 (Figure 5.38).  
Expression of PAX6 in HUES7 and RH5 TrypLE were not significantly different (p = 0.925) but 
were significantly different between RH5 cut and RH5 TrypLE (0.025 at day 4 and p = 0.002 
ad day 18), despite originating from the same starting cell pool. 
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Figure 5.35. Analysis of gene expression for TDGF1 and UTF1. 
Expression of both TDGF1 (A) and UTF1 (B) was detected in the pluripotent populations from all four cell lines.  
Expression of TDGF1(A) was down regulated through differentiation, most extensively in Shef3 between day 0 
and day 4.  Expression of UTF1 (B) was also down-regulated in all lines throughout differentiation.  Error bars 
represent 1SE.  Shef3 - orange, HUES7 – red, RH5 cut - blue and RH5 TrypLE - green.   
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Figure 5.36. Analysis of changes in Nestin and CRABP2 expression.  
Average expression of the Nestin (A) and CRABP2 (B) increased to a peak on day 10 in the Shef3 and HUES7 cell 
lines.  Both Nestin and CRABP2 expression continued to increase the RH5 TrypLE line until day 28.  The levels of 
Nestin and CRABP3 detected in RH5 cut at day 28 was considerably lower than levels seen in RH5 TrypLE.  Error 
bars represent 1SE.  Shef3 - orange, HUES7 – red, RH5 cut - blue and RH5 TrypLE - green.   
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Figure 5.37. Analysis of gene expression for SYP and TH 
The expression levels of both synaptophysin (A) and TH (B) were significantly higher in the HUES7 cell line than 
in either of the additional cell lines screened.  TH and SYP expression increased steadily in the remaining cell 
lines throughout differentiation, peaking at day 28.  Error bars represent 1SE.  Shef3 - orange, HUES7 – red, RH5 
cut - blue and RH5 TrypLE - green.   
 
 231 
0
50
100
150
200
250
Day 0 Day 4 Day 10 Day 18 Day 28
F
o
ld
 c
h
a
n
g
e
 i
n
 g
e
n
e
 e
x
p
re
s
s
io
n A
0
10
20
30
40
50
60
70
80
90
Day 0 Day 4 Day 10 Day 18 Day 28
F
o
ld
 c
h
a
n
g
e
 i
n
 g
e
n
e
 e
x
p
re
s
s
io
n B
 
Figure 5.38. Analysis of changes in PAX6 and OLIG2 expression. 
Expression of PAX6 (A) in the RH5 TrypLE cell line was consistently up regulated throughout differentiation to a 
peak on day 28, 134-fold higher than day 0 levels.  This was considerably higher than day 28 expression in RH5 
increasing in expression by just 5.34-fold from day 0.  PAX6 expression in HUES7 peaked on day 28 (142-fold 
increase from day 0).  Expression of PAX6 and OLIG2 (B) increased to a peak on day 10 in Shef3 followed by 
down regulation.  A peak in OLGI2 expression was also detected in HUES7 at day 10.  OLIG2 was up regulated in 
all four hESC lines between day 4 and day 10.  OLIG2 expression continued to increase in the RH5 cell lines 
throughout differentiation.  Shef3 - orange, HUES7 – red, RH5 cut - blue and RH5 TrypLE - green.   
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Figure 5.39. Analysis of changes in expression of HLXB9 and ISL1.  
HLXB9 gene expression (A) increased from day 0 to day 28 in RH5 cut and RH5 TrypLE. No change was detected 
in HUES7.  Expression of HLXB9 peaked in the Shef3 cell line at day 18, followed by a decline.  ISL1 (B) 
expression peaked in Shef3 on day 10, followed by down regulation.  The average ISL1 expression in HUES7 
peaked at day 18 but was not significantly different to the levels detected at day 10 (p = 0.844).  ISL1 expression 
increased throughout differentiation in the RH5 TrypLE and cut cell lines, peaking on day 28. Error bars 
represent 1SE.  Shef3 - orange, HUES7 – red, RH5 cut - blue and RH5 TrypLE - green.   
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Figure 5.40. Changes in gene expression for AFP and PTF1A. 
AFP (A) expression increased from day 0 to a peak at day 10.  AFP expression was highest in Shef3 (1617-fold 
increase from day 0).  AFP expression for HUES7, RH5 cut and TrypLE reached 46.3, 388.6 and 42.5 –fold 
increase from day 0 respectively. PTF1A (B) expression was consistently low in the Shef3, RH5 cut and RH5 
TrypLE until day 28 where expression increased by 99.73, 8.17 and 14.65-fold respectively.  In the HUES7 
expression levels of PTF1A increased from day 10 onwards, peaking on day 28 at 201.9-fold increased from 
day 0.  Shef3 - orange, HUES7 – red, RH5 cut - blue and RH5 TrypLE - green.   
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Expression of the motor neurons specific homeobox gene HB9 (HLXB9, also known as 
motor neuron and pancreas homeobox 1, MNX1) continued to increase from day 0 until 
day 28 in both RH5 cell lines (Figure 5.39A).  No change in HLXB9 expression was detected 
in the HUES7 cell line.  HLXB9 expression peaked in the Shef3 cell line at day 18 followed by 
a decline in expression. 
 Islet1 (ISL1) is best known for its activation of the insulin, glucagon and somatostatin gene 
in the pancreas (Karlsson et al., 1990; Leonard et al., 1992; Wang and Drucker, 1995).  
However it is also one of the earliest markers of motor neuron commitment (Ericson et al., 
1992; Ando et al., 2003).  ISL1 expression peaked in the Shef3 cell line at day 10, followed 
by a decrease in expression of these cells (Figure 5.39B).  In the HUES7 cell line, the average 
ISL1 expression peaked at day 18 , although this was not significantly different to the levels 
at day 10 (p = 0.844).  Levels of ISL1 continued to increase in the RH5 TrypLE and cut lines, 
confirming an increase in motor neuron progenitors in the later stages of differentiation. 
 
5.2.11.6 Alternative germ lineages 
Expression of the endodermal marker alpha feto protein (AFP), increased in the early 
stages of differentiation, with peak expression in all four lines on day 10 and decreasing 
thereafter (Figure 5.40).  The highest AFP expression was seen in the Shef3 cell line; 
1617-fold increased expression from day 0, considerably higher than for HUES7, RH5 cut 
and RH5 TrypLE: showing a 46.3, 388.6 and 42.5 -fold increased at day 10 respectively.  
Interestingly, after 18S and ACTB, AFP was the highest expressed gene across all samples, 
as determined by the raw gene expression Ct values. 
Expression of NODAL decreased throughout differentiation of the HUES7 and RH5 TrypLE 
cell lines as would be expected due to its role in mesodermal and endodermal tissue 
specification.  In both the RH5 cut and Shef3 cell line, an anomalous peak in expression was 
seen at day 10, amidst a gradual decline of expression throughout differentiation (data 
available upon request).  Expression of Brachyury homolog (T) increased to a peak between 
4-18 days in the four cell lines followed by a decline in expression to undetectable levels. 
The pancreas specific transcription factor 1a (PTF1A) is involved in GABAergic neuronal 
differentiation (Glasgow et al., 2005; Dullin et al., 2007).  Expression of PTF1A remained low 
in the Shef3, RH5 cut and RH5 TrypLE cell lines until day 28 where expression increased to a 
peak from day 0 by 99.73, 8.17 and 14.65-fold respectively (Figure 5.40B).  Expression of 
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PTF1A started to increase considerably earlier in the HUES7 cell line, from day 10 onwards 
to a peak 201.9-fold increase by day 28.  Up-regulation of PFT1A expression around 28 days 
of differentiation corresponded to the increases in immunostaining of the matured 
neurons for GABA. 
The comparative gene expression study herein has confirmed inherent variability between 
pluripotent hESC lines in response to neuronal differentiation, highlighting distinct 
differences in the terminal neural cell fate of choice amongst cell lines which would seem 
to be identical by appearance.   
 
5.2.12 Neural potential in part differentiated vs undifferentiated colonies.  
Data presented within, demonstrates the ability of all four hESCs lines to differentiate into 
functional neurons; however, the reproducibility and efficiency of neuronal differentiation 
relied upon consistent pluripotent hESC starting populations.  Pluripotent hESC expansion 
was shown in the previous chapter to rely upon consistent support from the iMEF layer and 
a balance in the growth factors controlling pluripotency.  However, to date, no 
investigation has been carried out on the effect of differentiating hESCs within a colony, on 
the surrounding cells of that colony, and indeed on the surrounding colonies.  A large 
amount of autocrine and paracrine cell-cell signalling takes place across a hESC colony and 
culture (Dvorak et al., 2005; Kunath et al., 2007; Stewart et al., 2008).  To determine 
whether variability in differentiation was a result of partial differentiation within a culture 
or colony, an experiment was carried out to compare the differentiation capability of 
pluripotent hESCs (as determined by morphology) isolated from colonies presenting areas 
of spontaneous differentiation, with hESCs from wholly undifferentiated colonies.   
This experiment was carried out using the two mechanically passaged hESC lines RH5 cut 
and Shef3 because the alternative hESC lines grew in a monolayer formation.  Pluripotent 
hESCs were manually dissected from wholly undifferentiated and partly differentiated 
colonies (Figure 5.41) according to Section 2.10.4 (5-22 fragments were induced to 
differentiate per well).  Embryoid bodies were monitored using bright field microscopy and 
scored for size, shape, attachment and the visible presence of outgrowing neurons.  After 
five days in culture, EBs from partially differentiated colonies were larger and more uniform 
in shape than EBs from entirely undifferentiated cells (Figure 5.42).   
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In RH5 cut, the percentage of EBs which attached to the culture surface within five days of 
plating following neuronal differentiation was higher in the group of EBs derived from 
wholly undifferentiated hESC colonies (82.2 % ± 16.7), compared with EBs comprising 
hESCs from colonies displaying areas of partial differentiation (68.6 % ± 16.3); however, this 
difference was not significant as determined by ANOVA (p = 0.333).  Images of EBs 
following plating were captured.  Examples of attached fragments which displayed areas of 
neuronal outgrowth were scored as and presented in Figure 5.43.  Examples of these EBs 
were seen in both cell lines.  Analysis of the attached EBs for neuronal outgrowth (Figure 
5.44) demonstrated that after 3 weeks differentiation, the wholly undifferentiated cells 
resulted in a higher proportion of neuronal differentiation (88.9 % ± 19.4) when compared 
to the hESC from spontaneously differentiating colonies (42.4 % ± 30.6); however, ANOVA 
demonstrated that these results were not significantly (p = 0.07).  When repeated in the 
Shef3 cell line, the results suggested higher efficiency of neuronal differentiation from 
partly differentiating colonies (50.0 %) than from undifferentiated colonies (28.6 %), 
confirming the insignificance of spontaneously differentiating cells on the fate of remaining 
pluripotent cells in a colony. 
 
5.2.13 The effect of EB size on neuronal yield.  
Having demonstrated that differentiating cells did not appear to significantly control the 
fate of remaining pluripotent cells, the effect of the size of differentiating EB on the fate of 
cells within was investigated.  Embryoid bodies were generated using mechanical 
dissection for both enzymatically and mechanically passaged cell lines; however, due to the 
large numbers of samples processed, it was not possible to precisely standardise the size of 
the fragments and consequently EBs varied in size (Figure 5.8D).  In 2006, a UK stem cell 
group proposed a method for standardising number of cells within an EB using forced 
aggregation (Burridge et al., 2007).  This method was applied to determining the optimal 
sized EB for neuronal differentiation. 
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Figure 5.41. Undifferentiated vs part differentiated hESC colonies.   
Wholly undifferentiated colonies (A-B x4 magnificaiton, C x10 magnificiation) were dissected into fragments (~ 200 µM) for comparision of neuronal differentiation efficieny with hESCs from 
colonies which displayed regions of spontaneously differentiated cells (highlighted in red; D-E x4 magnification, F x10 magnification). 
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Figure 5.42. Embryoid body from undifferentiated and part differentiated hESCs.   
EBs (five days post induction) from hESCs dissected from colonies which had undergone spontaneously differentiation were larger and more uniform in shape (A-B x4 magnification, C x10 
magnification) than EBs from hESCs dissected from entirely undifferentiated colonies (D-E x4 magnification, F x10 magnification). 
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Figure 5.43. Embryoid body attachment from undifferentiated and part differentiated hESCs.   
EBs with visible neurons spreading were identified from wholly undifferentiated (A) and partly differentiated hESC 
colonies (C).  Additionally examples of EBs which did not display any signs of neuronal differentiation were also 
visible from undifferentiated (B) and partly differentiated hESC colonies (D).  
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Figure 5.44. Neuronal yield from undifferentiated and part differentiated colonies. 
The number of fragments which were directed into neuronal lineage was higher in RH5 (blue) wholly 
undifferentiated colonies (92.9 %) when compared to colonies with areas of partial spontaneous differentiation 
(38.5 %), despite all cells forming the EBs being of pluripotent hESC morphology as detailed in Section 4.2.1.  The 
difference in neuronal differentiation between the two cell pools was not significant (p = 0.07).  When repeated in 
Shef3 a higher proportion of neuronal differentiation was higher from EBs derived from spontaneously 
differentiating colonies (50.0 %) when compared to undifferentiated colonies (28.6 %). 
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5.2.14 Forced aggregation  
The cell signalling within an EB varies depending on its size which is controlled by the number 
of cells within (Itskovitz-Eldor et al., 2000).  In an attempt to standardise the size of the EB and 
identify an optimal size for neuronal differentiation, pluripotent hESCs were dissociated into 
single cells using TrypLETM Express, counted and seeded into v-bottomed 96-well plates (1,000 
– 100,000 cells/well) in 200 µL NI media/well.  The 96-well plate was centrifuged at 400 g for 
five minutes, forcing the cells into a pellet.  Embryoid bodies with fewer than 5,000 cells did 
not aggregate and instead were smeared against the side of the wells (Figure 5.45).  In samples 
with >10,000 cells, EBs formed rounded aggregates which were resuspended after 48 hours 
using the force from dispensing a multi-channel pipette.  Embryoid bodies were differentiated 
for the remaining period as detailed in Section 2.10.4.   
Images of EBs were captured through differentiation and variation in neuronal yield 
determined by visual inspection of attached and spreading EBs.  After ten days in culture the 
number of attached and floating EBs were recorded (Figure 5.47).  There was no significant 
difference (p = 0.984) in the rate of attachment between EBs comprising different cell 
numbers, as determined by ANOVA.  The number of fragments from which neurons were 
spreading recorded no significant difference between EBs of different cell size (p = 0.847, 
Figure 5.48).  However, the total yield and purity of neurons per aggregate was higher in EBs of 
5,000 and 10,000 cells than 25,000 and 50,000 cells.  This was observational using bright field 
microscopy; however, neurons from larger EBs were mixed amongst non-neuronal 
(epithelial-like) cells (Figure 5.49), where neurons from smaller EBs were almost pure in 
population, suggesting that smaller EBs would be better for neuronal differentiation.  This 
observation was taken from two repeated experiments using RH5 TrypLE but would need to be 
repeated again with analysis and quantification of final neuronal yields for confirmation. 
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Figure 5.45. Forced aggregation of hESCs.   
Human ESCs forced into aggregation using 400 g, 1,000 (A), 3,000 (B), 5,000 (C), 10,000 (D), 20,000 (E), 100,000 (F).  
After 24 hours EBs had formed in wells with ≥ 10,000 cells, in 1,000 (Ai), 3,000 (Bi) and 5,000 (Ci) cells multiple small 
EBs formed with unknown cell number.  
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Figure 5.46. Floating aggregates 24 hours after resuspension  
Embryoid bodies were uniform in size following forced aggregation, however, the shape of the EBs remained 
irregular: 5,000, (A) 10,000 (B), 20,000 cells (C) and 100,000 cells (D). 
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Figure 5.47. Attachment of forced EBs.   
Embryoid bodies of 5,000 cells (blue), 10,000 cells (red), 25,000 cells (green) and 50,000 cells (orange), were 
generated following centrifugation.  Embryoid bodies were differentiated neuronally according to the method 
outlined in Section 2.10.4.  There was no significant difference in the attachment of EBs of varying cell numbers at 
determined by ANOVA (p = 0.984). Error bars represent 2SE.   
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Figure 5.48. Efficiency of forced aggregation on neuronal differentiation.   
After 28 days in culture the number of EBs from which neurons were spreading was recorded.  No significant 
difference (p = 0.847) in the number of attached EBs containing 5,000 cells (blue), 10,000 cells (red), 25,000 cells 
(green) and 50,000 cells (orange) which generated neurons was identified.  Despite this, the number of neurons 
from each EBs varied dramatically, indicating a larger and purer neuronal yield from EBs of 5-10,000 cells when 
compared to EBs of 25-50,000 cells. 
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Figure 5.49. Cell morphology from attached EBs following forced aggregation. 
Images of neuronal outgrowth from EBs of different cell number were captured nine days after plating: 5,000 (A-C), 
10,000 (D-F), 25,000 (G-I), 50,000 (J-L).  Neurons were visible spreading from all attached fragments.  EBs from 
25,000 and 50,000 cells, were highly irregular in shape yielding large numbers of non-neuronal cells in addition to 
neurons.  Many of the larger EBs displayed signs of apoptosis and high levels of cell debris.  
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5.3 Discussion 
Throughout this chapter, the responses of four hESCs lines (cultured using mechanical and 
enzymatic passaging techniques) were compared for their response to neuronal 
differentiation.  Data from this study demonstrated inherent variability between the 
differentiation responses of these hESC lines.  For the purpose of this comparative study, the 
phenotype of the end stage neurons was not directed allowing hESCs to respond to neuronal 
differentiation stimuli according to their endogenous programming. 
 
5.3.1 Development of the enhanced EB neuronal differentiation protocol 
During the early phases of this study, hESCs were established under routine culture and an 
enhanced protocol for neuronal differentiation developed.  Due to limited access to hESC lines 
on commencing this project, the early experiment were carried out using Shef3; one of the 
only hESC lines accessible from the UKSCB.  Shef3 was non-responsive to motor neuron and 
dopaminergic neuronal differentiation using ATRA and FGF8/SHH induced differentiation 
(Baharvand et al., 2007; Li et al., 2007); however, upon reflection the protocols used for these 
trials were not true replicates of the publications.  Human ESCs used for differentiation in the 
adherent ATRA protocol were cultured in the presence of the BMP inhibitor Noggin thus 
restricting commitment into mesodermal and endodermal germ lineages and enhancing the 
neuronal outcome.    Incorporation of Noggin has been used in this way to enhance neuronal 
yield in a range of differentiation studies (Bachiller et al., 2000; Pera et al., 2004; Iacovitti et al., 
2007; Sonntag et al., 2007), thus explaining the improved response in the publication to that of 
Shef3 cells in this study.   
Expression of CRABP2 gene expression by Shef3 would suggest that this line should have 
responded to ATRA induced differentiation using the adherent differentiation protocol 
(Baharvand et al., 2007); however, hECs expressing high levels of the CRABP2 protein were 
previously shown to be non-reponsive to ATRA induced neuronal differentiation, suggesting 
that CRABP2 is involved but does not control ATRA induced motor neuron differentiation 
(Matthaei et al., 1983).  In addition, the adherent ATRA induced differentiation was carried out 
in hESCs adapted to feeder-free MatrigelTM culture, but was repeated in this study in the 
presence of the iMEF layer.  Although the metabolic activity of iMEFs is reduced over time 
(Villa-Diaz et al., 2009), the presence of iMEFs during differentiation would inevitably have 
altered molecular signalling in the dish, and hence might explain poor success of protocol in 
the Shef3 line when recapitulating the published protocol for differentiation.  Despite this, the 
ability of Shef3 to commit into mature neurons was later demonstrated following a process of 
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semi-directed differentiation, whereby spontaneously differentiated neural rosettes, were 
mechanically dissected and directed into functional neurons by exposure to NBD media, thus 
confirming the ability of Shef3 to differentiate neuronally. 
Following these early observations an enhanced neuronal protocol was generated which 
proved to be successful at generating neurons from each of the four hESC lines.  
Differentiation was induced following a suspension EB culture for the first nine days of 
differentiation in a neural induction medium.  These medium contained neurotrophins which 
worked towards the immediate induction of ectodermal commitment (McKeehan et al., 1976; 
Chirgwin et al., 1979), reducing the loss of hESCs into non-neuronal germ lineages.   
Removal of bFGF enhanced the neuronal differentiation and purity amongst neural stem cells 
by reducing the proliferation of non-neuronal cells in culture (Qian et al., 1997; Lee et al., 
2000; Schwindt et al., 2009).  The absence of bFGF was also found to improve neuronal 
maturation, generating neurons with functional K+ ions channels, capable of firing 
reverberating APs following stimulation which were not generated by neurons derived in the 
presence of bFGF.  However, the complete removal of bFGF from culture resulted in a 
decrease of neuronal health and the accumulation of cell debris over time (as determined by 
the formation of vacuoles and blebbing amongst neuronal populations).  A similar effect was 
observed amongst neuronal populations from NTERA2 following removal of the supportive 
epithelial cell layer.  Basic FGF has been shown to enhance neuronal survival both directly and 
indirectly via its affect on surrounding cells (Unsicker et al., 1992), confirming the requirement 
by neurons for additional support from surrounding cells.  With this in mind, supplementation 
of cultures with survival promoting growth factors such as glial cell derived neurotrophic factor 
(GDNF) and brain derived neurotrophic factor (BDNF) in the end stages of differentiation, may 
have improved neuronal health and hence yield by reducing the detachment and death of 
neurons in culture (Sauer et al., 1993; Encinas et al., 2000; Tapia-Arancibia et al., 2004; Zeng et 
al., 2006; Bakshi et al., 2006).   
 
5.3.2 Embryoid bodies 
The poor attachment and cell spreading of EBs following plating made it difficult to isolate and 
process differentiating cells for characterisation.  Comparative analysis of different culture 
surfaces revealed that poly-L-ornithine increased EB attachment and laminin improved 
neuronal outgrowth; thus supporting claims that laminin positively selects for neural 
precursors by enhancing their survival and proliferation in culture (Lathia et al., 2007; Hall et 
al., 2008; Ma et al., 2008).  Fibronectin resulted in high rates of EB attachment but outgrowth 
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comprised mainly non-neuronal cells which were similar in appearance to pluripotent NTERA2 
(Figure 5.1C).  Fibronectin is incorporated into many of the feeder-free surface coatings for 
hESC expansion and has recently been proven to increase the survival and proliferation of 
hESCs (Amit et al., 2004; Baxter et al., 2009), explaining the outgrowth of pluripotent-like cells 
in these cultures.  For this reason, selective attachment of EBs containing neural precursors 
was achieved with a combination of poly-L-ornithine and laminin.   
 
5.3.3 Neuronal yield and functionality 
Following development of a successful differentiation protocol, all hESC lines were shown to 
generate neurons with typical neuronal morphology.  Neurons from all hESC lines fired Na+ APs 
in response to stimulation, which were reversibly inhibited by TTX; however, there were clear 
differences in the neuronal yields and reproducibility of differentiation between each of the 
four cell lines.   
Neuronal differentiation in Shef3 cell was highly variable, with a frequent failure to generate 
any cells of neuronal morphology.  Instead Shef3 demonstrated a preference for mesodermal 
differentiation, spontaneously differentiating into beating cardiomyocyte tissue (video 
available upon request).  Upon successful neuronal differentiation, the neuronal yield from 
Shef3 was consistently lower than was seen in the other hESC lines.  Embryoid body formation 
was also more variable in Shef3, with cell fragments frequently dissociating in suspension 
(Images available upon request).   
Differentiation amongst the RH5 cut cell line was more reproducible than in Shef3, yielding 
higher numbers of neurons; however, the neuronal yield was considerably lower than was 
seen in RH5 TrypLE.  This was considered to be a result of the differences in karyotype of these 
two cell lines, resulted from 18 months of diversion and adaptation to passaging.  Interestingly, 
the enzymatically passaged cell lines were more reliable in neuronal differentiation than 
mechanically passaged cell lines, yielding proportionally higher numbers of neurons.  This was 
unexpected due to their karyotypic instability.  However, this confirmed that the karyotypic 
stability of the cell line did not directly impact upon the ability a hESCs to differentiate 
neuronally.  Although different hESC lines have inherent differences in cell behaviour, the 
improved neuronal yield from enzymatically passaged cell lines was not only attributable to 
cell line variation, confirmed by the higher neuronal yield of RH5 TrypLE compared to RH5 cut, 
despite arising from the same original cell line.   
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It was not possible to definitively quantify the differences in neuronal yield amongst these 
different hESC lines, due to damage caused to neurons during processing for flow cytometry.  
Instead, in situ immuno fluorescence images were used in combination with bright field 
microscopy to compares neuronal yields between populations.  Quantification of differences 
between different hESC lines could have been achieved using a TissueFAX system (Tissue 
Gnostics, Vienna, Austria) to analyse fluorescent images in situ.  Unfortunately, this facility was 
not available for use during this study but would be adopted for analysis in the event of its 
repetition.   
Neurons derived from all four hESC lines positively expressed neuronal markers TUBB3, MAP2; 
but it was noticed that the staining for TUBB3 was considerably greater than that of MAP2.  
The tubulin family of proteins comprise three main isoforms (α, β γ-tubulin) which together 
form cytoskeletal microtubules across a range of cell types (Sullivan, 1988).  Beta-III-tubulin 
(TUBB3) is specifically expressed amongst neurons (Sullivan, 1988; Lee et al., 1990).  Cross 
reactivity with non-neuronal tubulins was ruled out by the co-expression of TUBB3 and the 
70 kDa Neurofilament protein which is also neuron specific.  According to early publications, 
TUBB3 is expressed throughout mature nerve cells in both dendrites and axons.  In contrast, 
MAP2 is preferentially localized towards dendrites with little or no staining amongst mature 
axons; this would explain the higher proportion of immunostaining for TUBB3 than MAP2 
(Bernhardt and Matus, 1984; Caceres et al., 1986; Chen et al., 1992).   
 
5.3.4 Comparison of gene expression in response to neuronal differentiation 
Early attempts at semi-quantitative RT-PCR were unsuccessful due to continuous detection of 
expression from pluripotency and neuronal genes throughout all stages of differentiation.  This 
was considered to be a result of too many PCR cycles and poor primer specificity.  Efforts were 
therefore transferred to Q-PCR analysis for relative quantification of gene expression 
throughout differentiation, using LDA gene expression cards (Adewumi et al., 2007).  Gene 
expression across each of the four hESC lines were screened at days 0, 4, 10, 18 and 28 which 
were considered to be key time points for neuronal differentiation.  The use of commercial 
LDA card meant that it was not possible to ensure gene specific amplification without 
pseudogene interference; however, pseudogenes were identified prior to designing the LDA 
cards providing reassurance of amplification for the true GOI (Personal communication: Ms. K. 
Warrington, ABI). 
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5.3.4.1 Determining the endogenous control gene 
Prior to analysis of gene expression, it was necessary to identify a suitable endogenous control 
gene to which all expression was standardised.  This gene was used to account for variation in 
loading or amplification efficiency between samples, enabling a comparison between cell lines.  
In an ideal system, the endogenous control gene would have a similar level of expression as 
the GOI (Bustin et al., 2005); however, the majority of Q-PCR studies, analysis of gene 
expression are carried out on continuous cell populations, within which the control genes are 
stability expressed.  In this study the hESCs were actively changing from a homogeneous 
pluripotent starting pool to a heterogeneous neuronal final population, with entirely different 
cell behaviour and structure.  Therefore identification of the endogenous control gene for this 
study was more complex.  All 96 genes included on the LDA card were analysed for stability in 
expression, which identified three suitable candidate genes which were the most stably 
expressed throughout the differentiating populations: RAF1, ACTB and GAPDH.  
RAF1 is an oncogenes which is involved in a range of cellular functions including proliferation, 
differentiation and apoptosis (Avruch et al., 1994; O'Shea et al., 1996; Sewing et al., 1997; 
Alberts et al., 2002a; Chen and Sytkowski, 2005).  Within each hESC line, RAF1 was the most 
consistently expressed gene throughout neuronal differentiation; however, when compared 
across hESC lines, RAF1 expression was more variable.  This was considered to be due to the 
differences in karyology of the different hESC lines.  Mutations in the RAF1 can cause 
interruption of the cell cycle resulting in tumorigenesis (Wang et al., 2005b).  The differences in 
RAF1 expression between cell lines might explain the difference in cell cycle duration of each 
of the cell lines.  RAF1 was therefore considered to be an unsuitable endogenous control gene. 
Beta-actin is a major cytoskeletal protein, expressed by all cells to control the structure, 
motility and integrity of the cell (Lambrechts et al., 2004), as such it is commonly assigned as 
an endogenous control for gene expression analysis.  Alterations in β-actin expression through 
differentiation have been described in detail (Serazin-Leroy et al., 1998; Ruan and Lai, 2007).  
In this example, variable ACTB expression was expected due to the difference in cell shape and 
structure of a neuron when compared to a hESCs, explaining its higher variability in expression 
throughout differentiation than GAPDH.   
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) has long been known for its 
involvement in glycolysis and more recently for its role in endocytosis, gene expression, DNA 
replication and repair and apoptosis (Mansur et al., 1993; Ishitani et al., 1996; Sirover, 1997; 
Suzuki et al., 2000b).  As such, GAPDH iss constitutively expressed in all cells and is widely used 
as an endogenous control for gene expression analysis.  GAPDH expression has been shown to 
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vary throughout the cell cycle and between different tissue types (Sirover, 1996; Radonic et al., 
2004; Barber et al., 2005); however, in this study GAPDH gene expression was the least 
variable throughout differentiation than any of the alternative genes screened.  For this 
reason, expression of all pluripotency and neural genes were standardised to GAPDH. 
For the purpose of LDA data analysis, a single endogenous control gene was used.  An 
alternative approach for analysis may have been to use a number of endogenous control genes 
for standardisation, or to pool RNA from triplicate samples for identification of an endogenous 
control.  This would have removed potential variability from sample loading or preparation, 
enabling true analysis of the most stable gene expressed (Warrington et al., 2000; 
Vandesompele et al., 2002). 
 
5.3.4.2 Comparative analysis of gene expression during differentiation 
Prior to differentiation, all populations expressed common markers of pluripotency (Table 1.1).  
In addition to expression of a range of genes associated with pluripotent populations DNMT3B, 
EBAF, FGF4, GDF3, TDGF1, UTF1 and TERT (Adewumi et al., 2007).  These markers were down 
regulated following neuronal differentiation in all populations.  However, in the latter stages of 
differentiation in RH5 cut, RH5 TrypLE and HUES7, expression of the pluripotency marker OCT4 
began to increase.  An increase in expression of Nanog was also detected in the day 28 
differentiating samples in several of the biological replicates, suggesting an outgrowth of 
pluripotent populations.  Despite the increase in OCT4 expression, the pluripotency specific 
OCT4B1 was not detected by immunostaining in day 28 neuronal samples.  Applied 
BiosystemsTM do not provide the primer sequence for amplification, therefore it was not 
possible to rule out amplification of alternative OCT4 isoforms which are expressed in somatic 
cells (Atlasi et al., 2008).  This would explain the increase in expression in later populations; 
however, outgrowth of pluripotent populations from differentiating cells has been previously 
identified following directed differentiation (Ramírez et al., 2007).  The reason for this is 
unclear, but it is possible that a trisomy for chromosome 12 which were detected amongst 
these cell lines may be partially responsible.  Nanog is a master regulator of pluripotency and is 
located on chromosome 12 (Chambers et al., 2003; Hyslop et al., 2005).  An addition copy of 
this gene may enhance the survival of pluripotent populations throughout differentiation 
(Draper et al., 2004a).  This would need to be further investigated.  If proven to be true, it’s 
effect of reversion to pluripotency (or reluctance on cells to terminally commit into 
differentiation), would drastically limit the number of hESC lines and methods of culture which 
could be applied to cell therapy preparations.   
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The expression of SOX2 was variable between biological replicates but did not change 
significantly throughout differentiation in the RH5 cut, RH5 TrypLE or HUES7 cell lines.  In 
contrast the average SOX2 expression in the Shef3 cell line consistently decreased throughout 
differentiation.  SOX2 is a key player in pluripotency (Fong et al., 2008) but is also expressed in 
neural precursors of the developing CNS and has been shown to play an active role in retaining 
neural progenitor identity, inhibiting further differentiation (Graham et al., 2003; Avilion et al., 
2003).  The loss of SOX2 in Shef3 following differentiation is indicative of a loss of pluripotency 
and neural progenitors, and might explain why a reduced number of neurons were generated 
in this cell line, when compared to the other three hESC lines.  Poor neuronal yields in Shef3 
may also be explained by its comparatively high levels of AFP during differentiation.  AFP is a 
marker for endodermal differentiation, indicating that a higher proportion of cells were lost 
into the endodermal lineage during Shef3 differentiation than in the other three hESC lines.   
The higher neuronal yields from RH5 TrypLE could be attributed to the high levels of 
endogenous Noggin expression within these samples.  Noggin is an inhibitor of BMP signalling 
which is required for mesodermal or endodermal commitment (Pera et al., 2004; Gerrard et 
al., 2005a; Sonntag et al., 2007).  Recombinant Noggin is frequently added in to differentiating 
neuronal culture to increase ectodermal lineage commitment and thus increase neuronal yield 
(Iacovitti et al., 2007; Sonntag et al., 2007).  It would therefore seem logical to assign some of 
the increased neuronal yield to the Noggin expression.  Interestingly, the Noggin gene is 
located upon chromosome 17 (NCBI, Entrez Gene), which is commonly duplicated upon 
prolonged hESC culture.  This might explain why the three hESC lines with trisomies for 
chromosome 17 were more efficient in response to neuronal differentiation than the 
karyotypically normal hESC line such as Shef3. 
The expression patterns of PTEN and RE1-silencing transcription factor (REST) also explain the 
differences in neuronal yields amongst the four hESC lines.  PTEN is a tumour suppressor gene 
which is involved in regulation of neural stem cell self renewal (Groszer et al., 2001).   Down 
regulation of PTEN results in a shorter cell cycle and therefore increased rates of proliferation 
(Groszer et al., 2001; Qu and Shi, 2009).  Average expression of PTEN was consistently lower in 
the RH5 TrypLE than in RH5 cut, HUES7 and Shef3 cell lines, which might explain the increased 
proliferation of neural progenitors in the RH5 TrypLE population.  In addition, REST plays a 
regulatory role in neural stem cells renewal, preventing their differentiation and maturation 
(Sun et al., 2005; Johnson et al., 2008; Jørgensen et al., 2009; Buckley et al., 2009).  A down 
regulation of REST has been correlated to increased neuronal maturation (Ballas et al., 2005; 
Sun et al., 2005).  Interestingly, REST expression was considerably higher in the Shef3 
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population during the mid stages of differentiation than in the other hESC lines, thus 
contributing to its lower neuronal yield.   
Nestin is an intermediate filament protein which is commonly used as a marker for neural 
progenitor cells, with lower expression levels in post-mitotic neurons (Lendahl et al., 1990).  
During this study, positive Nestin gene and protein expression was detected in pluripotent 
populations through to neuronal day 28 samples.  Nestin expression was particularly evident 
amongst neurons in RH5 TrypLE, RH5 cut and HUES7 day 28 samples These neurons were 
visibly proliferating in culture as demonstrated using live cell imaging (Video available upon 
request) which was indicative of neural precursors.  Prolonged retention and proliferation of 
neural precursors within these lines would explain their higher neuronal yield.  Expression of 
mature neuronal markers SYP, TH and HLXB9, demonstrated the ability of RH5 TrypLE derived 
neurons to commit into terminal differentiation under the correct stimuli.  If the maturity of 
the neurons derived from RH5 TrypLE could be enhanced to mimic the response of a primary 
neurons, RH5 TrypLE would make a good candidate cell line for the production of large 
numbers of neurons for pharmacological screening.   
Amongst Shef3 and HUES7, Nestin gene expression increased to a peaked mid differentiation 
indicative of commitment into a neural lineage, followed by a decrease in expression during 
neuronal maturation.  This suggests a faster maturation of neurons amongst these lines.  
Indeed, the decreased expression of Nestin in HUES7 correlated with an increase in expression 
of the matured neuronal marker SYP.  SYP expression was higher in HUES7 than any other 
hESCs, suggesting that the largest proportion of synaptically mature neurons of were derived 
from this cell line.  Comparatively low detection of SYP gene expression in RH5 cut, RH5 TrypLE 
and Shef3 lines would explain the absence of positive immuno staining for these lines.  It 
would be interesting to determine whether SYP expression increased in the remaining hESC 
line if samples were analysed after six weeks of differentiation, which would confirm the ability 
of neurons within these population to form mature synaptic vesicles for communication.   
The PAX6 gene encodes a transcription factor expressed by neuroectodermal and neural 
precursor to controls neural stem cell proliferation and differentiation during mammalian 
forebrain development (Perrier et al., ; Simpson and Price, 2002).  The gene expression levels 
of PAX6 increased throughout differentiation in RH5 TrypLE and HUES7, indicative of an 
increased neural progenitor pool; however, PAX6 expression was significantly lower in RH5 cut 
when compared to the other hESC lines and in combination with Noggin was one of the main 
differences in gene expression between the two RH5 cell lines.   
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OLIG2, ISL1 and CRABP2 are all markers for motor neuron commitment (Ericson et al., 1992; 
Novitch et al., 2001; Ando et al., 2003; Chaerkady et al., 2009).  The gene expression patterns 
of these genes in Shef3, RH5 cut and HUES7 were indicative of an increase in motor neuronal 
precursors within the EB, followed by their maturation following plating.  In contrast, 
expression of these genes continued to increase throughout differentiation in RH5 TrypLE.  In 
combination with the continued increased in Nestin and PAX6 expression, this data is 
conclusive of an expansion of neuronal precursors throughout RH5 TrypLE differentiation.   
Despite the persistence of neural precursors amongst differentiating populations in RH5 
TrypLE, gene expression for mature neuronal markers such as SYP, TH and HLXB9 were 
detected, in addition to the ability of neurons from this population to reproducibly fire genuine 
sodium action potentials.  Therefore it was proven possible for RH5 TrypLE derived neurons to 
terminally differentiate.  HLXB9 is a motor neuron specific marker (Lim et al., 2006); its 
expression increased throughout differentiation in both RH5 cell lines.  Gene expression for 
HLXB9 was also detected in the Shef3 samples, peaking at day 18, followed by a rapid decline 
at day 28 which might be explained by the loss of Shef3 neurons in culture during feeding. 
Interestingly, in the HUES7 cell line, HLXB9 was continually down regulated throughout 
differentiation.  Gene expression patterns amongst the HUES7 cell line were more indicative of 
midbrain dopaminergic and forebrain GABAergic neuronal differentiation, rather than the 
generation of hindbrain motor neurons.  This was supported by the up regulation of TH and 
PTF1A during the later stages of HUES7 differentiation.   
PTF1A is most commonly associated with endodermal differentiation (Afelik et al., 2006; Jarikji 
et al., 2009), however, it is also expressed amongst GABAergic neurons in the retina and 
cerebellum (Hoshino et al., 2005; Dullin et al., 2007).  PTF1A expression was up regulated 
throughout differentiation in all hESC lines but most significantly amongst the HUES7 cell line, 
indicative of increased GABAergic neuronal populations amongst each of the hESC lines. 
Up regulation of PTF1A corresponded to positive immunostaining hESC derived neurons for 
GABA. 
This study suggest than enzymatically passaged hESC lines were more responsive and 
reproducible in neuronal differentiation than the mechanically passaged lines.  The difference 
in neuronal yields from RH5 cut and RH5 TrypLE ruled out the possibility of this being simply 
due to cell line variation.  Although the reasons for this are not clear, it is possible that the 
lower yield in mechanically passaged hESC lines was a result of the iMEF feeder layer on which 
the pluripotent cells were cultures.  Amongst enzymatically passaged cells, the iMEF density 
for retaining pluripotency was lower due to monolayer culture of these enzymatically passaged 
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hESCs.  Amongst mechanically passaged line, the ratio of hESCs:iMEFs was lower, as such the 
pluripotency regulation of these lines may have been under more control by the iMEFs, making 
these cells less responsive to directed differentiation.  Adaptation of both hESC lines onto 
feeder-free culture systems followed by a repeated comparison would confirm whether the 
differences between mechanically and enzymatically passaged hESC lines were due to the 
effects of a more concentrated iMEF layer, or due to the karyotypic instability of the hESCs 
which enhance neuronal differentiation. 
Throughout the analysis of these four hESC lines, the reproducibility of gene expression was 
poor, as indicated by large error bars.  This variation may have in part been due to variation in 
the expression of the endogenous control GAPDH which has been shown to vary in expression 
throughout different tissue types (Barber et al., 2005).  In addition, although successful in 
generating functional neurons, the enhance differentiation protocol used the formation of EBs 
to initiate differentiation.  The size of EB is difficult to control, introducing variation in 
gradients of signalling molecules across the EB.  In an attempt to minimise the variation in 
differentiation using EBs an experiment was carried out to monitor the neuronal 
differentiation amongst EBs of a defined cell number. 
 
5.3.5 Standardising EB size 
The size and shape of EBs was difficult to standardise due to the large numbers of samples 
prepared and the tendency of EBs to aggregate together in culture forming irregular shapes.  
Aggregation of EBs was reduced by restricting the number of EBs per dish and gently 
triturating the samples every two days.  In an attempt to standardise the size of EB, a defined 
cell number was forced into aggregation using v-bottomed well plates, following methods first 
described by Burridge et al., 2007.  Preliminary data suggested that smaller EBs induced a 
purer neuronal yield than larger EB; however, the neuronal yield was not significantly different 
between EBs of 5,000 - 50,000 cells (p = 0.847).  Differences in neuronal yield may not have 
been as affected by EB size as mesodermal cardiac differentiation, because neurons from the 
ectodermal germ lineage which sits on the outer surface of the EB (Alberts et al., 2002b).  The 
outer EB surface was continuously exposed to neuronal stimuli, regardless of their internal 
dimensions.  In this case, the size of EB should be enhanced to minimise commitment of cells 
into alternative germ lineages, rather than to enhance ectodermal differentiation.  The results 
from this experiment were taken from just two repeated experiments and would therefore 
need to be repeated under controlled conditions for confirmation.  Gene expression analysis of 
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these EBs of different sizes would also provide good insight into the communication of cells 
within larger aggregates.   
The apparent null-effect of EB size on neuronal differentiation, suggested that alternative 
factors may be involved in the variability of neuronal differentiation between samples.  Cells 
within a population are in constant communication with each other via gap-junctions and 
secreted signalling molecule (Harb et al., 2008; Fox et al., 2008).  Therefore it would be fair to 
assume that the behaviour in one cell may impact upon the fate of its neighbour.  In this case, 
spontaneous differentiation within a cell colony may have restricted the terminal cell fate of 
the remaining pluripotent cells surrounding it.  
 
5.3.6 The effect of neighbouring hESCs on directability of differentiation 
Spontaneous differentiation is a common occurrence within hESCs; to determine whether 
pluripotent hESCs from colonies containing differentiating cells, had the same differentiation 
potential as pluripotent hESCs from entirely undifferentiated colonies, a preliminary 
comparative study to compare these two groups was carried out.  However, no significant 
difference in the neuronal differentiation of these two populations was identified by 
morphology.  A recent study modelled on mouse embryonic stem cells suggested that cells 
separated by more than 400 µM were not affected by each other’s signalling which might 
explain why pluripotent cells taken from undifferentiated areas of large hESC colonies were 
not significantly different in behaviour to those from wholly undifferentiated colonies (Peerani 
et al., 2009). 
 
5.3.7 Summary 
Results from this chapter have clearly demonstrated that all four hESC lines were capable of 
neuronal differentiation following the enhanced neuronal differentiation protocol.  Each hESC 
line was shown to be capable of generating neurons which fired electrical impulses upon 
stimulation; however, this was the extent of the similarities in neuronal differentiation 
between the different hESC lines.  The highest overall neuronal yield was achieved from the 
RH5 TrypLE hESC line, although the largest proportion of mature neurons after 28 days were 
generated by HUES7, confirming a difference in the rate of neuronal maturation between 
different hESC lines.  The neuronal yield form RH5 cut and RH5 TrypLE were surprisingly 
different, considering these two cell lines originated from the same starting population.  The 
differences in karyology of these lines, detected in Chapter 4 may in part explain the difference 
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in neuronal yield, due to the variable expression of genes known to be involved brain 
development.  The Shef3 line was highly variable in its response to neuronal differentiation, 
demonstrating an apparent preference for mesodermal and endodermal differentiation with 
high AFP gene expression and formation of beating cardiomyocytes upon differentiation.   
These results have clearly demonstrated that not all pluripotent hESCs are equally directable 
to neuronal cell fate.  These data have demonstrated that pluripotent hESC line culture using 
both mechanically and enzymatic techniques are capable of neuronal differentiation when 
provided with the correct stimuli.   
The difference in response of RH5 cut and RH5 TrypLE was indicative of an affect of passaging 
technique on the success of neuronal differentiation, thereby challenging hypothesis 3.  This 
may have been indirectly caused by the karyotypic stability of these lines, or the interaction 
with the iMEF layer which are consequential of the passaging technique; however, this clearly 
demonstrates a difference in the affect of culture on neuronal differentiation.  The 
incorporation of a wide range of techniques of passaging hESCs, may in part explain the 
different behaviours of hESCs which are observed amongst worldwide laboratories. 
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6 Product development of a live cell imaging facility – Linkam Scientific 
The differentiation studies detailed in previous chapters was carried out under part 
sponsorship from Linkam Scientific, a UK based engineering company.  Linkam Scientific are 
world experts in the field of temperature controlled microscopy and currently market a diverse 
range of products suited towards real-time imaging under cold temperatures.  On commencing 
this project, facilities for live cell imaging studies worldwide were identified to be restricted to 
short term time courses (<3-4 days), due to limitations with poor environmental stability and 
reduced humidity resulting in evaporation of long term applications such as the differentiation 
studies.  For this reason, Linkam undertook to develop, in collaboration with UCL and NIBSC, a 
novel live cell imaging system which would facilitate long term studies using neuronal 
differentiation as a model, the negating detrimental effects of evaporation and environmental 
stability.  The research and development for this system was carried out throughout the four 
year duration of this thesis, the process of which has been detailed herein.   
 
6.1 Importance of live cell imaging 
Biological imaging systems provide a valuable insight into the structure and interaction of cells, 
both with each other and with the environment around them.  Standard methods of imaging 
provide just snap shots of information of long term processes.  In contrast, live cell imaging 
(LCI) generates an entire story of the behaviour within a culture, enabling tracking of individual 
cells/events over time.   
There are a multitude of systems available for LCI; however, none of these systems truly 
facilitate long term studies (< week) under a stable culture environment.  The major limitation 
for long term LCI is the inability to retain a humidified atmosphere within an arrangement 
which is suitable for imaging.  Poor humidity control causes evaporation which increases the 
osmolarity of the culture media, resulting in cell shrinkage and death. 
This project was carried out in collaboration with Linkam Scientific Ltd (Surrey, UK), world 
leaders in temperature controlled microscopy, and set out to design a novel LCI device with 
accurate environmental control, overcoming common issues of humidity and evaporation, to 
facilitate long term studies on hESC culture behaviour and differentiation.   
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6.2 Current live cell imaging systems 
To develop a novel system which improved upon the quality and reliability of current LCI 
facilities, it was first necessary to compare and contrast the features that current systems 
incorporate.  A range from the market share in LCI systems were evaluated and combined for 
their advantages and disadvantages (Table 6.1).   
 
6.2.1 Micro-CO2 microscope incubator  
One of the first facilities for LCI with control over CO2 atmosphere was described in 1983 (Ince 
et al., 1983).  This early device incorporated temperature control accurate to ± 0.3 °C with CO2 
flow culturing cells in 35 mm petri-dishes (Figure 6.1).  Evaporation and sterility were 
controlled using a fine layer of mineral oil over the culture media; however, temperature was 
controlled by a heating coil surrounding the sides of the culture dish, which resulted in 
temperature gradients through the media and culture surface. 
 
6.2.2 Acrylic box 
Today, the most commonly used systems for LCI are variations of an acrylic box (Figure 6.2A) 
which sits around an inverted microscope.  The box is supplied with a CO2 feed and is heated 
to the desired temperature by a flow of warm air around the chamber.  These systems are 
easy to set up but are not easily removed, therefore requiring sole use of a microscope.  
Systems of this size typically suffer from large temperature gradients especially when located 
in air conditioned laboratories.  In addition, the nature and size of the system with poor sealing 
around the microscope mean that accurate gas control is difficult to achieve.  A humidified 
atmosphere is achieved with internal water reservoirs and gas pumped through a bubbler to 
humidify before entering the system.  However, the incorporation of the microscope within 
the box means that the maximum humidity levels reach only ~40 %, atmospheres higher than 
this causes condensation on the microscope lenses and subsequent interference to imaging.  
These systems are practical for short term studies which require warming and CO2 buffering 
but are not suitable for longer term studies due to media evaporation from the culture vessel.  
The large size of the vessels also mean that they require a number of hours to equilibrate at a 
stable humidified 37 °C atmosphere before an experiment can be run. 
There are a multitude of suppliers of these environmentally controlled boxes but the main 
supplier in the UK is Solent Scientific, which design systems to fit around a range of commercial 
microscopes.  Alternative systems designed specifically for Leica, Nikon, Olympus and Zeiss 
 256 
microscopes are also available.  In addition, In Vivo Scientific and Okolab supply similar 
systems using the same basic technology. 
 
6.2.3 Wafergen - SmartSlide  
The Wafergen (Fremont, Cailfornia, USA) SmartSlide use a proprietary 6-well plate format with 
integrated software for a temperature and gas (CO2 and O2) controlled system in addition to a 
facility for media exchange without interruption of the sample, thus extending the duration of 
imaging (Figure 6.2B).   This system has independent control over the culture environment 
within each of the 6-chambers enabling simultaneous screening of multiple conditions when 
incorporated into a motorised microscope stage; however, the proprietary dishes add 
additional costs and require adaptation of the cells in culture.  See 
http://www.wafergen.com/smartslide/index.htm for further information. 
 
6.2.4 Okolab CO2 incubator stage 
Okolab (Napoli, Italy) have two systems available for LCI: an acrylic box incubator which is 
similar in style to those detailed above, with additional black-out panels, excluding background 
light during fluorescence imaging (Section 6.2.2).  The alternative Okolab device uses a 6-well 
plate or six 35 mm culture dish format.  This system supplies humidity and gas control and a 
facility for cooling to extend the experimental temperature range between 10 – 50 °C (Figure 
6.2C).  This device uses pre-warmed water to maintain a stable temperature, therefore the 
dynamic response time is slow; however, this is one of the only LCI systems which enable 
hypothermic studies.  Humidity and gas is controlled by a large external control box, reducing 
the portability of the system.  For further information: http://www.oko-lab.com/39.page  
 
6.2.5 Chipman - Cell IQ 
The Cell IQ (Chipman, Tampere, Finland) is an environmentally controlled incubator, similar in 
size to a standard laboratory incubator, with an integrated microscope and intelligent image 
analysis software (Figure 6.2D).  The Cell IQ accommodates tissue culture flasks and well 
plates, and can culture and image two vessels simultaneously.  Gas atmosphere is supplied via 
a continual flow of pre-mixed gas through a patented perfusion lid.  Humidity is controlled via 
water reservoirs between the culture wells.  However, CO2 retention is poor and continual air 
flow over the culture vessel causes large levels of evaporation.  For further information:  
http://www.chipmantech.com/Cell_IQ.asp?ID=17&Level1ID=13 
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6.2.6 In Vivo Scientific 
In Vivo Scientific have two systems for LCI.  The first is a large environmentally controlled 
acrylic box set up around an inverted microscope as described in Section 6.2.2.  The alternative 
system is a small CO2 only controlled device which uses autoclavable cover slips within a small 
chamber perfused with gas (Figure 6.2E).  This system does not incorporate temperature 
control but it can be combined with the larger acrylic box system to maintain a warmed 
environment.  This system is portable and so does not require a dedicated microscope; 
however, the lack of temperature control means this system alone is only not ideal for 
mammalian cell studies. 
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Figure 6.1. Micro-CO2 microscope incubator 
Sealed miniature temperature and CO2 controlled environment with imaging live cells.  Cell culture media covered 
with mineral oil to minimise evaporation and aid uniform temperature (Ince et al., 1983).  
 
A
D E
B
C
 
Figure 6.2.  Live cell imaging systems.   
The typical acrylic box style incubator pictured here - Solent Scientific on an Olympus inverted microscope, systems 
by alternate manufacturers are similar in appearance (A).  Wafergen 6-well plate format proprietary incubator 
(B - red arrow) with integrated control software and set-up for media exchange (B - green arrow).  Okolab 6-well 
plate format humidified chamber with heating and cooling facility (C – red arrow).  Chipman - Cell IQ, combined 
incubator and microscope with integrated analysis software (D).  In Vivo Scientific CO2 controlled chamber (E). 
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6.3 Key design considerations 
Use of and exposure to the acrylic box style incubator, Cell IQ, and Wafergen LCI facilities 
made clear the strengths and weaknesses of each system.  With this it was possible to identify 
a range of key parameters which were critical for improvement in the Linkam LCI facility for 
optimised culture and imaging of hESCs.   
 Sample size: cover glass, micro-wells or tissue culture flasks. 
 Duration:  How long is the study: minutes, hours, days, weeks. 
 Sterility: it is necessary to run in a sterile environment? 
 Temperature control: How accurately does temperature control need to be?  Does the 
system need to run at a range of temperatures?  If so, does the system need a heating 
and cooling facility? 
Research and development rarely requires imaging of large numbers of cells at once, thus it 
was considered acceptable to use small culture vessels (35 mm dish) in the Linkam system.  
This reduced the size of the culture chamber and consequently improved the accuracy of 
control over environmental parameters.   
Studies using mammalian cells, especially hESCs frequently last days/weeks, and therefore 
require a CO2 supply to buffer the pH of the culture media.  For long term studies without 
disruption to imaging, a media exchange facility would be an advantage.  The system must also 
be easily cleaned (autoclavability would be an advantage), to avoid contamination in long term 
studies. 
Contamination risk could be reduced by ergonomic design.  Ease of loading to avoid spillage 
and sample disruption was an important consideration.  In addition the system should be 
sealed to contain the sample in any event of spillages, preventing contamination of the 
laboratory space or leakage onto the microscope optics. 
The sole occupancy of a piece of equipment on a laboratory microscope is not ideal for small 
laboratories and requires availability of an alternative microscope for any snap shot imaging.  
With this in mind a portable system would appeal to a larger range of customers.  In addition, 
a portable system which was detachable from the microscope would create the opportunity 
for multiple systems to be run in parallel with varying environmental conditions.  If the system 
could retain control over culture environment during transit, cells would not be exposed to 
changes in culture environment as is currently standard practice during imaging.   
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6.4 Development of the Linkam Live cell imaging facility 
With these design requirements in mind, work was carried out to develop a suitable LCI 
system.  Initial designs for the LCI system were provided by Arnold Kamp, Vince Kamp, Peter 
Grocutt and Rob Duncan at Linkam Scientific.  Manufacturing was carried out in by Linkam 
Scientific (Holland).  Modifications and design developments, creating a product for market 
were the result of this collaborative study.  
 
6.4.1 Linkam LCI facility - Prototype 1 
On commencement of this project, prototype 1 (Figure 6.3) was designed to offer fine control 
over temperature to ± 0.1 ˚C with easy access for sample loading using 35 mm round 
petri-dishes (Corning, 430165) into a glass plate located within a aluminium base and an easily 
machinable delrin lid.  This system was heated to temperature with a low vibration fan 
circulating air around the sample and out through vents in the base.  Temperature was 
controlled from a feedback sensor placed inside the cell culture media. 
 
6.4.1.1 Limitations with prototype 1. 
It was necessary to ensure that modifications and design features in the stage did not affect 
growth and stability of the cells in culture, mimicking the conditions within a standard 
laboratory incubator as best possible.   Using an invasive temperature sensor for feedback 
control on culture environment introduced an obvious entry point for contamination and 
obstruction to imaging.  It was therefore necessary to identify an alternative site within the 
system for locating the temperature sensor for control. 
The use of this system for long term studies was limited by the absence of a CO2 gas supply, for 
buffering the pH of the culture media.  Any gas supply should be supplied into a humidified 
atmosphere in order to control media evaporation, the necessity for which was demonstrate 
by a three day study of hESC proliferation in the Olympus acrylic box LCI system.  This study 
highlighted the adverse effects of low humidity (40 %) when running at 37 °C with a gas feed.  
Almost complete evaporation of the culture media occurred within three days resulting in the 
detachment and death of the cells in culture (video available on request).   
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Ince Acrylic box Cell IQ
Okolab CO2
incubator
Wafergen
In Vivo Scientific 
CO2 chamber
Portable      
Temperature
range (˚C)
37 RT+10 - 42 20-40 RT+3 - 50 25 - 50 
Temperature
accuracy (˚C)
± 0.3 ± 0.1 ± 0.2 ± 0.2 ± 0.2 
Gas control pre-mix  pre-mix CO2 0 - 100 % pre-mix pre-mix
Time to ready min hr min/hr min min sec
Humidity (%)  ≤ 40 5-50  not 
controlled
 not 
controlled
 not controlled
Vessel size 35 mm dish any
well plates
flasks
petri-dish, 
glass slide, well 
plate
Wafergen
vessel
coverglass
Specialist
consumables      
Media feed      
Autoclavable ?     
Comments
mineral oil 
prevents 
evaporation
sole use of 
microscope
integrated 
analysis 
software
cooling circuit,
Light blackout
6 simultaneous 
conditions
quick + easy to use
 
Table 6.1. Comparison commercially available of live cell imaging facilities. 
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Figure 6.3. Linkam LCI facility - Prototype 1. 
The removable lid in combination with the alimunium base improved ease of sample loading (A).  A 35 mm petri-dish 
(blue circle; B) was placed on top of a glass slide base.  When powered heated air flowed  from the fan outlet around 
the dish (yellow arrows - B) and out of the chamber through vents under a glass base slide (C).  The power and 
temperature was controlled by a feedback sensor (C) and control box (D) accurate to ± 0.1 °C. 
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6.4.2 Linkam LCI facility - Prototype 2 
Prototype 2 was designed to incorporate a CO2 gas feed around the culture vessel enabling 
longer term studies.  Utilising the theory that it is easier to control a small environment than a 
larger one, the system was split into two chambers.  The small inner chamber contained the 
sample under a gas controlled environment reducing the gas consumption.  The outer 
chamber served as an insulator to retain uniform heating of the inner chamber. 
 
6.4.2.1 Temperature control 
During heating, air was drawn over the fan and pushed around the outer chamber of the 
device, heating the inner chamber by convection.  The location of the fan to one side of the 
stage meant that it was necessary to ensure heating across the culture surface was uniform for 
consistent cell culture.  Thermocouples calibrated to ± 0.5 °C were placed on the base of the 
culture dish close to the fan (Figure 6.4A -X) and on the opposite side away from the fan 
(Figure 6.4A –Y).  The system was set to run at 37°C and temperature readings were recorded 
every minute for 1 hour.     
No overall difference in temperature was noted within the media across the base of the 
petri-dish despite one side being closer to the fan (Figure 6.5).  There was also no observed 
difference in the time taken for the media at each location to reach 37 °C (25 min).  Reassured 
that the temperature was constant across the culture surface it was possible to remove the 
temperature sensor from the culture surface into an alternative non-invasive location thus 
reducing the likelihood of contamination.   
The inner chamber contained the cell culture dish; therefore the conditions within this 
chamber must be controlled to the desired environment for culture.  The temperature and 
humidity sensor was therefore relocated to the inside the wall of the inner chamber (Figure 
6.4A).  The system was set to run at 37 °C and the temperature variation in the inner chamber, 
recorded every second.  Temperature control was extremely consistent varying by just -0.1 °C 
below the 37 °C set point (Figure 6.6).  Interestingly the temperature never increased above 
37 °C, so the cells were not exposed to even slight overheating. 
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Figure 6.4. Temperature and gas controlled stage - Prototype 2. 
The system was designed with two main chambers the inner chamber to hold the petri-dish, which was machined 
flat to seal with a glass slide (A).  Heated air was blown into the outer chamber (B) to heat the inner chamber via 
convection avoiding a flow of heated air over the culture surface.  Gas was mixed to the desired CO2 composition in 
the gas mixer (C) and pumped through a heated bubbler to humidify before entering system.  Air exited the system 
through vents under the petri-dish and inner chamber (D). 
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Figure 6.5. Comparison of the temperature across the base of the petri-dish. 
Thermocouples were located on the base of the culture dish as shown in Figure 6.4A. close to the fan (X, green), 
away from the fan (Y, red) and on the laboratory bench (blue).  No variation in temperature across the chamber was 
detected, despite the different distance from the heat source. 
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6.4.2.2 Evaporation 
After running the Linkam system at 37 °C, it became obvious that media was evaporating from 
the culture dish, 42.57 % ± 6.32 after just 48 hours (Figure 6.7).  Petri-dishes are subject to 
evaporation even in standard laboratory incubators because they are not sealed culture 
vessels.  In an attempt to understand whether the high level of evaporation was due to the 
dish or the conditions within the stage, the evaporation from the 35 mm dish in the stage was 
compared to that in a humidified 37 °C laboratory incubator (Heraeus, Hera Cell 150).  A 
comparison was run between the 35 mm dishes and three sizes of standard tissue culture flask 
T25, T75 and T150.   
Sixty 35 mm petri-dishes were each filled with 2 ml cell culture media.  Thirty dishes were 
randomly distributed throughout a 37 °C humidified incubator and the remaining thirty dishes 
at 4 °C as a control.  Triplicate sample from tissue culture flasks (T25, T75 and T150) were filled 
with cell culture media (5 ml, 15 ml and 30 ml respectively), maintaining a constant surface 
area: volume ratio in all vessels.  The weight of the empty vessel and vessel with media was 
recorded at the start of the experiment (Mettler-Toledo, AB240S).  On each day of ten days, 
three samples were weighed.  The percentage of evaporation was calculated from each vessel 
and the volume of remaining media presented (Figure 6.7).  Error bars represent 2 standard 
errors (SE = standard deviation/√(n), where n = sample number).   
Media loss from petri-dishes was significantly higher than that lost from all three sizes of 
T-flask as determined by ANOVA on day ten samples (p < 0.001) and was more variable as 
indicated by larger error bars.  This is likely to be due to the small neck of the flask which is 
fitted with 0.2 micron filter in the lid, serving mainly to prevent contamination but also 
reducing surface area for evaporation.   
Significantly more evaporation occurred from the Linkam stage compared to the laboratory 
incubator by day three; 42.6 % and 12.4 % evaporation respectively (p = 0.003).  The extreme 
level of evaporation from the 35 mm dishes indicated a requirement for frequent media 
feed/replacements or much improved humidity to decrease the rate of evaporation within the 
stage.  This was addressed in the next prototype. 
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Figure 6.6. Temperature stability of inner chamber. 
The temperature sensor was moved to the wall of the inner chamber and set to run at 37 °C.  the temperature 
within the inner chamber remained stable at 37 °C (-0.1 °C) throughout the duration of the study.  
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Figure 6.7. Media loss due to evaporation in petri-dishes and T-flasks.  
Media was incubated under a 37 °C, humidified 5 % CO2 atmosphere for ten days.  Surface area:volume ratio was 
consistent in all vessels.    The remaining media was plotted from T25 (orange, n=3), T75 (green, n=3), T150 (purple, 
n=3), 37 °C incubated petri-dishes (red, n=3), 4 °C refrigerated petri-dishes (blue, n=3) and a petri-dish within the 
Linkam stage (yellow, n=2).  Media loss from petri-dishes was considerably larger and more variable than the lost 
from all three sizes of T-flask.  By day three, 42.57 % of media had evaporated from the Linkam stage, which is 
comparable to evaporation levels in a standard incubator after nine days incubation at 37 °C (45.4 % loss) 
demonstrating a significantly higher rate of evaporation within the Linkam stage (p = 0.003 at day 3).  Error bars 
indicate ± 2SE.   
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6.4.2.3 Ease of loading 
The sample loading in prototype 2 was not ideal due to the narrow width of the culture dish 
compared with the inner chamber (Figure 6.8).  The cell culture dish could not be lowered into 
place and so was dropped into the chamber disturbing the sample and risking contamination 
from aerosol formation.  For this reason the method of loading was addressed in the overall 
design of the next prototype. 
 
6.4.2.4 CO2 control 
In an attempt to provide a CO2 atmosphere for prolonged cell culture, the desired CO2 gas mix 
was created with a gas mixer and sensor (Figure 6.4C) and passed through a heated bubbler to 
humidify before entering the stage.  Carbon dioxide is used in cell culture to balance the pH of 
the media (Freshney, 2005).  Its presence can be identified by the colour of the phenol red 
within cell culture media.  Accounting for subjectivity in colour, phenol red indicator is purple 
at pH 7.8, pink at pH 7.6, red at pH 7.4, orange at pH 7.0, yellow at pH 6.6 and lemon yellow 
below pH 6.5 (Freshney, 2005).  A change in colour is therefore indicative of a change in pH.  In 
the absence of cells, the colour of the media provides an idea of the CO2 atmosphere within 
the chamber.  The consistent purple colour of the media, confirmed that CO2 was either not 
entering, or was being continually lost from the inner chamber of the stage.  In order to reduce 
variables in the system, the gas mixer was removed for experimentation and premixed 5 % CO2 
bottles were purchased with certification from BOC for all further experiments.  Finally, it was 
suspected that the CO2 was dissolving in the water reservoir of the heated bubbler which 
would need to become saturated with CO2 before the correct concentration of CO2 would 
enter the stage which would be difficult to control.  With introduction of a water reservoir in 
the inner chamber it was thought to be no longer necessary to humidify the gas input.  The 
bubbler was therefore removed from further models. 
 
6.4.3 Linkam LCI facility - Prototype 3 
Ideally, an internal CO2 sensor would have been incorporated into the inner chamber to 
control the CO2 environment.  Carbon dioxide sensors use adsorption of infra red to determine 
the concentration of CO2, and as such require a minimum distance for detection, which 
exceeded the length of the inner chamber.  As an alternative to a CO2 sensor, a pH probe was 
inserted into the culture vessel through the lid of the inner chamber to monitor the pH for 
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correlation to CO2.  This was not designed as a feature for a final model, but rather as a 
method for monitoring CO2 within the chamber for optimised design. 
To aid sample loading, the inner chamber was altered to a base plate for the sample with a lid 
on springs forming all remaining walls of the inner chamber which sealed with a rubber seal 
when the system was closed.  To increase humidity and therefore reduce evaporation, two 
water reservoirs were machined into the base plate.  To improve heat circulation, the single 
horizontal fan was exchanged for two smaller vertical fans. 
 
6.4.3.1 Limitations with Prototype 3 
It rapidly became apparent that incorporation of a pH probe was unsuitable for monitoring the 
CO2 atmosphere because the 35 mm dish was loaded with 2 ml media to a 2 mm depth as 
standard.  To correctly measure pH, the probe must be submersed in media which was only 
just possible at a 2 mm depth.  After several days with consistently high evaporation, the pH 
probe was no longer submerged sufficiently to function.  The probe was removed for further 
studies and analysis reverted to the phenol red indicator used as a rough measure of CO2 until 
a suitable alternative was identified.  Using colour as an indicator, a CO2 environment within 
the inner chamber was only possible with a continual flow of premixed 5 % CO2 gas.  However, 
with a continual gas flow, evaporation remained a significant issue and despite incorporation 
of two water reservoirs, culture media dried up within days, demonstrating the need for a 
sealed inner chamber, to retain the humidified atmosphere.   
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Figure 6.8. Sample loading in prototype 2.   
The narrow dimensions of the inner of the chamber restricted the delicate loading of the culture dish which was 
dropped into place disturbing the sample, demonstrating a need alter the design of the system.  
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Figure 6.9. Linkam LCI facility - Prototype 3.   
The layout of the inner chamber was reversed to load sample onto a base plate and seal into a closed chamber 
when the entire system was shut.  Water reservoirs increased the humidity within inner chamber (A).  A pH probe 
was inserted into the culture media through an opening in the lid (A).  The inner chamber was sealed by tension and 
a rubber seal (A, B).  The single horizontal fan in prototype 2 was exchanged for two smaller fans, rotated into a 
vertical position to aid even heat distribution (C). 
 
 269 
6.4.4 Linkam LCI facility - Prototype 4 
In prototype 4, the inner chamber was sealed from below with a glass slide in the base plate to 
prevent water loss and reduce evaporation.  The outer chamber was also modified to divert 
the air flow around the inner chamber to aid even heating (Figure 6.10).  Outlets for the warm 
air were place on either side of the inner chamber to encourage the air to flow below the base 
plate and warm the glass slide.   
An external CO2 sensor was incorporated into the stage design (Figure 6.11).  With a pre-mixed 
5 % CO2 feed, purged into the inner chamber (frequency of purge was set by the user).  The gas 
outlet from the inner chamber was connected to the external CO2 sensor.   
 
6.4.4.1 Limitations with prototype 4 
The external CO2 valve failed to measure CO2 in the atmosphere of the gas outlet from the 
inner chamber, confirming an absence of CO2 for cell culture.  It was possible that the CO2 was 
absorbed by the length of the PVC tubing, before reaching the sensor.  All tubing was switched 
to silicone to prevent loss of CO2.  This tubing is used in hospitals because it is non-reactive, 
non-toxic and durable and was therefore considered suitable for use in this facility.  Using this 
system it was possible to record a short video of the behaviour of hESC derived neurons in 
culture (Video available on request).  However, all neurons detached from the culture surface 
over the 48 hours recording, indicating suboptimal culture conditions which were thought to 
be attributable to a lack of CO2, resulting in too high pH for cell survival.  Neurons remained 
attached and healthy in a control sample cultured within a standard laboratory incubator.   
Further efforts were made to identify a CO2 sensor which could be incorporated into the inner 
chamber for a feedback control system on gas purging when CO2 atmosphere dropped below 
the set point, rather than on a defined purge rate set by the user, reducing fluctuations in 
atmosphere which were not comparable to standard cell culture. 
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Figure 6.10. Linkam LCI facility - Prototype 4 altered air flow.  
Warm air flow was diverted (yellow arrow) around the outside of the inner chamber in a circle (B) maintaining 
temperature of inner chamber rather than air flow above and below the inner chamber as in prototype 3 (A) using 
metal baffles (red arrows).  A glass slide was added to base of inner chamber, creating a sealed environment to 
retain gas control and humidity for reduced evaporation. 
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Figure 6.11. Linkam LCI facility - Prototype 4 - external CO2 sensor.   
The external CO2 sensor was set to measure the CO2 atmosphere from the gas outlet of the inner chamber.  Gas 
flow was set to 50 cc/min and controlled with a valve.  Frequency and duration of purging was controlled by the 
user using LinkSYS software. 
 271 
6.4.5 Linkam LCI facility - Prototype 5 
Two years after beginning this project, a small CO2 sensor was identified which was small 
enough for use with the stage (Figure 6.12 A-B).  The sensor was positioned on the outside of 
the inner chamber, measuring CO2 within the chamber through glass panels.  LinkSYS software 
was modified to incorporate feedback control on CO2 for purging as necessary.  The inner 
chamber remained sealed with water reservoirs.  The shape of the outer chamber and baffles 
for heated air flow were altered to remove dead space which retained cooled air pockets and 
improved air flow and circulation. 
 
6.4.5.1 Limitations with prototype 5 
The new design and weight of the fans and electronics created and imbalance on the stage 
causing it to tip when not placed securely on the microscope (Figure 6.12E).  While this was 
not a problem for imaging, for portability, the system must be stable when moved from the 
microscope to prevent spillage in transit.   
Sealing the inner chamber with a glass slide contained the humidity within the chamber 
successfully resolved the problem with evaporation.  However, when running at 37 °C at 90 % 
humidity, condensation began to build up between the base of the petri-dish and the glass 
slide.  The glass slide was exposed to the warm inner chamber on one side, and the cold 
air-conditioned room and microscope on the other, creating a cooled surface on which the 
water from the humidified chamber condensed.  It was possible to generate a 48 hour video of 
mouse embryonic fibroblasts in culture before loss of focus due to condensation (video 
available on request); however, condensation eventually interfered with imaging.  The viability 
of the iMEFs from this run (96.0 %) were comparable to a control sample from a standard 
laboratory incubator (95.4 %); however, the overall cell number from the Linkam incubator 
sample was lower (1.2 x 105/ml) than a standard laboratory incubator (1.55 x 105/ml) 
suggesting a slower rate of proliferation in the stage, and thus suboptimal culture conditions.  
Modifications to the next model were aimed towards preventing condensation between the 
lens and the cell culture surface.   
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Figure 6.12. Linkam LCI facility - Prototype 5. 
In built CO2 sensor (A-B; red arrows).  Lid shut sensor (C; blue arrow).  Combined system with LinkSYS software (D).  
Imbalance on stage due to weight of fan (E).  Modifications to the inner chamber to incorporate a media feed 
system were installed ready for the programming software to process this system.  These pipes were sealed on the 
inlet and outlet to the chamber to prevent gas escaping through these tubes, until ready for use (Figure 6.13). 
A B
C D
 
Figure 6.13. Media feed and condensation in prototype 5.   
Media in and outlet pipes were incorporated into the design to enable feeding of long term cultures (A-B).  Feed 
pipes are stainless steel to enable ethanol and/or autoclave sterilisation.  The sealed inner chamber retained > 90 % 
humidity but the heat sink from the microscope and air conditioned room below the chamber caused condensation 
to build up between the culture dish and glass base plate (C, D). 
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6.4.6 Linkam LCI facility - Prototype 6 
Final modifications to the imaging system removed the glass slide from the inner chamber 
base plate so there was no longer a surface on which condensation could build up.  Instead the 
inner chamber was sealed around the petri-dish with a silicone ring to prevent loss of humidity 
and gas from the inner chamber (Figure 6.14).  In addition, the inner chamber was rotated 
90° with two outlets for heated air from the fan, improving the dispersal of warm air around 
the inner chamber.  In this way, warm air exited the system underneath the culture dish from 
two directions, reducing the heat sink from below the culture surface in the cooled laboratory 
atmosphere. 
Due to time restrictions on the duration of this project, it was not possible to fully trial 
Prototype 6 of the Linkam stage (Figure 6.15).  However, initial studies showed promising 
results for retained humidity ≥ 90 %, with a tightly controlled 5 % CO2 atmosphere and 
considerably reduced media loss over time (54.4 % evaporation after 7 days, when compared 
to the earlier 43.5 % evaporation after just 3 days in prototype 2), demonstrating that this 
system provides a facility which significantly improves upon the environmental conditions of 
current LCI systems. 
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Figure 6.14. Linkam LCI facility - Prototype 6 
Rotated inner chamber to allow heated air flow from two sides of the culture dish, preventing a exposure of a 
cooled surface for condensation to build up.  The inner chamber was sealed with a silicone ring around the culture 
dish to retain a humidified atmosphere and controlled CO2 environment. 
 
 
Figure 6.15. Linkam live cell imaging system.   
A portable incubator which facilitates long term LCI studies, with automated control over culture environment.  
Suitable for use with any laboratory microscope. 
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6.5 Discussion 
Although many of the environmentally controlled microscope incubator chambers on the 
market today provide fine control over temperature, humidity and gas flow, the portability and 
ease of use of the Linkam stage gives it an advantage over other products.   
Linkam Scientific have tailored this product for use in laboratories worldwide, minimising cost, 
whilst maximising the potential applications.  The use of readily available tissue culture dishes 
and the minimal gas consumption from a certified pre-mixed supply minimises running costs, 
whilst maximising confidence over culture environment.  Limitations to the usability of the 
Linkam system remain in the user software which is currently undergoing modifications to 
incorporate changes introduced to by advances in CO2 and temperature control.  On 
completion of these modifications a baseline model for LCI will be ready for market launch.   
Over the coming year, additional features will be developed and introduced as supplements to 
the basic model resulting from this study.  These additional features will be aimed and 
increasing the market audience for this product and will include suggestions resulting from use 
of the system in this study.  Modifications will include a gas mixing facility to enable hypoxic 
cells culture, a battery supply for improved portability between laboratories enabling 
concurrent systems to be run, a media feeding facility to enable long term uninterrupted 
imaging for differentiation studies and adaptations to suite culture vessels of different sizes 
(Section 8.5).  With these modifications, the stability of culture environment within the Linkam 
live cell imaging system, suggest a real place in the scientific research and development market 
for this system, providing an affordable option for laboratories to benefit from the advantages 
of live cell imaging. 
 276 
7 Final Discussion 
Pluripotent cells are capable of both self-renewal and differentiation into any cell type of the 
body (Thomson et al., 1995).  As such they are able to generate unlimited numbers of any 
desired cell type with huge potential for application to pharmacological screening and 
regenerative therapies where process is limited by cell supply.  However, the differentiation 
capabilities of these cells are variable between cell lines and laboratories, and conflicting 
evidence with regards to their stability in culture, raises concerns over their suitability for 
therapy.  
Throughout this project a comparative study into the stability and neuronal differentiation 
capability of a range of pluripotent cell lines (hEC and hESC) has been carried out.  
Comparative analysis of cell behaviour and morphology was achieved using a combination of 
bright field microscopy, epi-fluoresence microscopy and a live cell imaging facility, which was 
designed throughout the project for this purpose.  Finally an in depth comparison of the 
changes in gene and protein expression of the different hESC lines following induction of 
neuronal differentiation was undertaken, which highlighted internal programming amongst 
different hESC lines, that confer a preferential cell fate for differentiation. 
 
7.1 Expansion and stability of pluripotent cell lines in culture 
Five pluripotent cell lines were combined for comparison in this study of both hEC and hESC 
origin (NTERA2, Shef3, HUES7, RH5 TrypLE and RH5 cut).  The RH5 cut was a sub culture of the 
original enzymatically passaged RH5 cell line (referred to as RH5 TrypLE throughout this 
project), adapted into mechanical passaging, enabling a comparison of cell behaviour between 
two mechanically passaged (Shef3 and RH5 cut) and two enzymatically passaged cell lines 
(HUES7 and RH5 TrypLE).   
No differences were observed in the expression of OCT4, SOX2, SSEA4 and Tra-1-60 amongst 
pluripotent populations of each of the five cell lines studied.  However, there were significant 
differences in the behaviour of these lines in culture, and their susceptibility to spontaneous 
differentiation.  Seeding at low densities induced differentiation in all cell lines but this was 
most noticeably in the NTERA2.  Amongst mechanically passaged hESC lines, spontaneous 
differentiation was observed when cultured on low iMEF densities < 2.6 x 104 cell/cm2.  In all 
cases, low cell density resulted in cells of an epithelial morphology.  These cells were not fully 
characterised in culture but have been identified previously by multiple laboratories 
(Damjanov and Andrews, 1983; Pleasure et al., 1992; Amit et al., 2000). 
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In contrast, the effect of high seeding density induced differentiation was varied across the 
pluripotent lines (high iMEF density for mechanical passaged lines), generating a haphazard 
array of different cell types which were different between each of the hESCs studied.  In Shef3, 
spontaneous differentiation frequently resulted in the formation of patches of beating cells, 
similar in appearance to those of cardiomyocytes (Burridge et al., 2007), which were rarely 
observed in the HUES7 cell line and never observed in the NTERA2 or RH5 cut/TrypLE lines.  In 
itself, the cell types formed during spontaneous differentiation could be considered a good 
indicator of the preferred cell fate of a cell line.   
Additional observed differences between the pluripotent cell lines included the speed of 
proliferation.  Indeed reports of hESC doubling times range from 13-72 hours between 
different cell lines and laboratories (Cowan et al., 2004; Rosler et al., 2004; Thomson et al., 
2008), demonstrating inherent variation in the behaviour of different hESC lines.  In this study, 
mechanically passaged cell lines were considerably slower growing than the enzymatically 
passaged lines, which required passaging at approximately twice the frequency to retain 
pluripotent characteristics.  The increased proliferation in enzymatically passaged cell lines 
would enable rapid expansion of cell numbers, facilitating scaled-up bioprocessing of these 
lines for therapy.  However, rather than pluripotent cells, it is their differentiated progeny 
which would be used for therapy and in order to differentiate, a cell must exit the cell cycle 
(Walsh and Perlman, 1997; Maione and Amati, 1997; Brown et al., 2003).  It was therefore 
hypothesised that the apparent preference to proliferate would reduce the capacity of a cell 
line to subsequently differentiate (Section 7.3).   
Alterations in a cell’s behaviour, such as the speed of the cell cycle, are brought about by 
changes to the internal programming of the cell.  Indeed an increased rate of proliferation has 
been correlated to older hESC cultures, in which karyotypic abnormalities were more 
frequently detected (Cowan et al., 2004). 
 
7.2 Karyotypic stability in pluripotent cell lines 
The causes of karyotypic alterations in hESCs are the subject of huge debate in the field, with 
conflicting opinion over the influence of single cell dissociation by enzymatic passaging on 
hESC karyotypic stability (Cowan et al., 2004; Buzzard et al., 2004a; Draper et al., 2004a; 
Mitalipova et al., 2005; Suemori et al., 2006; Ellerström et al., 2007; Thomson et al., 2008).  
Data within this report largely supports concerns which suggest that enzymatic passaging of 
pluripotent cell lines induces the selection of chromosomal aberrations.  The HUES7 cell line 
was originally derived with a normal 46 XY karyotype (Cowan et al., 2004); however, 
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preparation of the UKSCB MCB resulted in additional copies of chromosomes 12 and 17 and 
over 45 subsequent passages further trisomies for chromosomes 14 and X were detected.  In 
contrast the mechanically passaged Shef3 retained its normal 46 XY karyotype throughout the 
project.  This data suggests that enzymatic passaging contributes towards karyotypic 
instability; however, it does not account for the possibility that one cell line may be more 
susceptible to aberrations than another (Buzzard et al., 2004a).  The adaptation of RH5 into 
mechanical passaging also resulted in small but significant alterations in the karyotype.  These 
alterations may have occurred as a result of previous abnormalities from earlier enzymatic 
passaging; however, the original 101 XX karyotype of this line upon derivation would suggest 
an inherent susceptibility to karyotypic instability.   
Chromosomal duplications, deletions and translocations can be detected using G-banding 
analysis, but this technique does not enable detection of smaller duplications/deletions in 
single loci, which were identified in RH5 cut and TrypLE using aCGH analysis.  Array CGH was 
not carried out on the Shef3 cell line in this study.  It is therefore possible that despite an 
apparently normal karyotype under G-banding analysis, the genomic content may indeed have 
undergone small alterations during culture which would require confirmation using aCGH 
analysis.  It could therefore be speculated that the lack of karyotypic instabilities reported 
amongst hESC culture laboratories result from inadequate G-banding analysis, rather than true 
stability of hESCs in culture.  Indeed recent publications which adopted aCGH technology for 
karyotypic analysis of hESC lines also detected smaller alterations which were missed under 
G-banding analysis, further supporting this theory (Thomson et al., 2008).   
Array CGH comparison of the RH5 cut and TrypLE populations, detected four minor variations 
between the lines.  Two of these were considered to be suitable candidates for the observed 
differences in neuronal yields of these cell lines.  RH5 cut demonstrated a loss of chromosomal 
region 5q35.1 which encodes the BTRCP2 gene (FBXW11; NCBI, Entrez Gene).  BTRCP2 is 
expressed at high levels in the foetal forebrain to regulate development (Koolen et al., 2006) 
and interacts with the BTRCP1 protein to form a dimer which is responsible for degradation of 
the REST protein (Suzuki et al., 2000a; Westbrook et al., 2008).  Down regulation of REST is 
required for neuronal differentiation (Ballas et al., 2005; Sun et al., 2005; Johnson et al., 2008; 
Jørgensen et al., 2009; Buckley et al., 2009).  Indeed gene expression analysis demonstrated a 
higher average REST expression in RH5 cut than in RH5 TrypLE.  Therefore the loss of this 
chromosomal region may in part explain the lower neuronal yield from RH5 cut than RH5 
TrypLE.  In addition aCGH analysis detected a gain of chromosomal region 2p25.2 in RH5 
TrypLE.  A loss of this region has been previously associated with Autism (Lo-Castro et al., 
2009), which has been linked to a reduction in the number of inhibitory neurons within the 
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cortical region of the brain (Vaccarino et al., 2009).  With this in mind, an additional copy of the 
2p25.2 chromosomal region may be implicated in the production of GABAergic inhibitory 
neurons, which were generated in higher numbers by the RH5 TrypLE cell line than any of the 
other three hESC lines investigated.   
Since the two RH5 cell lines arose from the same starting cell pool and were cultured in 
parallel using the same media, the mode of passaging was the only variable to cause 
differences in cell behaviour.  Therefore, the effect of passaging did not only impact upon 
length of the cell cycle and but also on the subsequent ability of the different lines to be 
directed into a neuronal cell fate.  With this in mind, the five pluripotent cell lines were 
compared for their gene expression profiles in response to induction of neuronal 
differentiation. 
 
7.3 Comparative neuronal differentiation in pluripotent cell lines 
Early neuronal differentiation studies were modelled on the established ATRA induced motor 
neuronal differentiation in NTERA2 (Pleasure et al., 1992).  The efficiency of differentiation 
using NTERA2 was highly variable, despite enhancements to the protocol.  On occasion, no 
neuronal differentiation occurred, generating cells of epithelial-like morphology. 
Upon successful differentiation, neurons were identifiable in culture just 10 days after ATRA 
induction, characterised by the expression of the neuronal markers TUBB3 and MAP2.  The 
number of neurons continued to increase throughout the subsequent weeks in culture.   
One of the key limitations for use of cell line derived neurons in pharmacological screening is 
their reduced response to neurotransmitter stimuli when compared to primary sourced 
neurons (Personal communication Dr. T. Sesardic, Bacteriology, NIBSC). For this reason, 
emphasis was placed on ensuring neuronal functionality amongst differentiated populations, 
with comparison to behaviour of primary neurons in response to stimulation.  Patch clamp 
analysis of NTERA2-derived neurons throughout differentiation demonstrated the ability to fire 
genuine sodium action potentials in response to manual depolarisation after just two weeks. 
This was the first study to compare the functionality of NTERA2 derived neurons throughout 
differentiation, and demonstrated that prolonged culture resulted in an increase in the overall 
neuronal yield, in addition to improvements in neuronal functionality.   
Calcium imaging enabled a visible comparison of the behaviour between NTERA2 derived 
neurons and primary neurons.  Rat neural tissue is frequently used for pharmacological 
screening, and as such was considered to be a suitable control for the comparison of cell line 
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derived and primary neural tissue.  Due to the detection of GABAergic neurons in NTERA2 
derived neuronal populations, primary neurons were sourced from the ganglionic eminence of 
an e14 rat, which is the source of GABAergic interneurons in the brain (Ang et al., 2003).   
Primary neurons generated recurrent, electrical communication across the monolayer of cells 
in culture in the absence of external stimulation.  Spontaneous activity was not seen in 
NTERA2 neuronal populations and required manual depolarisation to induce a response; 
however, this may simply have been a result of lower neuronal cell density in NTERA2 
populations with subsequently reduced production of neurotransmitter for stimulation of 
surrounding cells, rather than in inability to respond to surrounding signals.   
Maturation of NTERA2 neurons was demonstrated after prolonged culture by the generation 
of recurrent AP’s following stimulation; however, the size of electrical impulse from 6-week 
differentiated NTERA2 was much reduced from that of the primary neurons.  In addition, the 
calcium influx in response to glutamate was considerably less than was seen in primary 
neurons with an average cytosolic calcium levels reaching ~150 nM in comparison to ~800 nM 
in primary neurons.  This suggests a reduction in the number of functional glutamate ion 
channels when compared to primary neurons, thus reducing the electrical impulse generated 
by the cell. 
Transplantation of NTERA2 derived neurons into the brain of a 71-year old stroke victim, 
demonstrated the ability of cell line derived neurons to integrate into host tissue following 
transplantation (Nelson et al., 2002); however, minimal recovery of function was observed, 
which is a likely result of their immature neuronal phenotype.  The survival of these cells 
following transplant, in the absence of tumour formation is a promising result for the use of 
pluripotent derived cell lines in therapy; however, the poor efficacy of these cell in vivo 
actively demonstrates the requirement for improvements to cell line-derived neuronal 
function, in addition to neuronal yield. 
The NTERA2 cell line was originally derived from a germ cell tumour in 1975, and reported to 
have a hypertriploidy karyotype 63 XY t(12;13)(q13;qter) (Andrews et al., 1990; Andrews et al., 
1994).  Preparations for karyotypic analysis of this cell line during this study, failed to generate 
sufficient metaphase spreads for G-banding; however, given the propensity of pluripotent 
hESC lines to accumulate karyotypic alterations following extended culture (Section 7.2), it 
would be reasonable to assume that more than 30 years in culture under selection for 
pluripotent populations may have affected the ability of these cells to respond to 
differentiation stimuli, thus resulting in heterogeneity in differentiation.  With this in mind, it 
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was hypothesised that the irreproducible response of NTERA2 to differentiation, was a result 
of its original tumour origin and abnormal karyotype resulting from culture adaptation.  
To investigate this further, neuronal differentiation amongst a selection of hESCs was 
compared to that of NTERA2.  Pluripotent hESC lines with varying degrees of chromosomal 
abnormalities (Section 4.1.1) were selected for investigation.  In addition, the effect of 
passaging technique on the subsequent differentiation of the hESC lines was also investigated 
by comparison of the mechanically and enzymatically passaged cell lines.  Pluripotent 
populations were differentiated following the enhanced neuronal differentiation protocol 
developed within this study.   
Neuronal differentiation was initiated by standard EB formation but was selective for cells of 
ectodermal cell fate using a neural induction media.  Induction of differentiation in this media 
reported a more rapid down regulation of pluripotency (according to OCT4) and enhanced 
commitment of cells into the ectodermal fate, as confirmed by increased expression of Nestin 
after four days in NI media when compared to alternative media for EB differentiation 
methods (Li et al., 2007).  Additional improvements to neuronal purity were achieved by the 
removal of serum from differentiation media which reduced the overgrowth of non-neuronal 
cells in culture (Brewer et al., 1993; Brewer, 1995).  In a similar way, removal of bFGF from 
differentiation media after the first four days in culture, also enhanced neuronal purity as 
determined by TUBB3 expression (Schwindt et al., 2009). 
Neurons derived from all four hESC lines stained positively for neuronal markers TUBB3, MAP2 
and 70 kDa Neurofilament.  Data on the expansion of human neural precursor populations 
from a range of brain regions suggests that GABAergic neurons are the default neuronal 
phenotype of in vitro neuronal differentiation (Jain et al., 2003).  Correspondingly, 
immunostaining of hESC derived neurons confirmed a proportion of inhibitory GABAergic 
neurons within all hESC lines.  No positive staining for TH or SERT was detected in end stage 
populations; however, in the absence of a positive neuronal control for immunostaining 
studies, it was difficult to confirm negative staining.  Damage to the neuronal networks during 
preparation for flow cytometry analysis meant that it was not possible to quantify the 
neuronal yields for comparison between these lines.  However, visible inspection of colonies 
following differentiation, highlighted clear variations between the neuronal yield and purity 
from each hESC lines following differentiation; RH5 TrypLE was the most responsive cell line to 
neuronal differentiation, with the greatest reproducibility and highest neuronal yields.  In 
contrast, Shef3 was highly variable.  Neurons were visible following Shef3 differentiation but 
failed to spread in monolayer culture and were easily detached from the tissue culture surface 
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during feeding.  These observations of neuronal yields were confirmed by Q-PCR analysis of 
differentiating populations. 
Pluripotency prior to differentiation was confirmed by the expression OCT4, SOX2, Tra-1-60 
and SSEA4, in addition to positive expression of genes associated with pluripotency (DNMT3B, 
FGF4, EBAF, GDF3, TDGF1, UTF1 and TERT).  With the exception of SOX2, all of these genes 
were down regulated in the four hESC lines upon differentiation.  In addition to regulating 
pluripotency, SOX2 is also expressed amongst neural progenitors, regulating proliferation and 
inhibiting terminal differentiation (Graham et al., 2003).  Interestingly, SOX2 was significantly 
down regulated from day 0 in Shef3 (p = 0.007 to day 28), suggesting a reduced number of 
neural progenitors in this line, compared to the other hESC lines (HUES7, RH5 cut and RH5 
TrypLE) which retained consistent SOX2 expression throughout differentiation (p = 0.950, 
0.479, and 0.118 respectively). 
The reduced neuronal differentiation of Shef3 can be explained by several reasons.  Most 
significantly, a larger proportion of Shef3 cells were lost into the endodermal lineage during 
the EB stage of differentiation as determined by the highest expression of AFP of all hESC cell 
lines, 3-, 5.3- and 17.4-fold higher expression than RH5 cut, HUES7 and RH5 TrypLE 
respectively.   In addition Shef3 expressed the highest levels of REST, of all three lines, which 
inhibits neuronal differentiation (Ballas et al., 2005; Sun et al., 2005).  Despite this, some 
neuronal differentiation was identified in Shef3, suggesting that it was not completely blocked.  
Neuronal differentiation in Shef3 was mainly forebrain derived GABAergic neurons, as 
detected by higher up regulation of PAX6 and PTF1A than the motor neuronal markers: HXLB9, 
CRABP2 and ISL1.  In addition, gene expression analysis detected the up regulation of TH, a 
marker for midbrain dopaminergic neurons amongst day 28 samples although this was 
considerably lower than levels detected in the HUES7 populations. 
The HUES7 cell line was easily established in culture and responsive to neuronal 
differentiation.  This cell line also presented minimal motor neuronal differentiation with a 
continual down regulation of the motor neuron specific marker HLXB9.  Neurons derived from 
this line were of predominantly forebrain and midbrain phenotype, with high levels of PAX6 
and PTF1A and TH, peaking at day 28 with 142.5, 201.9 and 127-fold increase from day 0 
respectively.  This was the highest expression levels of TH in all of the four hESC lines, 
suggesting that this line may be best applied for studies wishing to generate dopaminergic 
neurons.  GABA was identified amongst HUES7 day 28 populations by immunostaining but TH 
positive neurons were not.  In the absence of a positive control it was not possible to confirm 
whether this was true negative staining.  However, the large error bars in TH gene expression 
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are suggestive of a variable dopaminergic neuronal yield in the HUES7 cell line.  As such it is 
possible that the immunostained samples were from a preparation when dopaminergic yield 
was genuinely low.  In light of this data, the immunostaining of final neuronal populations 
should be repeated in the presence of a positive control. 
HUES7 showed the greatest propensity for neuronal maturation of the four hESC lines, 
indicating the highest proportion of mature neurons as detected by SYP 136-fold increase in 
expression form day 0, compared to 15.42, 9.25, and 1.78-fold increase in expression by day 28 
in RH5 cut, RH5 TrypLE and Shef3 respectively.   
The RH5 cut cell line responded differently to neuronal differentiation than was seen in RH5 
TrypLE, despite arising from the same starting population of cells.  From this it could be 
concluded that the culture techniques of these two lines, do impact upon their outcome of 
differentiation.  However this cell line was passaged 36 times using enzymatic techniques prior 
to adaptation, suggesting that the hESC lines in culture are subject to continual adaptations. 
The largest differences between the neuronal differentiation of RH5 cut and RH5 TrypLE were 
observed in the expression of Noggin, whereby RH5 TrypLE expression increased by 27.8-fold 
on day 10 compared to 4.6-fold increase in RH5 cut on the same day (relative to day 0).  
Noggin is a BMP inhibitor which blocks the commitment of pluripotent cells in a mesodermal 
or endodermal cell fate (Pera et al., 2004; Gerrard et al., 2005a; Sonntag et al., 2007).  With 
this in mind, it was not surprising to see a higher overall neuronal yield in RH5 TrypLE than RH5 
cut.  Indeed, the RH5 TrypLE cell line presented the highest expression of Noggin in all four 
hESC lines, and might explain the high success of neuronal differentiation in this line.  Perhaps 
more interestingly, the Noggin gene is located on chromosome 17q21-22 (NCBI, Entrez gene), 
a region which is frequently duplicated upon enzymatic adaptation to culture.  This might 
explain why the HUES7 and RH5 TrypLE were apparently more reproducible in their neuronal 
differentiation than the mechanically passaged lines, and might suggest a benefit to enzymatic 
culture of hESC lines for use in pharmacological screening assays or neurodegenerative 
therapies. 
RH5 TrypLE retained high expression of many neural precursors including Nestin, PAX6, OLIG2, 
ISL1 and PTF1A, in addition to up regulation of mature neuronal markers in the latter stages of 
differentiation (SYP, TH and HLXB9) which was indicative of neuronal generation from all three 
developmental regions of the CNS (forebrain, midbrain and spinal cord).  However, expression 
of SYP and HLXB9 were lower in RH5 TrypLE than in RH5 cut, which in combination with the 
retention of precursor markers, was suggestive of a large proportion of immature neurons 
within the final day 28 population.  In addition, expression of PTEN was lowest in RH5 TrypLE 
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than in the other three hESC lines.  PTEN inhibits proliferation of neural stem cells, thus a 
reduction of PTEN  would explain higher proliferation amongst the RH5 TrypLE population of 
neurons (Groszer et al., 2001; Qu and Shi, 2009).   
The largely abnormal karyotype of the RH5 TrypLE cell line means that its incorporation into 
transplantation therapies is unlikely due to a risk of tumour formation following 
transplantation.  The risk of this was further emphasised by the apparent up regulation of 
pluripotency genes OCT4 and Nanog in day 28 samples which was also observed in the 
alternative enzymatically passaged cell line HUES7, suggesting an outgrowth of pluripotent 
cells within the differentiated populations.  However, the large reproducible neuronal yield 
from this cell line would be ideal for incorporation into pharmacological screening, reducing 
reliance upon primary tissue, and thus reducing animal sacrifice.   
The incorporation of cell line derived neurons into cell based assays is currently limited by both 
supply and sensitivity.  Neural precursors derived from pluripotent lines have a restricted 
capacity for proliferation prior to commitment into their terminal neuron cell fate (Maric and 
Barker, 2005; De Filippis et al., 2008).  Yet, the RH5 TrypLE cell line has demonstrated an 
enhanced expansion of neural precursors when compared to alternative cell lines, and an 
ability to terminally differentiate into a defined neuronal phenotype.  Thus, providing a near 
perfect solution to the shortage of cells for use in pharmacological screening, requiring only 
proof of sufficient sensitivity in the function of RH5 TrypLE derived neurons. 
Human ESC derived neurons were screened for their ability to generate an electrical impulse 
using patch-clamp analysis.  Neurons from all four hESC lines fired genuine rapid sodium action 
potentials which were reversibly inhibited following exposure to TTX.  However, similarly to 
the responses seen in immature NTERA2 derived neurons, only single AP’s were fired in 
response to stimulation, suggesting an immaturity in the behaviour of hESC derived neurons, 
and thus considered to be suboptimal when compared to the response of primary cells.  The 
functional data from these cells emphasises the requirement for further modifications to 
differentiation, in order to generate a more responsive end product (Section 8.2) 
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7.4 Summary 
Data from this study supports concerns that enzymatic passaging of pluripotent hESCs induces 
karyotypic instabilities, following identification of trisomies for chromosomes 12, 14, 17 and X 
in enzymatically passaged HUES7, and the retention of an outwardly normal karyotype in 
mechanical passaged Shef3.  However, aCGH analysis would need to be carried out on the 
Shef3 cell line to confirm the absence of minor alterations, after the identification of minor 
alterations in the RH5 cut line, suggesting that on the contrary to hypothesis 1, the method of 
culture does have an affect the karyotypic stability of a pluripotent cell line in culture. 
In disagreement with hypothesis 2, data from this study suggests that pluripotent cells are not 
equally directable into neuronal differentiation when cultured under optimal conditions.  
Spontaneous differentiation amongst each of the pluripotent cell lines demonstrated variation 
in the preferential cell fate of different cell lines, NTERA2 favoured epithelial differentiation, 
Shef3 appeared to favour mesodermal and endodermal differentiation with large variation in 
the response to neuronal differentiation.  Both RH5 cell lines were responsive to neuronal 
differentiation; however, RH5 TrypLE was more reproducible and yielded high numbers of 
neurons than RH5 cut, thought to be a results of endogenous inhibition towards mesodermal 
and endodermal lineages.  Finally, HUES7 was reproducibly induced into a neuronal cell fate 
but demonstrated restricted expansion of neural precursor populations. 
Finally, data from this study provides evidence against hypothesis 3: ‘The method of culture 
does not affect the ability of a pluripotent cell line to be differentiated into a functional 
neuron’.  All five pluripotent cell lines investigated were responsive to neuronal differentiation; 
however, the parallel culture of RH5 under mechanical and enzymatic passaging demonstrated 
divergence in their genomic content, including alterations in two candidate genes which 
influence neurogenesis, and may in part explain the differences in neuronal yields between the 
two RH5 cell lines.  These data suggest that the method of culture can indirectly affect the 
ability of a cell line to differentiate towards the target neuronal cell fate, by inducing 
karyotypic alterations within the population. 
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8 Future work 
In the event of any in-detailed research, the results obtained generate further areas for 
investigation.  As was the case with this project, the findings within highlighted a number of 
areas which required further attention, these have been outlined below.  Indeed, work on a 
number of these topics has begun in response to the results from this study and as such, 
represent the ongoing works to enhance neuronal yields from pluripotent cell lines with a view 
to future applications in regenerative therapies. 
 
8.1 Karyotypic analysis 
Data within this report supports concerns, which suggest that enzymatic passaging of 
pluripotent cell lines induces the selection of chromosomal aberrations.  However, the 
differences between enzymatic and mechanical passaging may not be considered truly 
representative in this study due to the comparison of a cell line which was abnormal from 
derivation, suggesting a propensity for karyotypic instability.  The effects of culture on 
karyotypic stability would therefore be better demonstrated with the adaptation of a range of 
hESC both normal and abnormal in starting pools into enzymatic passaging from mechanical 
and vice versa.  The populations would need to be cultured for a minimum of 20 passages 
under each condition (during which time most reports of abnormalities had been identified), 
followed by in depth analysis of gDNA content using both G-banding and aCGH technologies.  
Each sample would need to be compared to the genomic content of the original starting cell 
population.  In this way, it would be possible to clearly identify the impact of different 
passaging techniques on the stability of hESC lines in culture over time.  Subsequent 
comparison of the neuronal differentiation in mechanically or enzymatically passaged lines 
would then re-confirm the effects of passaging on the later directability into differentiation.  
 
8.2 Enhancing neuronal yield, survival and functionality 
8.2.1 Mesendodermal blockers 
The enhanced EB differentiation protocol within this study utilised a nine day EB formation 
stage.  Although selection for neural cells was induced from initiation of differentiation, studies 
into the development of EBs have clearly demonstrated the commitment of pluripotent cells 
into cell fates from all three germ lineages (Itskovitz-Eldor et al., 2000).  Through the duration 
of differentiation, culture media continued to select for neuronal populations, thus improving 
the purity of neurons as differentiation progressed.  However, neural precursors have a finite 
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expansion potential in culture (Jain et al., 2003; De Filippis et al., 2007; Elkabetz et al., 2008; 
Bajpai et al., 2009), and commitment of pluripotent cells into mesodermal or endodermal 
lineages in the early stages of differentiation, will have directly reduced the final neuronal 
yield.  Alternative differentiation protocols, incorporate incubations with BMP blockers such as 
Noggin to prevent the commitment of pluripotent cells into mesodermal or endodermal cell 
fates (Pera et al., 2004; Iacovitti et al., 2007), thereby enhancing the final neuronal yield.  
Additional studies have shown that incubation with Nodal inhibitors (Lefty and Cerb-S) also 
enhance neuroectodermal commitment, thus increasing neuronal yields from pluripotent 
populations (Vallier et al., 2004).  With this in mind, incorporation of Noggin and or 
Lefty/Cerb-S into the early stages of differentiation in NI media should therefore improve the 
commitment into ectodermal fate, thus enhancing subsequent neuronal yields.  This would 
prove to be a valuable addition to the media.  
 
8.2.2 Supplementation of Neurotrophins 
Results from the gene expression analysis study all suggest that the RH5 TrypLE cell line 
retained a progenitor state for longer in culture, enabling expansion of the neural precursors 
for generation of a larger neuronal yield.  Up regulation of mature neuronal marker SYP in 
addition to the demonstrable electrophysiological activity of this cell line confirmed the ability 
of this cell line to differentiate further into a more mature neuronal phenotype.  For this 
reason, The RH5 TrypLE cell line would seem to be an ideal candidate cell line for the 
production for large numbers of neurons for pharmacological screening.  However, it would 
first be necessary to demonstrate that RH5 TrypLE derived neurons could be matured into a 
neuronal phenotype with the sensitivity of a primary neuron to stimulation.  Neuronal 
maturation might be achievable by the addition of GDNF and BDNF into the maturing neuronal 
populations.  These neurotrophins have proven to be successful in aiding neuronal 
differentiation and maturation, in addition, to improved neuronal survival, thus reducing the 
high levels of cell death amongst differentiated neurons (Sauer et al., 1993; Encinas et al., 
2000; Obrietan et al., 2002; Zeng et al., 2006; Bakshi et al., 2006; Xuan et al., 2008).   
The effect of GDNF and BDNF on neuronal maturity would be easily investigated following 
supplementation into culture by the comparative behaviour under calcium imaging to 
neurotransmitter stimulation.   Additional functionality of these neurons could be carried out 
using High Performance Liquid Chromatography (HPLC) analysis to detect manufacture and 
release of the neurotransmitters following stimulation.  In the event of HPLC studies it would 
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be essential to supplement neuronal culture with all non-essential amino acids, from which the 
neurotransmitters could be synthesised (Wurtman, 1988).   
 
8.2.3 Hypoxic culture 
One of the main hurdles for using primary neurons, or neurons derived from progenitor lines 
in culture, is in overcoming their poor survival in culture, this should be enhanced following 
incorporation of GDNF and BDNF into culture; however, further alterations to differentiation 
may prove to be of additional benefit.  The bulk of the CNS is formed during the first trimester 
of embryonic development, prior to full vascularisation of the placenta and foetus (Gellén, 
1976; Hustin and Schaaps, 1987; O'rahilly and Müller, 1999a), as such, the nervous system 
develops mainly under a hypoxic environment, preventing damage by reactive oxygen species.  
Under laboratory differentiation, neurons are cultured in an ambient oxygen environment, 
with demonstrable susceptibility to damage by oxidative free radicals (Davis and Maher, 1994; 
Tan et al., 1998).  With this in mind, differentiation and extended culture of neurons under 
hypoxic conditions (1-2 % O2) should reduce the oxidative damage and thus enhance neuronal 
survival.  Preliminary studies have shown that the neuronal differentiation of mESCs is 
enhanced under hypoxic culture (Mondragon-Teran et al., 2009); however, this is yet to be 
translated into hESCs.   
In combination, the inhibition of mesodermal and endodermal commitment, supplementation 
of differentiation media with survival enhancing growth factors and hypoxic culture form the 
main focus of work continuing on from this project, with a view to enhancing neuronal yield 
for the treatment of neurodegenerative therapies. 
 
8.2.4 Electrical stimulation 
The neuronal phenotype generated during neurulation is largely dependent upon the 
developmental signalling from the cells and differentiation media around them.  A large 
number of neurons are formed during prenatal neurogenesis (O'rahilly and Müller, 1999b), 
with further neurogenesis and neuronal maturation occurring postnatally.  Therefore, it is 
likely that during neuronal maturation, early electrical impulses from pre-committed neurons 
are present.  In the same way that bone, muscle and tendons develop and regenerate in 
response to mechanical forces and stimuli around them to enhance their function (Benjamin 
and Hillen, 2003) it is possible that electrical stimulation of neurons throughout differentiation 
would improve their sensitivity and response to stimuli.  Indeed electrical stimulation of a 
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differentiating EB has demonstrably enhanced neuronal yields from mESCs but is yet to be 
demonstrated in hESCs (Yamada et al., 2007).   
Exposure to electrical impulses in culture could be achieved by differentiation a 
micro-electrode array (MEA) system.  Modern MEA’s comprise culture surface integrated with 
a number of platinum electrodes which are intended for recording electrical impulses across 
slices of excitable tissue; however, differentiation upon these arrays would enable regular 
burst of electrical stimulation across the culture at regular defined intervals.  In addition, these 
systems could record electrical activity and therefore enable continued monitoring of neuronal 
maturity throughout differentiation without disruption of the cells in culture.  Research into 
this hypothesis would provide a new area of focus for improved neuronal differentiation from 
pluripotent cells. 
 
8.3 Neuronal characterisation 
Despite clear differences in the numbers of neurons generated from the four different cell 
lines, the behaviour, morphology and functionality of the neuronal generated did not appear 
different according to live cell imaging and patch-clamping analysis.  Identification of the 
subclasses of neurons generated by each cell line would provide a better insight into the 
suitability of using these end stage cells for clinical or pharmaceutical applications.   
Immunostaining of neuronal populations using antibodies for dopaminergic (TH), serotonergic 
(SERT) and GABAergic (GABA) neurons were purchased for this study, but additional staining 
was restrict by the time and budget available within this project.  The presence of GABAergic 
neurons were identified amongst end stage neuronal populations; however, not all neurons in 
culture were GABAergic and without the incorporation of a positive control it was not possible 
to rule out the presence of TH and SERT neuronal populations.  Determination of neuronal 
subtype would ideally be repeated with optimised working antibodies for the aforementioned 
neuronal classes, in addition to screening for additional neuronal subclasses: glutamatergic, 
cholinergic, noradrenergic, glycinergic neurons, some of which have been demonstrably 
derived following ESC neuronal differentiation (Reyes et al., 2008; Michibata et al., 2009).  
 
8.4 Proteomics 
Data from within this study has correlated changes in gene expression to the success of 
neuronal differentiation; however, it is the proteins which are encoded by these genes which 
regulate a cell’s behaviour.  Interaction of different proteins within a cell can alter its 
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behaviour, thus regulation of differentiation, is controlled at a post-transcriptional level in 
addition to the level of gene expression.  The effect of differences between gene and protein 
expression were observed during his study by the up regulation of the OCT4 gene with no 
detection of the protein under immunofluorescence analysis, thus highlighting discrepancies in 
the assumed and true protein content of a cell. 
Proteomics enables the direct analysis of the proteins which are present within a cell (James, 
1997).   An understanding of the changes in protein expression can provide a valuable insight 
into essential components which direct neuronal differentiation, resulting in the visible change 
in phenotype.  In this way, proteomics analysis is able to identify the protein targets for 
recombinant substitution into differentiation media, for improvements to neuronal 
differentiation.   
In response to development of a reproducible protocol for differentiation, collaboration was 
set up for a comparative proteomic analysis of hESCs throughout neuronal differentiation (Dr. 
Jun Wheeler, and Dr. Iolanda Vendrell, Laboratory for Molecular structure, NIBSC).  This work 
aims to identify key target proteins which are up and down regulated upon successful 
neuronal differentiation to further enhance our understanding of the signalling required for 
successful neuronal differentiation.  
This work in currently ongoing; however, to date, proteins from the five differentiation time 
points of RH5 TrypLE have been analysed using 2D Gel electrophoresis.  A number of proteins 
which consistently showed up or down regulations between triplicate samples were identified 
by the intensity of staining.  These proteins will be isolated and identified using mass 
spectrophotometery, generating a range of candidate proteins which could be used for further 
enhancement of neuronal differentiation in vitro. 
 
8.5 Modifications to the Linkam live cell imaging facility 
Throughout this study, the Linkam LCI system was transformed from a basic short term facility 
without environmental control, to a high end environmentally controlled chamber which 
facilitated LCI over several days in culture, limited only by the requirement for media 
exchange.  Future modifications to the system are currently under development following 
feedback and data from within this study (as detailed below), generating a wide LCI product 
range, with a ‘mix and match’ style system to design a LCI imaging facility which covers the 
wide range of requirements for different research targets. 
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8.5.1 Media feed and flow rate 
The main limiting factor for long term LCI of mammalian cells is the need for regular media 
exchange, removing toxic build up and supplying the cells in culture with the necessary 
nutrients for survival.  The Wafergen system (Section 6.2.3) is currently the only LCI facility 
available which enables uninterrupted imaging during cell feeding.  However, culture of cells in 
this system demonstrated that evaporation of culture media and cell death was still a real 
problem.  In addition, the Wafergen system was not autoclavable and subsequent sterility of 
long term studies proved to be problematic (Personal communication Mr. P. 
Mondragon-Teran). 
The Linkam system is autoclavable and issues of evaporation have been considered and 
resolved in the design.  Using the stainless steel feed pipes in the current model, it would be 
possible to manually pump sterile media into and out of the dish.  However, this would cause 
movement and interruption to imaging which is not ideal.  Plans for modifications to the 
LinkSYS software for automated feeding are also in progress as an additional feature.   
 
8.5.2 Portability 
The ability to culture cells in a continuous environment and image will have huge advantages 
to understanding cell behaviour.  The Linkam system offers and affordable option for LCI in 
laboratories where the microscope cannot be dedicated solely to a single imaging experiment.  
The system can be easily moved on and off the microscope as required.  In addition, a battery 
power supply is currently under development to enable detachment from mains power and 
the gas supply, and transport under a controlled environment, providing an opportunity to 
move samples from building to building without exposure to suboptimal culture environment 
in transit.  This additional feature might also appeal to non-imaging based projects where live 
cell transport is necessary for experimentation such as functionality studies.  
 
8.5.3 Pressure control  
Stem cells cultured for therapeutic applications need to be cultured under in GMP grade 
facilities, which run under positive pressure (Healy et al., 2005).  It would be interesting to see 
what affect this pressure has on the growth and behaviour of cells and could be monitored in 
real time using the Linkam system with an incorporated pressure sensor.  Using the sealed 
inner chamber and a gas feed on valve control; it would be possible to modify the system to 
incorporate a pressure sensor to run experiments under different atmospheric pressures.  This 
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facility is not available on any marketed imaging system and would create an additional niche 
market for the Linkam imaging system.  Designs for such a modification are in discussion. 
 
8.5.4 Dynamic temperature control 
There are a number of design features of the Linkam stage which limit its use for monitoring 
cellular activity.  Expansion of the stages temperature range to 4 °C - 40 °C, would enable 
hypothermic and hyperthermic studies on cellular behaviour to be carried out.  However, this 
would require the presence of an active cooling circuit, which would increase the size of the 
system, reducing portability and also increase cost.   
 
8.5.5 Electrophysiology 
Incorporation of an MEA system into the stage, (Alpha MED Sciences Co., Ltd, Osaka, Japan) 
would combine electrophysiological studies with environmental control under live cell 
observation, creating a system which is not provided by any other manufacturer.  This would 
enable electrical stimulation throughout differentiation (Section 8.2.4) and would also 
facilitate electrophysiological recordings of developing neurons in culture.  The inner chamber 
would need to be enlarged to incorporate an MEA (50 mm x 50 mm square in addition to 
surrounding space for the connection leads), which would still sit neatly inside the overall 
outer chamber of the device.  However, is likely to alter the heating currents around the 
system which would need to be carefully mapped and may need further design modifications. 
 
8.5.6 Gas mixing 
The Linkam system was designed to run from pre-mixed gas supplies with an in built CO2 
sensor.  Development of system for additional monitoring and control of O2 is currently 
underway to enable hypoxic studies.  The refinement of the gas mixing feature (in prototype 2) 
would enable dynamic studies of oxygen tension to be carried out over long periods and is 
currently under investigation for sale as an additional feature to the system.  This additional 
feature will be incorporated into future investigations into the effect of hypoxic culture on 
neuronal differentiation in hESCs, and will be of particular interest when studying the effect of 
hypoxic culture on neuronal survival (Section 8.2.3). 
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9 Closing remarks 
The data from this study have highlighted clear differences in the responses of all pluripotent 
hESC lines to neuronal differentiation stimuli.  Inherent differences within the genetic 
programming of pluripotent populations have been identified demonstrating the requirement 
a detailed and informed cell line selection before undertaking lengthy differentiation studies at 
the risk of using cell lines with an alternative pre-determined cell fate.    
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neuronal cell substrates for use in a bioassay.
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Introduction
The ability to produce various neural cell types from pluripotent (stem) 
cells has been discussed in depth over recent years.  The application 
of these neural cells into cell based therapies and in bioassays for 
drug screening carries huge potential for the advancement of disease 
treatment.  One of the best established method of neuronal production 
uses retinoic acid induction of the human embryonal carcinoma 
(EC) cell line (NTERA2).  However, this method typically results in a 
heterogenous population of neural and non‑neural cells with varying 
levels of functionality.  Here we aim to highlight some of these issues 
using immunostaining, patch clamping and calcium imaging techniques.
Figure 1. Materials and methods of NTERA2 neural differentiation
Figure 2. Beta-III-tubulin staining (red) of NTERA2 neurons following 6 weeks ATRA exposure (left and 
middle).  Demonstrate proportion of neuronal cells in a given population (right).
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Figure 5. Patch clamping rig
Results
Physical constraints meant it was not possible to patch non‑neuronal, or cells •	
before 2 weeks of differentiation.  
Voltage‑gated channels were detected in < 50% cells beyond 2 weeks •	
The proportion of cells with functional voltage gated channels increased from •	
50 % at 2 weeks to 100 % at 6 weeks ATRA exposure.
Not all cells with voltage gated channels were able to generate APs.•	
100% primary neurons successfully patched demonstrated functional voltage •	
gated	channels	and	the	ability	to	fire	APs.	
A maximum of 19 cells could be patched on a single day. Low sample number •	
g difficulties	in	accurate	determination	cell	function	across	the	population.		
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Figure 6. Cumulative data from patched cells
Discussion
Cells with neuronal morphology and electrophysiological activity can 
be generated from the pluripotent cell line; NTERA2.  Techniques used 
here highlight the variability in the number of functional neurons from any 
given culture of pluripotent cells.  Patch‑clamping is a highly skilled and 
low	throughput	technique,	making	it	difficult	to	screen	of	large	numbers	
of cells.  Calcium imaging can be used as an alternative to monitor the 
flux	of	calcium	ions	across	large	numbers	of	cells,	in	response	to	various	
typical neurotransmitters, in a just a single run.  
Conclusion: Functional neurons can be generated from pluripotent (EC) 
cells.  However, numbers and function of the cells generated can vary 
enormously.  This work is currently being translated in human embryonic 
stem cell lines with an aim to increase overall yield of function end stage 
neurons.
Acknowledgements: We would like to thank the EPSRC, Linkam 
Scientific	and	NIBSC,	for	their	contributions	to	this	work,	without	which	it	
would not have taken place.
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Figure 3. Action potentials (AP) generated 2 weeks (top left), 5 weeks (top right), 
6 weeks (bottom left) of ATRA treatment.  Action potential from 1° neuron (bottom 
right).  Some cells generated a series of APs following manual depolarisation 
(seen here at 5 weeks and 1° neurons).
Figure 4.  Calcium imaging of NTERA2 neurons after 6 weeks ATRA.  Cells 
(left), Calcium reading (right).  Both cells responded of glutamate and to K+ 
depolarisation with an influx of calcium in the same pattern, but different levels 
of influx was observed.  Neither cell responded to ATP.  
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INTRODUCTION
As our knowledge of human embryonic stem cells increases, so 
do the applications of these cells for the treatment and screening 
of drugs for neurodegenerative disease such as Alzheimer’s and 
Parkinson’s disease.  Current methods for neurological drug 
screening utilise either primary neuronal cells, often from animal 
sources with associated supply and ethical considerations, or neural 
Neuronal differentiation in human  
embryonic stem cells
Gillett, M.L1., Bolsover, S3., Healy, L4., Stacey, G1,4., Mason, C2., Fleck, R.A1.
1  Cell Biology and Imaging.  The National Institute for Biological Standards and Control
2 Regenerative medicine, Department of Biochemical engineering, University College London.
3 Department of Physiology, University College London.
4  UK Stem cell Bank. The National Institute for Biological Standards and Control.
Neuronal differentiation of human embryonic stem cells.
MATERIALS AND METHODS
Over recent years, many research groups have published methods 
for neuronal differentiation of hES cells with varying levels of success. 
We set out to develop a method for obtaining such cells from the 
hES cell lines; HUES7 and Shef3.  Both lines were successfully dif-
ferentiated using the method detailed above, into cells of neuronal 
morphology which were shown to express neuronal markers; be-
ta-III-tubulin and 70kD neurofilament.  In addition, electrophysi-
ology studies of these cells using patch clamping demonstrated 
DISCUSSION
Patch clamping data demonstrated the cells ability to fire action 
potentials in response to depolarisation (E),  Action potentials were 
inhibited by exposure to TTX which blocks membrane sodium 
channels (F).  Recovery of action potentials was seen following a 
5minute wash step, demonstrating that the neuronal morphology 
corresponds to neuronal functionality in these cells.  
cell lines such as SHSY-5-Y cell lines which have proven to yield 
low and variable numbers of functional cells.  An effective cell based 
assay requires a reliable and reproducible supply of functional cells. 
We set out to develop and optimise a reliable method for neuronal 
differentiation of the human embryonic stem cell lines HUES7 and 
Shef3, for incorporation into a cell based drug screening assay.
Cells were stained for pluripotent stem cell markers, including 
SSEA4 (A).  Nestin was shown to be expressed in neural precursor 
cells (B).  End stage  neuronal cells were stained for neuronal 
markers: neurofilament (C) and beta-III-tubulin (D) to confirm 
neuronal morphology.
RESULTS
that the derived neurons were able to generate action potentials, 
upon manual depolarisation, which were inhibited by TTX.  Further 
characterisation of the resulting neurons will be necessary for use 
in specific applications, however,  initial results suggest that this 
method of neuronal differentiation from hES cells may provide a 
suitable alternative cell source to primary cells/ less optimal cell lines 
for use as functional neuronal cells in drug screening bioassays.
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Human embryonic stem cells (hESCs) are capable of developing into any
cell type within the human body and as such carry huge potential for
the understanding and treatment of human disease.
Neurodegenerative diseases such as Parkinson’s and Alzheimer’s are
just two of the potential targets for hESCs therapy. In order to develop
a successful therapy, either cell-or drug-based, it is necessary to
produce large numbers of the desired cell type which match both the
physical and behavioural properties of the damaged neurons. Many of
the current studies into hESC – derived neuronal differentiation focus
on the morphology and physical properties of the cells, rather than
their functionality i.e. whether the cells are able to generate the
electrical impulse of a primary neuron. This project has focused on the
development of a robust protocol for the differentiation of hESC lines
HUES7, Shef3 and RH5 to produce neurons which display both the
morphological and electrophysiological characteristics of a neuron.
Studies into changes in gene and protein expression throughout this
differentiation process were carried out in addition to neuronal
functionality studies using calcium imaging and patch clamping
techniques, thus demonstrating successful in vitro differentiation of
functional neurons from hESCs.
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Figure 4. Calcium imaging. Neurons derived from hESCs were incubated with a fluorescent
calcium indicator Fura2 (A). Exposure to 60mM Potassium stimulated opening of membrane
calcium channels. Calcium waves continued to be seen following washing with Hanks buffered
saline solution suggesting cells are continuing to respond to signals from each other. Each of the
coloured spikes (B) is the calcium response from a different cell shown in image A.
Figure 1. Undifferentiated human embryonic stem cell
colony cultured in knock-out hES medium (express markers
of pluripotency (SSEA4 – green). Fragments are cut from
the undifferentiated colony and cultured in suspension in a
neural induction media supplemented with bFGF for 5 days.
Floating fragments are transferred to a poly-ornithine/laminin
coated substrate after 10 days in suspension culture.
Outgrowth of neurons can be seen by day 11. Cells are
cultured on for a further 18 days in Neurobasal media.
Outgrowth of neurons Cells treated with Trypsin and
replated in the presence of neurotrophins for functionality
studies. Matured neurons express Beta-III-tubulin (red) and
can be maintained in culture for many weeks.
Day 1 Day 5 Day11 Day 28
Rosette formation occurs within the floating fragments which
are transferred into a Neurobasal media supplemented with
neurotrophins but removing bFGF from culture for a further 5
days.
Throughout this project, an optimised protocol for neuronal
differentiation of hESCs has been developed. This method has shown it
is possible to produce cells with neuronal morphology from pluripotent
human embryonic stem cells. Under immuno-fluorescence the derived
neurons can be seen to express 70kDa neurofilament (not shown) and
beta-III-tubulin both key neuronal markers. Prior to differentiation high
levels of pluripotency markers Oct4 and Nanog were expressed which
dramatically reduce during differentiation. Genes associated with neural
stem cells; Nestin, and matured neurons; Synaptophysin where shown to
increase by 7-fold and 12-fold respectively over 28 days of
differentiation. Most importantly, the end stage neurons were shown to
express functional calcium channels which open in response to
Potassium depolarisation. Patch-clamping studies into these cells after 4
weeks of differentiation showed the ability to fire true sodium action
potentials in response to manual depolarisation. These were reversibly
inhibited by the sodium channel blocker TTX. Whilst optimisation of
differentiation is still necessary to increase the cellular yield, the outlook
for production of reliably functional neurons from hESCs for use in drug
screening and successful transplantation therapies is increasingly
positive.
We would like to thank the EPSRC and Linkam Scientific for funding this
project.
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Figure 3. Patch clamping data from Shef3 derived neurons. Individual
cells were patch clamped with a glass pipette (A). Cells were manually
depolarised resulting in a series of action potentials fired (B). Following
2 minutes incubation with TTX action potentials were inhibited (C). Cells
washed in buffer for 5 minutes following TTX showed recovery in action
potential generation (D).
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Figure 2. Gene expression patterns throughout differentiation. RH5 Cell samples were taken on
day 0, 4, 10, 18 and 28 of differentiation. RNA was extracted following the Ambion Rnaqueous
protocol, DNase treated and cDNA synthesised before running on an ABI human pluripotency gene
expression low density array card to analyse changes in gene expression throughout differentiation.
All samples are presented relative to the Day0 expression levels, standardised to Raf1 housekeeping
gene which remained constant throughout the process. Expression of pluripotency genes: Nanog
(A) and Oct4 (B) reduce over the 28day protocol. Expression of Nestin (C), found in neural stem cells
and synaptophysin, found in mature neurons (D) were shown to increase 6.8-fold and 12.2-fold
respectively with time.
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